GET /api/compounds/list?format=api&page=2
HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 1453,
    "next": "https://mitotox.org/api/compounds/list?format=api&page=3",
    "previous": "https://mitotox.org/api/compounds/list?format=api",
    "results": [
        {
            "compound_ID": "D0101",
            "name": "Pramocaine",
            "synonyms": "pramoxine; Pramocaine; Proxazocain; pramocainum; Tronopthane; Tronothane; 140-65-8; 4-[3-(4-Butoxyphenoxy)propyl]morpholine; Pramocaine [INN:BAN]; Pramocainum [INN-Latin]; p-Butoxyphenyl gamma-morpholinopropyl ether; Pramocaina [INN-Spanish]; gamma-Morpholinopropyl 4-n-butoxyphenyl ether; CHEBI:8357; 4-(3-(p-Butoxyphenoxy)propyl)morpholine; UNII-068X84E056; Morpholine, 4-(3-(p-butoxyphenoxy)propyl)-; EINECS 205-425-7; BRN 0239059; 068X84E056; Morpholine, 4-[3-(4-butoxyphenoxy)propyl]-; Pramocaina; 4-(3-(4-butoxyphenoxy)propyl)morpholine; NCGC00016529-01; CAS-637-58-1; Pramocaine (INN); PX9; Spectrum_001380; Prestwick0_000716; Prestwick1_000716; Prestwick2_000716; Prestwick3_000716; Spectrum2_000030; Spectrum3_000925; Spectrum4_001024; Spectrum5_001511; CHEMBL1198; SCHEMBL26020; BSPBio_000931; KBioGR_001547; KBioSS_001860; 4-27-00-00127 (Beilstein Handbook Reference); DivK1c_000882; SPBio_000099; SPBio_002852; BPBio1_001025; DTXSID8040692; CTK6E3413; KBio1_000882; KBio2_001860; KBio2_004428; KBio2_006996; KBio3_001930; DQKXQSGTHWVTAD-UHFFFAOYSA-N; NINDS_000882; BDBM50225493; ZINC19594594; DB09345; MCULE-5337294231; IDI1_000882; NCGC00016529-02; NCGC00016529-03; NCGC00016529-04; LS-92486; SBI-0051653.P002; 4-[3-(4-Butoxyphenoxy)propyl]morpholine #; AB00053605; p-Butoxyphenyl .gamma.-morpholinopropyl ether; .gamma.-Morpholinopropyl 4-n-butoxyphenyl ether; C07892; D08407; AB00053605_13; AB00053605_14; Q1240076; BRD-K46523383-003-04-7",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C17H27NO3",
            "molecular_weight": "293.4",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "There is minimal absorption after topical administration and it is not given orally.",
            "cid": "4886",
            "classification": "D; C",
            "indications": "",
            "side_effects": "",
            "atc_codes": "D04AB07; C05AD07",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0102",
            "name": "Prilocaine",
            "synonyms": "prilocaine; 721-50-6; Propitocaine; Citanest; Prilocainum; Prilocaina; Astra 1515; Propanamide, N-(2-methylphenyl)-2-(propylamino)-; N-(2-Methylphenyl)-2-(propylamino)propanamide; o-Methyl-2-propylaminopropionanilide; 2-(Propylamino)-o-propionotoluidide; Astra 1512; Prilocainum [INN-Latin]; Prilocaina [INN-Spanish]; NSC 40027; o-Propionotoluidide, 2-(propylamino)-; o-Methyl-alpha-propylaminopropionanilide; 2-Methyl-alpha-propylaminopropionanilide; 2-(Propylamino)-N-(o-tolyl)propanamide; alpha-n-Propylamino-2-methylpropionanilide; CHEBI:8404; HSDB 3386; o-Propionotoluidide, 2-propylamino-; EINECS 211-957-0; BRN 2108498; 2-Methyl-.alpha.-propylaminopropionanilide; o-Propionotuluidide, 2-propylamino-; Prilocaine, 98%; prilocaine base; Prilocaine [USAN]; UNII-046O35D44R; Propitocaine (JAN); Prilocaine (USP/INN); Prilotekal; Prilocain; Prilocaine/; Prilocaine [USAN:USP:INN:BAN]; N-(2-methylphenyl)-N2-propylalaninamide; Spectrum_001649; L 67; 046O35D44R; N-(2-methylphenyl)-N(2)-propylalaninamide; Prestwick0_000199; Prestwick1_000199; Prestwick2_000199; Prestwick3_000199; Spectrum2_001549; Spectrum3_001052; Spectrum4_001192; Spectrum5_001175; (.+/-.)-Prilocaine; N-(2-methylphenyl)-2-propylamino-propanamide; CHEMBL1194; Lopac0_001005; SCHEMBL25467; BSPBio_000157; BSPBio_002604; KBioGR_001883; KBioSS_002129; ARONIS27056; DivK1c_000846; SPBio_001398; SPBio_002078; BPBio1_000173; EBD798; GTPL7276; DTXSID7031955; CTK2H7603; KBio1_000846; KBio2_002129; KBio2_004697; KBio2_007265; KBio3_001824; KS-00000XMI; MVFGUOIZUNYYSO-UHFFFAOYSA-N; NINDS_000846; HMS3604H09; HMS3651M13; ACT04759; HY-B0137; KS-000048JX; NSC40027; ABP000640; BDBM50225477; NSC-40027; s1619; STL257086; 2-(propylamino)-N-o-tolylpropanamide; AKOS015889404; AC-2100; CCG-205085; CS-1929; DB00750; LS-2304; MCULE-7176365958; NE41881; IDI1_000846; NCGC00015860-02; NCGC00015860-03; NCGC00162312-01; AS-14851; o-Methyl-.alpha.-propylaminopropionanilide; SC-26688; N1-(2-methylphenyl)-N2-propylalaninamide; SBI-0050978.P003; AB2000166; DB-055611; N-(2-methylphenyl)-N~2~-propylalaninamide; 4CH-023339; AB00053665; FT-0603506; FT-0660568; SW196783-3; .alpha.-n-Propyl-amino-2-methylpropionanilide; 86P818; C07531; D00553; AB00053665-12; AB00053665_13; AB00053665_14; A837435; N-(2-Methylphenyl)-2-(propylamino)propanamide #; Q413598; N-(2-methylphenyl)-2-(propylamino)propanimidic acid; Propranamide, N-(2-methylphenyl)-2-(propylamino)-; Q-100809; (RS)-N-(2-Methylphenyl)-2-(propylamino)propanamide; BRD-A53952395-003-05-3; BRD-A53952395-003-15-2; 721-50-6,1786-81-8(HCl); Propanamide, N-(2-methylphenyl)-2-(propylamino)- (9CI)",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C13H20N2O",
            "molecular_weight": "220.31",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "Prilocaine is metabolized in both the liver and the kidney and excreted via the kidney.",
            "protein_binding": "0.98",
            "half_life": "",
            "absorption": "",
            "cid": "4906",
            "classification": "N",
            "indications": "Agitation; Cardiac arrest; Cardiovascular insufficiency; Convulsion; Foetal acidosis; Ischaemia; Methaemoglobinaemia",
            "side_effects": "",
            "atc_codes": "N01BB04; N01BB54",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0103",
            "name": "Procaine",
            "synonyms": "procaine; 59-46-1; Vitamin H3; Novocaine; Spinocaine; Duracaine; Procain; Nissocaine; 2-(Diethylamino)ethyl 4-aminobenzoate; Procaina; Procainum; Novocain; Procaine, base; 2-Diethylaminoethyl p-aminobenzoate; Diethylaminoethyl p-aminobenzoate; Norocaine; Benzoic acid, 4-amino-, 2-(diethylamino)ethyl ester; 2-Diethylaminoethyl 4-aminobenzoate; p-Aminobenzoyldiethylaminoethanol; Factor H3; p-Aminobenzoic acid 2-diethylaminoethyl ester; Stoff H3; Procaine [INN:BAN]; Procainum [INN-Latin]; Procaina [INN-Spanish]; 4-Aminobenzoic acid diethylaminoethyl ester; Benzoic acid, p-amino-, 2-(diethylamino)ethyl ester; beta-Diethylaminoethyl 4-aminobenzoate; NSC 169497; CHEBI:8430; beta-(Diethylamino)ethyl 4-aminobenzoate; beta-(Diethylamino)ethyl p-aminobenzoate; UNII-4Z8Y51M438; HSDB 3388; 4-Aminobenzoic acid 2-diethylaminoethyl ester; 4-Aminobenzoesaeure-beta-diethylaminoethylester; EINECS 200-426-9; 2-Diethylaminoethylester kyseliny p-aminobenzoove; 2-(Diethylamino)ethyl p-aminobenzoate; BRN 0913480; 2-Diethylaminoethylester kyseliny p-aminobenzoove [Czech]; Gerovital; 4-aminobenzoic acid 2-(diethylamino)ethyl ester; MFDFERRIHVXMIY-UHFFFAOYSA-N; SP-01; NSC169497; 4Z8Y51M438; AK-50386; Anuject; Gerokit; Jenacain; Jenacaine; .beta.-(Diethylamino)ethyl p-aminobenzoate; 4-Amino-benzoic acid 2-diethylamino-ethyl ester; Gerovital H-3; MLS001304095; Anticort (TM); Procaine (INN); 2-(Diethylamino)ethyl-4-aminobenzoate; CAS-51-05-8; NCGC00015864-02; SMR000718771; Solution of novocain (TN); SP01A; novocaine;; SP-01A; SP01; 2-(diethylamino)ethyl 4-aminobenzoate;hydrochloride; aminocaine;anadolor; Neocaine (Salt/Mix); Novocain (Salt/Mix); Allocaine (Salt/Mix); Novocaine (Salt/Mix); Sevicaine (Salt/Mix); Spectrum_000838; Aminocaine (Salt/Mix); Scurocaine (Salt/Mix); Neotonocaine (Salt/Mix); Prestwick0_000041; Prestwick1_000041; Prestwick2_000041; Prestwick3_000041; Spectrum2_001296; Spectrum3_000556; Spectrum4_000488; Spectrum5_001186; Lopac-P-9879; CHEMBL569; Epitope ID:115010; Gerovital H3 (Salt/Mix); cid_5795; SCHEMBL3524; SAMPL3, G2; Lopac0_000966; BSPBio_000161; BSPBio_002231; KBioGR_000975; KBioSS_001318; 4-14-00-01138 (Beilstein Handbook Reference); ARONIS24492; DivK1c_000120; SPBio_001331; SPBio_002082; WLN: ZR DVO2N2&2; BPBio1_000179; GTPL4291; DTXSID7045021; BDBM64452; CTK6E8435; KBio1_000120; KBio2_001318; KBio2_003886; KBio2_006454; KBio3_001731; BBC/658; NINDS_000120; EBD36851; HY-B0546; KS-00000GZ6; ZINC1530757; ZX-AS004859; ZX-AT008592; BBL005106; HTS001398; s4668; SBB066226; STK177303; AKOS000115407; 2-(diethylamino)ethyl 4-azanylbenzoate; API0007241; CCG-205046; CS-2647; DB00721; DS-1216; MCULE-8861116126; NSC-169497; IDI1_000120; .beta.-Diethylaminoethyl 4-aminobenzoate; NCGC00015864-01; NCGC00015864-03; NCGC00015864-04; NCGC00162298-01; BR-50386; LS-35778; SC-54112; ST024758; SBI-0050939.P004; .beta.-(Diethylamino)ethyl 4-aminobenzoate; AB0031355; AX8149095; TR-018212; TR-020622; 2-(N,N-diethylamino)ethyl 4-amino-benzoate; AB00053531; FT-0654843; P1961; ST24031565; X4422; EN300-33930; 4-amino-benzoic acid2-diethylamino-ethyl ester; A16131; A19427; C07375; D08422; M-7441; 4-Amino-benzoic acid-beta-diethylaminoethylester; AB00053531-09; AB00053531_11; AB00053531_12; p-Aminobenzoic acid, 2-(diethylamino)ethyl ester; A832329; AE-641/00560024; Benzoic acid,4-amino-,2-(diethylamino)ethyl ester; Q423741; 2-(diethylamino)ethyl 4-azanylbenzoate;hydrochloride; BRD-K24616672-003-05-2; BRD-K24616672-003-10-2; 4-aminobenzoic acid 2-(diethylamino)ethyl ester;hydrochloride; BENZOIC ACID,4-AMINO,2-DIETHYLAMINOETHYL ESTER PROCAIN BASE; InChI=1/C13H20N2O2/c1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C13H20N2O2",
            "molecular_weight": "236.31",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "With normal kidney function, the drug is excreted rapidly by tubular excretion.",
            "protein_binding": "",
            "half_life": "7.7 minutes",
            "absorption": "",
            "cid": "4914",
            "classification": "S; N; C",
            "indications": "",
            "side_effects": "",
            "atc_codes": "N01BA02; C05AD05; N01BA52; S01HA05",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0104",
            "name": "Propofol",
            "synonyms": "propofol; 2,6-DIISOPROPYLPHENOL; 2078-54-8; Diprivan; Disoprofol; Disoprivan; Diisopropylphenol; Fresofol; Ampofol; 2,6-Bis(1-methylethyl)phenol; Propofolum; Rapinovet; Phenol, 2,6-bis(1-methylethyl)-; Recofol; Ivofol; Propofol-Lipuro; Pofol; ICI 35868; 2,6-di(propan-2-yl)phenol; Propofolum [Latin]; Diprifusor; Diprofol; Propovan; Phenol, 2,6-diisopropyl-; 2,6-Diisopropyl phenol; Diprivan 10; Diprivan Injectable emulsion; 2,6-bis(propan-2-yl)phenol; UNII-YI7VU623SF; NSC 5105; ICI-35868; CCRIS 9000; HSDB 7123; C12H18O; EINECS 218-206-6; 2,6-bis(Isopropyl)phenol; CHEMBL526; BRN 1866484; YI7VU623SF; AI3-26295; CHEBI:44915; NSC5105; OLBCVFGFOZPWHH-UHFFFAOYSA-N; NCGC00015389-08; Aquafol; CAS-2078-54-8; DSSTox_CID_3523; DSSTox_RID_77063; DSSTox_GSID_23523; 2,6 Diisopropylphenol; Dipravan; Propoven; Aquafo; Propofol IDD-D; Diprivan (TN); Propofol [USAN:INN:BAN]; SMR000059151; 2, 6-Diisopropylphenol; SR-01000075468; Propofol (JAN/USAN/INN); DDS-04F; ghl.PD_Mitscher_leg0.558; Propofol [USAN:USP:INN:BAN]; Propofol (Diprivan); ICI 35,868; ICI-35,868; ZD-0859; Phenol,6-diisopropyl-; 2,6-diisopropyl-phenol; ACMC-1CPLW; Prestwick0_000931; Prestwick1_000931; Prestwick2_000931; Prestwick3_000931; 2,6-di isopropyl phenol; Biomol-NT_000248; Lopac-D126608; Diisopropylphenol (Related); 2,6-bis(methylethyl)phenol; Lopac0_000437; SCHEMBL36245; BSPBio_000862; 4-06-00-03435 (Beilstein Handbook Reference); KSC490K5P; MLS001066348; MLS001335999; MLS002454360; BIDD:GT0436; SPECTRUM1505022; SPBio_003031; 2,6-Diisopropylphenol, 97%; BPBio1_000950; BPBio1_000969; GTPL5464; Phenol,6-bis(1-methylethyl)-; DTXSID6023523; CTK3J0557; Propofol 1.0 mg/ml in Methanol; 2,6-Diisopropylphenol, >=97%; 3f33; 3p50; HMS1570L04; HMS2089O21; HMS2094E17; HMS2097L04; HMS2231E16; HMS3259E03; HMS3261G16; HMS3369I16; HMS3714L04; Pharmakon1600-01505022; ZINC968303; BCP02920; KS-00000MQ0; NSC-5105; Tox21_110134; Tox21_201371; Tox21_303225; Tox21_500437; ANW-24224; BDBM50058046; CP0141; LS-996; MFCD00008885; NSC758909; Phenol, 2, 6-bis(1-methylethyl)-; AKOS009159417; Tox21_110134_1; AC-2038; AM90311; CCG-204529; CS-W020057; DB00818; LP00437; MCULE-1903292305; NC00449; NSC-758909; RTR-009757; TRA0038441; VZ22957; 2,6-DIISOPROPYLPHENOL; PROPOFOL; MLS-0318084; NCGC00015389-01; NCGC00015389-02; NCGC00015389-03; NCGC00015389-04; NCGC00015389-05; NCGC00015389-06; NCGC00015389-07; NCGC00015389-09; NCGC00015389-10; NCGC00015389-11; NCGC00015389-14; NCGC00091538-01; NCGC00091538-02; NCGC00091538-03; NCGC00091538-04; NCGC00091538-05; NCGC00091538-06; NCGC00257228-01; NCGC00260670-01; NCGC00261122-01; AS-13299; CPD000059151; H835; SAM002264610; SC-18796; SY013479; 2,6-Diisopropylphenol, analytical standard; BCP0726000298; MLS-0318084.P017; ST2415947; TR-009757; AB00513968; D0617; EU-0100437; FT-0610672; ST50405911; MFCD00008885 (98%); C07523; D00549; AB00513968-07; AB00513968_08; A814898; D126608; Q422740; Q-201631; SR-01000075468-1; SR-01000075468-4; SR-01000075468-6; BRD-K82255054-001-03-5; BRD-K82255054-001-08-4; Propofol, British Pharmacopoeia (BP) Reference Standard; Propofol, European Pharmacopoeia (EP) Reference Standard; Z1245735300; Propofol, United States Pharmacopeia (USP) Reference Standard; Propofol, Pharmaceutical Secondary Standard; Certified Reference Material; InChI=1/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H; Propofol for peak identification, European Pharmacopoeia (EP) Reference Standard; Propofol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material",
            "trade_name": "Diprivan",
            "abbrev_name": "",
            "description": "General anesthetics",
            "molecular_formula": "C12H18O",
            "molecular_weight": "178.27",
            "state": "liquid",
            "clearance": "* 23 - 50 mL/kg/min\n* 1.6 - 3.4 L/min [70 Kg adults]",
            "volume_of_distribution": "* 60 L/kg [healthy adults]",
            "route_of_elimination": "It is chiefly eliminated by hepatic conjugation to inactive metabolites which are excreted by the kidney.",
            "protein_binding": "95 to 99%, primarily to serum albumin and hemoglobin",
            "half_life": "Initial distribution phase t<sub>1/2&alpha;</sub>=1.8-9.5 minutes. Second redistirubtion phase t<sub>1/2&beta;</sub>=21-70 minutes. Terminal elimination phase t<sub>1/2&gamma;</sub>=1.5-31 hours.",
            "absorption": "Rapid - time to onset of unconsciousness is 15-30 seconds, due to rapid distribution from plasma to the CNS. Distribution is so rapid that peak plasma concentrations cannot be readily measured. Duration of action is 5-10 minutes.",
            "cid": "4943",
            "classification": "N",
            "indications": "",
            "side_effects": "",
            "atc_codes": "N01AX10",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [
                "F010503",
                "F020601",
                "F0504"
            ],
            "references": [
                "RC03640",
                "RC03641",
                "RC03822"
            ]
        },
        {
            "compound_ID": "D0105",
            "name": "Quinisocaine",
            "synonyms": "Dimethisoquin; Quinisocaine; Isochinol; Pruralgan; Quinisocain; Quinoleine; Chinisocain; Histaderme; Prulantex; Pruralgin; Chinisocainum; 86-80-6; Quinisocaine [INN:BAN]; Quinisocainum [INN-Latin]; Quinisocaina [INN-Spanish]; UNII-772EN3BH6I; 3-Butyl-1-(2-dimethylaminoethoxy)isoquinoline; EINECS 201-700-0; BRN 0018179; 772EN3BH6I; ISOQUINOLINE, 3-BUTYL-1-(2-(DIMETHYLAMINO)ETHOXY)-; 1-(2-Dimethylaminoethoxy)-3-butylisochinolin; XNMYNYSCEJBRPZ-UHFFFAOYSA-N; 3-Butyl-1-[2-(dimethylamino)ethoxy]isoquinoline; Ethanamine, 2-((3-butyl-1-isoquinolinyl)oxy)-N,N-dimethyl-; Ethanamine, 2-[(3-butyl-1-isoquinolinyl)oxy]-N,N-dimethyl-; [2-(3-butylisoquinolyloxy)ethyl]dimethylamine; Quinisocaina; Quinisocainum; NCGC00016618-01; CAS-2773-92-4; Isoquinoline, 3-butyl-1-[2-(dimethylamino)ethoxy]-; quinolein; Kinisokain; N-{2-[(3-butyl-1-isoquinolinyl)oxy]ethyl}-N,N-dimethylamine; Quinisocaine (INN); Prestwick0_000630; Prestwick1_000630; Prestwick2_000630; Prestwick3_000630; SCHEMBL8191; BSPBio_000600; 5-21-03-00414 (Beilstein Handbook Reference); SPBio_002819; BPBio1_000660; CHEMBL127643; DTXSID8048525; CHEBI:93295; 2-[(3-Butyl-1-isoquinolinyl)oxy]-N,N-dimethylethanamine; NSC39695; ZINC1671507; BDBM50225699; NSC-39695; AKOS022143560; MCULE-8714132699; WLN: T66 CNJ BO2N1&1 D4; NCGC00016618-02; LS-85370; ST076784; 2-(Dimethylamino)ethoxy-3-butyl-isoquinoline; AB00514685; D08462; 3-Butyl-1-[2-(dimethylamino)ethyl]isoquinoline; AO-080/43342670; Isoquinoline, 3-butyl-1-[2-(dimethylamino)ethyl]-; Q1478199; 1-(.beta.-Dimethylaminoethoxy)-3-N-butylisoquinoline; BRD-K73391359-003-03-7; 2-[(3-Butyl-1-isoquinolinyl)oxy]-N,N-dimethylethanamine #; 2-[(3-Butylisoquinolin-1-yl)oxy]-N,N-dimethylethan-1-amine",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C17H24N2O",
            "molecular_weight": "272.4",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "6857",
            "classification": "D",
            "indications": "",
            "side_effects": "",
            "atc_codes": "D04AB05",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [
                "F02010202",
                "F02040101"
            ],
            "references": [
                "RC00536",
                "RC00537"
            ]
        },
        {
            "compound_ID": "D0106",
            "name": "Risperidone",
            "synonyms": "risperidone; 106266-06-2; Risperidal; Risperdal; Rispolept; Risperdal Consta; Risperin; Rispolin; Sequinan; Risperidona; Risperidonum; Apexidone; Risperidal M-Tab; Risperidonum [Latin]; Risperidona [Spanish]; Risperdal M-Tab; Belivon; Psychodal; Spiron; R 64 766; C23H27FN4O2; UNII-L6UH7ZF8HC; R 64766; R-64766; R 64,766; RAPZEAPATHNIPO-UHFFFAOYSA-N; CHEMBL85; L6UH7ZF8HC; 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; BRN 4891881; CHEBI:8871; R-64-766; Risperidone, 99%; 3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one; 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one; NCGC00015883-05; CAS-106266-06-2; DSSTox_CID_25193; DSSTox_RID_80740; DSSTox_GSID_45193; 3-[2-[4-(6-fluoranyl-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-FLUORO-BENZO[D]ISOXAZOL-3-YL)-PIPERIDIN-1-YL]-ETHYL}-2-METHYL-6,7,8,9-TETRAHYDRO-PYRIDO[1,2-A]PYRIMIDIN-4-ONE; Zophrenal; Risperdal (TN); 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino]ethyl}-6,7,8,9-tetrahydro-2-methylpyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidin-4-one; 4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-; 4H-Pyrido(1,2-a)pyrimidin-4-one, 6,7,8,9-tetrahydro-3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-2-methyl-; 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-; SMR000466323; Risperidone (RIS); Risperidone, placebo; Risperidone [USAN:BAN:INN]; SR-01000075399; Relday; Rispen; Risperidone-ISM; HSDB 7580; Risperidone???; R64766; 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl}-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; Risperidone [USAN:USP:INN:BAN]; MFCD00274576; KS-1106; Risperidone(Risperdal); Risperidone (Risperdal); Lopac-R-118; Prestwick0_001029; Prestwick1_001029; R-118; GTPL96; Risperidone(R 64 766); SCHEMBL27911; MLS000759429; MLS001165758; MLS001424081; US8802672, Risperidone; BIDD:GT0262; R 62 766; SPBio_003078; PYR332; DTXSID8045193; Risperidone (JP17/USAN/INN); HMS1571M19; HMS2051H07; HMS2089C22; HMS2098M19; HMS2233O11; HMS3373M18; HMS3393H07; HMS3657G13; HMS3715M19; Pharmakon1600-01506038; ZINC538312; ACT04270; BCP08161; Risperidone 1.0 mg/ml in Methanol; Tox21_110253; ANW-42874; BDBM50001885; BG0309; CR0023; NP-202; NSC759895; s1615; STK646402; AKOS005577302; Tox21_110253_1; AC-1306; API0004081; CCG-100930; CS-1619; DB00734; MCULE-4027175053; NC00180; NSC-759895; PB26023; Risperidone, >=98% (HPLC), powder; RTR-001241; NCGC00015883-01; NCGC00015883-02; NCGC00015883-03; NCGC00015883-04; NCGC00015883-06; NCGC00015883-07; NCGC00015883-08; NCGC00015883-11; NCGC00094352-01; NCGC00094352-02; NCGC00094352-03; NCGC00179257-01; 3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one; 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one; 4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6 ,7,8,9-tetrahydro-2-methyl-; AK172045; CC-34268; CPD000466323; HY-11018; SAM001246595; SC-16313; AB0004623; LS-134196; TR-001241; AB00514010; EU-0101074; FT-0631037; R0087; SW197348-4; KS-00000760; 4767-EP2269990A1; 4767-EP2272537A2; 4767-EP2272841A1; 4767-EP2275420A1; 4767-EP2275423A1; 4767-EP2280008A2; 4767-EP2280010A2; 4767-EP2298731A1; 4767-EP2298776A1; 4767-EP2301936A1; 4767-EP2308867A2; 4767-EP2308870A2; 4767-EP2308875A1; 4767-EP2316836A1; 66R062; D00426; J10290; Q-4040; AB00514010-09; AB00514010-11; AB00514010-12; AB00514010_13; AB00514010_14; A801409; C-21900; L000510; Q412443; J-001555; SR-01000075399-2; SR-01000075399-8; BRD-K53857191-001-04-5; BRD-K53857191-001-10-2; Z1522566617; Risperidone, British Pharmacopoeia (BP) Reference Standard; Risperidone, European Pharmacopoeia (EP) Reference Standard; Risperidone, United States Pharmacopeia (USP) Reference Standard; Risperidone, Pharmaceutical Secondary Standard; Certified Reference Material; 3-Ethyl-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one(Risperidone Impurity); Risperidone for system suitability, European Pharmacopoeia (EP) Reference Standard; Risperidone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; (risperidone)3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one; 1026102-43-1; 2-(2-(4-(benzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-7,8,9,9a-tetrahydro-1H-pyrido[1,2-a]pyrimidin-4(6H)-one; 2-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-6,7,8,8a-tetrahydro-5H-naphthalen-1-one; 3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one; 3-[2-[4(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; 3-[2-[4(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl4H-pyrido[1,2-a]pyrimidin-4-one; 3-[2-[4-(6 fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; 3-[2-[4-(6-fluoro- 1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl4H-pyrido[1,2-a]pyrimidin-4-one; 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidiny]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-A]pyrimidin-4-one; 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-me thyl-4H-pyrido[1,2-a]pyrimidin-4-one; 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one; 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[2,1-b]pyrimidin-4-one; 3-{2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-ethyl}- 6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl}-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimid-in-4-one; 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (Resperidone); 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (risperidone); 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one(risperidone); 3-{2-[4-(6-fluorobenzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benz-isoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-; 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-methyl-1,3-dihydro-indol-2-one(Norastemizole)",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C23H27FN4O2",
            "molecular_weight": "410.5",
            "state": "solid",
            "clearance": "Risperidone is cleared by the kidneys. Clearance is decreased in the elderly and those with renal creatinine clearance of 15 mL/min to 59 mL/min, which decreases clearance by 60% [L1214].",
            "volume_of_distribution": "1 to 2 L/kg",
            "route_of_elimination": "Risperidone is extensively metabolized in the liver. In healthy elderly subjects, renal clearance of both risperidone and 9-hydroxyrisperidone was decreased, and elimination half-lives are prolonged compared to young healthy subjects [A31772, L1214].",
            "protein_binding": "Risperidone, ~88% bound in human plasma; 9-hydroxyrisperidone, ~77% bound in human plasma [A31772].",
            "half_life": "3 hours in extensive metabolizers [A31772]\nUp to 20 hours in poor metabolizers [A31772]\n",
            "absorption": "Well absorbed. The absolute oral bioavailability of risperidone is 70% (CV=25%). The relative oral bioavailability of risperidone from a tablet is 94% (CV=10%) when compared to a solution.",
            "cid": "5073",
            "classification": "N",
            "indications": "Abnormal behaviour; Anxiety; Autism; Bipolar disorder; Breast cancer; Carcinogenicity; Delusion; Dementia; Dementia Alzheimer's type; Dementia with Lewy bodies; Diabetes mellitus; Distractibility; Hallucination; Hostility; Irritability; Liver disorder; Mental disability; Mental disorder; Mental retardation; Nephropathy; Parkinson's disease; Parkinsonism; Pituitary tumour; Poverty of speech; Pressure of speech; Psychotic disorder; Renal failure; Renal impairment; Schizoaffective disorder; Social avoidant behaviour; Suspiciousness; Tachyphrenia",
            "side_effects": "Ataxia (0.01); Viral infection (0.02); Abdominal discomfort; Abdominal pain; Abdominal pain upper; Acne; Aggression; Agitation; Akathisia; Alanine aminotransferase increased; Altered state of consciousness; Amenorrhoea; Anaemia; Angiopathy; Anxiety; Apathy; Arrhythmia; Arthralgia; Aspartate aminotransferase increased; Asthenia; Automatism; Back pain; Balance disorder; Blood creatine phosphokinase increased; Blood prolactin increased; Body temperature increased; Bone pain; Bradykinesia; Breast disorder; Cardiac disorder; Cardiovascular disorder; Cellulitis; Cerebrovascular accident; Chest discomfort; Chest pain; Confusional state; Conjunctivitis; Connective tissue disorder; Constipation; Cough; Dandruff; Decreased appetite; Depressed level of consciousness; Dermatitis; Diarrhoea; Disturbance in attention; Disturbance in sexual arousal; Dizziness; Dizziness postural; Drooling; Dry mouth; Dry skin; Dysarthria; Dyskinesia; Dyspepsia; Dysphagia; Dyspnoea; Ear pain; Ejaculation failure; Enuresis; Epistaxis; Erectile dysfunction; Erythema; Extrapyramidal disorder; Eye disorder; Fatigue; Feeling abnormal; Flat affect; Gait disturbance; Galactorrhoea; Gastrointestinal disorder; Gastrointestinal pain; Gynaecomastia; Headache; Hyperkeratosis; Hyperkinesia; Hypersensitivity; Hypersomnia; Hypertension; Hypertonia; Hypoaesthesia; Hypokinesia; Hypotension; Immune system disorder; Increased appetite; Infection; Infestation; Influenza; Insomnia; Joint stiffness; Joint swelling; Laryngeal pain; Lethargy; Libido decreased; Loss of consciousness; Malnutrition; Mania; Mediastinal disorder; Menstrual disorder; Mental disability; Mental disorder; Middle insomnia; Muscle contractions involuntary; Muscle rigidity; Muscle twitching; Musculoskeletal discomfort; Myalgia; Nasal congestion; Nasopharyngitis; Nausea; Neck pain; Nervous system disorder; Nervousness; Neuropathy peripheral; Oculogyric crisis; Oedema; Oedema peripheral; Orthostatic hypotension; Osteoarthritis; Pain; Pain in extremity; Palpitations; Parkinsonism; Pharyngitis; Pneumonia; Pollakiuria; Posture abnormal; Pruritus; Psychotic disorder; Pulmonary congestion; Rash; Respiratory tract congestion; Respiratory tract infection; Rhinitis; Rhinorrhoea; Salivary hypersecretion; Seborrhoeic dermatitis; Shock; Sinus congestion; Sinusitis; Skin disorder; Sluggishness; Somnolence; Suicide attempt; Syncope; Tachycardia; Tardive dyskinesia; Tension; Thirst; Tooth disorder; Toothache; Transient ischaemic attack; Tremor; Upper respiratory tract infection; Urethral disorder; Urinary incontinence; Urinary tract disorder; Urinary tract infection; Vision blurred; Visual acuity reduced; Visual impairment; Vomiting; Weight decreased; Weight increased",
            "atc_codes": "N05AX08",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001"
            ],
            "function": [
                "F020103"
            ],
            "references": [
                "RC00899"
            ]
        },
        {
            "compound_ID": "D0107",
            "name": "Ropivacaine",
            "synonyms": "Ropivacaine; 84057-95-4; (S)-Ropivacaine; Ropivacainum; Ropivacaina; Naropin; Ropivacaine [INN]; Ropivacaina [Spanish]; Ropivacainum [INN-Latin]; Ropivacaina [INN-Spanish]; (2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide; UNII-7IO5LYA57N; (S)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide; 7IO5LYA57N; (-)-1-Propyl-2',6'-pipecoloxylidide; CHEBI:8890; (2S)-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide; Ropivacaine (INN); L-N-n-propylpipecolic acid-2,6-xylidide; (2S)-N-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide; S-Ropivacaine; (S)-(-)-1-propyl-2',6'-pipecoloxylidide; LEA-103; Noropine; Narop; AL-381; Naropin (TN); NCGC00164597-01; Ropivacaine [INN:BAN]; 98717-15-8; (-)-1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilid; Ropivacaine base; AK326168; LEA-103 HCl; SCHEMBL33292; BIDD:GT0203; GTPL7602; CHEMBL1077896; DTXSID4040187; ZKMNUMMKYBVTFN-HNNXBMFYSA-N; ZINC897002; 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, (2S)-; BBL102321; STL556120; AKOS017343283; DB00296; AS-35173; K500; SC-23114; C07532; D08490; AB00698466-07; AB00698466_10; 057R954; A840710; Q279504; Q-201677; (-)-1-propyl-2',6'-dimethyl-2-piperidylcarboxyanilide",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C17H26N2O",
            "molecular_weight": "274.4",
            "state": "solid",
            "clearance": "* 387 +/- 107 mL/min\n* unbound plasma clearance=7.2 +/- 1.6 L/min",
            "volume_of_distribution": "",
            "route_of_elimination": "Ropivacaine is extensively metabolized in the liver, predominantly by aromatic hydroxylation mediated by cytochrome P4501A to 3-hydroxy ropivacaine. After a single IV dose approximately 37% of the total dose is excreted in the urine as both free and conjugated 3-hydroxy ropivacaine. In total, 86% of the ropivacaine dose is excreted in the urine after intravenous administration of which only 1% relates to unchanged drug.",
            "protein_binding": "94%, mainly to a1-acid glycoprotein",
            "half_life": "Approximately 4.2 hours.",
            "absorption": "Bioavailability is 87%–98% following epidural administration.",
            "cid": "175805",
            "classification": "N",
            "indications": "Labour pain; Pregnancy; Procedural pain",
            "side_effects": "Abnormal labour (0.017); Vomiting neonatal (0.017); Abdominal distension; Abdominal pain; Agitation; Alanine aminotransferase increased; Anaemia; Anxiety; Apgar score low; Arrhythmia; Arthralgia; Back pain; Body temperature decreased; Body temperature increased; Bradycardia; Bradycardia foetal; Breast disorder; Breast feeding; Bronchospasm; Chest pain; Chills; Confusional state; Constipation; Dermatitis; Diarrhoea; Dizziness; Dyspepsia; Dyspnoea; Dysuria; Feeling abnormal; Fever neonatal; Foetal distress syndrome; Gastrointestinal pain; Haematuria; Headache; Hyperhidrosis; Hypertension; Hypoaesthesia; Hypoglycaemia neonatal; Hypokalaemia; Hypotension; Hypothermia; Hypoxia; Infection; Injection site reaction; Jaundice neonatal; Micturition disorder; Musculoskeletal discomfort; Myalgia; Nausea; Neonatal infection; Neonatal tachypnoea; Oedema peripheral; Pain; Paraesthesia; Paresis; Post procedural complication; Pruritus; Purpura; Rash; Respiratory disorder neonatal; Rhinitis; Somnolence; Tachycardia; Tachycardia foetal; Tachypnoea; Tremor; Urinary incontinence; Urinary retention; Urinary tract infection; Vascular purpura; Vomiting",
            "atc_codes": "N01BB09",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0108",
            "name": "Rosiglitazone",
            "synonyms": "rosiglitazone; 122320-73-4; Avandia; Brl-49653; 5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione; Rosiglizole; Brl 49653; rosiglitazone (Avandia); BRL49653; rosiglitazona; rosiglitazonum; Avandaryl; TDZ 01; Rosiglitazone [INN:BAN]; Avandamet; C18H19N3O3S; CHEBI:50122; Rosigilitazone; 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione; 5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate; YASAKCUCGLMORW-UHFFFAOYSA-N; 2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-; NCGC00095124-01; AK-72839; 5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione; DSSTox_CID_17131; DSSTox_RID_79303; DSSTox_GSID_37131; Q-201681; 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione; 2,4-thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-; CAS-122320-73-4; SR-01000763023; 155141-29-0; Rosiglitazon; Rezult; Rosi; HSDB 7555; Rosiglitazone base; 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione; 5-[4-[2-[N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione; Gaudil (TN); Rosiglitazone-Avandia; Rosiglitazone (INN); Spectrum_001703; Spectrum2_001241; Spectrum3_000997; Spectrum4_001125; Spectrum5_001464; Avandia;BRL-49653; SCHEMBL5169; BSPBio_002693; KBioGR_001609; KBioSS_002183; KSC914G9L; SPECTRUM1504263; SPBio_001142; GTPL1056; DTXSID7037131; SCHEMBL14383595; CTK8B4395; KBio2_002183; KBio2_004751; KBio2_007319; KBio3_001913; KS-00000IPU; Rosiglitazone, >=98% (HPLC); HMS1922J11; HMS2094O13; HMS3649G08; HMS3656K16; HMS3744M11; Pharmakon1600-01504263; ACT04332; BCP03047; Tox21_111434; ANW-44906; BBL029079; BDBM50030474; BG0432; CCG-39102; GP6434; MFCD00871760; NSC758698; STL350047; AKOS015894872; Tox21_111434_1; AC-3459; API0006964; BCP9000017; CS-1088; DB00412; MCULE-8293284864; MP-0331; NSC-758698; RTC-064102; SB17326; VA11695; 2,4-Thiazolidinedione, 5-004-02-((((methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-; 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]-phenyl]methyl]-2,4-thiazolidine-dione; NCGC00095124-02; NCGC00095124-03; NCGC00095124-04; NCGC00095124-05; NCGC00095124-06; NCGC00095124-08; 4CA-1110; BR-72839; CC-34292; HY-17386; SC-19017; BCP0726000232; AB0011992; AB2000652; AX8017813; LS-151340; FT-0602578; R0106; S2556; ST24029274; SW197573-6; 20R734; 6P-065; D08491; J10213; S00306; AB00698473-15; AB00698473-17; AB00698473-18; AB00698473-19; AB00698473_20; AB00698473_21; AB00698473_22; AB00698473_23; C-20817; Q424771; SR-01000763023-5; SR-01000763023-6; BRD-A97437073-001-02-3; BRD-A97437073-001-03-1; BRD-A97437073-001-04-9; SR-01000763023-12; (RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion; 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4dione; 5-[4-[2-[Methyl(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione; IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin); (+/-)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione; 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- (9CI); 5-[[4-[2-(methyl-(2-pyridyl)amino)ethoxy]phenyl]methyl] thiazolidine-2,4-dione; 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy]phenyl]methyl]-2,4-thiazolidinedione; 5-[[4-[2-(Methyl-2-pyridinylamino)e thoxy]phenyl]methyl]-2,4-thiazolidinedione; 5-[[4-[2-(methyl-pyridin-2-ylamino)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione; 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione; 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]phenyl methyl]thiazolidine-2,4-dione",
            "trade_name": "Avandia",
            "abbrev_name": "RSG",
            "description": "thiazolidinedione class of anti-diabetic drug; PPARgamma agonist",
            "molecular_formula": "C18H19N3O3S",
            "molecular_weight": "357.4",
            "state": "solid",
            "clearance": "* Oral clearance (CL) = 3.03 ± 0.87 L/hr [1 mg Fasting]\n* Oral CL = 2.89 ± 0.71 L/hr [2 mg Fasting]\n* Oral CL = 2.85 ± 0.69 L/hr [8 mg Fasting]\n* Oral CL = 2.97 ± 0.81 L/hr [8 mg Fed]\n* 3.15 L/hr [Population mean, Pediatric patients]",
            "volume_of_distribution": "* 17.6 L [oral volume of distribution Vss/F]\n* 13.5 L [population mean, pediatric patients]",
            "route_of_elimination": "Following oral or intravenous administration of [14C]rosiglitazone maleate, approximately 64% and 23% of the dose was eliminated in the urine and in the feces, respectively.",
            "protein_binding": "99.8% bound to plasma proteins, primarily albumin.",
            "half_life": "3-4 hours (single oral dose, independent of dose)",
            "absorption": "The absolute bioavailability of rosiglitazone is 99%. Peak plasma concentrations are observed about 1 hour after dosing. Administration of rosiglitazone with food resulted in no change in overall exposure (AUC), but there was an approximately 28% decrease in C<sub>max</sub> and a delay in T<sub>max</sub> (1.75 hours). These changes are not likely to be clinically significant; therefore, rosiglitazone may be administered with or without food. Maximum plasma concentration (Cmax) and the area under the curve (AUC) of rosiglitazone increase in a dose-proportional manner over the therapeutic dose range.",
            "cid": "77999",
            "classification": "A",
            "indications": "Diabetes mellitus; Diabetic ketoacidosis; Insulin resistance; Type 1 diabetes mellitus; Type 2 diabetes mellitus; Weight decreased",
            "side_effects": "Anaemia (0.071); Arthralgia; Asthenia; Back pain; Diarrhoea; Fatigue; Headache; Hyperglycaemia; Hypertension; Hypoglycaemia; Musculoskeletal discomfort; Nasopharyngitis; Sinusitis; Upper respiratory tract infection",
            "atc_codes": "A10BG02; A10BD04; A10BD03",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001",
                "T002",
                "T004",
                "T005",
                "T019",
                "T091"
            ],
            "function": [
                "F01",
                "F010401",
                "F0105",
                "F0201",
                "F02010202",
                "F02010203",
                "F020103",
                "F0203",
                "F02040101",
                "F020403",
                "F02110302",
                "F0301",
                "F030802"
            ],
            "references": [
                "RC00187",
                "RC00188",
                "RC00189",
                "RC00190",
                "RC00191",
                "RC00552",
                "RC00553",
                "RC00560",
                "RC00561",
                "RC00952",
                "RC00992",
                "RC00993",
                "RC01300",
                "RC01314",
                "RC03449",
                "RC03450",
                "RC03451",
                "RC03452",
                "RC03632",
                "RC04875",
                "RC04966",
                "RC04970",
                "RC04975"
            ]
        },
        {
            "compound_ID": "D0109",
            "name": "Salicylic acid",
            "synonyms": "salicylic acid; 2-Hydroxybenzoic acid; 69-72-7; o-hydroxybenzoic acid; 2-Carboxyphenol; o-Carboxyphenol; Rutranex; Salonil; Retarder W; Keralyt; Duoplant; Freezone; Saligel; Ionil; Psoriacid-S-stift; Stri-Dex; Salicylic acid soap; Benzoic acid, 2-hydroxy-; Salicylic acid collodion; Verrugon; Phenol-2-carboxylic acid; Acidum salicylicum; Trans-Ver-Sal; Orthohydroxybenzoic acid; 2-Hydroxybenzenecarboxylic acid; Acido salicilico; Ionil-Plus; Salicylic acid, tech.; Kyselina salicylova; Clear away wart remover; Duofil wart remover; Domerine; Sebucare; Duofilm; Sebulex; Salicyclic acid; Ionil plus; Dr. Scholl's corn removers; Kyselina salicylova [Czech]; Dr. Scholl's callus removers; Dr. Scholl's wart remover kit; Kyselina 2-hydroxybenzoova; Occlusal; Acido salicilico [Italian]; Advanced pain relief corn removers; Caswell No. 731; Kyselina 2-hydroxybenzoova [Czech]; Advanced pain relief callus removers; Acido o-idrossibenzoico [Italian]; NSC 180; Salicylic acid [USAN:JAN]; Salicylic acid & Sulfur Soap; 2-hydroxy-benzoic acid; CCRIS 6714; HSDB 672; AI3-02407; UNII-O414PZ4LPZ; EPA Pesticide Chemical Code 076602; BRN 0774890; CHEBI:16914; EINECS 200-712-3; MFCD00002439; CHEMBL424; O414PZ4LPZ; MLS000069653; NSC180; K 537; YGSDEFSMJLZEOE-UHFFFAOYSA-N; ATA fraction 10, ammonium salt; NCGC00159447-05; SMR000059163; Mediplast pads; Salicylic acid, 99+%; Akurza Lotion; Hydrisalic Gel; Akurza Cream; Salex Lotion; Salex Cream; DSSTox_CID_6368; DuoPlant Gel; DHS Sal Shampoo; DSSTox_RID_78106; P&S Shampoo; DSSTox_GSID_26368; Acido o-idrossibenzoico; Durasal; ortho-Hydroxybenzoic Acid; Salicylic acid, 99+%, ACS reagent; salicylicum acidum; CAS-69-72-7; Propa pH Peel-Off Acne Mask; Salicylic acid, tech; NSC629474; phenol derivative, 7; Salicylic acid (TN); Benzoic acid, hydroxy-; Salicylic acid [USP:JAN]; Salicylic acid (6CI,8CI); salicylic-acid; Anti-blemish; hydroxy-benzoic acid; ortho-salicylic acid; CMC_13852; Fostex (Salt/Mix); Pernox (Salt/Mix); Duofilm Wart Remover; Phenol-2-carboxylate; Duofilm (Salt/Mix); Salicylic Acid,(S); Sebulex (Salt/Mix); 2-hydroxobenzoic acid; Domerine (Salt/Mix); Sebucare (Salt/Mix); 2-Hydroxybenzoate, I; Natural Salicylic Acid; o-hydroxy benzoic acid; 2-hydroxy benzoic acid; Spectrum_000948; Salicylic acid,medicinal; ACMC-1AZIK; Opera_ID_582; 18917-89-0; 18917-95-8; Salicylic acid ACS grade; WLN: QVR BQ; Benzoic acid, o-hydroxy-; Bazuka Extra Strength Gel; 2-Hydroxybenzenecarboxylate; bmse000252; Epitope ID:124929; Retarder SAX (Salt/Mix); UPCMLD-DP126; EC 200-712-3; SCHEMBL1967; Oprea1_040343; KBioSS_001428; KSC203I1R; ARONIS27188; BIDD:ER0602; DivK1c_000301; Salicylic acid (JP17/USP); 2-Hydroxybenzoic Acid, Natural; FEMA3985; GTPL4306; SALICYLIC ACID (SEE ALSO ALPHA HYDROXY ACIDS); SGCUT00012; ZINC1554; Salicylic acid inclusion complex; Salicylic acid, >=99%, FG; Salicylic acid, LR, >=99%; component of Tinver (Salt/Mix); DTXSID7026368; UPCMLD-DP126:001; BDBM26193; component of Keralyt (Salt/Mix); CTK1A3418; KBio1_000301; KBio2_001428; KBio2_003996; KBio2_006564; KS-00000KPH; Alpha/Beta Hydroxy Acids (Glycolic Acid, Salicylic Acid); E9A559BE-383B-4F83-BC02-3031D03D558A; NSC-180; NINDS_000301; HMS2233A10; HMS3373M19; KUC106694N; Salicylic acid, p.a., 99.0%; Benzoic acid, 2-hydroxy- (9CI); BCP09067; HY-B0167; to_000004; Tox21_113453; Tox21_201471; Tox21_303109; ANW-43703; s4539; SBB052826; STK258681; AKOS000118979; Salicylic acid, BioXtra, >=99.0%; CCG-212792; DB00936; LS-2169; MCULE-8407868694; NE10196; RTR-032850; ALPHA/BETA HYDROXY ACIDS (SALICYLIC ACID) (SEE ALPHA/BETA HYDROXY ACIDS); IDI1_000301; KS-000048O6; SMP2_000145; NCGC00159447-02; NCGC00159447-04; NCGC00159447-06; NCGC00257065-01; NCGC00259022-01; 29656-58-4; AK112186; BP-12826; KSC-11-207-4; Salicylic acid & Sulfur Soap (Salt/Mix); Salicylic acid, ACS reagent, >=99.0%; Salicylic acid, plant cell culture tested; Salicylic acid, ReagentPlus(R), >=99%; SC-18305; TS-03583; Salicylic Acid 1.0 mg/ml in Acetonitrile; SBI-0051510.P003; AB1002436; ST2416966; TR-032850; FT-0645123; Salicylic acid, tested according to Ph.Eur.; ST51046715; Salicylic acid, SAJ first grade, >=99.0%; 3253-EP2269610A2; 3253-EP2269988A2; 3253-EP2270002A1; 3253-EP2270006A1; 3253-EP2270008A1; 3253-EP2270011A1; 3253-EP2270113A1; 3253-EP2272935A1; 3253-EP2275401A1; 3253-EP2275413A1; 3253-EP2275420A1; 3253-EP2277867A2; 3253-EP2280003A2; 3253-EP2280008A2; 3253-EP2280010A2; 3253-EP2281563A1; 3253-EP2281816A1; 3253-EP2284146A2; 3253-EP2284147A2; 3253-EP2284160A1; 3253-EP2284178A2; 3253-EP2284179A2; 3253-EP2287156A1; 3253-EP2289510A1; 3253-EP2289883A1; 3253-EP2289890A1; 3253-EP2292592A1; 3253-EP2292597A1; 3253-EP2292617A1; 3253-EP2295053A1; 3253-EP2295401A2; 3253-EP2295416A2; 3253-EP2295424A1; 3253-EP2295433A2; 3253-EP2298734A2; 3253-EP2298735A1; 3253-EP2298748A2; 3253-EP2298757A2; 3253-EP2298758A1; 3253-EP2298759A1; 3253-EP2298764A1; 3253-EP2298765A1; 3253-EP2301931A1; 3253-EP2301937A1; 3253-EP2301940A1; 3253-EP2305243A1; 3253-EP2305248A1; 3253-EP2305257A1; 3253-EP2305646A1; 3253-EP2305651A1; 3253-EP2305655A2; 3253-EP2305662A1; 3253-EP2305663A1; 3253-EP2305664A1; 3253-EP2305675A1; 3253-EP2308851A1; 3253-EP2308854A1; 3253-EP2308873A1; 3253-EP2308875A1; 3253-EP2311807A1; 3253-EP2311809A1; 3253-EP2311810A1; 3253-EP2311814A1; 3253-EP2311831A1; 3253-EP2311842A2; 3253-EP2314574A1; 3253-EP2314588A1; 3253-EP2316457A1; 3253-EP2316458A1; 3253-EP2316459A1; 3253-EP2316825A1; 3253-EP2316826A1; 3253-EP2316827A1; 3253-EP2316828A1; 3253-EP2316836A1; 3253-EP2372017A1; 3253-EP2380874A2; C00805; D00097; Salicylic acid, Vetec(TM) reagent grade, 98%; 44642-EP2281819A1; 44642-EP2292619A1; 44642-EP2305659A1; 44642-EP2311818A1; AB00489876_15; BENZOIC ACID,2-HYDROXY SALICYLIC ACID; Salicylic acid, puriss. p.a., >=99.0% (T); 197900-EP2269975A2; 197900-EP2269997A2; 197900-EP2275415A2; Q193572; component of Solarcaine first aid spray (Salt/Mix); J-509667; component of Fostex medicated bar and cream (Salt/Mix); F2191-0216; Salicylic acid, certified reference material, TraceCERT(R); UNII-I3P9R8317T component YGSDEFSMJLZEOE-UHFFFAOYSA-N; Salicylic acid, British Pharmacopoeia (BP) Reference Standard; Salicylic acid, European Pharmacopoeia (EP) Reference Standard; Salicylic acid, United States Pharmacopeia (USP) Reference Standard; InChI=1/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10; Salicylic acid, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material; Salicylic acid, Pharmaceutical Secondary Standard; Certified Reference Material; 8052-31-1; Salicylic acid, meets analytical specification of Ph. Eur., BP, USP, 99.5-100.5% (calc. to the dried substance)",
            "trade_name": "",
            "abbrev_name": "",
            "description": "a lipophilic monohydroxybenzoic acid, a type of phenolic acid, and a beta hydroxy acid (BHA); active metabolite of aspirin; bacteriostatic, fungicidal, and keratolytic actions",
            "molecular_formula": "C7H6O3",
            "molecular_weight": "138.12",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "338",
            "classification": "D; S; N",
            "indications": "Arthropod bite; Bedridden; Dermatitis; Dermatitis infected; Fungal infection; Ichthyosis; Ichthyosis acquired; Inflammation; Juvenile idiopathic arthritis; Keratosis pilaris; Osteoarthritis; Pain; Palmoplantar keratoderma; Pityriasis rubra pilaris; Psoriasis; Pyoderma; Rheumatic disorder; Rheumatoid arthritis; Skin disorder; Skin hypertrophy",
            "side_effects": "",
            "atc_codes": "D01AE12; N02BA12; S01BC08; N02BA04",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001",
                "T002",
                "T408"
            ],
            "function": [
                "F0105",
                "F010701",
                "F0108",
                "F0201",
                "F02010202",
                "F02040101",
                "F02060101",
                "F0303"
            ],
            "references": [
                "RC00542",
                "RC00543",
                "RC00917",
                "RC00918",
                "RC00970",
                "RC03513",
                "RC03539",
                "RC03556",
                "RC04120",
                "RC04244",
                "RC04368",
                "RC04492",
                "RC04616"
            ]
        },
        {
            "compound_ID": "D0110",
            "name": "Salsalate",
            "synonyms": "Salsalate; sasapyrine; 552-94-3; Salicylsalicylic acid; Disalicylic acid; Disalcid; 2-Carboxyphenyl salicylate; Sasapyrinum; Saloxium; Diacesal; Diplosal; Sasapirin; Disalyl; Nobacid; Salical; Salina; Salysal; Salicyloylsalicylic acid; Sal Ester Sal; Sasapyrin; o-Salicylsalicylic acid; Disalicylsaeure; Salsalatum; Salicylic acid, salicylate; Salsalato; Salflex; Salsalatum [INN-Latin]; Benzoic acid, 2-hydroxy-, 2-carboxyphenyl ester; 2-(2-hydroxybenzoyl)oxybenzoic acid; Salicylic acid, bimolecular ester; O-Salicylcylsalicylsaeure; NSC-49171; Salicyloxysalicylic acid; Salsalato [INN-Spanish]; 2-((2-Hydroxybenzoyl)oxy)benzoic acid; UNII-V9MO595C9I; 2-Hydroxybenzoic acid 2-carboxyphenyl ester; EINECS 209-027-4; MFCD00020252; NSC 49171; BRN 2590908; CHEBI:9014; V9MO595C9I; WVYADZUPLLSGPU-UHFFFAOYSA-N; NSC49171; NCGC00096014-01; AK114551; DSSTox_CID_3572; DSSTox_RID_77088; Salicylsalicylic acid, 98%; DSSTox_GSID_23572; Q-100630; Mono-gesic; O-Salicyloylsalicylic Acid; Disalicylic acid;; Disalcid (TN); CAS-552-94-3; Sasapyrine (JAN); Salsalate [USAN:INN:BAN]; 2-(2-hydroxyphenylcarbonyloxy)benzoic acid; Salsalate (USP/INN); 2-Salicyloyloxybenzoic Acid; Disalgesic; Salsalate [USAN:USP:INN:BAN]; 2-(2-hydroxybenzoyloxy)benzoic acid; Spectrum_001998; 2-Salicylsalicylic acid; Spectrum2_000693; Spectrum3_000173; Spectrum4_000940; Spectrum5_000670; ACMC-209lm5; 2-{[(2-hydroxyphenyl)carbonyl]oxy}benzoic acid; SCHEMBL15562; BSPBio_001665; KBioGR_001500; KBioSS_002572; SPECTRUM200331; SPBio_000845; CHEMBL154111; ZINC2062; Salicylic acid bimolecular ester; DTXSID1023572; Salsalate, >=98% (HPLC); BDBM85244; KBio2_002563; KBio2_005131; KBio2_007699; KBio3_001165; KS-00000WSM; HMS2091A05; HMS3652P07; Pharmakon1600-00200331; HY-B1245; NSC_5161; Benzoic acid, 2-carboxyphenyl ester; Tox21_111548; ANW-32283; CCG-39652; GL4615; NSC755823; s4188; Salicylic Acid 2-Carboxyphenyl Ester; SBB003097; Salicylsalicylic acid;Disalicylic acid; AKOS003368478; Tox21_111548_1; 2-Carboxyphenyl salicylate, AldrichCPR; API0002421; CS-4891; DB01399; MCULE-7200376848; NSC-755823; NCGC00096014-02; NCGC00096014-03; AC-18298; AS-12645; CAS_552-94-3; CC-09787; LS-37546; ST083489; 2-[(2-Hydroxybenzoyl)oxy]benzoic acid #; SBI-0206687.P002; AX8015186; DB-020760; TC-121028; FT-0632376; S0129; ST24027407; SW219189-1; 2-[(2-hydroxyphenyl)carbonyloxy]benzoic acid; D00428; AB01563259_01; AB01563259_02; C-16063; SR-05000001536; Q1320691; SR-05000001536-1; 2-[(2-Hydroxybenzoyl)oxy]benzoic Acid (Salicylsalicylic Acid); Salicylsalicylic Acid (2-[(2-Hydroxybenzoyl)oxy]benzoic Acid); Salsalate, United States Pharmacopeia (USP) Reference Standard; Aspirin Impurity E; 2-Hydroxybenzoic Acid 2-Carboxyphenyl Ester; Salicylic Acid Salicylate; 2-Hydroxybenzoic Acid 2-Carboxyphenyl Ester; Salsalate (Aspirin Impurity E), Pharmaceutical Secondary Standard; Certified Reference Material",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C14H10O5",
            "molecular_weight": "258.23",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "Salicylate: 90-95% bound at plasma salicylate concentrations <100 mcg/mL; 70-85% bound at concentrations of 100-400 mcg/mL; 25-60% bound at concentrations >400 mcg/mL.",
            "half_life": "The parent compound has an elimination half-life of about 1 hour. Salicylic acid (the active metabolite) biotransformation is saturated at anti-inflammatory doses of salsalate. Such capacity limited biotransformation results in an increase in the half-life of salicylic acid from 3.5 to 16 or more hours.",
            "absorption": "Salsalate is insoluble in acid gastric fluids (< 0.1 mg/ml at pH 1.0), but readily soluble in the small intestine where it is partially hydrolyzed to two molecules of salicylic acid. A significant portion of the parent compound is absorbed unchanged. The amount of salicylic acid available from salsalate is about 15% less than from aspirin, when the two drugs are administered on a salicylic acid molar equivalent basis (3.6 g salsalate/5 g aspirin). Food slows the absorption of all salicylates including salsalate.",
            "cid": "5161",
            "classification": "N",
            "indications": "Arthritis; Osteoarthritis; Rheumatic disorder; Rheumatoid arthritis",
            "side_effects": "",
            "atc_codes": "N02BA06",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0111",
            "name": "Simvastatin",
            "synonyms": "simvastatin; 79902-63-9; Zocor; Synvinolin; Sinvacor; Denan; Lipex; MK-733; Simvastatine; Sivastin; Lodales; Simvastatina; Simvastatinum; Cholestat; Colemin; Simovil; Medipo; Pantok; Labistatin; Nivelipol; Rendapid; Vasotenal; Velostatin; Coledis; Corolin; Zocord; Zorced; Simvastatin lactone; Simvastatin (Zocor); Lipovas; Simcard; Simvacor; Simvoget; Rechol; Simlup; Simvastatine [French]; Simvastatinum [Latin]; Simvastatina [Spanish]; (1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate; MK-0733; UNII-AGG2FN16EV; DRG-0320; MK 0733; CCRIS 7558; HSDB 7208; AGG2FN16EV; 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one; L 644128-000U; BRN 4768037; CHEBI:9150; (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate; RYMZZMVNJRMUDD-HGQWONQESA-N; C25H38O5; Simcor; Simvastatin, 98%; (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate; [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; DSSTox_CID_3581; DSSTox_RID_77090; DSSTox_GSID_23581; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester; Zosta; Simvast CR; [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate; Butanoic acid, 2,2-dimethyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha,3alpha,7beta,8beta(2S*,4S*),8abeta))-; SMR000718785; Simvastatin [USAN:INN:BAN]; Zocor (TN); Simvastatin, Compactin; Simvastatin & Primycin; SR-05000001894; MK 733; Kolestevan; Lipinorm; Modutrol; Simvotin; Sinvascor; Valemia; Eucor; Nor-Vastina; Simvastatin,(S); simvastatin predrug; (+)-Simvastatin; NCGC00016940-01; Simvastatin(Zocor); inactive simvastatin; 8-[2-((2R,4R)-4-hydroxy-6-oxo(2H-3,4,5-trihydropyran-2-yl))ethyl](1S,7S,8S,3R, 8aR)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthyl 2,2-dimethylbutanoate; Simvastatin [USAN:USP:INN:BAN]; TNP00259; Prestwick_171; CAS-79902-63-9; KS-1113; Spectrum_001717; SpecPlus_000895; Prestwick0_000865; Prestwick1_000865; Prestwick2_000865; Prestwick3_000865; Spectrum2_001671; Spectrum3_000669; Spectrum4_000632; Spectrum5_001428; SCHEMBL2471; CHEMBL1064; BSPBio_000909; BSPBio_002337; KBioGR_001244; KBioSS_002197; MLS001304029; MLS001333077; MLS001333078; MLS002154038; MLS006011866; ARONIS24119; BIDD:GT0769; DivK1c_006991; SPECTRUM1504236; SPBio_001881; SPBio_002830; BPBio1_001001; GTPL2955; Simvastatin (JP17/USP/INN); Simvastatin, analytical standard; DTXSID0023581; BCBcMAP01_000007; KBio1_001935; KBio2_002197; KBio2_004765; KBio2_007333; KBio3_001557; RYMZZMVNJRMUDD-HGQWONQESA-; HMS1570N11; HMS1922H13; HMS2089D12; HMS2093E06; HMS2097N11; HMS2231N22; HMS3259B12; HMS3412P08; HMS3676P08; HMS3714N11; Pharmakon1600-01504236; ZINC3780893; Tox21_110696; Tox21_300400; BBL024390; BDBM50139181; CCG-39069; MFCD00072007; NSC633782; NSC758706; s1792; SBB080618; STK801938; AKOS005111006; AKOS015842733; Simvastatin, >=97% (HPLC), solid; Tox21_110696_1; AC-1530; AT-7048; CS-2269; DB00641; MCULE-8390617062; NC00719; NSC-633782; NSC-758706; MRF-0000729; NCGC00017324-01; NCGC00017324-02; NCGC00017324-03; NCGC00017324-04; NCGC00017324-05; NCGC00017324-07; NCGC00017324-08; NCGC00017324-09; NCGC00254418-01; 2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester; butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta; CPD000718785; HY-17502; LS-46264; SAM002589969; SC-12666; ST057168; SBI-0206773.P001; AB0069097; ST2407853; D00434; J10128; W-3044; 28049-EP2269989A1; 28049-EP2269990A1; 28049-EP2270011A1; 28049-EP2270505A1; 28049-EP2272825A2; 28049-EP2272841A1; 28049-EP2277865A1; 28049-EP2280001A1; 28049-EP2280006A1; 28049-EP2281813A1; 28049-EP2284158A1; 28049-EP2287165A2; 28049-EP2287166A2; 28049-EP2292620A2; 28049-EP2295406A1; 28049-EP2295409A1; 28049-EP2295417A1; 28049-EP2295422A2; 28049-EP2298731A1; 28049-EP2298742A1; 28049-EP2298745A1; 28049-EP2298769A1; 28049-EP2298772A1; 28049-EP2298776A1; 28049-EP2298779A1; 28049-EP2301923A1; 28049-EP2301931A1; 28049-EP2301936A1; 28049-EP2305219A1; 28049-EP2305648A1; 28049-EP2308839A1; 28049-EP2308878A2; 28049-EP2314588A1; 96639-EP2287163A1; 96639-EP2305678A1; 99548-EP2270011A1; 99548-EP2298779A1; 99548-EP2301923A1; 99548-EP2301931A1; AB00053395-07; AB00053395-08; AB00053395-10; AB00053395_11; AB00053395_13; 902S639; Q670131; SR-05000001894-1; SR-05000001894-2; BRD-K22134346-001-05-8; BRD-K22134346-001-11-6; BRD-K22134346-001-15-7; Z1741982918; Simvastatin, British Pharmacopoeia (BP) Reference Standard; Simvastatin, European Pharmacopoeia (EP) Reference Standard; Simvastatin, United States Pharmacopeia (USP) Reference Standard; Simvastatin, Pharmaceutical Secondary Standard; Certified Reference Material; Simvastatin for peak identification, European Pharmacopoeia (EP) Reference Standard; (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyly-2,2-dimethyl butanoate; (1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbu; (1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate; InChI=1/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1",
            "trade_name": "Zocor",
            "abbrev_name": "",
            "description": "statin; Hypolipidemics; lipid-lowering drug; competitively inhibit the enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase",
            "molecular_formula": "C25H38O5",
            "molecular_weight": "418.6",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "Simvastatin can cross the blood-brain-barrier.",
            "route_of_elimination": "Following an oral dose of 14C-labeled simvastatin in man, 13% of the dose was excreted in urine and 60% in feces.",
            "protein_binding": "Both simvastatin and its β-hydroxyacid metabolite are highly bound (approximately 95%) to human plasma proteins.",
            "half_life": "3 hours",
            "absorption": "Absorption of simvastatin, estimated relative to an intravenous reference dose, in each of two animal species tested, averaged about 85% of an oral dose. In animal studies, after oral dosing, simvastatin achieved substantially higher concentrations in the liver than in non-target tissues. However, because simvastatin undergoes extensive first-pass metabolism, the availability of the drug in the systemic is low. Peak plasma concentration occurs 1.3 - 2.4 hours after administration.",
            "cid": "54454",
            "classification": "A; C",
            "indications": "Acute coronary syndrome; Alcohol abuse; Alcoholism; Angina pectoris; Arteriosclerosis; Arteriosclerosis coronary artery; Blood cholesterol increased; Blood triglycerides increased; Blood triglycerides normal; Cardiac failure congestive; Cardiovascular disorder; Carotid artery disease; Cerebrovascular accident; Cerebrovascular disorder; Coronary artery disease; Diabetes mellitus; Dyslipidaemia; Foetor hepaticus; Hepatocellular injury; High density lipoprotein decreased; Hypercholesterolaemia; Hypertension; Hypothyroidism; Lipid metabolism disorder; Liver disorder; Low density lipoprotein increased; Menarche; Myocardial infarction; Nephrotic syndrome; Obstruction; Peripheral vascular disorder; Premature menopause; Skin ulcer; Type II hyperlipidaemia; Type IIb hyperlipidaemia; Type IV hyperlipidaemia",
            "side_effects": "Arthralgia (0.001); Gastrointestinal disorder (0.005); Abdominal pain; Asthenia; Atrial fibrillation; Bronchitis; Cataract; Constipation; Dermatitis; Diabetes mellitus; Diarrhoea; Dyspepsia; Eczema; Endocrine disorder; Flatulence; Gastritis; Gastrointestinal pain; Headache; Infection; Insomnia; Musculoskeletal discomfort; Musculoskeletal disorder; Myalgia; Nausea; Oedema; Pruritus; Rash; Regurgitation; Sinusitis; Swelling; Upper respiratory tract infection; Vertigo",
            "atc_codes": "C10BX01; C10BX04; C10BA04; C10BA02; A10BH51; C10AA01",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001",
                "T002",
                "T004",
                "T004012",
                "T005",
                "T019",
                "T181",
                "T387",
                "T408"
            ],
            "function": [
                "F010401",
                "F0108",
                "F0201",
                "F020103",
                "F02110103",
                "F0303",
                "F0504",
                "F06"
            ],
            "references": [
                "RC00192",
                "RC00193",
                "RC00194",
                "RC00195",
                "RC00196",
                "RC00994",
                "RC03460",
                "RC03464",
                "RC03465",
                "RC03643",
                "RC04663",
                "RC04122",
                "RC04246",
                "RC04370",
                "RC04494",
                "RC04618",
                "RC04677",
                "RC04692"
            ]
        },
        {
            "compound_ID": "D0112",
            "name": "Sodium",
            "synonyms": "Sodium; 7440-23-5; Natrium; Sodium-23; Sodio; Sodium metal; Sodio [Spanish]; Sodium (liquid alloy); UNII-9NEZ333N27; HSDB 687; EINECS 231-132-9; UN1428; UNII-23J3BHR95O; 9NEZ333N27; Sodium, dry stick; MFCD00085307; Na; Sodium, 99.8%, oiled sticks, wrapped in aluminium foil; monosodium; mono sodium; mono-sodium; sodium atom; Sodium, CP; Sodium hydride, CP; ACMC-1BKTZ; 11Na; Sodium, ACS reagent, dry; EC 231-132-9; Sodium hydride, dry, 95%; SODIUM, LARGE PIECES; HSDB 745; NAH 80; DTXSID1049774; CHEBI:26708; CTK2H7876; KEAYESYHFKHZAL-UHFFFAOYSA-N; EINECS 231-587-3; ANW-56400; UN1427; AKOS015833457; Sodium Phyllo-pentaoxodimanganate(III); Sodium, SAJ first grade, >=99.5%; Sodium, 99%, lumps, contains kerosene; TRA-0177117; Sodium [UN1428] [Dangerous when wet]; Sodium hydride, 57-63% oil dispersion; Sodium, 40 wt % dispersion in paraffin; SC-91613; Sodium [UN1428] [Dangerous when wet]; LS-145497; LS-190862; RT-000087; Sodium, 99.95% trace metals basis, ingot; FT-0689077; Sodium, 25-35 wt % dispersion in paraffin; KS-00001935; EC 231-587-3; AB01566864_01; Sodium hydride [UN1427] [Dangerous when wet]; Sodium hydride, 60 % dispersion in mineral oil; A838715; Sodium standard for AAS, ready-to-use, in nitric acid; Sodium, Oil based standard solution, Specpure, Na 5000g/g; Sodium, 30wt% dispersion in toluene, <0.1 mm particle size; Sodium, cubes, contains mineral oil, 99.9% trace metals basis; Sodium, in kerosene, pieces (large), >=99.8% (sodium basis); Sodium, Oil based standard solution, Specpure?, Na 1000?g/g; Sodium hydride (in oil dispersion) 60% dispersion in mineral oil; Sodium standard for ICP, for ICP, ready-to-use, in nitric acid; Sodium standard for AAS, analytical standard, 10.00 g/L Na in nitric acid; Sodium, Ion chromatography standard solution, Specpure, Na+ 1000g/ml; Sodium hydride, powder (moistened with oil), in soluble SecuBags(R), 55-65% (gas-volumetric)",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "Na",
            "molecular_weight": "22.9897693",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "5360545",
            "classification": "A",
            "indications": "Addison's disease; Apnoea; Aspiration; Cardiac arrest; Cardiovascular insufficiency; Chest discomfort; Coma; Confusional state; Convulsion; Diabetes mellitus; Diabetic ketoacidosis; Diarrhoea; Disorientation; Dissociation; Dyspnoea; Feeling abnormal; Haemolysis; Headache; Hypertension; Hyperventilation; Hyponatraemia; Hypophosphataemia; Hypotension; Ileus paralytic; Injury; Intestinal obstruction; Lactic acidosis; Mental disorder; Metabolic acidosis; Metabolic alkalosis; Mydriasis; Nausea; Nephropathy toxic; Panic reaction; Poisoning; Pyloric stenosis; Respiratory fume inhalation disorder; Respiratory rate decreased; Shock; Small intestinal obstruction; Thermal burn; Toxicity to various agents; Vomiting",
            "side_effects": "Abdominal distension; Abdominal pain; Flatulence; Gastrointestinal pain; Nausea; Vomiting",
            "atc_codes": "A12CA",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0113",
            "name": "Stavudine",
            "synonyms": "stavudine; sanilvudine; 3056-17-5; Zerit; 2',3'-Didehydro-3'-deoxythymidine; Estavudina; Stavudinum; Zerit Xr; Zerut XR; BMY-27857; Stavudinum [INN-Latin]; 2',3'-Anhydrothymidine; Estavudina [INN-Spanish]; d4T; Thymidine, 2',3'-didehydro-3'-deoxy-; ddeThd; D 4T (nucleoside); BMY 27857; 3'-Deoxy-2'-thymidinene; 2',3'-Didehydro-3'-deoxythimidine; D 4T; Dideoxydidehydrothymidine; Stavudin; UNII-BO9LE4QFZF; 3'-Deoxy-2',3'-didehydrothymidine; 1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine; NSC 163661; HSDB 7338; BO9LE4QFZF; Stavudine (d4T); 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione; CHEMBL991; BRN 0618327; 2'-Thymidinene, 3'-deoxy-; 1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; MLS000028546; STV; CHEBI:63581; XNKLLVCARDGLGL-JGVFFNPUSA-N; 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione; 1-[(2R,5S)-5-(HYDROXYMETHYL)-2,5-DIHYDROFURAN-2-YL]-5-METHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE; NCGC00023212-07; SMR000058350; DSSTox_CID_3819; 1-((2R,5S)-5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione; DSSTox_RID_77198; DSSTox_GSID_23819; Stavudine [USAN:BAN:INN]; ddeTyd; Zent; Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)- (7CI,8CI); Stavudine [USAN:INN:BAN]; CAS-3056-17-5; Zerit(TM); Sanilvudine (JAN); 3'-Deoxy-2',3'-didehydrothymidine, 98%; Zerit (TN); SR-01000075802; Stavudine (USAN/INN); D4T & GM-CSF; NSC163661; Stavudine [USAN:USP:INN:BAN]; D4TMBY-27857-3; PubChem5805; Opera_ID_1281; 3'-deoxythymidin-2'-ene; D 1413; cid_5155; 3''-deoxy-2''-thymidine; Lopac0_000336; SCHEMBL38661; 2',3'-DIDEHYDRO-3'-DEOXYTHYMIDINE (DDI); cid_18283; MLS000759504; MLS001055348; MLS001077292; MLS001424091; MLS006011922; BIDD:GT0082; 2',3'-Anhydrothymidine; d4T; DTXSID1023819; CTK8B1419; 1-(2,3-Dideoxy-beta-D-glycero-2-pentenofuranosyl)thymine; 1-(cis-5-(Hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; HMS2051O20; HMS2234C10; HMS3039O05; HMS3259L21; HMS3261C13; HMS3428C07; HMS3714N22; Pharmakon1600-01502339; ZINC137884; 220020-60-0; BCP02952; HY-B0116; Tox21_110886; Tox21_201393; Tox21_300583; Tox21_500336; ABP000995; ANW-26914; BBL033763; BDBM50013111; MFCD00132921; NSC759897; STK801888; 2',3'-Didehydro-3'-deoxy-thymidine; AKOS005622554; Tox21_110886_1; AC-5263; CCG-100902; CS-1872; DB00649; KS-1115; LP00336; LS-1160; MCULE-9252477726; NC00152; NC00684; NSC-759897; KS-00000H34; 2'',3''-didehydro-3''-deoxythymidine; 3''-deoxy-2'',3''-didehydrothymidine; 3'-Deoxy-2',3'-didehydro-D-thymidine; NCGC00023212-03; NCGC00023212-04; NCGC00023212-05; NCGC00023212-08; NCGC00023212-09; NCGC00023212-10; NCGC00023212-11; NCGC00023212-12; NCGC00023212-13; NCGC00023212-14; NCGC00254372-01; NCGC00258944-01; NCGC00261021-01; 1-[5-(hydroxymethyl)-2,5-dihydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione & Colony-stimulating factor 2; BR-77340; CPD000058350; CPD000673569; H940; SAM001246729; SAM002589948; SC-03292; SMR000673569; 2',3'-didehydro-2',3'-dideoxythymidine; AB0013374; AB1009564; Thymidine, 2',3'-didehydro-, 3'-deoxy-; D3580; EU-0100336; FT-0082665; FT-0603625; 2'',3''-dideoxy-2'',3''-didehydrothymidine; C07312; D00445; J10003; S-2155; AB00383018_18; 056S175; A820433; Q423984; J-700246; Q-201742; SR-01000075802-1; SR-01000075802-4; 2',3'-Didehydro-3'-deoxythymidine, >=98% (TLC); Z1695906749; Stavudine, European Pharmacopoeia (EP) Reference Standard; 1-(2,3-Dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)thymine; Stavudine, United States Pharmacopeia (USP) Reference Standard; 1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; 1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (ddeThd); 1-[(2R,5S)-2,5-Dihydro-5-(hydroxymethyl)-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione; 3'- Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor; Stavudine for system suitability, European Pharmacopoeia (EP) Reference Standard; 1-[(2R,5S)-5-(Hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-(1H,3H)-dione",
            "trade_name": "Zerit",
            "abbrev_name": "d4T",
            "description": "Antiretroviral; dideoxynucleoside analog; inhibits reverse transcriptase",
            "molecular_formula": "C10H12N2O4",
            "molecular_weight": "224.21",
            "state": "solid",
            "clearance": "* Renal cl=272 mL/min [Healthy subjects receiving 80 mg PO]\n* 594 +/- 164 mL/min [HIV-infected adult and pediatric patients following 1-hour IV infusion]\n* 9.75 +/- 3.76 mL/min/kg [HIV- Exposed or -Infected Pediatric Patients(Age 5 weeks – 15 years) following 1-hour IV infusion]",
            "volume_of_distribution": "* 46 ± 21 L",
            "route_of_elimination": "",
            "protein_binding": "Negligible",
            "half_life": "0.8-1.5 hours (in adults)",
            "absorption": "Following oral administration, stavudine is rapidly absorbed (bioavailability is 68-104%).",
            "cid": "18283",
            "classification": "J",
            "indications": "Immunodeficiency; Infection; Lactic acidosis; Pancreatitis",
            "side_effects": "Dermatitis; Diarrhoea; Headache; Nausea; Neurological symptom; Neuropathy peripheral; Rash; Vomiting",
            "atc_codes": "J05AR07; J05AF04",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T234"
            ],
            "function": [
                "F06",
                "F060102"
            ],
            "references": [
                "RC03639",
                "RC03676"
            ]
        },
        {
            "compound_ID": "D0114",
            "name": "Streptozocin",
            "synonyms": "streptozocin; STREPTOZOTOCIN; 18883-66-4; streptozosin; Streptozocine; Streptozocinum; Estreptozocina; Streptozocinium; alpha-Streptozocin; streptozotocin (stz); CHEBI:9288; C8H15N3O7; N-D-Glucosyl-(2)-N'-nitrosomethylharnstoff; UNII-8H27GUR065; 8H27GUR065; 2-deoxy-2-{[methyl(nitroso)carbamoyl]amino}-alpha-D-glucopyranose; DSSTox_CID_1282; DSSTox_RID_76055; DSSTox_GSID_21282; 66395-18-4; alkylating agent; 2-Desoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose; binds to DNA; 1-methyl-1-nitroso-3-((2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)urea; Zanosar (TN); SR-05000001720; 2-deoxy-2-[[(methylnitrosoamino)carbonyl]amino]-D-glucose; NCGC00016738-01; CAS-18883-66-4; Spectrum_000960; Streptozotocin - Zanosar; Prestwick3_000732; Spectrum2_000062; Spectrum3_001087; Spectrum4_001244; Spectrum5_001047; Epitope ID:134282; N-(Methylnitrosocarbamoyl)-alpha-D-glucosamine; SCHEMBL4748; CHEMBL1603; BSPBio_000684; BSPBio_002734; KBioGR_001768; KBioSS_001440; MLS004774123; DivK1c_000531; SPECTRUM1500543; SPBio_000243; BPBio1_000754; Streptozocin (JAN/USAN/INN); DTXSID2021282; BCBcMAP01_000142; HMS501K13; KBio1_000531; KBio2_001440; KBio2_004008; KBio2_006576; KBio3_001954; BIS4356; NINDS_000531; ZX-AFC000345; HMS1921A07; HMS2092I09; HMS2097C06; HMS3714C06; Pharmakon1600-01500543; 2-Deoxy-2[[(methylnitrosoamino)-carbonyl]amino]-D-glucopyranose; ACT03364; ZINC3977737; Streptozocin, >=98.0% (HPLC); Tox21_110585; Tox21_201859; Tox21_302974; CCG-39870; MFCD00006607; NSC757321; s1312; AKOS025310730; Tox21_110585_1; API0015373; DB00428; NSC-757321; IDI1_000531; SMP1_000282; NCGC00178500-01; NCGC00178500-02; NCGC00178500-03; NCGC00178500-04; NCGC00178500-07; NCGC00256594-01; NCGC00259408-01; CC-34553; SMR001233317; SBI-0051517.P003; AB2000735; AB00513906; SW199198-2; C07313; D05932; 24975-EP2275420A1; 24975-EP2277858A1; 24975-EP2292227A2; 24975-EP2295053A1; 24975-EP2298767A1; 24975-EP2314574A1; 27771-EP2272827A1; 27771-EP2295055A2; 27771-EP2295416A2; 27771-EP2295426A1; 27771-EP2295427A1; 27771-EP2298748A2; 27771-EP2298764A1; 27771-EP2298765A1; 27771-EP2298778A1; 27771-EP2305642A2; 27771-EP2308833A2; 27771-EP2308861A1; 27771-EP2311453A1; 27771-EP2311842A2; 27771-EP2314587A1; 27773-EP2277858A1; 27773-EP2292227A2; 27773-EP2298767A1; 27773-EP2314587A1; AB00052092-03; AB00052092_04; AB00052092_05; 883S664; C-16594; Q257331; SR-01000939745; SR-01000939745-3; SR-05000001720-1; SR-05000001720-2; W-201687; Streptozocin, Vetec(TM) reagent grade, 98%, powder; N-(Methylnitrosocarbamoyl)-|A-D-glucosamine; Streptozotocin; Streptozocin, >=75% alpha-anomer basis, >=98% (HPLC), powder; alpha-D-Glucopyranose, 2-deoxy-2-(((methylnitrosoamino)carbonyl)amino)-; 3-methyl-3-nitroso-1-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea; 1-methyl-1-nitroso-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl]urea",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C8H15N3O7",
            "molecular_weight": "265.22",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "As much as 20% of the drug (or metabolites containing an N-nitrosourea group) is metabolized and/or excreted by the kidney.",
            "protein_binding": "",
            "half_life": "5-15 minutes",
            "absorption": "Poor oral absorption (17-25%)",
            "cid": "29327",
            "classification": "L",
            "indications": "",
            "side_effects": "",
            "atc_codes": "L01AD04",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0115",
            "name": "Sulindac",
            "synonyms": "sulindac; Clinoril; 38194-50-2; Arthrocine; Sulindac sulfoxide; Sulindaco; Sulindacum; Aflodac; Mobilin; Sulreuma; MK 231; Sulindacum [INN-Latin]; Sulindaco [INN-Spanish]; C20H17FO3S; CCRIS 3305; CHEBI:9352; (Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid; cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; EINECS 253-819-2; BRN 2951842; Algocetil; Artribid; Citireuma; Clisundac; Imbaral; Reumofil; Sulinol; CHEMBL15770; Sudac; 1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-, (Z)-; NCGC00015970-02; Arthrobid; Klinoril; CAS-38194-50-2; DSSTox_CID_3624; 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid; DSSTox_RID_77117; DSSTox_GSID_23624; cis-Sulindac; Sulindac (Clinoril); 2-[(1Z)-5-fluoro-1-[(4-methanesulfinylphenyl)methylidene]-2-methyl-1H-inden-3-yl]acetic acid; Clinoril (TN); MK-231; Sulindac [USAN:BAN:INN:JAN]; {(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid; SR-01000075237; Moblilin; (Z)-2-[5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl]acetic Acid; 2-(5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylene}inden-3-yl)acetic acid; 32004-68-5; EINECS 250-893-8; EINECS 256-402-3; Sulindac [USAN:USP:INN:BAN:JAN]; Tocris-1707; Clinoril;Aflodac;Sulreuma; Prestwick3_000073; Spectrum5_001024; Lopac-S-8139; S 8139; Sulindac, >=98.0%; SCHEMBL4202; SCHEMBL4203; 5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid; Lopac0_001070; BSPBio_000285; BSPBio_002890; MLS001056554; SPECTRUM1500556; Sulindac (JP17/USP/INN); BPBio1_000315; GTPL5425; DTXSID4023624; CHEBI:93811; HMS501O03; cMAP_000021; MLKXDPUZXIRXEP-MFOYZWKCSA-N; HMS1921C11; HMS2092K15; HMS2095O07; HMS2231N24; HMS3259K06; HMS3263E22; HMS3414N11; HMS3649P19; HMS3678N09; HMS3712O07; Pharmakon1600-01500556; HY-B0008; Tox21_110270; Tox21_301418; Tox21_501070; BDBM50012899; BDBM50103504; CCG-39264; NSC757344; s2007; SBB058181; AKOS015895412; cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidenyl)indene-3-acetic acid; Tox21_110270_1; CS-0569; DB00605; KS-5153; LP01070; NC00540; NSC-757344; (Z)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-[[4-(methyl-sulfinyl)phenyl]methylene]-1H-indene-3-acetic acid; 1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)-; IDI1_000601; NCGC00015970-01; NCGC00015970-03; NCGC00015970-04; NCGC00015970-05; NCGC00015970-06; NCGC00015970-07; NCGC00015970-08; NCGC00015970-11; NCGC00025268-01; NCGC00025268-02; NCGC00025268-03; NCGC00094349-01; NCGC00094349-02; NCGC00255143-01; NCGC00261755-01; BP-30208; CPD000326718; LS-81610; SAM002554933; SMR000326718; SBI-0051040.P004; Sulindac, meets USP testing specifications; AB2000418; RT-000169; AB00513800; EU-0101070; ST24026687; ST51015123; SW219748-1; U0099; 9222-EP2275420A1; 9222-EP2277565A2; 9222-EP2277566A2; 9222-EP2277567A1; 9222-EP2277568A2; 9222-EP2277569A2; 9222-EP2277570A2; 9222-EP2280008A2; 9222-EP2281815A1; 9222-EP2284166A1; 9222-EP2292280A1; 9222-EP2295055A2; 9222-EP2295409A1; 9222-EP2298764A1; 9222-EP2298765A1; 9222-EP2301933A1; 9222-EP2305640A2; 9222-EP2305652A2; 9222-EP2308872A1; 9222-EP2311453A1; 9222-EP2311827A1; 9222-EP2314585A1; 9222-EP2314590A1; 9222-EP2316829A1; C01531; D00120; W-5115; AB00052105-07; AB00052105_08; AB00052105_09; Q963093; J-008554; J-012337; SR-01000075237-2; SR-01000075237-3; SR-01000075237-5; SR-01000075237-7; BRD-A13946108-001-04-9; BRD-A13946108-001-08-0; SR-01000075237-13; Sulindac, European Pharmacopoeia (EP) Reference Standard; Sulindac, United States Pharmacopeia (USP) Reference Standard; (Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)-benzylidene)-1H-inden-3-yl)acetic acid; (Z)-5-Fluoro-2-methyl-1-[(p-methylsulfinyl)benzylidene]-1H-indene-3-acetic Acid; (Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)-phenyl]methylene]-1H-indene-3-acetic acid; {(1z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-indene-3-yl}acetic acid; 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylene]inden-1-yl]acetic acid; Sulindac|(1Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid",
            "trade_name": "Clinoril",
            "abbrev_name": "",
            "description": "nonsteroidal anti-inflammatory drug (NSAID) of the arylalkanoic acid class",
            "molecular_formula": "C20H17FO3S",
            "molecular_weight": "356.4",
            "state": "solid",
            "clearance": "* Renal cl=68.12 +/- 27.56 mL/min [NORMAL (19-41 yrs)]",
            "volume_of_distribution": "",
            "route_of_elimination": "Sulindac is excreted in rat milk; concentrations in milk were 10 to 20% of those levels in plasma. It is not known if sulindac is excreted in human milk. Approximately 50% of the administered dose of sulindac is excreted in the urine with the conjugated sulfone metabolite accounting for the major portion. Hepatic metabolism is an important elimination pathway.",
            "protein_binding": "At 1 mcg/ml concentrations, approximately 93% sulindac and 98% of its sulfide metabolite are bound to human serum albumin.",
            "half_life": "The mean half-life of sulindac is 7.8 hours while the mean half-life of the sulfide metabolite is 16.4 hours.",
            "absorption": "Approximately 90% absorbed in humans following oral administration.",
            "cid": "1548887",
            "classification": "M",
            "indications": "Ankylosing spondylitis; Arthritis; Back pain; Bedridden; Bursitis; Gout; Gouty arthritis; Mixed connective tissue disease; Osteoarthritis; Rheumatic disorder; Rheumatoid arthritis; Rotator cuff syndrome; Systemic lupus erythematosus; Tenosynovitis",
            "side_effects": "Gastrointestinal pain (0.1)",
            "atc_codes": "M01AB02",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001",
                "T002",
                "T387",
                "T408"
            ],
            "function": [
                "F01",
                "F010401",
                "F0108",
                "F0201",
                "F02010102",
                "F02010103",
                "F0206",
                "F0221",
                "F0303",
                "F05",
                "F0504",
                "F070105",
                "F070106"
            ],
            "references": [
                "RC00997",
                "RC00998",
                "RC04128",
                "RC04252",
                "RC04376",
                "RC04500",
                "RC04624",
                "RC04774",
                "RC04787",
                "RC04800",
                "RC04813",
                "RC04826",
                "RC04839",
                "RC04852",
                "RC04865"
            ]
        },
        {
            "compound_ID": "D0116",
            "name": "Tamoxifen",
            "synonyms": "tamoxifen; 10540-29-1; trans-Tamoxifen; Crisafeno; Soltamox; Tamoxifene; Diemon; Tamoxifeno; Tamoxifenum; Citofen; Istubol; Oncomox; Retaxim; Tamizam; Tamoxen; Valodex; Tamoxifene [INN-French]; Tamoxifenum [INN-Latin]; Tamoxifeno [INN-Spanish]; Tamoxifen (Z); Tamoxifen [INN:BAN]; Tamoxifen and its salts; ICI 47699; ICI-46474; CCRIS 3275; UNII-094ZI81Y45; HSDB 6782; CHEMBL83; EINECS 234-118-0; 1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; (Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; 2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; CHEBI:41774; NKANXQFJJICGDU-QPLCGJKRSA-N; (2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)dimethylamine; trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; (Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC); Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-; (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE; MFCD00010454; C26H29NO; 094ZI81Y45; Novaldex; Tomaxithen; Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-; DSSTox_CID_14187; DSSTox_RID_79121; DSSTox_GSID_34187; W-108788; 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethyl-ethanamine; Ethylamine, N,N-dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-, (Z)-; [3H]tamoxifen; Tamoxifen (INN); Tamoxifen (TN); [3H]-tamoxifen; Tamoplex (TN); SMR000059172; CAS-10540-29-1; TRANS FORM OF TAMOXIFEN; Ethanamine, 2-(4-((1Z)-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-; Tamoxifen, 7; ICI47699; (E/Z)-Tamoxifen; ICI-47699; ICI-46,474; Tocris-0999; 1ya4; Tamoxifen, >=99%; 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; Prestwick2_000146; Prestwick3_000146; Spectrum5_001417; Spectrum5_002043; UPCMLD-DP027; EC 234-118-0; SCHEMBL4084; BIDD:PXR0003; Lopac0_001203; BSPBio_000252; BSPBio_001150; BSPBio_001982; MLS001332535; MLS001332536; BIDD:ER0008; BIDD:GT0009; Tamoxifen, analytical standard; BPBio1_000278; GTPL1016; GTPL5384; DTXSID1034187; Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-; TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1)); Tamoxifen Drug Standard Solution; BDBM20607; cid_2733526; AOB5640; cMAP_000044; HMS1362J11; HMS1792J11; HMS1990J11; HMS2090N08; HMS2232C12; HMS3261D09; HMS3403J11; HMS3411P04; 7728-73-6; EBD41546; ZINC1530689; Tox21_201243; Tox21_300539; Tox21_500494; (Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine; (Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; 1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene; 2060AH; GA9513; HY-13757A; LS-393; NSC727681; AKOS022143035; AM84324; CCG-205277; CS-2870; DB00675; KS-1472; LP00494; NSC-727681; VA11813; ICI47699;Z-Tamoxifen;trans-Tamoxifen; IDI1_000258; IDI1_002170; QTL1_000079; NCGC00024928-01; NCGC00024928-03; NCGC00024928-04; NCGC00024928-05; NCGC00024928-07; NCGC00024928-08; NCGC00024928-09; NCGC00024928-10; NCGC00024928-11; NCGC00024928-12; NCGC00024928-13; NCGC00024928-14; NCGC00024928-15; NCGC00024928-16; NCGC00024928-17; NCGC00024928-18; NCGC00024928-19; NCGC00254455-01; NCGC00258795-01; NCGC00261179-01; SC-45564; SBI-0051170.P004; AX8001839; B5965; ST24049322; ST24049323; C07108; D08559; 10331-EP2270008A1; 10331-EP2270018A1; 10331-EP2272827A1; 10331-EP2272832A1; 10331-EP2275102A1; 10331-EP2277865A1; 10331-EP2277876A1; 10331-EP2280012A2; 10331-EP2281815A1; 10331-EP2289892A1; 10331-EP2292233A2; 10331-EP2292576A2; 10331-EP2292614A1; 10331-EP2292617A1; 10331-EP2295416A2; 10331-EP2295426A1; 10331-EP2295427A1; 10331-EP2298305A1; 10331-EP2298746A1; 10331-EP2298748A2; 10331-EP2298778A1; 10331-EP2298780A1; 10331-EP2301536A1; 10331-EP2301538A1; 10331-EP2301933A1; 10331-EP2305640A2; 10331-EP2305642A2; 10331-EP2305671A1; 10331-EP2305689A1; 10331-EP2308833A2; 10331-EP2308855A1; 10331-EP2308861A1; 10331-EP2311455A1; 10331-EP2311825A1; 10331-EP2311827A1; 10331-EP2311840A1; 10331-EP2311842A2; 10331-EP2316452A1; 10331-EP2316831A1; 10331-EP2316832A1; 10331-EP2316833A1; 10331-EP2316834A1; 10331-EP2374454A1; AB00053547-16; AB00053547-17; AB00053547-18; AB00053547_19; AB00053547_20; 540T291; A801229; L024126; Q412178; BRD-K93754473-001-02-9; BRD-K93754473-048-04-6; BRD-K93754473-048-05-3; BRD-K93754473-048-10-3; Tamoxifen, certified reference material, TraceCERT(R); 1-[4-(2-Dimethylaminoethoxy)phenyl]-1,2-diphenyl-1-butene; (Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine; (Z)-2-(4-(1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethan-1-amine; (Z)-2-(4-(1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethanamine; 2-[4-[(1Z)-1,2-Diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethylethanamine; 2-[4-[(Z)-1,2-di(phenyl)but-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-{4-[(1Z)-1,2-Diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethan-1-amine; (Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene, trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine",
            "trade_name": "Nolvadex, Genox, Tamifen",
            "abbrev_name": "",
            "description": "non-steroidal antiestrogen used to treat estrogen receptor positive breast cancers; selective estrogen receptor modulator",
            "molecular_formula": "C26H29NO",
            "molecular_weight": "371.5",
            "state": "solid",
            "clearance": "Clearance (CL/F) as body weight adjusted in female pediatric patients was approximately 2.3-fold higher than in female breast cancer patients.",
            "volume_of_distribution": "",
            "route_of_elimination": "65% of the dose was excreted from the body over 2 weeks in which fecal excretion was the primary route of elimination. Tamoxifen is excreted mainly as polar conjugates, with unchanged drug and unconjugated metabolites accounting for less than 30% of the total fecal radioactivity.",
            "protein_binding": "",
            "half_life": "The decline in tamoxifen plasma concentrations is biphasic with a terminal elimination half-life of approximately 5 to 7 days. The estimated half-life of N-desmethyl tamoxifen is 14 days.",
            "absorption": "When a single oral dose of 20 mg is given, the average peak plasma concentration (Cmax) is 40 ng/mL which occurred approximately 5 hours after dosing (Tmax). The Cmax of N-desmethyl tamoxifen is 15 ng/mL. Steady-state concentrations for tamoxifen is achieved in 4 weeks, while steady-state concentrations for N-desmethyl tamoxifen is achieved in 8 weeks.",
            "cid": "2733526",
            "classification": "L",
            "indications": "Adenocarcinoma; Albright's disease; Bone cancer metastatic; Bone pain; Brain neoplasm; Breast cancer stage IV; Carcinoid tumour; Cerebrovascular accident; Contralateral breast cancer; Deep vein thrombosis; Embolism; Endometrial cancer; Hyperplasia; Intraductal proliferative breast lesion; Lobular breast carcinoma in situ; Malignant melanoma; Menarche; Neoplasm; Neoplasm malignant; Pancreatic carcinoma; Pulmonary embolism; Sarcoma; Soft tissue disorder; Thrombocytopenia",
            "side_effects": "Dry mouth (0.02); Vulvovaginal candidiasis (0.04); Abdominal pain; Alopecia; Amenorrhoea; Anaemia; Anxiety; Arthralgia; Arthritis; Arthropathy; Aspartate aminotransferase increased; Asthenia; Back pain; Blood bilirubin increased; Blood creatinine increased; Bone pain; Breast neoplasm; Breast pain; Bronchitis; Cardiovascular disorder; Cataract; Chest pain; Constipation; Cough; Cyst; Decreased appetite; Deep vein thrombosis; Depression; Dermatitis; Diarrhoea; Dizziness; Dyspepsia; Dyspnoea; Embolism; Endometrial cancer; Fatigue; Fluid retention; Flushing; Fracture; Gastrointestinal disorder; Gastrointestinal pain; Headache; Hip fracture; Hot flush; Hypercholesterolaemia; Hyperhidrosis; Hypersensitivity; Hypertension; Infection; Influenza; Injury; Insomnia; Lymphoedema; Menopausal symptoms; Menstrual disorder; Menstruation irregular; Mood swings; Multiple fractures; Musculoskeletal discomfort; Musculoskeletal pain; Myalgia; Nausea; Neoplasm; Oedema; Oedema peripheral; Oligomenorrhoea; Osteoarthritis; Osteoporosis; Ovarian cyst; Pain; Paraesthesia; Pharyngitis; Phlebitis superficial; Platelet count decreased; Pulmonary embolism; Rash; Sepsis; Sinusitis; Thrombocytopenia; Urinary tract infection; Vaginal discharge; Vaginal haemorrhage; Vaginal infection; Vaginal inflammation; Vomiting; Vulvovaginitis; Weight decreased; Weight increased",
            "atc_codes": "L02BA01",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001",
                "T002",
                "T004",
                "T005",
                "T019",
                "T021",
                "T387",
                "T408"
            ],
            "function": [
                "F010401",
                "F0105",
                "F010503",
                "F0108",
                "F0201",
                "F020103",
                "F020403",
                "F02060101",
                "F0303",
                "F0504"
            ],
            "references": [
                "RC00197",
                "RC00198",
                "RC00199",
                "RC00200",
                "RC00201",
                "RC00212",
                "RC00213",
                "RC00214",
                "RC00215",
                "RC00216",
                "RC00217",
                "RC00218",
                "RC00219",
                "RC00220",
                "RC00221",
                "RC00954",
                "RC00955",
                "RC00956",
                "RC00957",
                "RC00999",
                "RC01000",
                "RC03534",
                "RC03535",
                "RC03557",
                "RC03824",
                "RC04131",
                "RC04255",
                "RC04379",
                "RC04503",
                "RC04656",
                "RC04627",
                "RC04670",
                "RC04685",
                "RC04895"
            ]
        },
        {
            "compound_ID": "D0117",
            "name": "Telbivudine",
            "synonyms": "Telbivudine; Epavudine; 2'-Deoxy-L-thymidine; L-Thymidine; beta-L-Thymidine; Tyzeka; L-dT; 3424-98-4; Telbivudin; Sebivo; L-Deoxythymidine; NV-02B; LDT600; NV 02B; LdT; UNII-2OC4HKD3SF; CHEBI:63624; 1-(2-Deoxy-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione; 2OC4HKD3SF; 26879-47-0; 1-(2-deoxy-beta-L-ribofuranosyl)-5-methyluracil; 1-((2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; Thymine, 1-(2-deoxy-beta-L-erythro-pentofuranosyl)-; Telbivudine [USAN]; beta-L-2'-Deoxythymidine; 2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-b-L-erythro-pentofuranosyl)-5-methyl-; 1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione; LLT; Tyzeka (TN); NB 02B; Telbivudine (USAN/INN); Telbivudine [USAN:INN:BAN]; Sebivo;Tyzeka; LDT-600; 5-methyl-l-uridine; 2-Deoxy-L-thymidine; b-L-2'-deoxy-thymidine; 1-(2-Deoxy-beta-L-erythropentafuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione; Telbivudine(Tyzeka, Sebivo); SCHEMBL124279; Telbivudine (Sebivo, Tyzeka); CHEMBL374731; Epavudine;L-Thymidine;NV 02B; ZINC2159; Telbivudine, >=98% (HPLC); DTXSID30187813; IQFYYKKMVGJFEH-CSMHCCOUSA-N; HY-B0017; BDBM50088372; CT-990; GC4386; MFCD02683612; s1651; AKOS025117349; AC-5632; API0025947; CS-1934; DB01265; SB20806; 1-(2-Deoxy-beta-L-erythro-pentofuranosyl)-5-methyl-2,4(1H,3H)-Pyrimidinedione; NCGC00346560-01; 1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione; AS-35209; AB2000195; LS-186402; LS-187347; SW220236-1; D06675; AB01274717-01; AB01274717_02; Q413621; BRD-K15976406-001-01-7; Thymine, 1-(2-deoxy-.beta.-L-erythro-pentofuranosyl)-; Z2574360267; 1-[(2s,4r,5s)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione; 1-((2S,4S,5S)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C10H14N2O5",
            "molecular_weight": "242.23",
            "state": "solid",
            "clearance": "* 7.6 +/- 2.9 L/h [Normal renal function (Clcr>80 mL/min)]\n* 5.0 +/- 1.2 L/h [Mild renal function impairement (Clcr=50-80 mL/min)]\n* 2.6 +/- 1.2 L/h [Moderate renal function impairement (Clcr=30-49 mL/min)]\n* 0.7 +/- 0.4 L/h [Severe renal function impairement (Clcr<30 mL/min)]",
            "volume_of_distribution": "",
            "route_of_elimination": "Telbivudine is eliminated primarily by urinary excretion of unchanged drug.",
            "protein_binding": "In vitro binding of telbivudine to human plasma proteins is low (3.3%).",
            "half_life": "Approximately 15 hours.",
            "absorption": "Absorbed following oral administration. Telbivudine absorption and exposure were unaffected when a single 600–mg dose was administered with a high–fat (~55 g), high–calorie (~950 kcal) meal.",
            "cid": "159269",
            "classification": "J",
            "indications": "",
            "side_effects": "",
            "atc_codes": "J05AF11",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0118",
            "name": "Tenofovir",
            "synonyms": "Tenofovir; 147127-20-6; PMPA; (R)-9-(2-Phosphonomethoxypropyl)adenine; PMPA gel; (R)-PMPA; Truvada; (R)-9-[2-(Phosphonomethoxy)propyl]adenine; UNII-W4HFE001U5; (R)-(((1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)PHOSPHONIC ACID; GS-1278; W4HFE001U5; CHEBI:63625; ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid; 9-[(R)-2-(phosphonomethoxy)propyl]adenine; (R)-(1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methylphosphonic acid; Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-; D,L-Tenofovir; GS 1275; Q-201787; Viread (prodrug for Tenofovir); Tenofovir gel; [(1R)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methylphosphonic acid; (((1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl)phosphonic acid; (R)-[[2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic acid; {[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl}phosphonic acid; (R)-9-(Phosphonomethoxypropyl)adenine; GNA & Tenofovir; HHA & Tenofovir; TFV gel; 9-PMPA; PMPA-(R); Tenofovir [USAN:INN:BAN]; anh. tenofovir; Phosphonic acid, (((1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)-; Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-; anhydrous tenofovir; Phosphonic acid, ((2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)-, (R)-; tenofovir (anh.); AK-33334; (R)-9-(2-Phosphonoylmethoxypropyl)adenine; Tenofovir (Viread); PubChem9452; tenofovir (anhydrous); GS 1278; KS-5021; Tenofovir,TDF,PMPA/; CHEMBL483; EC 604-571-2; SCHEMBL39724; KSC525E7B; Tenofovir gel (GS-1278); DTXSID9040132; Tenofovir, >=98% (HPLC); CTK4C5270; SGOIRFVFHAKUTI-ZCFIWIBFSA-N; BCPP000049; HMS3264H05; ZINC1543475; ABP000917; AC-760; BG0625; CP-558; AKOS015856701; AKOS015894941; ACN-029240; API0015388; CS-1609; BR-33334; HY-13910; SC-01187; AB0017664; AX8018435; TR-035738; AM20090678; FT-0601652; ST24033314; (R)-(+)-9-[2-Phosphonylmethoxyethyl]adenine; (R)-9-[2-(phosphonomethoxy) propyl] adenine; C17407; J90012; S-2389; 24230-EP2298783A1; 24230-EP2314590A1; AB01274787-01; AB01274787_02; AB01274787_03; 114611-EP2272516A2; 114611-EP2298783A1; 127T206; Q155954; SR-01000883934; SR-01000883934-1; BRD-K15891719-001-02-8; [[(1R)-2(6-Amino-9H-Purin-9-Yl)-1-Methylethoxy]Methyl]Phosphonic Acid; [2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYLPHOSPHONIC ACID; Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA)",
            "trade_name": "Viread",
            "abbrev_name": "PMPA; TFV",
            "description": "antiviral; nucleotide analog reverse-transcriptase inhibitor (NtRTI); inhibits viral reverse transcriptase; tenofovir is an acyclic analog of deoxyadenosine 5'-monophosphate (d-AMP);",
            "molecular_formula": "C9H14N5O4P",
            "molecular_weight": "287.21",
            "state": "solid",
            "clearance": "The clearance of tenofovir is highly dependent on the patient renal stage and hence the clearance rate in patients with renal impairment is reported to be of 134 ml/min while in patients with normal function the clearance rate can be of 210 ml/min.[A178525]",
            "volume_of_distribution": "Accumulation of tenofovir in plasma is related to the presence of nephrotoxic effects.[A178060] It is reported that tenofovir presents a volume of distribution of 0.813 L/kg.[A16539]",
            "route_of_elimination": "Tenofovir is eliminated in the urine by tubular secretion and glomerular filtration. The elimination of this compound is driven by the activity of the human organic anion transporters 1 and 3 and its secretion is mainly ruled by the activity of the multidrug resistance-associated protein 4.[A178060]",
            "protein_binding": "Tenofovir is minimally bound to plasma proteins and only about 7.2% of the administered dose is found in the bound state.[A16539]",
            "half_life": "The reported half-life of tenofovir is of 32 hours.[A178231]",
            "absorption": "Tenofovir as the active moiety presents a very low bioavailability when orally administered. Hence, the administration of this active agent is required to be under its two prodrug forms, [tenofovir disoproxil] and [tenofovir alafenamide]. This reduced absorption is suggested to be related to the presence of two negative charges among its structure. This negative charge limits its cellular penetration, and its passive diffusion across cellular membranes and intestinal mucosa hindering its availability for oral administration.[A178060]\n\nIntravenous tenofovir has been shown to produce a maximum plasma concentration of 2500 ng/ml with an AUC of 4800 ng.h/ml.[A18473]",
            "cid": "464205",
            "classification": "J",
            "indications": "Chronic hepatitis B; Foetor hepaticus; Hepatitis B e antigen positive; Hepatocellular injury; Infection; Liver disorder",
            "side_effects": "Fatigue (0.08); Upper respiratory tract infection (0.05); Abdominal pain; Asthenia; Back pain; Body temperature increased; Chest pain; Decreased appetite; Depression; Dermatitis; Diarrhoea; Dizziness; Dyspepsia; Fasting; Flatulence; Gastrointestinal pain; Glycosuria; Headache; Hyperhidrosis; Insomnia; Musculoskeletal discomfort; Myalgia; Nausea; Neuropathy peripheral; Pain; Pneumonia; Rash; Vomiting; Weight decreased",
            "atc_codes": "J05AF07",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T234"
            ],
            "function": [
                "F020103",
                "F060102"
            ],
            "references": [
                "RC01014",
                "RC03678"
            ]
        },
        {
            "compound_ID": "D0119",
            "name": "Thioridazine",
            "synonyms": "thioridazine; Mellaril; Thioridazin; 50-52-2; Melleril; Meleril; Malloryl; Sonapax; Mellaril-S; Mallorol; Mellerets; Mellerette; Melleretten; Tioridazina; dl-Thioridazine; Thioridazinum; Melleryl; TP-21; Melleril (liquid); (+-)-Thioridazine; Thioridazine prolongatum; 10-(2-(1-Methylpiperidin-2-yl)ethyl)-2-(methylthio)-10H-phenothiazine; Orsanil; Thioridazinum [INN-Latin]; Tioridazina [INN-Spanish]; 2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine; 3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine; HSDB 3189; C21H26N2S2; EINECS 200-044-2; CHEMBL479; 10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylthio)phenothiazine; 10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine; 10H-Phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylthio)-; AI3-51923; CHEBI:9566; NCGC00016059-05; Mellarit; Thiozine; Phenothiazine, 10-((1-methyl-2-piperidyl)ethyl)-2-(methylthio)-; DSSTox_CID_3656; 10H-Phenothiazine, 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylthio)-; DSSTox_RID_77130; DSSTox_GSID_23656; Thioxidazine; Thioridazine, prolongatum; Phenothiazine, 10-[2-(1-methyl-2-piperidyl)ethyl]-2-(methylthio)-; 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylthio)-10H-phenothiazine; CAS-50-52-2; Mellaril-S (TN); Thioridazine [USAN:INN:BAN]; NSC186060; Thioridazine (USP/INN); Mellaril (*Hydrochloride*); Thioridazine [USAN:USP:INN:BAN]; Mellaril (Salt/Mix); Spectrum_001066; Prestwick0_000078; Prestwick1_000078; Prestwick2_000078; Prestwick3_000078; Spectrum2_001332; Spectrum3_000585; Spectrum4_000356; Spectrum5_001062; (.+/-.)-Thioridazine; Biomol-NT_000017; SCHEMBL9566; Lopac0_001252; BSPBio_000295; BSPBio_002030; GTPL100; KBioGR_000791; KBioGR_002308; KBioSS_001546; KBioSS_002310; DivK1c_000066; SPBio_001483; SPBio_002216; BPBio1_000325; BPBio1_001175; DTXSID6023656; SCHEMBL12434241; KBio1_000066; KBio2_001546; KBio2_002308; KBio2_004114; KBio2_004876; KBio2_006682; KBio2_007444; KBio3_001530; KBio3_002788; cMAP_000015; KLBQZWRITKRQQV-UHFFFAOYSA-N; NINDS_000066; HMS2090J04; BCP19922; Tox21_110294; 6960AB; BDBM50002338; NS-835; Tox21_110294_1; API0003283; CCG-205326; DB00679; MCULE-7796139302; IDI1_000066; NCGC00016059-03; NCGC00016059-04; NCGC00016059-07; NCGC00016059-08; NCGC00016059-09; NCGC00016059-10; NCGC00016059-11; NCGC00016059-13; NCGC00016059-14; NCGC00089809-02; NCGC00089809-03; SC-19270; SBI-0051219.P004; AX8153985; LS-105605; AB00053553; 1452-EP2272537A2; 1452-EP2275420A1; 1452-EP2298776A1; D00373; Q58375; AB00053553-16; AB00053553_17; AB00053553_18; 242T875; L001321; BRD-A84481105-003-17-2; 10-[2-(1-Methyl-2-piperidinyl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine; 10-[2-(1-methyl-piperidin-2-yl)-ethyl]-2-methylsulfanyl-10h-phenothiazine; 10H-Phenothiazine, 10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylthio-; (Thioridazine)10-[2-(1-Methyl-piperidin-2-yl)-ethyl]-2-methylsulfanyl-10H-phenothiazine; 10-[2-(1-Methyl-2-piperidinyl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine #; 10-[2-(1-Methyl-piperidin-2-yl)-ethyl]-2-methylsulfanyl-10H-phenothiazine (thioridazine); Thioridazine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material",
            "trade_name": "Mellaril , Melleril",
            "abbrev_name": "",
            "description": "phenothiazine antipsychotic",
            "molecular_formula": "C21H26N2S2",
            "molecular_weight": "370.6",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "0.95",
            "half_life": "21-25 hours",
            "absorption": "0.6",
            "cid": "5452",
            "classification": "N",
            "indications": "",
            "side_effects": "",
            "atc_codes": "N05AC02",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001"
            ],
            "function": [
                "F010401",
                "F020103",
                "F020403"
            ],
            "references": [
                "RC00903",
                "RC01009",
                "RC04896"
            ]
        },
        {
            "compound_ID": "D0120",
            "name": "Tipranavir",
            "synonyms": "Tipranavir; 174484-41-4; Aptivus; PNU-140690; TPV; UNII-ZZT404XD09; U-140690; PNU 140690; ZZT404XD09; CHEBI:63628; 3'-((1R)-1-((6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-phenethyl-6-propyl-2H-pyran-3-yl)propyl)-5-(trifluoromethyl)-2-pyridinesulfonanilide; N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE; N-(3-{(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide; C31H33F3N2O5S; Aptivus(TM); 2-Pyridinesulfonamide, N-[3-[(1R)-1-[(6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-; Tipranavir (INN); Aptivus (TN); Tipranavir [INN:BAN]; HSDB 8083; NCGC00182028-01; 2-Pyridinesulfonamide, N-(3-((1R)-1-((6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)-; N-{3-[(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}-5-(trifluoromethyl)pyridine-2-sulfonamide; U 140690; 1d4y; 2o4l; 2o4n; 2o4p; DSSTox_CID_28548; DSSTox_RID_82820; DSSTox_GSID_48622; SCHEMBL40629; SCHEMBL40630; N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-phenethyl-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide; CHEMBL183041; CHEMBL222559; DTXSID6048622; CTK8E7540; Tox21_112962; AKOS030254403; ZINC100016058; ZINC100022637; CS-1210; DB00932; NCGC00379087-01; HY-15148; RT-016034; CAS-174484-41-4; FT-0675248; X2005; D08605; W-5247; A811642; Q423404; J-010991; 2-Pyridinesulfonamide, N-(3-(1-(5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)-, (R-(R*,R*))-; N-(3-((R)-1-((R)-6-hydroxy-4-oxo-2-phenethyl-2-propyl-3,4-dihydro-2H-pyran-5-yl)propyl)phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide; N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-phenethyl-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide; N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide; N-[3-[(1R)-1-[(2R)-6-oxidanyl-4-oxidanylidene-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C31H33F3N2O5S",
            "molecular_weight": "602.7",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "Extensive (> 99.9%), to both human serum albumin and &alpha;-1-acid glycoprotein.",
            "half_life": "5-6 hours",
            "absorption": "Absorption is limited, although no absolute quantification of absorption is available.",
            "cid": "54682461",
            "classification": "J",
            "indications": "Acquired immunodeficiency syndrome; Autoimmune disorder; Drug interaction",
            "side_effects": "Abdominal pain (0.034); Weight decreased (0.022); Alanine aminotransferase increased; Amylase increased; Anaemia; Aspartate aminotransferase increased; Body temperature increased; Dermatitis; Diarrhoea; Nausea; Rash; Vomiting; White blood cell count decreased",
            "atc_codes": "J05AE09",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [
                "F0108"
            ],
            "references": [
                "RC02155",
                "RC02776",
                "RC03397"
            ]
        },
        {
            "compound_ID": "D0121",
            "name": "Tolcapone",
            "synonyms": "Tolcapone; 134308-13-7; Tasmar; Ro 40-7592; (3,4-Dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone; 3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone; Ro-40-7592; (3,4-dihydroxy-5-nitrophenyl)(p-tolyl)methanone; (3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone; UNII-CIF6334OLY; CCRIS 7904; Methanone, (3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-; CHEMBL1324; CIF6334OLY; C14H11NO5; CHEBI:63630; Ro-407592; NCGC00181767-01; DSSTox_CID_3685; DSSTox_RID_77146; DSSTox_GSID_23685; Q-201840; Talcapone; Tolcapone [USAN:INN]; Tasmar (TN); CAS-134308-13-7; Tolcaponum; Tolcapon; Tolcapona; Tolcapone (JAN/USAN/INN); 3,4-dihydroxy-5'-methyl-5-nitrobenzophenone; Tolcapone [USAN:USP:INN:BAN]; TCW; SCHEMBL33869; MLS006012044; BIDD:GT0032; GTPL6646; DTXSID3023685; Tolcapone, >=98% (HPLC); CTK8E7392; KS-00000XJL; Methanone,(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl); 3s68; MIQPIUSUKVNLNT-UHFFFAOYSA-N; HMS2089K14; HMS3652M17; HMS3715D16; BCP09156; EBD47899; Tox21_112963; Tox21_302414; AC-791; BDBM50108877; BG0651; MFCD00866569; s4021; ZINC35342789; AKOS015902328; Tox21_112963_1; API0004441; AS-7085; CCG-221217; CS-1173; DB00323; KS-1314; NCGC00181767-02; NCGC00181767-03; NCGC00255188-01; AK671145; CC-35089; HY-17406; LS-91226; SMR001614567; AB0012754; AX8154334; DB-013561; RT-016044; FT-0082597; FT-0631149; SW219511-1; 3,4-dihydroxy-5-nitro-4'-methylbenzophenone; 4'-methyl-3,4-dihydroxy-5-nitrobenzophenone; C07949; D00786; W-5146; AB01275441-01; AB01275441_02; (3,4-Dihydroxy-5-nitro-phenyl)-p-tolyl-methanone; 308T137; C-17206; Q413840; SR-05000001444; SR-05000001444-1; BRD-K10852020-001-01-1; 5-[(4-METHYLPHENYL)CARBONYL]-3-NITROBENZENE-1,2-DIOL; Tolcapone, United States Pharmacopeia (USP) Reference Standard; InChI=1/C14H11NO5/c1-8-2-4-9(5-3-8)13(17)10-6-11(15(19)20)14(18)12(16)7-10/h2-7,16,18H,1H",
            "trade_name": "",
            "abbrev_name": "",
            "description": "methyl-transferase inhibitors; inhibits the enzyme catechol-O-methyl transferase (COMT); uncoupler; contain the nitrophenol protonophore",
            "molecular_formula": "C14H11NO5",
            "molecular_weight": "273.24",
            "state": "solid",
            "clearance": "* 7 L/h",
            "volume_of_distribution": "* 9 L",
            "route_of_elimination": "Tolcapone is almost completely metabolized prior to excretion, with only a very small amount (0.5% of dose) found unchanged in urine. The glucuronide conjugate of tolcapone is mainly excreted in the urine but is also excreted in the bile.",
            "protein_binding": "> 99.9% (to serum albumin)",
            "half_life": "2-3.5 hours",
            "absorption": "Rapidly absorbed (absolute bioavailability is about 65%)",
            "cid": "4659569",
            "classification": "N",
            "indications": "Parkinson's disease; Parkinsonism",
            "side_effects": "Abdominal pain; Abnormal dreams; Agitation; Alopecia; Arthritis; Asthenia; Body temperature increased; Cataract; Chest discomfort; Chest pain; Chromaturia; Confusional state; Constipation; Decreased appetite; Diarrhoea; Discomfort; Dizziness; Dry mouth; Dyskinesia; Dyspepsia; Dyspnoea; Endophthalmitis; Euphoric mood; Fall; Fatigue; Feeling abnormal; Flatulence; Gastrointestinal pain; Haemoglobin; Haemorrhage; Hallucination; Headache; Hyperhidrosis; Hyperkinesia; Hypertonia; Hypokinesia; Hypotension; Ill-defined disorder; Influenza; Irritability; Loss of consciousness; Malaise; Mental retardation; Micturition disorder; Muscle spasms; Musculoskeletal stiffness; Nausea; Neck pain; Neoplasm skin; Ocular hyperaemia; Panic reaction; Paraesthesia; Shock; Sinus congestion; Sleep disorder; Somnolence; Syncope; Upper respiratory tract infection; Urinary tract infection; Uterine neoplasm; Vomiting",
            "atc_codes": "N04BX01",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001",
                "T002",
                "T408"
            ],
            "function": [
                "F0105",
                "F010503",
                "F010701",
                "F0108",
                "F0201",
                "F02010202",
                "F02040101",
                "F0303"
            ],
            "references": [
                "RC00524",
                "RC00525",
                "RC00958",
                "RC03506",
                "RC03826",
                "RC04135",
                "RC04259",
                "RC04383",
                "RC04507",
                "RC04631"
            ]
        },
        {
            "compound_ID": "D0122",
            "name": "Tolfenamic Acid",
            "synonyms": "tolfenamic acid; 13710-19-5; Clotam; Tolfedine; 2-[(3-Chloro-2-methylphenyl)amino]benzoic Acid; N-(3-Chloro-2-methylphenyl)anthranilic acid; Acido tolfenamico; Acide tolfenamique; Acidum tolfenamicum; 2-(3-Chloro-2-methylanilino)benzoic acid; GEA 6414; N-(2-Methyl-3-chlorophenyl)anthranilic acid; UNII-3G943U18KM; N-(3-Chloro-o-tolyl)-anthranilic acid; Benzoic acid, 2-[(3-chloro-2-methylphenyl)amino]-; Anthranilic acid, N-(3-chloro-o-tolyl)-; CHEBI:32243; 3G943U18KM; NCGC00016705-05; Bifenac; CAS-13710-19-5; 2-((3-Chloro-2-methylphenyl)amino)benzoic acid; DSSTox_CID_25409; DSSTox_RID_80860; DSSTox_GSID_45409; Tolfine; 2-([3-Chloro-2-methylphenyl]amino)benzoic acid; SR-01000000102; Tolfenamic; tolfenamic-acid; Prestwick_579; Clotam (TN); Spectrum_001263; ACMC-209cat; Tolfenamic acid, NSAID; Prestwick0_000205; Prestwick1_000205; Prestwick2_000205; Prestwick3_000205; Spectrum2_001446; Spectrum3_001762; Spectrum4_000238; Spectrum5_001143; Oprea1_692996; SCHEMBL25190; Tolfenamic acid (JAN/INN); BSPBio_000189; BSPBio_003223; KBioGR_000935; KBioSS_001743; flufenamic acid analogue, 32; MLS000028531; BIDD:GT0343; SPECTRUM1501198; SPBio_001311; SPBio_002110; BPBio1_000209; CHEMBL121626; cid_610479; GTPL8769; ZINC2188; DTXSID1045409; BDBM35905; KBio2_001743; KBio2_004311; KBio2_006879; KBio3_002723; YEZNLOUZAIOMLT-UHFFFAOYSA-; YEZNLOUZAIOMLT-UHFFFAOYSA-N; HMS1568J11; HMS1921P13; HMS2090D04; HMS2095J11; HMS2230J13; HMS3370A02; HMS3651E06; HMS3712J11; Pharmakon1600-01501198; HY-B0335; KS-00000H6I; Tox21_110570; ANW-20211; CCG-39189; NSC757873; s1959; SBB058187; AKOS012836098; Tox21_110570_1; 2-(3-Chloro-o-toluidino)benzoic Acid; API0002084; CS-2377; DB09216; MCULE-9901889833; NSC-757873; SEL10850963; 2(3-Chloro-2-methylanilino)benzoic acid; NCGC00016705-01; NCGC00016705-02; NCGC00016705-03; NCGC00016705-04; NCGC00016705-06; NCGC00016705-07; NCGC00016705-10; NCGC00022587-03; NCGC00022587-04; NCGC00022587-05; AK305709; AS-13748; DA-11289; n-(3-chloro-ortho-tolyl)anthranilic acid; SMR000058289; SBI-0051687.P002; AB0032595; AB2000392; TC-108956; 2-(3-Chloro-2-methylanilino)benzoic acid #; AB00052244; FT-0652603; ST51015128; SW196753-3; UNM000001237003; X5948; 2-(3-chloro-2-methylphenylamino)benzoic acid; D01183; J10240; Q59412; AB00052244-15; AB00052244_16; AB00052244_17; A807198; Benzoic acid, 2-(3-chloro-2-methylphenylamino)-; 2-[(3-chloranyl-2-methyl-phenyl)amino]benzoic acid; J-006962; SR-01000000102-2; SR-01000000102-3; Tolfenamic acid, VETRANAL(TM), analytical standard; BRD-K50133271-001-05-4; BRD-K50133271-001-10-4; Benzoic acid, 2-((3-chloro-2-methylphenyl)amino)- (9CI); Tolfenamic acid, European Pharmacopoeia (EP) Reference Standard; Tolfenamic Acid, Pharmaceutical Secondary Standard; Certified Reference Material; InChI=1/C14H12ClNO2/c1-9-11(15)6-4-8-12(9)16-13-7-3-2-5-10(13)14(17)18/h2-8,16H,1H3,(H,17,18)",
            "trade_name": "Clotam, Tufnil",
            "abbrev_name": "",
            "description": "anthranilic acid derivatives (or fenamate) class of NSAID drugs; COX inhibitor",
            "molecular_formula": "C14H12ClNO2",
            "molecular_weight": "261.7",
            "state": "solid",
            "clearance": "The estimated clearance rate of tolfenamic acid is 0.142-0.175 L.h/kg.[A31842] When tested intravenously, the reported clearance rate was 72.4 ml.h/kg.[A31849]",
            "volume_of_distribution": "The volume of distribution is of 1.79-3.2 L/kg.[A31842] When tested intravenously, the reported steady-state volume of distribution was 0.33 L/kg.[A31849]",
            "route_of_elimination": "Tolfenamic acid is cleared relatively fast and it undergoes by hepatic metabolism where the produced metabolites are renally cleared as glucuronic acid conjugates.[A31851] Most of the elimination occurs by extrarenal mechanisms in which the unchanged drug together with its glucuronide in urine accounts for only 8.8% of the administered dose.[A7838]",
            "protein_binding": "Tolfenamic acid presents high protein binding properties reaching 99.7% of the administered dose.[A7838] Studies have studied the changes in protein binding depending on the presence of certain disorders that modify the dialysis equilibrium. These studies verify that modifications in blood creatinine, urea and bilirubin can significantly alter the concentration of unbound tolfenamic acid. The main binding structure is predicted to be related to lipid membrane structures.[A31850]",
            "half_life": "The estimated half-life of tolfenamic acid is 8.01-13.50 hours.[A31842] When tested intravenously, the reported half-life was 6.1h.[A31849]",
            "absorption": "Tolfenamic acid pharmacokinetic is marked by a short tmax of 0.94-2.04 h.[A31842] It also presented a linear pharmacokinetic profile with an AUC from 13-50 mcg/ml.h if administered in a dose of 2-8 mg/kg respectively.[A31843] The oral absorption is delayed and it gives a mean lag-time to absorption of 32 min. The peak plasma concentration of 11.1 mcg/ml.[A31849] The bioavailability of tolfenamic acid is around 75%.[A31851]",
            "cid": "610479",
            "classification": "M",
            "indications": "",
            "side_effects": "",
            "atc_codes": "M01AG02",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001",
                "T408"
            ],
            "function": [
                "F01",
                "F010502",
                "F0108",
                "F0201",
                "F02010102",
                "F02010103",
                "F0206",
                "F0221",
                "F0303",
                "F0504",
                "F070105",
                "F070106"
            ],
            "references": [
                "RC02157",
                "RC02778",
                "RC03399",
                "RC03805",
                "RC04137",
                "RC04261",
                "RC04385",
                "RC04509",
                "RC04633",
                "RC04766",
                "RC04779",
                "RC04792",
                "RC04805",
                "RC04818",
                "RC04831",
                "RC04844",
                "RC04857"
            ]
        },
        {
            "compound_ID": "D0123",
            "name": "Tolmetin",
            "synonyms": "tolmetin; 26171-23-3; 1-Methyl-5-p-toluoylpyrrole-2-acetic acid; Tolectin; Tolmetine; Tolmetinum; Tolmetina; Tolmetino; Tolmetina [DCIT]; McN-2559; Tolmetine [INN-French]; Tolmetinum [INN-Latin]; Tolmetino [INN-Spanish]; 1H-Pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)-; MCN 2559; 2-(1-METHYL-5-(4-METHYLBENZOYL)-1H-PYRROL-2-YL)ACETIC ACID; UNII-D8K2JPN18B; 1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid; 5-(p-Toluoyl)-1-methylpyrrole-2-acetic acid; HSDB 3403; Acido 1-metil-5-(p-tolnil)-pirrol-2-acetico; EINECS 247-497-2; Pyrrole-2-acetic acid, 1-methyl-5-p-toluoyl-; BRN 0485305; CHEMBL1020; D8K2JPN18B; 1-Methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetic acid; Acido 1-metil-5-(p-tolnil)-pirrol-2-acetico [Spanish]; 2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetic acid; CHEBI:71941; UPSPUYADGBWSHF-UHFFFAOYSA-N; [1-Methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetic acid; 1-Methyl-5-p-toluoyl-pyrrole-2-acetic acid; Tolmetin Sodium, Dihydrate; Tolmetin [USAN:BAN:INN]; Tolmetin (USAN/INN); McN-2559-21-98; Tolmetin [USAN:INN:BAN]; 2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetic acid; PubChem15045; Spectrum_000935; Prestwick0_000856; Prestwick1_000856; Prestwick2_000856; Prestwick3_000856; Spectrum2_001205; Spectrum3_000603; Spectrum4_000359; Spectrum5_001194; SCHEMBL3150; Oprea1_869397; BSPBio_000871; BSPBio_002106; KBioGR_000797; KBioSS_001415; 5-22-06-00392 (Beilstein Handbook Reference); BIDD:GT0468; DivK1c_000213; SPBio_000990; SPBio_002792; BPBio1_000959; GTPL7311; ZINC2191; DTXSID2043951; CTK1A2122; KBio1_000213; KBio2_001415; KBio2_003983; KBio2_006551; KBio3_001606; NINDS_000213; HMS2090D06; BCP09085; KS-00000H6J; ANW-52106; BDBM50295287; AKOS015850645; API0009078; CS-W008734; DB00500; GS-6529; ACM26171233; IDI1_000213; AK-34409; BR-34409; SBI-0051537.P002; AB0023814; AX8154345; LS-136618; TR-011846; 4CH-007739; FT-0649942; ST24027131; W4953; 1-methyl- 5-(p-toluoyl)pyrrole-2-acetic acid; C07149; D02355; S-3564; 171T233; A818238; 1-Methyl-5-(4-methylbenzoyl)pyrrole-2-acetic acid; J-504975; Q3992411; BRD-K82562631-236-02-0; BRD-K82562631-325-03-9; 1H-Pyrrole-2-aceticacid, 1-methyl-5-(4-methylbenzoyl)-; [1-Methyl-5-(4-methyl-benzoyl)-1H-pyrrol-2-yl]-acetic acid; [1-Methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetic acid #; 2-[1-methyl-5-(4-methylphenyl)carbonyl-pyrrol-2-yl]ethanoic acid; 2-[1-methyl-5-[(4-methylphenyl)-oxomethyl]-2-pyrrolyl]acetic acid; [1-Methyl-5-(4-methyl-benzoyl)-1H-pyrrol-2-yl]-acetic acid(tolmetin); 2-{1-methyl-5-[(4-methylphenyl)carbonyl]-1H-pyrrol-2-yl}acetic acid; TLT",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C15H15NO3",
            "molecular_weight": "257.28",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "Biphasic elimination from the plasma consisting of a rapid phase with a half-life of one to 2 hours followed by a slower phase with a half-life of about 5 hours.",
            "absorption": "Rapidly and almost completely absorbed with peak plasma levels being reached within 30-60 minutes after an oral therapeutic dose.",
            "cid": "5509",
            "classification": "M",
            "indications": "Arthritis; Juvenile idiopathic arthritis; Osteoarthritis; Peptic ulcer; Rheumatoid arthritis; Ulcer",
            "side_effects": "Nausea (0.11)",
            "atc_codes": "M02AA21; M01AB03",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0124",
            "name": "Troglitazone",
            "synonyms": "troglitazone; 97322-87-7; Rezulin; Romglizone; Prelay; CS-045; Romozin; Noscal; CS 045; Rezulin (TN); GR 92132X; CCRIS 8969; GR92132X; CI 991; CI-991; GR-92132X; C24H27NO5S; CHEBI:9753; (+-)-all-rac-5-(p-((6-Hydroxy-2,5,7,8-tetramethyl-2-chromanyl)methoxy)benzyl)-2,4-thiazolidinedione; 5-(4-(6-Hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl)thiazolidine-2,4-dione; CS045; Troglitazone (CS-045); BRN 4338399; GXPHKUHSUJUWKP-UHFFFAOYSA-N; NCGC00164445-01; DSSTox_CID_3719; DSSTox_RID_77162; DSSTox_GSID_23719; 2,4-Thiazolidinedione, 5-((4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy)phenyl)methyl)-; 5-{4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione; troglitazona; troglitazonum; BDBM50101974; 5-(4-((6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy)benzyl)thiazolidine-2,4-dione; 5-[(4-{[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl)methyl]oxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione; CAS-97322-87-7; Troglitazone [USAN:BAN:INN]; SR-05000000454; 5-[[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-2,4-thiazolidinedione; Troglitazone (JAN/USAN/INN); Troglitazone [USAN:INN:BAN]; 5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]thiazolidine-2,4-dione; 2,4-thiazolidinedione, 5-[[4-[(3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-; (+/-)-5-[4-[(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy]benzyl]-2,4-thiazolidinedione; Spectrum5_001973; UPCMLD-DP017; SCHEMBL4959; 5-(4-((6-hydroxy-2,5,7,8-tetramethylchroman-2-yl-methoxy)benzyl)-2,4-thiazolidinedione); 5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione; MLS006010817; GTPL2693; CHEMBL3542292; DTXSID8023719; UPCMLD-DP017:001; UPCMLD-DP017:002; CTK7H5564; KS-00001DVG; Troglitazone, >=98% (HPLC); HMS2089D22; HMS2093D04; HMS3649G12; HMS3713D08; BCP06753; Tox21_112119; Tox21_300470; BDBM50088494; BG0468; GP8940; HSCI1_000037; s8432; AKOS000281116; AKOS024457434; Tox21_112119_1; API0004529; CCG-208125; CS-1634; DB00197; VA11909; SMP2_000224; NCGC00161599-01; NCGC00161599-02; NCGC00161599-03; NCGC00161599-04; NCGC00161599-05; NCGC00161599-06; NCGC00161599-07; NCGC00161599-08; NCGC00161599-09; NCGC00161599-11; NCGC00254440-01; AK307955; AS-56378; CC-35518; HY-50935; K752; SC-46000; SMR001550129; AB0125513; DB-057670; LS-151313; FT-0630994; D00395; 18524-EP2269989A1; 18524-EP2270011A1; 18524-EP2272825A2; 18524-EP2272841A1; 18524-EP2275414A1; 18524-EP2295409A1; 18524-EP2298742A1; 18524-EP2301936A1; 18524-EP2305219A1; 18524-EP2305648A1; 18524-EP2308847A1; 18524-EP2314576A1; 18524-EP2314588A1; AB00643330-02; 322T877; C-22371; Q7844989; SR-05000000454-2; SR-05000000454-3; SR-05000000454-5; BRD-A13084692-001-02-5; 5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]-2,4-dioxothiazolidine; 5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]thiazolidine -2,4-dione; (5R)-5-[[4-[[(2S)-6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl]methoxy]phenyl]methyl]thiazolidine-2,4-dione; 2,4-Thiazolidinedione, 5-[[4-[(3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]- (9CI); 5-[[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1- benzopyran-2-yl)methoxy]phenyl]methyl]-2,4-thiazlidinedione; 5-[[4-[(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione; 5-[4-(6-Hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-2-ylmethoxy)benzyl]thiazolidine-2,4-dione; 5-{4-(6-hydroxy-2, 5, 7, 8-tetramethylchroman-2-yl-methoxy) benzyl) thiazolidine-2,4-dione; 5-{4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2h-chromen-2-yl)methoxy]benzyl}-1,3-thiazolidin-2,4-dion",
            "trade_name": "Rezulin, Resulin, Romozin, Noscal",
            "abbrev_name": "TRO",
            "description": "antidiabetic; anti-inflammatory; thiazolidinediones; PPAR-alpha agonist and strong PPAR-gamma agnoist",
            "molecular_formula": "C24H27NO5S",
            "molecular_weight": "441.5",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "> 99% (primarily to serum albumin)",
            "half_life": "16-34 hours",
            "absorption": "Absorbed rapidly. Food increases the extent of absorption by 30% to 85%.",
            "cid": "5591",
            "classification": "A",
            "indications": "Type 2 diabetes mellitus",
            "side_effects": "",
            "atc_codes": "A10BG01",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001",
                "T002",
                "T027",
                "T387",
                "T408",
                "T409"
            ],
            "function": [
                "F01",
                "F010401",
                "F0108",
                "F0201",
                "F02010201",
                "F02010202",
                "F020103",
                "F02040101",
                "F020403",
                "F02060101",
                "F020603",
                "F020605",
                "F02110302",
                "F021203",
                "F022101",
                "F0303",
                "F030602",
                "F05",
                "F0504",
                "F06",
                "F0701",
                "F070104"
            ],
            "references": [
                "RC00548",
                "RC00549",
                "RC00556",
                "RC00557",
                "RC00959",
                "RC00960",
                "RC01001",
                "RC01002",
                "RC03526",
                "RC03527",
                "RC03528",
                "RC03529",
                "RC03530",
                "RC03531",
                "RC03631",
                "RC04138",
                "RC04262",
                "RC04386",
                "RC04510",
                "RC04657",
                "RC04634",
                "RC04671",
                "RC04686",
                "RC04876",
                "RC04899",
                "RC04964",
                "RC04968",
                "RC04973",
                "RC04977",
                "RC04978",
                "RC04979",
                "RC04982",
                "RC04983",
                "RC04988",
                "RC04989",
                "RC04990",
                "RC04991",
                "RC04992",
                "RC04993",
                "RC04994",
                "RC04995",
                "RC04996",
                "RC04997",
                "RC04998",
                "RC04999"
            ]
        },
        {
            "compound_ID": "D0125",
            "name": "Trovafloxacin",
            "synonyms": "Trovafloxacin; 147059-72-1; TVFX; Trovafloxacin [INN]; UNII-9F388J00UK; Trovafloxacin (INN); CHEBI:9763; 7-[(1R,5S,6s)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; C20H15F3N4O3; 9F388J00UK; Trovan (oral); 7-[(1S,5R)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid; Fluorinated quinolone; CP-99,219; trovafloxacine; trovafloxacino; trovafloxacinum; 7-((1R,5S)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 7-((1R,5S,6S)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 7-[(1R,5S)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 7-[(1R,5S,6s)-6-Amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; TR6; CP99219; CHEMBL428; SCHEMBL34465; SCHEMBL34466; SCHEMBL9177464; DTXSID0041145; CTK4C5244; EX-A897; WVPSKSLAZQPAKQ-CDMJZVDBSA-N; BCP12644; ZINC12503149; AKOS000277872; AKOS015909896; ZINC100030989; ZINC147175374; API0004697; DB00685; (1alpha,5alpha,6alpha)-7-(6-Amino-3-azabicyclo[3.1.0]hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 7-((1R,5S)-6-Amino-3-aza-bicyclo[3.1.0]hex-3-yl)-1-(2,4-difluoro-phenyl)-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid; CC-35528; LS-95890; SC-47970; FT-0601549; C07664; D08654; C-22002; Q544393; 1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-(6-amino-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-, (1-alpha,5-alpha,6-alpha)-; 1,8-Naphthyridine-3-carboxylic acid, 7-(6-amino-3-azabicyclo[3.1.0]hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-, (1alpha,5alpha,6alpha)-; 1,8-Naphthyridine-3-carboxylic acid, 7-[(1alpha,5alpha,6alpha)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-, methanesulfonate (1:1); 7-[(1alpha,5alpha)-6beta-Amino-3-azabicyclo[3.1.0]hexane-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C20H15F3N4O3",
            "molecular_weight": "416.4",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "Approximately 50% of an oral dose is excreted unchanged (43% in the feces and 6% in the urine).",
            "protein_binding": "The mean plasma protein bound fraction is approximately 76%, and is concentration-independent.",
            "half_life": "Following oral administration, half-life ranged from 9.1 hours to 12.2 hours over the dosage range of 100 to 200 mg tablets. Following intravenous infusion, half-life ranged from 9.4 to 12.7 hours over a dosage range of 100 to 300 mg.",
            "absorption": "Well-absorbed from the gastrointestinal tract after oral administration and does not depend on concomitant food intake. The absolute bioavailability is approximately 88%.",
            "cid": "62959",
            "classification": "J",
            "indications": "Abdominal infection; Abortion infected; Diabetic foot infection; Endometritis; Infection; Osteomyelitis; Parametritis; Pelvic infection",
            "side_effects": "Dermatitis (0.02); Vaginal inflammation (0.02); Abdominal pain; Dizziness; Gastrointestinal pain; Headache; Nausea; Vomiting",
            "atc_codes": "J01MA13",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001",
                "T002",
                "T004",
                "T005",
                "T019"
            ],
            "function": [
                "F020103"
            ],
            "references": [
                "RC00207",
                "RC00208",
                "RC00209",
                "RC00210",
                "RC00211"
            ]
        },
        {
            "compound_ID": "D0126",
            "name": "Valproic Acid",
            "synonyms": "VALPROIC ACID; 2-Propylpentanoic acid; 99-66-1; Dipropylacetic acid; 2-Propylvaleric acid; Depakine; Depakene; Ergenyl; Di-n-propylacetic acid; Valproate; Mylproin; Pentanoic acid, 2-propyl-; 4-Heptanecarboxylic acid; n-Dipropylacetic acid; Propylvaleric acid; Myproic Acid; Di-n-propylessigsaure; n-DPA; Dipropylacetate; Convulex; Depakin; Vupral; Acido valproico; Acide valproique; Acidum valproicum; Avugane; Baceca; Stavzor; Kyselina 2-propylvalerova; 2-n-Propyl-n-valeric acid; Acetic acid, dipropyl-; Abbott 44090; Valproinsaeure; Savicol; Depakine chrono; Depakin chrono; Acide valproique [INN-French]; Acido valproico [INN-Spanish]; Acidum valproicum [INN-Latin]; 2-PROPYL-PENTANOIC ACID; Di-n-propylessigsaure [German]; Valeric acid, 2-propyl-; divalproex; Epilim; Kyselina 2-propylvalerova [Czech]; 2,2-di-n-propylacetic acid; Di-n-propylessigsaeure; UNII-614OI1Z5WI; NSC 93819; VPA; HSDB 3582; Depakene (TN); EINECS 202-777-3; MFCD00002672; CHEMBL109; (n-C3H7)2CHCOOH; BRN 1750447; AI3-10500; 614OI1Z5WI; CHEBI:39867; NIJJYAXOARWZEE-UHFFFAOYSA-N; Depakote CP; NCGC00091149-01; Convulsofin; Deproic; Alti-Valproic; Novo-Valproic; Penta-Valproic; Dom-Valproic; Med Valproic; Dipropyl Acetate; Nu-Valproic; DSSTox_CID_3733; DSSTox_RID_77171; DSSTox_GSID_23733; Valproic acid USP; PMS-Valproic Acid; 2-Propylpentanoic acid, 99%; Valproic acid (USP); CAS-99-66-1; Depakote (TM); SMR000499581; Valproic acid [USAN:INN:BAN]; 2 PP (base); Valproic Acid, Sodium Salt (2:1); Valproinsaure; Novo-divalproex; Sandoz valproic; Dom-valproate; Gen-divalproex; Apo-valproic; A-44090; APO-divalproex; DOM-divalproex; Epival er; PHL-valproate; PMS-valproate; PMS-Divalproex; Erganyl; Stavzor; Dom-valproic acid; Apo-valproic syrup; PHL-valproic acid; Epiject I.V.; 2-propyl-Pentanoate; Epical (TM); Epilim (Salt/Mix); Valproic acid [USAN:USP:INN:BAN]; 2-PropylpentanoicAcid; Depacon (Salt/Mix); Convulex (Salt/Mix); Eurekene (Salt/Mix); G2M-777; Valparin (Salt/Mix); Novo-Valproic - ECC; Spectrum_000521; Divalproex (Salt/Mix); Dom-valproic acid syrup; Ratio-Valproic - ECC; Valdisoval (Salt/Mix); ACMC-209sdq; 2 -propylpentanoic acid; di-n-propyl acetic acid; S(-)-4-En-valproate; 33433-82-8; Spectrum2_000946; Spectrum3_001733; Spectrum4_000376; DOM-valproic acid E.C.; Heptane-4-carboxylic acid; PHL-valproic acid E.C.; PMS-valproic acid E.C.; Novo-valproic soft gel cap; EC 202-777-3; SCHEMBL2275; S-2-n-Propyl-4-pentenoate; (S)-2-propyl-4-pentanoate; KBioGR_000871; KBioGR_002277; KBioSS_001001; KBioSS_002278; KSC493G8T; MLS001076682; MLS001335927; MLS001335928; MLS002415770; BIDD:GT0858; DivK1c_000273; SPBio_000912; GTPL7009; DTXSID6023733; WLN: QVY3 & 3; CTK3J3389; KBio1_000273; KBio2_001001; KBio2_002277; KBio2_003569; KBio2_004845; KBio2_006137; KBio2_007413; KBio3_002626; KBio3_002757; KS-00000CCR; NIJJYAXOARWZEE-UHFFFAOYSA-; Valproic acid [USAN:BAN:INN]; NINDS_000273; HMS2089J06; HMS2231E06; HMS3259C18; HMS3370C21; HMS3715B15; ACT05281; NSC93819; ZINC3008621; Tox21_111091; Tox21_201963; Tox21_300603; ANW-41052; BDBM50003616; LMFA01020291; NSC-93819; SBB065764; STL445581; AKOS009156895; Tox21_111091_1; Valproic Acid 1.0 mg/ml in Methanol; CCG-221127; CS-1765; DB00313; LS-2068; MCULE-7136317196; NC00584; RTR-031980; TRA0085608; NCGC00091149-02; NCGC00091149-03; NCGC00091149-04; NCGC00091149-05; NCGC00091149-06; NCGC00091149-08; NCGC00091149-09; NCGC00162288-07; NCGC00254365-01; NCGC00259512-01; AK128830; AS-11354; CPD000499581; HY-10585; SAM002564230; SBI-0050864.P003; AB0009719; LS-161170; TR-031980; 791-EP2306789A1; FT-0609289; P0823; 6400-EP1441224A2; 6400-EP2272537A2; 6400-EP2272827A1; 6400-EP2275420A1; 6400-EP2280008A2; 6400-EP2298764A1; 6400-EP2298765A1; 6400-EP2308867A2; 6400-EP2308870A2; 6400-EP2311494A1; 6400-EP2311840A1; 6400-EP2314585A1; 6400-EP2374790A1; A19450; C07185; D00399; AB00698315-06; Q240642; Q-200321; Sodium valproate; 2-Propylpentanoic acid sodium salt; SR-01000075242-7; F2191-0115; Z1511532065; Valproic acid, European Pharmacopoeia (EP) Reference Standard; Valproic acid, United States Pharmacopeia (USP) Reference Standard; InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10); Valproic acid for system suitability, European Pharmacopoeia (EP) Reference Standard; Valproic acid solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; Valproic acid, Pharmaceutical Secondary Standard; Certified Reference Material",
            "trade_name": "Depakote, Epilim, Convulex",
            "abbrev_name": "Valproate",
            "description": "Antiepileptics; fatty acid derivative; branched short-chain fatty acid (SCFA) made from valeric acid; broad spectrum of anticonvulsant activity",
            "molecular_formula": "C8H16O2",
            "molecular_weight": "144.21",
            "state": "solid",
            "clearance": "0.56 L/hr/m<sup>2</sup>[label]\n\nPediatric patients between 3 months and 10 years of age have 50% higher clearances by weight. Pediatric patients 10 years of age or older approximate adult values.[FDA Label]",
            "volume_of_distribution": "11 L/1.73m<sup>2</sup>.[label]",
            "route_of_elimination": "Most drug is eliminated through hepatic metabolism, about 30-50%.[label] The other major contributing pathway is mitochondrial beta-oxidation, about 40%. Other oxidative pathways make up an additional 15-20%. Less than 3% is excreted unchanged in the urine.",
            "protein_binding": "Protein binding is linear at low concentrations, 10% bound at 4 mcg/mL, but becomes non-linear at higher concentrations, increasing up to 18.5% bound at 135 mcg/mL.[label] This may be due to binding at separate high and low affinity sites on albumin proteins.[A178066] Binding is expected to decrease in the elderly and patients with hepatic dysfunction.",
            "half_life": "13-19 hours.[label]\n\nThe half-life in neonates ranges from 10-67 hours while the half-life in pediatric patients under 2 months of age ranges from 7-13 hours.",
            "absorption": "The intravenous and oral forms of valproic acid are expected to produce the same AUC, Cmax, and Cmin at steady-state.[label] The oral delayed-release tablet formulation has a Tmax of 4 hours. Differences in absorption rate are expected from other formulations but are not considered to be clinically important in the context of chronic therapy beyond impacting frequency of dosing. Differences in absorption may create earlier Tmax or higher Cmax values on initiation of therapy and may be affected differently by meals.[L6196] The extended release tablet formulation had Tmax increase from 4 hours to 8 hours when taken with food. In comparison, the sprinkle capsule formulation had Tmax increase from 3.3 hours to 4.8 hours. Bioavailability is reported to be approximately 90% with all oral formulations with enteric-coated forms possibly reaching 100%.[A178066]",
            "cid": "3121",
            "classification": "N",
            "indications": "Acquired immunodeficiency syndrome; Aggression; Agitation; Amino acid metabolism disorder; Autoimmune disorder; Bipolar disorder; Complex partial seizures; Decreased interest; Dehydration; Delusion of grandeur; Depressed mood; Drug interaction; Epilepsy; Fasting; Flight of ideas; Headache; Hepatic enzyme increased; Hepatic function abnormal; Hostility; Hyperammonaemia; Hyperammonaemic encephalopathy; Hyperglycaemia; Hyperkinesia; Irritability; Lennox-Gastaut syndrome; Loss of consciousness; Major depression; Migraine; Myoclonic epilepsy; Nonketotic hyperglycinaemia; Partial seizures; Petit mal epilepsy; Pregnancy; Pressure of speech; Psychotic disorder; Somnolence; Status epilepticus; Systemic lupus erythematosus; Thrombocytopenia; Urinary tract infection",
            "side_effects": "Coagulopathy (0.07); Sleep disorder (0.04); Abdominal pain; Affect lability; Alopecia; Amblyopia; Amnesia; Asthenia; Ataxia; Back pain; Body temperature increased; Bronchitis; Constipation; Decreased appetite; Depression; Dermatitis; Diarrhoea; Diplopia; Dizziness; Dyspepsia; Dyspnoea; Ecchymosis; Fatigue; Gastrointestinal pain; Headache; Increased appetite; Infection; Influenza; Injury; Insomnia; Mental disability; Mood swings; Muscle twitching; Nausea; Nervousness; Nystagmus; Oedema peripheral; Pain; Paraesthesia; Pharyngitis; Rash; Rhinitis; Somnolence; Tension; Thinking abnormal; Thrombocytopenia; Tinnitus; Tremor; Vision blurred; Vomiting; Weight decreased; Weight increased",
            "atc_codes": "N03AG01",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001",
                "T002",
                "T021",
                "T084",
                "T408"
            ],
            "function": [
                "F0108",
                "F0201",
                "F02060101",
                "F02110112",
                "F0303",
                "F0504"
            ],
            "references": [
                "RC03532",
                "RC03628",
                "RC03763",
                "RC04140",
                "RC04264",
                "RC04388",
                "RC04512",
                "RC04636"
            ]
        },
        {
            "compound_ID": "D0127",
            "name": "Zalcitabine",
            "synonyms": "zalcitabine; Dideoxycytidine; 7481-89-2; 2',3'-DIDEOXYCYTIDINE; ddCyd; HIVID; ddC; Cytidine, 2',3'-dideoxy-; Zalcitibine; NSC 606170; 4-Amino-1-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; 2,3-dideoxycytidine; UNII-6L3XT8CB3I; Ro 24-2027/000; CCRIS 692; C9H13N3O3; HSDB 7156; Ro-24-2027/000; CHEMBL853; BRN 0654956; 6L3XT8CB3I; CHEBI:10101; 1-(2,3-Dideoxy-beta-D-ribofuranosyl)cytosine; WREGKURFCTUGRC-POYBYMJQSA-N; 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one; MFCD00012188; NCGC00090705-08; DSSTox_CID_3747; ddC (Antiviral); 4-AMINO-1-[(2R,5S)-5-(HYDROXYMETHYL)OXOLAN-2-YL]-1,2-DIHYDROPYRIMIDIN-2-ONE; DSSTox_RID_77182; DSSTox_GSID_23747; 2',3'-Dideoxycytidine, 98%; NSC606170; 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one; NSC-606170; SMR000058253; Hivid(TM); Zalcitabine [USAN:INN:BAN]; Hivid (TN); Interferon AD + ddC; ddC & GM-CSF; ddC & sCD4; PC-SOD & ddC; Zalcitabine (JAN/USP/INN); DS-4152 & ddC; 3-[(5S,2R)-5-(hydroxymethyl)oxolan-2-yl]-6-amino-3-hydropyrimidin-2-one; ddC & NP (from PHCA or HSA); SRI-7707; Zalcitabine [USAN:USP:INN:BAN]; CAS-7481-89-2; KS-1130; ddC & IFN.alpha.; .beta.-D-DDC; dideoxycytidine (DDC); Prestwick0_001037; Prestwick1_001037; Prestwick2_001037; Prestwick3_001037; ddC & Interferon.alpha.; 2', 3'-dideoxycytidine; bmse000712; UPCMLD-DP115; D 5782; SCHEMBL3598; TimTec1_004969; Lopac0_000360; BSPBio_001253; 3'-Azido-3'-deoxythymidine/2',3'-Dideoxycytidine; 5-25-14-00313 (Beilstein Handbook Reference); MLS000069636; MLS000759540; MLS001055363; MLS001424210; MLS006011951; SPBio_003104; BPBio1_001378; GTPL4828; ddC|||2',3'-Dideoxycytidine; DTXSID0023747; UPCMLD-DP115:001; KS-00000MRJ; ZINC39906; 2',3'-Dideoxycytidine & sCD4(soluble recombinant protein); AOB5609; HMS1548B19; HMS1571O15; HMS2051H18; HMS2090C12; HMS2098O15; HMS2236N08; HMS3261G21; HMS3715O15; Pharmakon1600-01502360; .beta.-D-2',3'-Dideoxycytidine; Zalcitabine, 2'3'-Dideoxycytidine; BCP13878; Hivid;Dideoxycytidine;NSC 606170; Tox21_113491; Tox21_201655; Tox21_303169; Tox21_500360; AC-824; ANW-36530; BDBM50145605; Lecithinized superoxide dismutase & .beta.-D-2',3'-Dideoxycytidine; NSC759655; s1719; SBB066036; Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxycytidine; AKOS015854844; AKOS015894505; Tox21_113491_1; AB01085; CCG-101050; CS-1110; DB00943; LP00360; LS-1645; MCULE-6071296177; NC00300; NSC-759655; RTC-064018; 2',3'-Dideoxycytidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate); SRI-7707-13; SRI-7707-14; SRI-7707_15; SRI-7707_17; NCGC00090705-01; NCGC00090705-02; NCGC00090705-03; NCGC00090705-05; NCGC00090705-06; NCGC00090705-07; NCGC00090705-09; NCGC00090705-10; NCGC00090705-11; NCGC00090705-13; NCGC00090705-15; NCGC00179242-01; NCGC00257202-01; NCGC00259204-01; NCGC00261045-01; CPD000058253; HY-17392; K278; SAM001246779; SC-09165; ST069364; ddC;Dideoxycytidine;2',3'-Dideoxycytidine; 2',3'-Dideoxycytidine & Interferon.alpha.; 2',3'-Dideoxycytidine, >=98% (HPLC); AB0014137; AB2000246; DB-019728; Ro-242027000; TC-064018; D3581; EU-0100360; Ro-24-2027000; ST24043185; SW197364-4; 2',3'-Dideoxycytidine, >=99.0% (HPLC); C07207; D00412; M-2084; 42060-EP2295503A1; 42060-EP2298761A1; 42060-EP2305695A2; 42060-EP2305696A2; 42060-EP2305697A2; 42060-EP2305698A2; 42060-EP2311808A1; 42060-EP2311829A1; 78798-EP2298783A1; 78798-EP2305695A2; 78798-EP2305696A2; 78798-EP2305697A2; 78798-EP2305698A2; Cytidine, 2',3'-dideoxy- & Interferon.alpha.; 481D892; SR-01000075822; SR-01000736919; J-700276; Q-201941; Q2344582; SR-01000075822-1; SR-01000736919-5; Cytidine, 2',3'-dideoxy- & Colony-stimulating factor; Ro-242027000/Ro-24-2027-000; Z1550648753; Zalcitabine, United States Pharmacopeia (USP) Reference Standard; 4-Amino-1-(5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one; 4-Amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2(1H)-one; .beta.-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor",
            "trade_name": "Hivid",
            "abbrev_name": "ddC",
            "description": "nucleoside analogs ; nucleoside reverse transcriptase inhibitor (NRTI); dideoxynucleoside compound; potent inhibitor of HIV replication",
            "molecular_formula": "C9H13N3O3",
            "molecular_weight": "211.22",
            "state": "solid",
            "clearance": "* 285 mL/min [HIV-infected patients receiving 1.5 mg IV infusion for 1 hour]",
            "volume_of_distribution": "* 0.304 to 0.734 L/kg",
            "route_of_elimination": "Renal excretion of unchanged drug appears to be the primary route of elimination, accounting for approximately 80% of an intravenous dose and 60% of an orally administered dose within 24 hours after dosing (n=19). Renal clearance exceeds glomerular filtration rate suggesting renal tubular secretion contributes to the elimination of zalcitabine by the kidneys.",
            "protein_binding": "Less than 4%",
            "half_life": "2 hours",
            "absorption": "Bioavailability is over 80% following oral administration.",
            "cid": "24066",
            "classification": "J",
            "indications": "Acquired immunodeficiency syndrome; Autoimmune disorder; Disease progression; Drug intolerance",
            "side_effects": "",
            "atc_codes": "J05AF03",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T005",
                "T091",
                "T234",
                "T387"
            ],
            "function": [
                "F020103",
                "F0307",
                "F0504",
                "F060102",
                "F060104",
                "F0604"
            ],
            "references": [
                "RC03674",
                "RC04696",
                "RC04700",
                "RC04704",
                "RC04708",
                "RC04712",
                "RC04716",
                "RC04720"
            ]
        },
        {
            "compound_ID": "D0128",
            "name": "Zidovudine",
            "synonyms": "zidovudine; Azidothymidine; 30516-87-1; 3'-Azido-3'-deoxythymidine; Retrovir; AZT; Zidovudinum; Compound S; Thymidine, 3'-azido-3'-deoxy-; ZIDOVUDINE [AZT]; BW A509U; zidovudin; Zidovudinum [Latin]; Zidovudina [Spanish]; BWA509U; ZDV; DRG-0004; UNII-4B9XT59T7S; 3'-Deoxy-3'-azidothymidine; CCRIS 105; Aztec; NSC 602670; BW-A509U; BW-A-509U; HSDB 6515; 3'-Azido-3'-deoxythymidine (AIDS); CHEMBL129; BW-A 509U; MLS000028548; 4B9XT59T7S; 1-((2R,4S,5S)-4-AZIDO-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-5-METHYLPYRIMIDINE-2,4(1H,3H)-DIONE; 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione; CHEBI:10110; HBOMLICNUCNMMY-XLPZGREQSA-N; NCGC00023945-05; SMR000058351; Zidovudina; DSSTox_CID_127; 3-Azido-3-deoxythymidine; AZT Antiviral; AZT, Antiviral; 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)-5-methylpyrimidine-2,4-(1H,3H)-dione; DSSTox_RID_75386; AZT (Antiviral); DSSTox_GSID_20127; Propolis+AZT; Retrovir(TM); AZT & Li & EPO; Retrovir (TN); Cpd S; BWA-509U; Intron A & AZT; Racemic Liposomal AZT; Liposomal AZT-SN-1; Liposomal AZT-SN-3; Zidovudine+PRO 140; Zidovudine [USAN:INN:BAN:JAN]; PC-SOD+AZT; 3'-Azido-2',3'-Dideoxythymidine; AZT & srCD4; AZT & rIFN.alpha.2; AZT & rsT4; rIFN-beta seron & AZT; AZT & EPO; AZT & GM-CSF; AZT & HPA; AZT & sCD4; AZT & SST; zudovidine; AZT & Li & GM-CSF; AZT+PRO 140; Met-SDF-1.beta. & AZT; AZT & Li & IL-1; AZT & Li & IL-6; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Interferon-.alpha.-2; AZT & Concanavalin A (ConA); AZT & Lymphoblastoid Interferon; AZT & PM-19; Met-SDF-1.beta. & Zidovudine; 4lhm; 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (AZT); 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione [AZT]; AZT & rsCD4 & rIFN.alpha.A; 3'-azido-3'-deoxythymidine, AZT; DS-4152 & AZT; 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione; 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione; AZT & Colony-stimulating factor 2; AZT & NP (from PHCA or HSA); ZVD; MFCD00006536; 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3''-azido-thymidine; K7 [P Ti2 W10 O40]; Zidovudine [USAN:USP:INN:BAN:JAN]; Zidovudine & IFNL1; Zidovudine & IFNL2; Zidovudine & IFNL3; Zidovudine (Retrovir); 3&prime;-Azido-3&prime;-deoxythymidine; Spectrum_001348; AZT & CD4(178)-PE 40; AZT & IFN.alpha.; Azidothymidine;AZT;ZDV; Zidovudine & IL-29; Zidovudine & IL-28A; Zidovudine & IL-28B; AZT & Interleukin 29; Opera_ID_1602; Prestwick3_000333; Spectrum2_000927; Spectrum3_001507; Spectrum4_000332; Spectrum5_001101; 3'azido-3'deoxythymidine; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; Azidothymidine; Zidovudine; Interferon AD + 3'-azido-3'-deoxythymidine; AZT & Interleukin 28A; AZT & Interleukin 28B; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; 3'-azido3'-deoxythymidine; AZT & IFNL1; AZT & IFNL2; AZT & IFNL3; AZT & Interferon lambda-1; AZT & Interferon lambda-2; AZT & Interferon lambda-3; 3''-Deoxy-3-azidothymidine; BSPBio_000365; BSPBio_003153; KBioGR_000703; KBioSS_001828; MLS001055351; MLS001076358; MLS002153202; MLS002222249; Zidovudine & Interleukin 29; DivK1c_000524; SPECTRUM1502109; 3'-deoxy-3'-azido-thymidine; SPBio_000834; Zidovudine & Interleukin 28A; Zidovudine & Interleukin 28B; AZT & IL-28A; AZT & IL-28B; BPBio1_000403; GTPL4825; Zidovudine (JP17/USP/INN); 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; DTXSID8020127; SCHEMBL14615088; SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); AZT & IL-29; CTK4I2082; HMS501K06; KBio1_000524; KBio2_001828; KBio2_004396; KBio2_006964; KBio3_002653; KS-00000WOF; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); 3''-Azido-3''-deoxy-thymidine; NINDS_000524; Zidovudine & Interferon lambda-1; Zidovudine & Interferon lambda-2; Zidovudine & Interferon lambda-3; HMS1921J20; HMS2090G11; HMS2092D06; HMS2096C07; HMS2234K17; HMS3259H17; HMS3713C07; Pharmakon1600-01502109; 1-((2R,4R,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; ZINC3779042; 3''azido-2''3''-dideoxythymidine; Tox21_110062; Tox21_110894; Tox21_202203; Tox21_300578; ANW-26899; BBL033764; BDBM50002692; CCG-39924; CZ0012; NSC758185; STK801891; AKOS005622576; AKOS015842610; Tox21_110062_1; 3''-azido-2'',3''-dideoxythymidine; DB00495; LS-1159; MCULE-8664408343; NC00666; NSC-758185; IDI1_000524; NCGC00014918-01; NCGC00023945-03; NCGC00023945-04; NCGC00023945-06; NCGC00023945-07; NCGC00023945-08; NCGC00023945-09; NCGC00023945-10; NCGC00023945-12; NCGC00023945-13; NCGC00178237-01; NCGC00178237-02; NCGC00254276-01; NCGC00259752-01; 1-((2R,4S,5S)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; 399024-19-2; AS-13019; CPD000058351; SAM002548971; SBI-0051731.P002; AB0012841; FT-0601543; Propolis & Thymidine, 3'-azido-3'-deoxy-; S2579; SW198799-2; EN300-52518; 3'-Azido-3'-deoxythymidine, >=98% (HPLC); C07210; D00413; J10271; W-5037; 3'-Azido-3'deoxythymidine & Interferon .alpha.; 3'-Azido-3'-deoxythymidine, >=99.0% (HPLC); Q198504; SR-01000000098; SR-05000001587; J-700147; SR-01000000098-3; SR-05000001587-1; BRD-K72903603-001-04-6; BRD-K72903603-001-14-5; Z1723414428; Zidovudine, European Pharmacopoeia (EP) Reference Standard; 3'-Azido-3'-deoxythymidine & Recombinant Interferon-.alpha.-2; Zidovudine, United States Pharmacopeia (USP) Reference Standard; 3'-Azido-3'-deoxythymidine & CD4-Pseudomonas exotoxin A hybrid; Beta interferon(rIFN-beta seron) & 3'-Azido-3'-deoxythymidine(AZT); Lecithinized superoxide dismutase & Thymidine, 3'-azido-3'-deoxy-; 3'-Azido-2',3'-dideoxythymidine & sCD4(soluble recombinant protein); Sulfated polysaccharide-peptidoglycan DS-4152 & 3'-Azido-3'-deoxythymidine; Thymidine, 3'-azido-3'-deoxy- & PRO 140 (Anti-CCR5 monoclonal antibody); Zidovudine, Pharmaceutical Secondary Standard; Certified Reference Material; (AZT) 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; (AZT)1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(AZT); 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione; 3'-Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor; 3'-Azido-3'-deoxythymidine & Lithium & Granulocyte-macrophage colony-stimulating factor; 3'-Azido-3'deoxythymidine & Recombinant Soluble CD4 & Recombinant Interferon.alpha.A; 4-(4-Azido-5-hydroxy-tetrahydro-furan-2-yl)-5-methyl-3H-pyrazine-2,6-dione; Met-Stromal Cell-derived Factor-1.beta. (Human) & 3'-Azido-3'-deoxythymidine; 1-((2R,4S,5S)-4-(diazoamino)-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; 1-((2R,4S,5S)-4-azido-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; 1-((2R,5S)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; 1-((2S,4R,5R)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione; 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (AzddThd, AZT); 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (N3ddThd); 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(3''-azido-2'',3''-dideoxythymidine); 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(azidothymidine, AZT); 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(Zidovudine, AZT); 146426-54-2; 3'-Azido-3'deoxythymidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate); 3-((2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)triaz-1-en-2-ium-1-ide; 3-Azido-1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-D-erythro- pentofuranuronic acid",
            "trade_name": "Retrovir",
            "abbrev_name": "ZDV; AZT",
            "description": "nucleoside analogs ; nucleoside reverse transcriptase inhibitor (NRTI); dideoxynucleoside compound; potent inhibitor of HIV replication",
            "molecular_formula": "C10H13N5O4",
            "molecular_weight": "267.24",
            "state": "solid",
            "clearance": "* 0.65 +/- 0.29 L/hr/kg [HIV-infected, Birth to 14 Days of Age]\n* 1.14 +/- 0.24 L/hr/kg [HIV-infected, 14 Days to 3 Months of Age]\n* 1.85 +/- 0.47 L/hr/kg [HIV-infected, 3 Months to 12 Years of Age].\nThe transporters, ABCB1, ABCC4, ABCC5, and ABCG2 are involved with the clearance of zidovudine.",
            "volume_of_distribution": "Apparent volume of distribution, HIV-infected patients, IV administration = 1.6 ± 0.6 L/kg",
            "route_of_elimination": "As in adult patients, the major route of elimination was by metabolism to GZDV. After intravenous dosing, about 29% of the dose was excreted in the urine unchanged and about 45% of the dose was excreted as GZDV.",
            "protein_binding": "30-38%",
            "half_life": "Elimination half life, HIV-infected patients, IV administration = 1.1 hours (range of 0.5 - 2.9 hours)",
            "absorption": "Rapid and nearly complete absorption from the gastrointestinal tract following oral administration; however, because of first-pass metabolism, systemic bioavailability of zidovudine capsules and solution is approximately 65% (range, 52 to 75%). Bioavailability in neonates up to 14 days of age is approximately 89%, and it decreases to approximately 61% and 65% in neonates over 14 days of age and children 3 months to 12 years, respectively. Administration with a high-fat meal may decrease the rate and extent of absorption.",
            "cid": "35370",
            "classification": "J",
            "indications": "Acquired immunodeficiency syndrome; Autoimmune disorder; Disease progression; Immunodeficiency; Infection; Opportunistic infection; Pregnancy; Teratogenicity",
            "side_effects": "Hepatomegaly (0.11); Neutropenia (0.03); Abdominal pain; Agranulocytosis; Anaemia; Asthenia; Body temperature increased; Breath sounds abnormal; Chest pain; Chills; Constipation; Cough; Decreased appetite; Dermatitis; Diarrhoea; Discomfort; Dizziness; Dysgeusia; Dyspepsia; Dyspnoea; Feeling abnormal; Gastrointestinal pain; Headache; Hyperhidrosis; Ill-defined disorder; Insomnia; Lymphadenopathy; Malaise; Mouth ulceration; Musculoskeletal discomfort; Myalgia; Nasopharyngitis; Nausea; Neuropathy peripheral; Paraesthesia; Pharyngitis; Rash; Rhinorrhoea; Somnolence; Splenomegaly; Stomatitis; Thrombocytopenia; Vomiting; Weight decreased; Wheezing",
            "atc_codes": "J05AF01; J05AR05; J05AR01; J05AR04",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001",
                "T005",
                "T091",
                "T234",
                "T235",
                "T236",
                "T387",
                "T408"
            ],
            "function": [
                "F0108",
                "F0201",
                "F020103",
                "F02060101",
                "F0303",
                "F0307",
                "F0504",
                "F060102",
                "F060104",
                "F0604"
            ],
            "references": [
                "RC03558",
                "RC03577",
                "RC03578",
                "RC03679",
                "RC04143",
                "RC04267",
                "RC04391",
                "RC04515",
                "RC04639",
                "RC04693",
                "RC04697",
                "RC04701",
                "RC04705",
                "RC04709",
                "RC04713",
                "RC04717"
            ]
        },
        {
            "compound_ID": "D0129",
            "name": "2,4-dinitrophenol",
            "synonyms": "2,4-dinitrophenol; 51-28-5; Aldifen; Solfo Black B; Tertrosulphur PBR; Phenol, 2,4-dinitro-; Solfo Black G; alpha-Dinitrophenol; 2,4-Dnp; Nitro kleenup; 1-Hydroxy-2,4-dinitrobenzene; Fenoxyl carbon N; Chemox PE; Solfo Black BB; Solfo Black SB; Dinitrofenolo; Dinofan; DINITROPHENOL; Tertrosulphur Black PB; Solfo Black 2B Supra; 2,4-Dinitrofenol; Maroxol-50; Osmoplastic-R; Osmotox-Plus; Sulphur Black 1; Nitrophen (VAN); Nitrophene (VAN); RCRA waste number P048; NSC 1532; .alpha.-Dinitrophenol; Camello mosquito coils; Caswell No. 392; EK 102; Dinitrofenolo [Italian]; Phenol, alpha-dinitro-; Tertrosulfur pbr; X 32; UNII-Q13SKS21MN; 2,4-Dinitrofenol [Dutch]; 1'alpha-2,4-Dinitrophenol; Cobra salts (Impregna salts); Shirakiku brand mosquito coils; 2,4-dinitro-phenol; CCRIS 3102; HSDB 529; CHEBI:42017; EINECS 200-087-7; Phenol, .alpha.-dinitro-; RCRA waste no. P048; EPA Pesticide Chemical Code 037509; Q13SKS21MN; AI3-01535; UFBJCMHMOXMLKC-UHFFFAOYSA-N; Fenoxyl; 1326-82-5; DSSTox_CID_523; Tertrosulfur black pb; DSSTox_RID_75640; DSSTox_GSID_20523; DNF; CAS-51-28-5; PubChem11250; Spectrum_001934; SpecPlus_000938; Spectrum2_000673; Spectrum3_001694; Spectrum4_000913; Spectrum5_001670; WLN: WNR BQ ENW; Epitope ID:112424; EC 200-087-7; SCHEMBL77643; BSPBio_003248; KBioGR_001406; KBioSS_002480; SPECTRUM330008; MLS001066358; BIDD:ER0505; DivK1c_007034; SPBio_000765; ARONIS010084; CHEMBL273386; SR-1C5; DTXSID0020523; SCHEMBL13973810; CTK1G9509; KBio1_001978; KBio2_002473; KBio2_005041; KBio2_007609; KBio3_002468; NSC1532; HMS1923K21; HMS2233H07; HMS3372P06; KS-000041JJ; NSC-1532; Tox21_201462; Tox21_300030; ANW-46655; BBL023448; CCG-39730; LS-154; MFCD00007115; STK397797; ZINC12358776; AKOS000118988; AKOS015912556; DB04528; MCULE-6678680789; NE10472; NCGC00091778-01; NCGC00091778-02; NCGC00091778-03; NCGC00091778-04; NCGC00091778-05; NCGC00091778-06; NCGC00254114-01; NCGC00259013-01; 2,4-dinitrophenol (h2o w/w 18% max); AS-39888; SC-81242; SMR000471854; TR-032491; D0109; FT-0610210; 2,4-Dinitrophenol (wetted with 15 % water); 9456-EP2284174A1; 9456-EP2316829A1; C02496; AB00053210_08; 2,4-Dinitrophenol, SAJ special grade, >=98.0%; AF-936/31262030; Q209226; 2,4-Dinitrophenol, moistened with water, >=98.0%; W-105909; 2,4-Dinitrophenol, PESTANAL(R), analytical standard; BRD-K21910317-001-02-4; BRD-K21910317-001-06-5; BRD-K21910317-001-12-3; F0850-6525; 2,4-Dinitrophenol, technical, moistened with water, >=97.0% (HPLC); InChI=1/C6H4N2O5/c9-6-2-1-4(7(10)11)3-5(6)8(12)13/h1-3,9",
            "trade_name": "",
            "abbrev_name": "DNP; 2,4-DNP",
            "description": "chemically related to trinitrophenol (picric acid); uncoupler",
            "molecular_formula": "C6H4N2O5",
            "molecular_weight": "184.11",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "1493",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F0105",
                "F010501",
                "F02010203",
                "F02010204",
                "F02010206",
                "F02010207",
                "F020401",
                "F020403",
                "F02110306",
                "F02110309",
                "F0308"
            ],
            "references": [
                "RC00904",
                "RC00905",
                "RC00906",
                "RC00907",
                "RC00961",
                "RC01321",
                "RC01322",
                "RC01323",
                "RC01324",
                "RC01325",
                "RC01326",
                "RC01327",
                "RC01328",
                "RC03507",
                "RC03597",
                "RC03598",
                "RC03710",
                "RC04905"
            ]
        },
        {
            "compound_ID": "D0130",
            "name": "2-Acetylaminofluorene",
            "synonyms": "2-Acetamidofluorene; 2-Acetylaminofluorene; 53-96-3; N-(9H-Fluoren-2-yl)acetamide; N-2-Fluorenylacetamide; 2-AAF; Acetamide, N-9H-fluoren-2-yl-; 2-(Acetylamino)fluorene; N-Fluoren-2-ylacetamide; N-acetyl-2-aminofluorene; 2-Acetaminofluorene; 2-FAA; 2-Fluorenylacetamide; N-(2-Fluorenyl)acetamide; 2-Acetoaminofluorene; Acetoaminofluorene; Azetylaminofluoren; N-9H-Fluoren-2-ylacetamide; 2-Acetylamino-fluoren; ACETYLAMINOFLUORENE; RCRA waste number U005; 2-Acetylaminfluorene; 2-Aminoacetylfluorene; 2-Fluorenil acetamide; Acetamide, N-fluoren-2-yl-; Fluorene, 2-acetamido-; CCRIS 1; UNII-9M98QLJ2DL; Azetylaminofluoren [German]; NSC 12279; 2-Acetylamino-fluoren [German]; HSDB 4077; 2-ACETYLAMINOFLUORENE-3-YL; EINECS 200-188-6; RCRA waste no. U005; BRN 2807677; 9M98QLJ2DL; AI3-52433; CHEBI:17356; AAF; Fluorenylacetamide; 2-acetylaminoflourene; 2-Acetylaminofluorine; ACMC-209lbc; DSSTox_CID_18; N-2-Fluorenyl Acetamide; N-Fluoren-2-yl acetamide; 2-Acetamidofluorene, 95%; DSSTox_RID_79424; DSSTox_GSID_39227; Oprea1_431359; SCHEMBL75140; N-9H-fluoren-2-yl-Acetamide; CHEMBL311469; DTXSID0039227; CTK3J0353; CZIHNRWJTSTCEX-UHFFFAOYSA-N; WLN: L B656 HHJ EMV1; ZINC154557; BCP30181; KS-000017GW; NSC12279; Tox21_200830; 5024AF; ANW-31894; BBL001828; LS-188; NSC-12279; SBB056657; STK386197; AKOS004006242; CCG-231696; MCULE-6066498727; RTR-031363; TRA0066210; CAS-53-96-3; SEL11071160; NCGC00188968-01; NCGC00188968-02; NCGC00258384-01; AFF; CC-08502; DB-020315; TR-031363; A0076; FT-0631234; N-(2-Fluorenyl)acetamide, >=98% (HPLC); ST50308153; T7962; C02778; C-12543; SR-01000394055; Q4382200; SR-01000394055-1; BRD-K63993117-001-01-3; 2-Acetylaminofluorene;2-AAF;2 Fluorenylacetamide;Fluoren-2-ylacetamide; InChI=1/C15H13NO/c1-10(17)16-13-6-7-15-12(9-13)8-11-4-2-3-5-14(11)15/h2-7,9H,8H2,1H3,(H,16,17",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C15H13NO",
            "molecular_weight": "223.27",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "5897",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F0108"
            ],
            "references": [
                "RC01659",
                "RC02280",
                "RC02901"
            ]
        },
        {
            "compound_ID": "D0131",
            "name": "3-Nitropropionate",
            "synonyms": "3-Nitropropanoate; 3-nitro-1-propionate; CHEMBL451226; 3-nitropropanoate anion; 3-nitropropionate anion; 3-nitropropanoate(1-); 3-nitropropionate(1-); SCHEMBL3292643; CHEBI:59899; BDBM50274515; Q27126950",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C3H4NO4-",
            "molecular_weight": "118.07",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "6971075",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [
                "T002008"
            ],
            "function": [
                "F020103"
            ],
            "references": [
                "RC01141"
            ]
        },
        {
            "compound_ID": "D0132",
            "name": "3-NPA",
            "synonyms": "3-nitropropionic acid; 3-Nitropropanoic acid; 504-88-1; Bovinocidin; Hiptagenic acid; Propanoic acid, 3-nitro-; beta-Nitropropionic acid; 3-Nitropropionate; Propionic acid, 3-nitro-; 3-NP acid; beta-Nitropropanoic acid; NCI-C03076; NSC 64266; NITROPROPIONIC ACID, BETA; UNII-QY4L0FOX0D; 3-NPA; beta-Nitropropanoate; BOVINOCIDIN (3-nitropropionic acid); CCRIS 454; HSDB 4147; 3-nitro-propionic acid; EINECS 208-003-0; QY4L0FOX0D; BNP; .beta.-Nitropropionic acid; BRN 1759889; CHEBI:16348; WBLZUCOIBUDNBV-UHFFFAOYSA-N; NSC64266; DSSTox_CID_982; DSSTox_RID_75904; 3-nitro-1-propionate; DSSTox_GSID_20982; CHEMBL451226; CAS-504-88-1; Nitropropionic aci, beta; SR-01000076030; 3-nitropropionic-acid; 3-Nitroporpionic Acid; Spectrum_001674; 3-Nitro-Propanoic acid; SpecPlus_000692; Substrate analogue, 20; beta -nitropropionic acid; Spectrum2_000876; Spectrum3_000993; Spectrum4_001119; Spectrum5_001895; Lopac-N-5636; WLN: WN2VQ; OE</=-nitropropionic acid; Nitropropionic acid, .beta.; 3-Nitropropionic acid, 8CI; Lopac0_000838; SCHEMBL70072; BSPBio_002685; KBioGR_001598; KBioSS_002154; 4-02-00-00771 (Beilstein Handbook Reference); MLS001066410; 3-Nitropropionic acid, 97%; DivK1c_006788; SPECTRUM1504206; SPBio_000951; 3-NP; DTXSID1020982; 3-Nitropropionic acid, >=97%; BDBM82201; CTK3I9712; KBio1_001732; KBio2_002154; KBio2_004722; KBio2_007290; KBio3_001905; HMS2235N03; HMS3262H17; HMS3369D16; ZINC895862; Propanoic acid, 3-nitro- (9CI); BCP15066; Tox21_202460; Tox21_303007; Tox21_500838; 6949AB; CCG-40325; MFCD00007406; NSC-64266; AKOS006221915; AKOS015833440; 504-88-1 (FREE ACID); CM10288; CS-W013591; FCH3459604; HY-W012875; LP00838; LS-1311; RTR-031911; SDCCGMLS-0066769.P001; TRA0076505; KS-0000184K; 3-Nitropropanoic acid; 3-nitropropanoate; NCGC00015744-01; NCGC00015744-02; NCGC00015744-03; NCGC00015744-04; NCGC00015744-05; NCGC00015744-06; NCGC00015744-07; NCGC00094169-01; NCGC00094169-02; NCGC00094169-03; NCGC00094169-04; NCGC00256389-01; NCGC00260009-01; NCGC00261523-01; CC-15785; SC-89718; SMR000471863; DB-008848; TR-031911; EU-0100838; FT-0632243; C05669; N 5636; C-31013; Q223104; SR-01000076030-1; SR-01000076030-5; 13104-55-7",
            "trade_name": "",
            "abbrev_name": "BPA, 3-NPA",
            "description": "mycotoxin; a potent mitochondrial inhibitor; irreversibly inactivates SDH",
            "molecular_formula": "C3H5NO4",
            "molecular_weight": "119.08",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "1678",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [
                "T004"
            ],
            "function": [
                "F020403"
            ],
            "references": [
                "RC04907"
            ]
        },
        {
            "compound_ID": "D0133",
            "name": "5-Aminolevulinic Acid",
            "synonyms": "5-Aminolevulinic acid; Aminolevulinic acid; 106-60-5; 5-Amino-4-oxopentanoic acid; 5-Aminolevulinate; delta-aminolevulinic acid; Pentanoic acid, 5-amino-4-oxo-; Aladerm; 5-Amino-4-oxovaleric acid; Kerastick; Ameluz; delta-ALA; 5-Amino-4-oxopentanoate; 5-amino-levulinate; 5-ALA; 5-amino-levulinic acid; 5-amino-4-oxo-pentanoic acid; DALA; CCRIS 8958; UNII-88755TAZ87; EINECS 203-414-1; CHEMBL601; Levulinic acid, 5-amino-; 4-oxo-5-amino-pentanoic acid; CHEBI:17549; ZGXJTSGNIOSYLO-UHFFFAOYSA-N; 88755TAZ87; 5-azanyl-4-oxidanylidene-pentanoic acid; Aminolevulinate; delta-aminolevulinate; Aminolevulinic; 5-Aminolaevulinate; SMR000857229; D-aminolevulinic acid; 5-Aminolaevulinic acid; BF-200 ALA; 5-aminolevulinicacidhydrochloride; FVT; Amino-levulinic acid; Spectrum_001582; 5-Amino-4-oxovalerate; SpecPlus_000858; 5ALA; Spectrum2_001662; Spectrum3_001654; Spectrum4_000618; Spectrum5_001505; 4-Carboxy-2-Oxobutylamine; 5-amino-4-oxo-Pentanoate; SCHEMBL8243; BSPBio_003407; KBioGR_001176; KBioSS_002062; MLS001333097; MLS001333098; BIDD:GT0260; DivK1c_006954; SPBio_001843; GTPL4784; PEN029; DTXSID8048490; KBio1_001898; KBio2_002062; KBio2_004630; KBio2_007198; KBio3_002627; HMS2231I19; HMS3259E22; HMS3369O14; Levulinic acid, 5-amino- (8CI); ALBB-023627; BCP23830; ZINC3782550; ZX-AN022141; 1451AA; AC-054; BDBM50240386; FCH831578; LMFA01100055; SBB071696; AKOS003587520; CS-W000450; DB00855; HY-W000450; LS41389; MCULE-8676354165; NC00601; NCGC00178086-01; AK-41254; AS-30950; CPD000857229; Pentanoic acid, 5-amino-4-oxo- (9CI); SAM002589919; SC-15622; SBI-0206721.P001; AX8017444; DB-040692; LS-101793; FT-0620021; ST45026832; C00430; D07567; Z-3294; 33871-EP2275420A1; 33871-EP2295055A2; 33871-EP2295416A2; 33871-EP2298748A2; 33871-EP2298764A1; 33871-EP2298765A1; 33871-EP2305642A2; 33871-EP2305825A1; 33871-EP2311453A1; 33871-EP2311808A1; 33871-EP2311829A1; AB00053763-07; AB00053763-08; AB00053763_09; AB00053763_10; 106A605; C-49907; Q238474; 35BEC718-C970-426A-9859-BF58284C60B4; Aminolevulinic Acid;ALA;5-Amino-4-oxopentanoic acid;5-amino-4-oxo-pentanoic acid;5-amino-4-keto-valeric acid",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C5H9NO3",
            "molecular_weight": "131.13",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "Mean half-life is 0.70 &plusmn; 0.18 h after the oral dose and 0.83 &plusmn; 0.05 h after the intravenous dose.",
            "absorption": "Oral bioavailability is 50-60%.",
            "cid": "137",
            "classification": "L",
            "indications": "",
            "side_effects": "",
            "atc_codes": "L01XD04",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0134",
            "name": "7H-Dibenzo(c,g)-carbazole",
            "synonyms": "7H-Dibenzo[c,g]carbazole; 194-59-2; 7H-DIBENZO(C,G)CARBAZOLE; Dibenzo(c,g)carbazole; 7H-DB(c,g)C; 3,4,5,6-Dibenzocarbazole; 3,4:5,6-Dibenzocarbazole; NSC 87519; UNII-SZF1OJI89D; CCRIS 209; 7-Aza-7H-dibenzo(c,g)fluorene; 7-Aza-7H-dibenzo[c,g]fluorene; HSDB 5098; EINECS 205-895-3; SZF1OJI89D; BRN 0213015; STJXCDGCXVZHDU-UHFFFAOYSA-N; 7H-Dibenzo(c,g)carbazole [Polycyclic aromatic compounds]; AK130239; DIBENZO[C,G]CARBAZOLE; 7H-Dibenzo(c,g)carbazole [Polycyclic aromatic hydrocarbons]; 3,5,6-Dibenzcarbazol; 3,5,6-Dibenzcarbazole; 3,5,6-Dibenzocarbazole; 3,4,5,6-Dibenzcarbazol; 3,4,5,6-Dibenzcarbazole; NCIOpen2_005134; SCHEMBL492860; DTXSID9059755; CHEBI:82312; CTK0H5289; KS-00000FLC; STJXCDGCXVZHDU-UHFFFAOYSA-; NSC87519; ZINC1562130; ACM194592; NSC-87519; WLN: T D6 C6 B566 MMJ; AKOS015913990; DS-6628; OL10172; VZ30979; LS-60592; LS-60595; AX8001125; DB-044865; TX-017370; CS-0078865; D4473; FT-0614184; C19221; C-16778; Q26841191; 7H-Dibenzo[c,g]carbazole, BCR(R) certified Reference Material; InChI=1/C20H13N/c1-3-7-15-13(5-1)9-11-17-19(15)20-16-8-4-2-6-14(16)10-12-18(20)21-17/h1-12,21H",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C20H13N",
            "molecular_weight": "267.3",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "9134",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0135",
            "name": "Acrolein",
            "synonyms": "ACROLEIN; Acrylaldehyde; 2-Propenal; 107-02-8; Propenal; Acrylic aldehyde; prop-2-enal; Allyl aldehyde; Ethylene aldehyde; Acraldehyde; Aqualin; Magnacide H; Aqualine; Slimicide; Crolean; 2-Propen-1-one; Acquinite; Magnacide; Prop-2-en-1-al; Acrylaldehyd; Acroleina; Acroleine; Akrolein; Akroleina; Biocide; Papite; Aldeide acrilica; Aldehyde acrylique; Acraldehydeacroleina; polyacrolein; Propenaldehyde; trans-Acrolein; NSC 8819; Akrolein [Czech]; Propenal [Czech]; Rcra waste number P003; Magnacide H and B; Akroleina [Polish]; Acroleina [Italian]; Acrylaldehyd [German]; Caswell No. 009; 2-Propenaldehyde; Propadien-1-ol; Acroleine [Dutch, French]; Aldeide acrilica [Italian]; Aldehyde acrylique [French]; UNII-7864XYD3JJ; Acrolein, inhibited; Propenal, inhibited; Acraldehydeacroleina [Italian]; UN 1092; CCRIS 3278; HSDB 177; CHEBI:15368; CH2=CHCHO; EINECS 203-453-4; UN1092; CHEMBL721; RCRA waste no. P003; Acrylic aldehyde, inhibited; EPA Pesticide Chemical Code 000701; AI3-24160; 7864XYD3JJ; HGINCPLSRVDWNT-UHFFFAOYSA-N; Acrolein, analytical standard; 2-Propenal, homopolymer; Aldehyde, Allyl; Aldehyde, Acrylic; Aldehyde, Ethylene; 81788-96-7; allol; Allylaldehyde; Acrolien; Aerolein; Acrolein Monomer; prop-2-en-1-one; Acrolein (stabilized with hydroquinone); prop-2-en -1-al; PubChem23303; 1,2-Propadien-1-ol; DSSTox_CID_23; Epitope ID:143621; EC 203-453-4; DSSTox_RID_75326; WLN: VH1U1; Acroleine(DUTCH, FRENCH); DSSTox_GSID_20023; trans-Acrolein Formylethylene; 25068-14-8; GTPL2418; DTXSID5020023; CTK0H5093; CTK2I6890; DTXSID50526220; NSC8819; ZINC897143; Acrolein 5000 microg/mL in Water; BCP07056; NSC-8819; STR00291; Acrolein 100 microg/mL in Acetone; Tox21_200984; BDBM50010912; LS-422; MFCD00006998; Acrolein 5000 microg/mL in Methanol; AKOS000120766; CM11306; NCGC00091484-01; NCGC00091484-02; NCGC00258537-01; Acrolein, inhibited [UN1092] [Poison]; CAS-107-02-8; SC-80607; Acrolein, inhibited [UN1092] [Poison]; DB-026460; A0137; FT-0621871; C01471; InChI=1/C3H4O/c1-2-3-4/h2-3H,1H; 33383-EP2272972A1; 33383-EP2272973A1; 33383-EP2277872A1; 33383-EP2280002A1; 33383-EP2305661A1; 33383-EP2311815A1; 33383-EP2371803A1; 33383-EP2374538A1; 33383-EP2377842A1; 33383-EP2377843A1; A801558; Acrolein 5000 microg/mL in Water, Second Source; Q342790; Acrolein 5000 microg/mL in Methanol, Second Source; Acrolein, contains hydroquinone as stabilizer, 90%; F2191-0151; Acrolein Solution, 1000 microg/mL in Methanol (naturally short expiry)",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C3H4O",
            "molecular_weight": "56.06",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "7847",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0136",
            "name": "Aflatoxin B1",
            "synonyms": "AFLATOXIN B1; 1162-65-8; Aflatoxin B; NSC 529592; HSDB 3453; CCRIS 12; UNII-9N2N2Y55MH; NSC-529592; AFB1; EINECS 214-603-3; Aflatoxin B1, crystalline; BRN 1269174; 9N2N2Y55MH; CHEBI:2504; 2,3,6aalpha,9aalpha-Tetrahydro-4-methoxycyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)benzopyran-1,11-dione; (6aR,9aS)-4-methoxy-2,3,6a,9a-tetrahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h]chromene-1,11-dione; 1H,11H-Cyclopenta[c]furo[3',2':4,5]furo[2,3-h][1]benzopyran-1,11-dione,2,3,6a,9a-tetrahydro-4-methoxy-, (6aR,9aS)-; Cyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)benzopyran-1,11-dione, 2,3,6a,9a-tetrahydro-4-methoxy-; Cyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)benzopyran-1,11-dione, 2,3,6a,9a-tetrahydro-4-methoxy-, (6aR,9aS)-; Aflatoxin-B1; NSC529592; Cyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)benzopyran-1,11-dione, 2,3,6a,9a-tetrahydro-4-methoxy-, (6aR-cis)-; 2,3,6aalpha,9aalpha-Tetrahydro-4-methoxycyclopenta(c)furo(2',3':4,5)furo(2,3-h)chromene-1,11-dione; Aflatoxin B1 2 microg/mL in Acetonitrile; Cyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)benzopyran-1,11-dione, 2,3,6aalpha,9aalpha-tetrahydro-4-methoxy-; OQIQSTLJSLGHID-UHFFFAOYSA-N; Aflatoxin B1 from Aspergillus flavus, from Aspergillus flavus; (+/-)-Aflatoxin B1; BIDD:ER0313; SCHEMBL126480; Standard Solution Aflatoxin B1; CHEMBL1697694; DTXSID9020035; CTK4A9707; Aflatoxin B1, reference material; DTXSID00873175; OQIQSTLJSLGHID-WNWIJWBNSA-N; BDBM120261; ZINC402671; 4-(methyloxy)-2,3,6a,9a-tetrahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h]chromene-1,11-dione; 4-Methoxy-2,3,6a,9a-tetrahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h]chromene-1,11-dione; HY-N6615; LS-584; MFCD00869647; AKOS030241596; VA10187; NCGC00247669-01; CS-0034371; ST50405315; 162A658; Q4689278; WLN: T F5 C6 B655 DOV GV OO QO RUT&&TTJ LO1; Aflatoxin B1 solution, 20 mug/mL in methanol, analytical standard; Aflatoxin B1 solution, 2 mug/mL in acetonitrile, analytical standard; Aflatoxin B1 solution, 3 mug/mL in benzene:acetonitrile (98:2), analytical standard; Aflatoxin B1 solution, 3.79 mug/g in acetonitrile, ERM(R) certified Reference Material; Aflatoxin B1 solution, certified reference material, 20 mug/mL in methanol, ampule of 1 mL; (9aS,6aR)-4-methoxy-2,3,6a,9a-tetrahydrocyclopenta[2,1-c]furano[3',2'-5,4]fura no[2,3-h]chromene-1,11-dione; 10279-73-9; 2,3,6a,9a-tetrahydro-4-methoxycyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)benzo-pyran-1,11-dione; Aflatoxin B1 solution, certified reference material, 3 mug/mL in benzene:acetonitrile (98:2), ampule of 1 mL; AFLATOXIN-B1 (SEE ALSO AFLATOXIN-B2 (CAS 7220-81-7) & AFLATOXINS (CAS 1402-68-2)); Cyclopenta[c]furo[3',5]furo[2,3-h][1]benzopyran-1,11-dione, 2,3,6a,9a-tetrahydro-4-methoxy-; Cyclopenta[c]furo[3',5]furo[2,3-h][1]benzopyran-1,11-dione, 2,3,6a,9a-tetrahydro-4-methoxy-, (6aR-cis)-; Cyclopenta[c]furo[3',5]furo[2,3-h][1]benzopyran-1,11-dione, 2,3,6a.alpha.,9a.alpha.-tetrahydro-4-methoxy-",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C17H12O6",
            "molecular_weight": "312.27",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "186907",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0137",
            "name": "Aluminium",
            "synonyms": "Aluminum; Aluminium; 7429-90-5; Aluminum metal; Aluminum powder; aluminio; Aluminum 27; Metana; Adom; Alumina fibre; Aluminium flake; Aluminum dust; Noral aluminium; Noral aluminum; Aluminium bronze; Alaun [German]; Aluminum dehydrated; Aluminum production; Aluminum A00; Aluminum, elemental; Aluminium, elementar; Aluminum pyro powders; Metana aluminum paste; Aluminum soluble salts; Aluminum welding fumes; AO Al; Noral non-leafing grade; Pigment metal 1; Aluminum (metal); C-Pigment 1 [German]; AD1M; Aluminum (fume or dust); Noral ink grade aluminium; Noral Ink Grade Aluminum; AO A1; Al; Aluminum metal, alkyls; Aluminum, pyro powders; Noral Extra Fine Lining Grade; Caswell No. 028A; Emanay atomized aluminum powder; AD 1; AV00; aluminium atom; Aluminum, soluble salts; Aluminum, welding fumes; Allbri aluminum paste and powder; Aa1193; JISC 3108; JISC 3110; Aluminum (dust or fume); AV000; 13Al; UNII-CPD4NFA903; UNII-KZJ3T010RQ; Aluminum metal, total dust; AA1199; Aluminum metal, pyro powders; NA9260; Aluminum metal, soluble salts; Aluminum metal, welding fumes; AA 1099; HSDB 507; A 00; A 95; A999V; A 995; A 999; Aluminum metal, respirable fraction; C.I. 77000; EINECS 231-072-3; UN1309; UN1396; EPA Pesticide Chemical Code 000111; CPD4NFA903; A999; CI 77000; MFCD00134029; L16; Aluminum compounds; AR2; C-Pigment 1; Alloy; Aluminum alloy; aluminium(0); 12011-61-9; Aluminium, 99.5%, shot (2-10 mm); Aluminum, pyro powders/welding fumes; Alumen; Aluminum, foil, thickness 0.025 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.075 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.075 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.075 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.10 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.10 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.10 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.10 mm, length 20 m, purity 99%; Aluminum, foil, thickness 0.10 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.125 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.125 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.125 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.20 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.25 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.25 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.25 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.25 mm, length 20 m, purity 99%; Aluminum, foil, thickness 0.3 mm, diameter 4 mm, purity 99%; Al(0); Nano-aluminium; Aluminum, foil, thickness 0.025 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.075 mm, 10 mm diameter, purity 99%; Aluminum, foil, thickness 0.075 mm, 25 mm diameter, purity 99%; Aluminum, foil, thickness 0.075 mm, 50 mm diameter, purity 99%; Aluminum, foil, thickness 0.075 mm, diameter 4 mm, purity 99%; Aluminum, foil, thickness 0.075 mm, diameter 8 mm, purity 99%; Aluminum, foil, thickness 0.075 mm, length 20 m, purity 99%; Aluminum, foil, thickness 0.10 mm, 10 mm diameter, purity 99%; Aluminum, foil, thickness 0.10 mm, 15 mm diameter, purity 99%; Aluminum, foil, thickness 0.10 mm, 25 mm diameter, purity 99%; Aluminum, foil, thickness 0.10 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 0.10 mm, 8 mm diameter, purity 99%; Aluminum, foil, thickness 0.10 mm, diameter 4 mm, purity 99%; Aluminum, foil, thickness 0.10 mm, size 25 x 25 mm, purity 99%; Aluminum, foil, thickness 0.10 mm, size 50 x 50 mm, purity 99%; Aluminum, foil, thickness 0.125 mm, 10 mm diameter, purity 99%; Aluminum, foil, thickness 0.125 mm, 25 mm diameter, purity 99%; Aluminum, foil, thickness 0.125 mm, 4 mm diameter, purity 99%; Aluminum, foil, thickness 0.125 mm, 50 mm diameter, purity 99%; Aluminum, foil, thickness 0.125 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 0.125 mm, diameter 8 mm, purity 99%; Aluminum, foil, thickness 0.125 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.125 mm, length 20 m, purity 99%; Aluminum, foil, thickness 0.20 mm, 25 mm diameter, purity 99%; Aluminum, foil, thickness 0.20 mm, 50 mm diameter, purity 99%; Aluminum, foil, thickness 0.20 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 0.20 mm, diameter 10 mm, purity 99%; Aluminum, foil, thickness 0.20 mm, diameter 15 mm, purity 99%; Aluminum, foil, thickness 0.20 mm, diameter 25 mm, purity 99%; Aluminum, foil, thickness 0.20 mm, diameter 4 mm, purity 99%; Aluminum, foil, thickness 0.20 mm, diameter 50 mm, purity 99%; Aluminum, foil, thickness 0.20 mm, diameter 6 mm, purity 99%; Aluminum, foil, thickness 0.20 mm, diameter 8 mm, purity 99%; Aluminum, foil, thickness 0.20 mm, size 25 x 25 mm, purity 99%; Aluminum, foil, thickness 0.20 mm, size 50 x 50 mm, purity 99%; Aluminum, foil, thickness 0.25 mm, 10 mm diameter, purity 99%; Aluminum, foil, thickness 0.25 mm, 50 mm diameter, purity 99%; Aluminum, foil, thickness 0.25 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 0.25 mm, diameter 25 mm, purity 99%; Aluminum, foil, thickness 0.25 mm, size 50 x 50 mm, purity 99%; Aluminum, foil, thickness 0.3 mm, 10 mm diameter, purity 99%; Aluminum, foil, thickness 0.3 mm, size 25 x 25 mm, purity 99%; Aluminum, foil, thickness 0.3 mm, size 50 x 50 mm, purity 99%; Aluminum, foil, thickness 1.5 mm, size 50 x 50 mm, purity 99%; Aluminum, foil, thickness 0.006 mm, size 25 x 25 mm, purity 99%; Aluminum, foil, thickness 0.006 mm, size 50 x 50 mm, purity 99%; Aluminum, foil, thickness 0.008 mm, size 25 x 25 mm, purity 99%; Aluminum, foil, thickness 0.008 mm, size 50 x 50 mm, purity 99%; Aluminum, foil, thickness 0.009 mm, size 25 x 25 mm, purity 99%; Aluminum, foil, thickness 0.009 mm, size 50 x 50 mm, purity 99%; Aluminum, foil, thickness 0.010 mm, size 25 x 25 mm, purity 99%; Aluminum, foil, thickness 0.010 mm, size 50 x 50 mm, purity 99%; Aluminum, foil, thickness 0.0125 mm, size 100 x 100 mm, purity 99%; Aluminum, foil, thickness 0.018 mm, size 300 x 300 mm, purity 99%; Aluminum, foil, thickness 0.020 mm, size 300 x 300 mm, purity 99%; Aluminum, foil, thickness 0.025 mm, size 100 x 100 mm, purity 99%; Aluminum, foil, thickness 0.025 mm, size 150 x 150 mm, purity 99%; Aluminum, foil, thickness 0.025 mm, size 25 x 25 mm, purity 99%; Aluminum, foil, thickness 0.025 mm, size 300 x 300 mm, purity 99%; Aluminum, foil, thickness 0.025 mm, size 50 x 50 mm, purity 99%; Aluminum, foil, thickness 0.075 mm, size 100 x 100 mm, purity 99%; Aluminum, foil, thickness 0.075 mm, size 150 x 150 mm, purity 99%; Aluminum, foil, thickness 0.075 mm, size 25 x 25 mm, purity 99%; Aluminum, foil, thickness 0.075 mm, size 300 x 300 mm, purity 99%; Aluminum, foil, thickness 0.075 mm, size 50 x 50 mm, purity 99%; Aluminum, foil, thickness 0.10 mm, size 100 x 100 mm, purity 99%; Aluminum, foil, thickness 0.10 mm, size 150 x 150 mm, purity 99%; Aluminum, foil, thickness 0.10 mm, size 300 x 300 mm, purity 99%; Aluminum, foil, thickness 0.125 mm, 4 mm diameter, high purity 99.999%; Aluminum, foil, thickness 0.125 mm, 50 mm diameter, high purity 99.999%; Aluminum, foil, thickness 0.125 mm, diameter 25 mm, high purity 99.999%; Aluminum, foil, thickness 0.125 mm, diameter 6 mm, high purity 99.999%; Aluminum, foil, thickness 0.125 mm, length 1 m, high purity 99.999%; Aluminum, foil, thickness 0.125 mm, length 2 m, high purity 99.999%; Aluminum, foil, thickness 0.125 mm, size 100 x 100 mm, purity 99%; Aluminum, foil, thickness 0.125 mm, size 150 x 150 mm, purity 99%; Aluminum, foil, thickness 0.125 mm, size 25 x 25 mm, purity 99%; Aluminum, foil, thickness 0.125 mm, size 300 x 300 mm, purity 99%; Aluminum, foil, thickness 0.125 mm, size 50 x 50 mm, purity 99%; Aluminum, foil, thickness 0.20 mm, size 100 x 100 mm, purity 99%; Aluminum, foil, thickness 0.20 mm, size 150 x 150 mm, purity 99%; Aluminum, foil, thickness 0.20 mm, size 300 x 300 mm, purity 99%; Aluminum, foil, thickness 0.25 mm, size 100 x 100 mm, purity 99%; Aluminum, foil, thickness 0.25 mm, size 150 x 150 mm, purity 99%; Aluminum, foil, thickness 0.25 mm, size 300 x 300 mm, purity 99%; Aluminum, foil, thickness 0.3 mm, size 100 x 100 mm, purity 99%; Aluminum, foil, thickness 0.3 mm, size 150 x 150 mm, purity 99%; Aluminum, foil, thickness 0.5 mm, size 100 x 100 mm, purity 99%; Aluminum, foil, thickness 1.5 mm, size 100 x 100 mm, purity 99%; Aluminum, lump, 15 mm max. lump size, weight 20 g, high purity 99.999%; Aluminum, lump, 15 mm max. lump size, weight 50 g, high purity 99.999%; Aluminum, molten; Aluminum, CP; Aluminum, foil, thickness 0.010 mm, size 25 x 25 mm, high purity 99.999%; Aluminum, foil, thickness 0.010 mm, size 50 x 50 mm, high purity 99.999%; Aluminum, foil, thickness 0.015 mm, size 25 x 25 mm, high purity 99.999%; Aluminum, foil, thickness 0.015 mm, size 50 x 50 mm, high purity 99.999%; Aluminum, foil, thickness 0.020 mm, size 100 x 100 mm, high purity 99.999%; Aluminum, foil, thickness 0.125 mm, size 100 x 100 mm, high purity 99.999%; Aluminum, foil, thickness 0.125 mm, size 25 x 25 mm, high purity 99.999%; Aluminum, foil, thickness 0.125 mm, size 50 x 50 mm, high purity 99.999%; Aluminum, foil, thickness 0.50 mm, size 50 x 50 mm, high purity 99.999%; Aluminum, foil, thickness 2.0 mm, size 100 x 100 mm, high purity 99.999%; Aluminum, honeycomb, thickness 20 mm, size 300 x 300 mm, cell size 6.3 mm; Aluminum, honeycomb, thickness 20 mm, size 600 x 600 mm, cell size 6.3 mm; Aluminum <75 micron; Aluminum powder, coated; Aluminum, molten [NA9260] [Class 9]; Aluminum powder, uncoated; EC 231-072-3; KSC377C8J; Aluminum, puriss., 98.5%; Aluminum powder, coated [UN1309] [Flammable solid]; ALUMINUM (SEE ALSO ALUMINUM OXIDE 1344-28-1); DTXSID3040273; CHEBI:28984; CHEBI:33629; CTK2H7184; HSDB 7331; KS-00000UIP; Aluminum powder, uncoated [UN1396] [Dangerous when wet]; XAGFODPZIPBFFR-UHFFFAOYSA-N; ANW-36460; AKOS024438057; DB01370; LS-1637; RTR-023999; TRA-0207175; LS-16450; LS-16478; SC-81859; Aluminum Ultrathin foil, 1.0 micron thick; Aluminum, molten [NA9260] [Class 9]; Aluminum, powder, >=91% (complexometric); TR-023999; Aluminum, grit, >=97.0% (complexometric); FT-0622244; Y2040; Aluminum Ultrathin foil, 0.0075 micron thick; Aluminum, foil, thickness 2.0 mm, 99.999%; Aluminum, <=30 mum, spherical powder, >=99%; Aluminum, rod, 100mm, diameter 12.7mm, 99%; Aluminum, rod, 200mm, diameter 12.7mm, 99%; Aluminum, rod, 500mm, diameter 12.7mm, 99%; Aluminum hydride [UN2463] [Dangerous when wet]; Aluminum, powder (fine), >=93% (complexometric); Aluminum, rod, 1000mm, diameter 12.7mm, 99%; Aluminum, sphere, 100pcs, diameter 6.0mm, 99%; Aluminum, sphere, 200pcs, diameter 6.0mm, 99%; Aluminum, sphere, 50pcs, diameter 6.0mm, 99%; Aluminum, wire, diam. 0.127 mm, >=99.99%; Aluminium, 99.9995%, (trace metal basis), shot; Aluminum powder, spherical, APS 10.0-14.0 micron; Aluminum, ReagentPlus(R), powder, <75 mum, 99%; Aluminium powder, spherical, APS 10.0-14.0 micron; Aluminum powder, coated [UN1309] [Flammable solid]; A035000000; Aluminum, granular, <1 mm, 99.7% trace metals basis; Aluminum powder, spherical, APS approximately 0.07 micron; Aluminum powder, uncoated [UN1396] [Dangerous when wet]; Aluminum, ACS reagent, 99%, wire, wire diam. ~1.5 mm; Aluminum, foil, thickness 8 mum, 99% trace metals basis; Aluminum, pellets, 3-12 mm, 99.99% trace metals basis; Aluminum, powder, <75 mum, >=99.95% trace metals basis; Aluminum, rod, 50mm, diameter 28mm, as drawn, 99.999%; Aluminum, wire reel, 1m, diameter 0.01mm, hard, 99.99%; Aluminum, wire reel, 1m, diameter 0.02mm, hard, 99.99%; Aluminum, wire reel, 5m, diameter 0.02mm, hard, 99.99%; Aluminum, disc, 0.5-1.7 mm, >=99.99% trace metals basis; Aluminum, foil, diameter 6 mm, thickness 1.5 mm, purity 99%; Aluminum, foil, length 2 m, thickness 0.15 mm, purity 99%; Aluminum, foil, length 5 m, thickness 0.025 mm, purity 99%; Aluminum, foil, length 5 m, thickness 0.25 mm, purity 99%; Aluminum, foil, thickness 0.008 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.008 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.008 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.010 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.010 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.010 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.015 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.015 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.015 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.018 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.018 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.018 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.020 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.020 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.020 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.025 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.025 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.025 mm, purity 99%, length 1 m; Aluminum, foil, thickness 0.030 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.030 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.030 mm, purity 99%, length 2 m; Aluminum, foil, thickness 0.040 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.040 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.040 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.05 mm, 99.8% trace metals basis; Aluminum, foil, thickness 0.05 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.05 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.05 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.05 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.050 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.050 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.050 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.060 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.060 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.060 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.15 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.15 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.15 mm, length 20 m, purity 99%; Aluminum, foil, thickness 0.15 mm, purity 99%, length 5 m; Aluminum, foil, thickness 0.20 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.20 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.20 mm, length 20 m, purity 99%; Aluminum, foil, thickness 0.20 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.25 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.3 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 0.3 mm, 8 mm diameter, purity 99%; Aluminum, foil, thickness 0.3 mm, diameter 6 mm, purity 99%; Aluminum, foil, thickness 0.3 mm, diameter 8 mm, purity 99%; Aluminum, foil, thickness 0.3 mm, length 0.5 m, purity 99%; Aluminum, foil, thickness 0.3 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.3 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.3 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.3 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.38 mm, length 1 m, purity 99%; Aluminum, foil, thickness 0.38 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.38 mm, length 2 m, purity 99%; Aluminum, foil, thickness 0.38 mm, length 5 m, purity 99%; Aluminum, foil, thickness 0.5 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 0.5 mm, 8 mm diameter, purity 99%; Aluminum, foil, thickness 0.5 mm, diameter 4 mm, purity 99%; Aluminum, foil, thickness 1.0 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 1.0 mm, 8 mm diameter, purity 99%; Aluminum, foil, thickness 1.0 mm, purity 99%, diameter 4 mm; Aluminum, foil, thickness 1.5 mm, 4 mm diameter, purity 99%; Aluminum, foil, thickness 1.5 mm, 8 mm diameter, purity 99%; Aluminum, IRMM(R) certified Reference Material, 0.1 mm foil; Aluminum, IRMM(R) certified Reference Material, 1.0 mm foil; Aluminum, IRMM(R) certified Reference Material, 1.0 mm wire; Aluminum, Oil based standard solution, Specpure, Al 1000g/g; Aluminum, Oil based standard solution, Specpure, Al 5000g/g; Aluminum, pellets, 3-8 mesh, >=99.999% trace metals basis; Aluminum, rod, 1000mm, diameter 5.0mm, as drawn, 99.999%; Aluminum, rod, 1000mm, diameter 6.0mm, as drawn, 99.999%; Aluminum, rod, 100mm, diameter 10.0mm, as drawn, 99.999%; Aluminum, rod, 100mm, diameter 12.0mm, as drawn, 99.999%; Aluminum, rod, 100mm, diameter 15.0mm, as drawn, 99.999%; Aluminum, rod, 100mm, diameter 20.0mm, as drawn, 99.999%; Aluminum, rod, 100mm, diameter 25.0mm, as drawn, 99.999%; Aluminum, rod, 100mm, diameter 28mm, as drawn, 99.999%; Aluminum, rod, 100mm, diameter 30.0mm, as drawn, 99.999%; Aluminum, rod, 100mm, diameter 5.0mm, as drawn, 99.999%; Aluminum, rod, 100mm, diameter 6.0mm, as drawn, 99.999%; Aluminum, rod, 200mm, diameter 10.0mm, as drawn, 99.999%; Aluminum, rod, 200mm, diameter 12.0mm, as drawn, 99.999%; Aluminum, rod, 200mm, diameter 15.0mm, as drawn, 99.999%; Aluminum, rod, 200mm, diameter 20.0mm, as drawn, 99.999%; Aluminum, rod, 200mm, diameter 5.0mm, as drawn, 99.999%; Aluminum, rod, 200mm, diameter 6.0mm, as drawn, 99.999%; Aluminum, rod, 44mm, diameter 77.5mm, as drawn, 99.999%; Aluminum, rod, 500mm, diameter 10.0mm, as drawn, 99.999%; Aluminum, rod, 500mm, diameter 12.0mm, as drawn, 99.999%; Aluminum, rod, 500mm, diameter 15.0mm, as drawn, 99.999%; Aluminum, rod, 500mm, diameter 5.0mm, as drawn, 99.999%; Aluminum, rod, 500mm, diameter 6.0mm, as drawn, 99.999%; Aluminum, rod, 50mm, diameter 20.0mm, as drawn, 99.999%; Aluminum, rod, 50mm, diameter 25.0mm, as drawn, 99.999%; Aluminum, rod, 50mm, diameter 30.0mm, as drawn, 99.999%; Aluminum, rod, 50mm, diameter 50.0mm, as drawn, 99.999%; Aluminum, wire reel, 100m, diameter 0.25mm, hard, 99.99+%; Aluminum, wire reel, 100m, diameter 0.5mm, as drawn, 99.5%; Aluminum, wire reel, 100m, diameter 0.7mm, as drawn, 99.5%; Aluminum, wire reel, 100m, diameter 1.0mm, as drawn, 99.5%; Aluminum, wire reel, 10m, diameter 0.015mm, hard, 99.99%; Aluminum, wire reel, 10m, diameter 0.02mm, hard, 99.99%; Aluminum, wire reel, 10m, diameter 0.25mm, hard, 99.99+%; Aluminum, wire reel, 10m, diameter 0.5mm, as drawn, 99.5%; Aluminum, wire reel, 10m, diameter 0.7mm, as drawn, 99.5%; Aluminum, wire reel, 10m, diameter 1.0mm, as drawn, 99.5%; Aluminum, wire reel, 1m, diameter 0.015mm, hard, 99.99%; Aluminum, wire reel, 1m, diameter 0.25mm, hard, 99.99+%; Aluminum, wire reel, 1m, diameter 0.5mm, as drawn, 99.999%; Aluminum, wire reel, 1m, diameter 1.0mm, as drawn, 99.999%; Aluminum, wire reel, 1m, diameter 1.5mm, as drawn, 99.999%; Aluminum, wire reel, 1m, diameter 2.0mm, as drawn, 99.999%; Aluminum, wire reel, 1m, diameter 3.0mm, as drawn, 99.999%; Aluminum, wire reel, 20m, diameter 0.02mm, hard, 99.99%; Aluminum, wire reel, 20m, diameter 0.25mm, hard, 99.99+%; Aluminum, wire reel, 20m, diameter 0.7mm, as drawn, 99.5%; Aluminum, wire reel, 20m, diameter 1.0mm, as drawn, 99.5%; Aluminum, wire reel, 25m, diameter 0.25mm, as drawn, 99.5%; Aluminum, wire reel, 25m, diameter 0.30mm, as drawn, 99.5%; Aluminum, wire reel, 2m, diameter 2.0mm, as drawn, 99.999%; Aluminum, wire reel, 2m, diameter 3.0mm, as drawn, 99.999%; Aluminum, wire reel, 500m, diameter 0.5mm, as drawn, 99.5%; Aluminum, wire reel, 500m, diameter 0.7mm, as drawn, 99.5%; Aluminum, wire reel, 500m, diameter 1.0mm, as drawn, 99.5%; Aluminum, wire reel, 50m, diameter 0.25mm, hard, 99.99+%; Aluminum, wire reel, 50m, diameter 0.5mm, as drawn, 99.5%; Aluminum, wire reel, 5m, diameter 0.005mm, hard, 99.95%; Aluminum, wire reel, 5m, diameter 0.015mm, hard, 99.99%; Aluminum, wire reel, 5m, diameter 0.25mm, as drawn, 99.5%; Aluminum, wire reel, 5m, diameter 0.25mm, hard, 99.99+%; Aluminum, wire reel, 5m, diameter 0.30mm, as drawn, 99.5%; Aluminum, wire reel, 5m, diameter 1.0mm, as drawn, 99.999%; Aluminum, wire reel, 5m, diameter 1.5mm, as drawn, 99.999%; Aluminum, wire reel, 5m, diameter 2.0mm, as drawn, 99.999%; Aluminum, wire reel, 5m, diameter 3.0mm, as drawn, 99.999%; Aluminum, wire, diam. 0.58 mm, >=99.99% trace metals basis; Aluminum, wire, diam. 1.0 mm, 99.999% trace metals basis; Aluminum alloy, ERM(R) certified Reference Material, AlMg3, disc; Aluminum alloy, ERM(R) certified Reference Material, AlSi12, disc; Aluminum, foil, diameter 10 mm, thickness 0.025 mm, purity 99%; Aluminum, foil, diameter 25 mm, thickness 0.009 mm, purity 99%; Aluminum, foil, diameter 50 mm, thickness 0.030 mm, purity 99%; Aluminum, foil, diameter 50 mm, thickness 0.15 mm, purity 99%; Aluminum, foil, diameter 8 mm, thickness 0.0125 mm, purity 99%; Aluminum, foil, length 1 m, thickness 0.10 mm, coil width 152 mm; Aluminum, foil, length 10 m, thickness 0.075 mm, purity 99%; Aluminum, foil, length 20 m, thickness 0.025 mm, purity 99%; Aluminum, foil, length 20 m, thickness 0.060 mm, purity 99%; Aluminum, foil, thickness 0.008 mm, 15 mm diameter, purity 99%; Aluminum, foil, thickness 0.008 mm, 25 mm diameter, purity 99%; Aluminum, foil, thickness 0.008 mm, 4 mm diameter, purity 99%; Aluminum, foil, thickness 0.008 mm, 50 mm diameter, purity 99%; Aluminum, foil, thickness 0.008 mm, 8 mm diameter, purity 99%; Aluminum, foil, thickness 0.008 mm, diameter 10 mm, purity 99%; Aluminum, foil, thickness 0.008 mm, diameter 6 mm, purity 99%; Aluminum, foil, thickness 0.008 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.009 mm, 10 mm diameter, purity 99%; Aluminum, foil, thickness 0.009 mm, 50 mm diameter, purity 99%; Aluminum, foil, thickness 0.009 mm, diameter 15 mm, purity 99%; Aluminum, foil, thickness 0.009 mm, diameter 4 mm, purity 99%; Aluminum, foil, thickness 0.009 mm, diameter 6 mm, purity 99%; Aluminum, foil, thickness 0.009 mm, diameter 8 mm, purity 99%; Aluminum, foil, thickness 0.010 mm, 15 mm diameter, purity 99%; Aluminum, foil, thickness 0.010 mm, 25 mm diameter, purity 99%; Aluminum, foil, thickness 0.010 mm, 8 mm diameter, purity 99%; Aluminum, foil, thickness 0.010 mm, diameter 10 mm, purity 99%; Aluminum, foil, thickness 0.010 mm, diameter 4 mm, purity 99%; Aluminum, foil, thickness 0.010 mm, diameter 50 mm, purity 99%; Aluminum, foil, thickness 0.010 mm, diameter 6 mm, purity 99%; Aluminum, foil, thickness 0.010 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.010 mm, length 20 m, purity 99%; Aluminum, foil, thickness 0.0125 mm, 10 mm diameter, purity 99%; Aluminum, foil, thickness 0.0125 mm, 25 mm diameter, purity 99%; Aluminum, foil, thickness 0.0125 mm, 50 mm diameter, purity 99%; Aluminum, foil, thickness 0.0125 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 0.0125 mm, diameter 4 mm, purity 99%; Aluminum, foil, thickness 0.0125 mm, purity 99%, diameter 15 mm; Aluminum, foil, thickness 0.015 mm, 4 mm diameter, purity 99%; Aluminum, foil, thickness 0.015 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 0.015 mm, 8 mm diameter, purity 99%; Aluminum, foil, thickness 0.015 mm, diameter 10 mm, purity 99%; Aluminum, foil, thickness 0.015 mm, diameter 15 mm, purity 99%; Aluminum, foil, thickness 0.015 mm, diameter 25 mm, purity 99%; Aluminum, foil, thickness 0.015 mm, diameter 50 mm, purity 99%; Aluminum, foil, thickness 0.015 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.015 mm, length 20 m, purity 99%; Aluminum, foil, thickness 0.018 mm, 15 mm diameter, purity 99%; Aluminum, foil, thickness 0.018 mm, 50 mm diameter, purity 99%; Aluminum, foil, thickness 0.018 mm, diameter 10 mm, purity 99%; Aluminum, foil, thickness 0.018 mm, diameter 25 mm, purity 99%; Aluminum, foil, thickness 0.018 mm, diameter 4 mm, purity 99%; Aluminum, foil, thickness 0.018 mm, diameter 6 mm, purity 99%; Aluminum, foil, thickness 0.018 mm, diameter 8 mm, purity 99%; Aluminum, foil, thickness 0.018 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.018 mm, length 20 m, purity 99%; Aluminum, foil, thickness 0.020 mm, 10 mm diameter, purity 99%; Aluminum, foil, thickness 0.020 mm, 15 mm diameter, purity 99%; Aluminum, foil, thickness 0.020 mm, diameter 25 mm, purity 99%; Aluminum, foil, thickness 0.020 mm, diameter 4 mm, purity 99%; Aluminum, foil, thickness 0.020 mm, diameter 50 mm, purity 99%; Aluminum, foil, thickness 0.020 mm, diameter 6 mm, purity 99%; Aluminum, foil, thickness 0.020 mm, diameter 8 mm, purity 99%; Aluminum, foil, thickness 0.020 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.020 mm, length 20 m, purity 99%; Aluminum, foil, thickness 0.025 mm, 15 mm diameter, purity 99%; Aluminum, foil, thickness 0.025 mm, 25 mm diameter, purity 99%; Aluminum, foil, thickness 0.025 mm, 4 mm diameter, purity 99%; Aluminum, foil, thickness 0.025 mm, coil width 25 mm, length 5 m; Aluminum, foil, thickness 0.025 mm, diameter 50 mm, purity 99%; Aluminum, foil, thickness 0.025 mm, diameter 6 mm, purity 99%; Aluminum, foil, thickness 0.025 mm, diameter 8 mm, purity 99%; Aluminum, foil, thickness 0.025 mm, length 1 m, coil width 25 mm; Aluminum, foil, thickness 0.025 mm, length 2 m, coil width 25 mm; Aluminum, foil, thickness 0.025 mm, length 20 m, purity 99%; Aluminum, foil, thickness 0.030 mm, 10 mm diameter, purity 99%; Aluminum, foil, thickness 0.030 mm, 15 mm diameter, purity 99%; Aluminum, foil, thickness 0.030 mm, 25 mm diameter, purity 99%; Aluminum, foil, thickness 0.030 mm, 8 mm diameter, purity 99%; Aluminum, foil, thickness 0.030 mm, diameter 4 mm, purity 99%; Aluminum, foil, thickness 0.030 mm, diameter 6 mm, purity 99%; Aluminum, foil, thickness 0.030 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.030 mm, length 20 m, purity 99%; Aluminum, foil, thickness 0.040 mm, 10 mm diameter, purity 99%; Aluminum, foil, thickness 0.040 mm, 15 mm diameter, purity 99%; Aluminum, foil, thickness 0.040 mm, 25 mm diameter, purity 99%; Aluminum, foil, thickness 0.040 mm, 50 mm diameter, purity 99%; Aluminum, foil, thickness 0.040 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 0.040 mm, 8 mm diameter, purity 99%; Aluminum, foil, thickness 0.040 mm, diameter 4 mm, purity 99%; Aluminum, foil, thickness 0.040 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.040 mm, length 20 m, purity 99%; Aluminum, foil, thickness 0.05 mm, length 0.5 m, coil width 6 mm; Aluminum, foil, thickness 0.05 mm, length 0.5 m, purity 99%; Aluminum, foil, thickness 0.05 mm, length 1 m, coil width 10 mm; Aluminum, foil, thickness 0.05 mm, length 1 m, coil width 6 mm; Aluminum, foil, thickness 0.05 mm, length 10 m, coil width 10 mm; Aluminum, foil, thickness 0.05 mm, length 10 m, coil width 6 mm; Aluminum, foil, thickness 0.05 mm, length 2 m, coil width 10 mm; Aluminum, foil, thickness 0.05 mm, length 2 m, coil width 6 mm; Aluminum, foil, thickness 0.05 mm, length 5 m, coil width 10 mm; Aluminum, foil, thickness 0.05 mm, length 5 m, coil width 6 mm; Aluminum, foil, thickness 0.050 mm, 10 mm diameter, purity 99%; Aluminum, foil, thickness 0.050 mm, 15 mm diameter, purity 99%; Aluminum, foil, thickness 0.050 mm, 25 mm diameter, purity 99%; Aluminum, foil, thickness 0.050 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 0.050 mm, 8 mm diameter, purity 99%; Aluminum, foil, thickness 0.050 mm, diameter 4 mm, purity 99%; Aluminum, foil, thickness 0.050 mm, diameter 50 mm, purity 99%; Aluminum, foil, thickness 0.050 mm, length 0.5 m, purity 99%; Aluminum, foil, thickness 0.050 mm, length 1 m, coil width .1 mm; Aluminum, foil, thickness 0.050 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.050 mm, length 2 m, coil width .1 mm; Aluminum, foil, thickness 0.050 mm, length 5 m, coil width .1 mm; Aluminum, foil, thickness 0.060 mm, 10 mm diameter, purity 99%; Aluminum, foil, thickness 0.060 mm, 4 mm diameter, purity 99%; Aluminum, foil, thickness 0.060 mm, 50 mm diameter, purity 99%; Aluminum, foil, thickness 0.060 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 0.060 mm, 8 mm diameter, purity 99%; Aluminum, foil, thickness 0.060 mm, diameter 15 mm, purity 99%; Aluminum, foil, thickness 0.060 mm, diameter 25 mm, purity 99%; Aluminum, foil, thickness 0.060 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.075 mm, 15 mm diameter, purity 99%; Aluminum, foil, thickness 0.075 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 0.075 mm, diameter 15 mm, purity 99%; Aluminum, foil, thickness 0.075 mm, diameter 6 mm, purity 99%; Aluminum, foil, thickness 0.075 mm, length 10 m, purity 99%; Aluminum, foil, thickness 0.08 mm, 25 mm diameter, purity 99%; Aluminum, foil, thickness 0.08 mm, 4 mm diameter, purity 99%; Aluminum, foil, thickness 0.08 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 0.08 mm, 8 mm diameter, purity 99%; Aluminum, foil, thickness 0.08 mm, diameter 10 mm, purity 99%; Aluminum, foil, thickness 0.08 mm, diameter 15 mm, purity 99%; Aluminum, foil, thickness 0.08 mm, diameter 50 mm, purity 99%; Aluminum, foil, thickness 0.08 mm, size 25 x 25 mm, purity 99%; Aluminum, foil, thickness 0.08 mm, size 50 x 50 mm, purity 99%; Aluminum, foil, thickness 0.09 mm, 6 mm diameter, purity 99.99%; Aluminum, foil, thickness 0.09 mm, diameter 4 mm, purity 99.99%; Aluminum, foil, thickness 0.09 mm, diameter 8 mm, purity 99.99%; Aluminum, foil, thickness 0.09 mm, length 0.5 m, purity 99.99%; Aluminum, foil, thickness 0.09 mm, length 1 m, purity 99.99%; Aluminum, foil, thickness 0.09 mm, length 2 m, purity 99.99%; Aluminum, foil, thickness 0.09 mm, length 5 m, purity 99.99%; Aluminum, foil, thickness 0.10 mm, 15 mm diameter, purity 99.5%; Aluminum, foil, thickness 0.10 mm, 25 mm diameter, purity 99.5%; Aluminum, foil, thickness 0.10 mm, 50 mm diameter, purity 99%; Aluminum, foil, thickness 0.10 mm, 50 mm diameter, purity 99.5%; Aluminum, foil, thickness 0.10 mm, 6 mm diameter, purity 99.5%; Aluminum, foil, thickness 0.10 mm, 8 mm diameter, purity 99.5%; Aluminum, foil, thickness 0.10 mm, diameter 10 mm, purity 99.5%; Aluminum, foil, thickness 0.10 mm, diameter 4 mm, purity 99.5%; Aluminum, foil, thickness 0.10 mm, diameter 50 mm, purity 99%; Aluminum, foil, thickness 0.10 mm, length 0.5 m, purity 99%; Aluminum, foil, thickness 0.10 mm, length 0.5 m, purity 99.5%; Aluminum, foil, thickness 0.10 mm, length 1 m, coil width 610 mm; Aluminum, foil, thickness 0.10 mm, length 1 m, purity 99.5%; Aluminum, foil, thickness 0.10 mm, length 2 m, coil width 152 mm; Aluminum, foil, thickness 0.10 mm, length 2 m, purity 99.5%; Aluminum, foil, thickness 0.10 mm, length 5 m, coil width 152 mm; Aluminum, foil, thickness 0.10 mm, length 5 m, purity 99.5%; Aluminum, foil, thickness 0.125 mm, 15 mm diameter, purity 99%; Aluminum, foil, thickness 0.125 mm, diameter 15 mm, purity 99%; Aluminum, foil, thickness 0.13 mm, >=99.99% trace metals basis; Aluminum, foil, thickness 0.15 mm, 4 mm diameter, purity 99%; Aluminum, foil, thickness 0.15 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 0.15 mm, 8 mm diameter, purity 99%; Aluminum, foil, thickness 0.15 mm, diameter 10 mm, purity 99%; Aluminum, foil, thickness 0.15 mm, diameter 15 mm, purity 99%; Aluminum, foil, thickness 0.15 mm, diameter 25 mm, purity 99%; Aluminum, foil, thickness 0.15 mm, size 25 x 25 mm, purity 99%; Aluminum, foil, thickness 0.15 mm, size 50 x 50 mm, purity 99%; Aluminum, foil, thickness 0.20 mm, 10 mm diameter, purity 99%; Aluminum, foil, thickness 0.20 mm, 15 mm diameter, purity 99%; Aluminum, foil, thickness 0.20 mm, 4 mm diameter, purity 99%; Aluminum, foil, thickness 0.20 mm, 8 mm diameter, purity 99%; Aluminum, foil, thickness 0.20 mm, length 1 m, coil width 600 mm; Aluminum, foil, thickness 0.20 mm, length 2 m, coil width 600 mm; Aluminum, foil, thickness 0.20 mm, length 5 m, coil width 600 mm; Aluminum, foil, thickness 0.20 mm, purity 99%, diameter 8 mm; Aluminum, foil, thickness 0.25 mm, 15 mm diameter, purity 99%; Aluminum, foil, thickness 0.25 mm, 4 mm diameter, purity 99%; Aluminum, foil, thickness 0.25 mm, 8 mm diameter, purity 99%; Aluminum, foil, thickness 0.25 mm, 99.999% trace metals basis; Aluminum, foil, thickness 0.25 mm, diameter 15 mm, purity 99%; Aluminum, foil, thickness 0.25 mm, diameter 4 mm, purity 99%; Aluminum, foil, thickness 0.25 mm, diameter 8 mm, purity 99%; Aluminum, foil, thickness 0.3 mm, 15 mm diameter, purity 99%; Aluminum, foil, thickness 0.3 mm, 25 mm diameter, purity 99%; Aluminum, foil, thickness 0.3 mm, 50 mm diameter, purity 99%; Aluminum, foil, thickness 0.3 mm, diameter 15 mm, purity 99%; Aluminum, foil, thickness 0.3 mm, diameter 25 mm, purity 99%; Aluminum, foil, thickness 0.3 mm, diameter 50 mm, purity 99%; Aluminum, foil, thickness 0.38 mm, 10 mm diameter, purity 99%; Aluminum, foil, thickness 0.38 mm, 15 mm diameter, purity 99%; Aluminum, foil, thickness 0.38 mm, 25 mm diameter, purity 99%; Aluminum, foil, thickness 0.38 mm, 50 mm diameter, purity 99%; Aluminum, foil, thickness 0.38 mm, 6 mm diameter, purity 99%; Aluminum, foil, thickness 0.38 mm, 8 mm diameter, purity 99%",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "Al",
            "molecular_weight": "26.981538",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "5359268",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [
                "T004"
            ],
            "function": [
                "F020603",
                "F0504"
            ],
            "references": [
                "RC03659",
                "RC03660"
            ]
        },
        {
            "compound_ID": "D0138",
            "name": "Benzimidazole",
            "synonyms": "BENZIMIDAZOLE; 51-17-2; 1H-Benzimidazole; 1H-Benzo[d]imidazole; Benzoimidazole; 1,3-Benzodiazole; o-Benzimidazole; 3-Azaindole; Benziminazole; Benzoglyoxaline; Azindole; 1H-Benzoimidazole; 1,3-Diazaindene; Benzimidazol; N,N'-Methenyl-o-phenylenediamine; NSC 759; 1H-1,3-benzodiazole; BZI; UNII-E24GX49LD8; CCRIS 5967; Benzimidazole, 98%; CHEBI:41275; HSDB 2797; EINECS 200-081-4; MFCD00005585; BRN 0109682; AI3-03737; E24GX49LD8; HYZJCKYKOHLVJF-UHFFFAOYSA-N; DSSTox_CID_4573; benzimidazole phase betaetha; benzimidazole phase alphalpha; benzimidazole phase gammaamma; DSSTox_RID_77454; DSSTox_GSID_24573; F3366-5347; CAS-51-17-2; bezimidazole; benz-imidazole; Hbzim; Hbim; 1H-benzimidazol; 4dsu; PubChem11074; ACMC-209ks6; Epitope ID:140095; SCHEMBL6009; SCHEMBL6010; WLN: T56 BM DNJ; 5-23-06-00196 (Beilstein Handbook Reference); KSC270M3P; MLS001066336; BDBM7939; CHEMBL306226; NSC759; SCHEMBL5197771; DTXSID8024573; CTK1H0637; KS-00000KLW; NSC-759; HMS2233D03; HMS3370L16; ZINC331902; Tox21_202107; Tox21_303321; ANW-31204; BBL007563; HTS027706; LS-151; SBB004294; STK397462; AKOS000119163; AM81999; CS-W019944; DB02962; MCULE-8167283494; PS-5765; RTR-018244; NCGC00091255-01; NCGC00091255-02; NCGC00257173-01; NCGC00259656-01; ((non-Isotopelabelled)Benzimidazole-13C6; AK109037; M020; SC-15192; SMR000471839; SY012765; AB1003114; DB-002016; ST2415489; TR-018244; 264-EP2269999A1; 264-EP2270006A1; 264-EP2270010A1; 264-EP2270505A1; 264-EP2271628A1; 264-EP2272517A1; 264-EP2272825A2; 264-EP2272828A1; 264-EP2272832A1; 264-EP2274983A1; 264-EP2275102A1; 264-EP2275105A1; 264-EP2275409A1; 264-EP2275412A1; 264-EP2277858A1; 264-EP2280000A1; 264-EP2280009A1; 264-EP2281563A1; 264-EP2281815A1; 264-EP2281818A1; 264-EP2281819A1; 264-EP2281824A1; 264-EP2284157A1; 264-EP2284920A1; 264-EP2287155A1; 264-EP2289876A1; 264-EP2292586A2; 264-EP2292592A1; 264-EP2292593A2; 264-EP2292611A1; 264-EP2292612A2; 264-EP2294066A1; 264-EP2295433A2; 264-EP2298755A1; 264-EP2298767A1; 264-EP2298770A1; 264-EP2298774A1; 264-EP2301536A1; 264-EP2301538A1; 264-EP2301921A1; 264-EP2301923A1; 264-EP2301925A1; 264-EP2301926A1; 264-EP2301932A1; 264-EP2302003A1; 264-EP2305219A1; 264-EP2305250A1; 264-EP2305640A2; 264-EP2305642A2; 264-EP2305643A1; 264-EP2305651A1; 264-EP2305662A1; 264-EP2305695A2; 264-EP2305696A2; 264-EP2305697A2; 264-EP2305698A2; 264-EP2305769A2; 264-EP2308492A1; 264-EP2308510A1; 264-EP2308562A2; 264-EP2308833A2; 264-EP2308840A1; 264-EP2308852A1; 264-EP2308854A1; 264-EP2308867A2; 264-EP2308870A2; 264-EP2309855A1; 264-EP2311455A1; 264-EP2311810A1; 264-EP2311826A2; 264-EP2311830A1; 264-EP2311831A1; 264-EP2311842A2; 264-EP2314575A1; 264-EP2314582A1; 264-EP2314583A1; 264-EP2314587A1; 264-EP2315303A1; 264-EP2315763A1; 264-EP2316452A1; 264-EP2316459A1; 264-EP2371811A2; 264-EP2371812A1; 264-EP2372804A1; 264-EP2377847A1; 264-EP2378585A1; 658-EP2281819A1; 658-EP2298076A1; 658-EP2298077A1; 658-EP2301353A1; 658-EP2305031A1; 658-EP2305034A1; 658-EP2305035A1; 658-EP2305658A1; B0054; FT-0606545; ST50214470; C02009; 25950-EP2269978A2; 25950-EP2269985A2; 25950-EP2269991A2; 25950-EP2284150A2; 25950-EP2284151A2; 25950-EP2284152A2; 25950-EP2284153A2; 25950-EP2284155A2; 25950-EP2284156A2; 25950-EP2284164A2; 25950-EP2287140A2; 25950-EP2287148A2; 25950-EP2287150A2; 25950-EP2289871A1; 25950-EP2292590A2; 25950-EP2295419A2; 25950-EP2298732A1; 25950-EP2298774A1; 25950-EP2301912A2; 25950-EP2301913A1; 25950-EP2301914A1; 25950-EP2301916A2; 25950-EP2301918A1; 25950-EP2301921A1; 25950-EP2301926A1; 25950-EP2305637A2; 25950-EP2308832A1; 25950-EP2308863A1; 25950-EP2308875A1; 25950-EP2309855A1; 25950-EP2311796A1; 25950-EP2311797A1; 25950-EP2311798A1; 25950-EP2311799A1; 25950-EP2314558A1; 25950-EP2371811A2; 134823-EP2287165A2; 134823-EP2287166A2; 134823-EP2292612A2; 134823-EP2292620A2; Q415190; W-105914; InChI=1/C7H6N2/c1-2-4-7-6(3-1)8-5-9-7/h1-5H,(H,8,9; 157198-80-6",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C7H6N2",
            "molecular_weight": "118.14",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "5798",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001"
            ],
            "function": [
                "F020103"
            ],
            "references": [
                "RC01381"
            ]
        },
        {
            "compound_ID": "D0139",
            "name": "Daidzein",
            "synonyms": "daidzein; 486-66-8; 4',7-Dihydroxyisoflavone; Daidzeol; 7,4'-Dihydroxyisoflavone; 7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)-; 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one; 7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; UNII-6287WC5J2L; CCRIS 7600; K 251b; EINECS 207-635-4; MFCD00016954; BRN 0231523; CHEMBL8145; 4',7-Dihydroxy-iso-flavone; d-(+)-alpha-methylbenzylamine; CHEBI:28197; ZQSIJRDFPHDXIC-UHFFFAOYSA-N; 6287WC5J2L; Daidzein,(S); Daidzein, 98%; AK-94232; Diadzein; 7-Hydroxy-3-(4-hydroxy-phenyl)-chromone; DSSTox_CID_2310; 7-Hydroxy-3-(4-hydroxy-phenyl)-chromen-4-one; DSSTox_RID_76543; DSSTox_GSID_22310; Q-200924; CAS-486-66-8; SMR000326832; Daidzein (6CI); 4,7-Dihydroxyisoflavone; SR-01000075492; NPI 031E; 4&prime;,7-Dihydroxyisoflavone; PubChem9841; 220930-96-1; Spectrum_000255; Tocris-1417; BiomolKI_000060; Spectrum2_000053; Spectrum3_000191; Spectrum4_001964; Spectrum5_000857; Lopac-D-7802; BiomolKI2_000066; UPCMLD-DP052; 4',7-dihydroxy isoflavone; 4',7-dihydroxy-Isoflavone; Lopac0_000412; Oprea1_182317; Oprea1_305345; SCHEMBL19814; BSPBio_001741; Daidzein, analytical standard; KBioGR_002432; KBioSS_000735; SPECTRUM200789; 5-18-04-00089 (Beilstein Handbook Reference); MLS000859973; MLS001304056; MLS006011853; BIDD:ER0120; DivK1c_001023; SPBio_000205; Daidzein, >=98%, synthetic; Isoflavone, 4',7-dihydroxy-; BIMB2005; BMK1-F12; GTPL2828; MEGxm0_000123; NPI-031E; d-(+)-alpha-methylbenzyl amine; DTXSID9022310; UPCMLD-DP052:001; ACon0_001477; ACon1_000543; BDBM23420; HMS503M07; K-251b; KBio1_001023; KBio2_000735; KBio2_003303; KBio2_005871; KBio3_001241; KS-00000MGD; AOB5524; OR1035T; 4',7-Dihydroxyisoflavone, 97%; NINDS_001023; ZX-AFC000144; 7,4'-Dihydroxy-isoflavone (3a); HMS1922P18; HMS2233H24; HMS3261C06; HMS3267J04; HMS3370C03; HMS3412O12; HMS3468L18; HMS3649B20; HMS3655A18; HMS3676O12; ALBB-015933; BCP28286; HY-N0019; ZX-AN014640; ZX-AT022124; Tox21_201444; Tox21_303650; Tox21_500412; BBL010490; BS0244; CCG-38357; CD-190; LMPK12050038; s1849; SBB066056; STK801626; ZINC18847034; Daidzein (4',7-Dihydroxyisoflavone); 7-hydroxy-3-(4-hydroxyphenyl)-4H-; AKOS002385052; Isoflavone, 4',7-dihydroxy- (8CI); AC-6035; ACN-034764; CS-2332; Daidzein, purum, >=98.0% (TLC); DB13182; KS-5260; LP00412; LS-2143; MCULE-8239511422; SDCCGMLS-0066422.P001; SDCCGSBI-0050397.P003; IDI1_001023; SMP1_000089; NCGC00015365-01; NCGC00015365-02; NCGC00015365-03; NCGC00015365-04; NCGC00015365-05; NCGC00015365-06; NCGC00015365-07; NCGC00015365-08; NCGC00015365-09; NCGC00015365-10; NCGC00015365-11; NCGC00015365-12; NCGC00015365-13; NCGC00015365-14; NCGC00015365-15; NCGC00015365-16; NCGC00015365-17; NCGC00015365-18; NCGC00025156-01; NCGC00025156-02; NCGC00025156-03; NCGC00025156-04; NCGC00025156-05; NCGC00025156-06; NCGC00025156-07; NCGC00025156-08; NCGC00025156-09; NCGC00025156-10; NCGC00168978-01; NCGC00168978-02; NCGC00257367-01; NCGC00258995-01; NCGC00261097-01; CC-17424; SC-46504; ST057515; AB0010476; AB1004493; BB 0259520; D2668; EU-0100412; FT-0080019; FT-0603419; FT-0665448; N1862; R1341; SW218107-2; 7-hydroxy-3-(4-hydroxyphenyl)-chromen-4-one; 7-HYDROXY-3-(4-HYDROXYPHENYL)CHROMONE; C10208; D 7802; S00273; US8552057, 7; AB00052712-08; AB00052712_10; 486D668; C-15745; Daidzein, primary pharmaceutical reference standard; Q408732; SR-01000075492-1; SR-01000075492-3; SR-01000075492-7; SR-01000075492-8; BRD-K42095107-001-02-3; BRD-K42095107-001-05-6; BRD-K42095107-001-08-0; SR-01000075492-12; 80E3ED75-D852-4D97-9BD6-B5ADE7EA25A1; 7-Hydroxy-3-(4-hydroxy-phenyl)-4H-1-benzo-pyran-4-one; UNII-71B37NR06D component ZQSIJRDFPHDXIC-UHFFFAOYSA-N; Daidzein, United States Pharmacopeia (USP) Reference Standard; Daidzein, Pharmaceutical Secondary Standard; Certified Reference Material; 4 inverted exclamation marka,7-Dihydroxyisoflavone; 7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 7-Hydroxy-3-(4-hydroxyphenyl)chromone",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C15H10O4",
            "molecular_weight": "254.24",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "5281708",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T019"
            ],
            "function": [
                "F020103"
            ],
            "references": [
                "RC01454"
            ]
        },
        {
            "compound_ID": "D0140",
            "name": "Anisomycin",
            "synonyms": "anisomycin; 22862-76-6; Flagecidin; (-)-Anisomycin; TCMDC-125504; UNII-6C74YM2NGI; (2R,3S,4S)-4-hydroxy-2-(4-methoxybenzyl)pyrrolidin-3-yl acetate; NSC76712; NSC-76712; (2R,3S,4S)-2-(p-Methoxybenzyl)-3,4-pyrrolidinediol 3-acetate; Upjohn 204t3; 2-(p-Methoxybenzyl)-3,4-pyrrolidinediol 3-acetate; 6C74YM2NGI; 1,4,5-Trideoxy-1,4-imino-5-(p-methoxyphenyl)-D-xylo-pentitol 3-acetate; MLS001066392; Anisomycin,streptomyces griseolus; CHEBI:338412; Anisomycin from Streptomyces griseolus; Antibiotic PA-106; SMR000471874; NSC 76712; (2R,3S,4S)-2-[(4-Methoxyphenyl)methyl]-3,4-pyrrolidinediol 3-acetate; [(2R,3S,4S)-4-hydroxy-2-[(4-methoxyphenyl)methyl]pyrrolidin-3-yl] acetate; 2-p-Methoxyphenylmethyl-3-acetoxy-4-hydroxypyrrolidine; C14H19NO4; EINECS 245-269-7; (2R,3S,4S)-2-((4-Methoxyphenyl)methyl)-3,4-pyrrolidinediol 3-acetate; (2R,3S,4S)-4-hydroxy-2-[(4-methoxyphenyl)methyl]pyrrolidin-3-yl acetate; 3,4-Pyrrolidinediol, 2-((4-methoxyphenyl)methyl)-, 3-acetate, (2R,3S,4S)-; 3,4-Pyrrolidinediol, 2-[(4-methoxyphenyl)methyl]-, 3-acetate, (2R,3S,4S)-; BRN 0020705; ANM; AI3-50846; SR-01000597397; GNF-Pf-4549; Wuningmeisu C; (2R,3S,4S)-2-(p-Methoxyphenylmethyl)-3-acetoxy-4-hydroxypyrrolidine; 3,4-Pyrrolidinediol, 2-(p-methoxybenzyl)-, 3-acetate, (2S,3R,4R)-; Anisomycin, Streptomyces griseolus; 3,4-Pyrrolidinediol, 2-((4-methoxyphenyl)methyl)-, 3-acetate, (2R-(2alpha,3alpha,4beta))-; 6185-RBK-10; (-) Anisomycin; 3,4-Pyrrolidinediol, 2-((4-methoxyphenyl)methyl)-, 3-acetate, (2R-(2-alpha,3-alpha,4-beta))-; Spectrum_001534; Prestwick3_000412; Spectrum2_000632; Spectrum4_000748; Spectrum5_001495; 2-[(4-Methoxyphenyl)methyl]-3,4-pyrrolidinediol 3-acetate; CBiol_002064; BSPBio_000364; BSPBio_001436; KBioGR_001076; KBioSS_002014; ZINC954; 5-21-05-00523 (Beilstein Handbook Reference); DivK1c_000855; SPECTRUM1503906; 2-(p-Methoxybenzyl)-3,4-pyrrolidinediol-3-acetate; SPBio_000624; (2R,3S,4S)-2-(4-Methoxybenzyl)-3,4-pyrrolidinediol-3-acetate; BPBio1_000402; CHEMBL423192; cid_253602; SCHEMBL2270183; DTXSID5040966; BDBM63919; HMS502K17; KBio1_000855; KBio2_002014; KBio2_004582; KBio2_007150; BIA4315; NINDS_000855; YKJYKKNCCRKFSL-RDBSUJKOSA-N; ZX-AFC000035; Bio1_000350; Bio1_000839; Bio1_001328; HMS1922K06; HMS2096C06; HMS2231E05; HMS3267L11; HMS3414L17; HMS3678L15; EBD11190; BS0234; CCG-39185; GA2328; MFCD00077650; AKOS015916532; API0001506; CS-4981; DB07374; SDCCGMLS-0066810.P001; IDI1_000855; KS-0000001J; QTL1_000009; NCGC00025097-02; NCGC00025097-03; NCGC00025097-04; AS-44380; HY-18982; NCI60_041689; AB00513833; B6674; C11281; Anisomycin, Antibiotic for Culture Media Use Only; Q378498; SR-01000597397-1; SR-01000597397-3; BRD-K91370081-001-04-6; BRD-K91370081-001-17-8; 3, 2-(p-methoxybenzyl)-, 3-acetate, (2S,3R,4R)-; Anisomycin from Streptomyces griseolus, >=98% (HPLC), solid; (2R,3S,4S)-2-(4-Methoxybenzyl)-3,4-pyrrolidinediol 3-Acetate; acetic acid [(2R,3S,4S)-4-hydroxy-2-p-anisyl-pyrrolidin-3-yl] ester; [(2R,3S,4S)-2-[(4-methoxyphenyl)methyl]-4-oxidanyl-pyrrolidin-3-yl] ethanoate; 3, 2-[(4-methoxyphenyl)methyl]-, 3-acetate, [2S-(2.alpha.,3.alpha.,4.beta.)]-; 3,4-Pyrrolidinediol, 2-(p-methoxybenzyl)-, 3-acetate, (2S,3R,4R)- (8CI); acetic acid [(2R,3S,4S)-4-hydroxy-2-[(4-methoxyphenyl)methyl]-3-pyrrolidinyl] ester",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C14H19NO4",
            "molecular_weight": "265.3",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "253602",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0141",
            "name": "Annonacin",
            "synonyms": "Annonacin; 111035-65-5; UNII-40372ET6TM; 40372ET6TM; NSC606194; C35H64O7; CHEMBL67945; SCHEMBL14666180; DTXSID20892989; 9095AF; ZINC43242049; NSC-606194; NCI60_004657; B83674F237; C20213; Q2058866; (5S)-5-Methyl-3-[(2R,8R,13R)-2,8,13-trihydroxy-13-{(2R,5R)-5-[(1R)-1-hydroxytridecyl]oxolan-2-yl}tridecyl]furan-2(5H)-one; 2(5H)-Furanone, 5-methyl-3-(2,8,13-trihydroxy-13-(tetrahydro-5-(1-hydroxytridecyl)-2-furanyl)tridecyl)-",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C35H64O7",
            "molecular_weight": "596.9",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "354398",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0142",
            "name": "Arsenic",
            "synonyms": "Arsenic; 7440-38-2; Arsenic compounds; Arsenicals; Arsenic, inorganic; Arsenic-75; Arsen; Gray arsenic; Grey arsenic; Arsenic Black; Metallic arsenic; Colloidal arsenic; Agent SA; Arsenic, elemental; Arsenowodor [Polish]; Arsen [German,Polish]; Arsenic hydride (AsH3); Arsenwasserstoff [German]; UNII-V1I29R0RJQ; CCRIS 55; Arsenic and arsenic compounds; UNII-N712M78A8G; HSDB 509; HSDB 510; EINECS 231-148-6; EINECS 232-066-3; UN1558; UN2188; Arsenic, organic compounds; UN 2188; V1I29R0RJQ; As; N712M78A8G; Arsenic and certain arsenic compounds; arsenico; arsenicum; Arsenic standard solution, for AAS, 1 mg/ml As in 2% KOH; Arsenic Lump (Metals Basis); arsenic atom; Arsenic lump; 33As; EC 232-066-3; Arsenic [UN1558] [Poison]; CHEMBL1231052; DTXSID3023760; DTXSID4023886; CHEBI:27563; CTK2H7066; Arsenic [UN1558] [Poison]; RQNWIZPPADIBDY-UHFFFAOYSA-N; Arsenic, >=99.999%, pieces; Arsine [UN2188] [Poison gas]; Arsine [UN2188] [Poison gas]; 5482AF; AKOS015902733; LS-1736; LS41729; RTR-024040; Arsenic, 99.999% trace metals basis; TRA-0199538; Arsenic, water-soluble compounds, n.o.s; Arsenic, water-soluble compounds, n.o.s.; LS-21723; FT-0694838; FT-0696579; C06269; Arsenic, powder, >=99.997% trace metals basis; Q21060492",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "As",
            "molecular_weight": "74.92159",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "5359596",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0143",
            "name": "Nickel",
            "synonyms": "Nickel; 7440-02-0; Raney alloy; Fibrex; Nickel catalyst; Nickel, soluble salts; Nickel ion; Nickel compounds; Nickel particles; Fibrex P; Nickel, elemental; Nichel [Italian]; nickel(1+); Nickel 200; Nickel 201; Nickel 205; Nickel 207; Nickel 270; Carbonyl nickel powder; niccolum; niquel; Alcan 756; Metallic nickel; Nickel, ion (Ni1+); Ni; NI 0901-S (harshaw); CCRIS 427; Nickel,Raney Nickel; UNII-7OV03QG267; EL12; NP 2; Ni 4303T; HSDB 1096; Ni 270; Ni 0901-S; Nickel, elemental/metal; RCH 55/5; Nickel, soluble compounds; EINECS 231-111-4; Nickel [Nickel and nickel compounds]; 28Ni; CI 77775; C.I. 77775; CHEBI:28112; PXHVJJICTQNCMI-UHFFFAOYSA-N; 7OV03QG267; Nickel metal and insoluble compounds; MFCD00011137; Nickel, metal and insoluble compounds; Nickel [Nickel and certain nickel compounds]; Nickel, metal, soluble, insoluble, and inorganic; Nickel and compounds; Nickel, dextrin complexes; Niccolum metallicum; Raney Nickel Catalyst; Dextrin, nickel complex; Nickel and nickel compounds; Nickel, 99.9%, (trace metal basis), powder, -325 mesh; Raney(R)-Nickel, activated catalyst, 50% slurry in water; Nickel standard solution, for AAS, 1 mg-ml Ni in 2-5% HNO3; Nickel hydride; Nickel, crucible, cylindrical, length 1 pcs, outside diameter 33mm; Nickel, crucible, cylindrical, length 1 pcs, outside diameter 47mm; Raney Nickle; Raney-Nickel; Raney-Nickle; RaneyTM nickel; Raney's nickel; Ni on silica; Nickel on silica; RaNi; nickel on alumina; Raney(R) nickel; Nickel Monohydride; nickel(I) cation; RaneyNickelCatalyst; 3NI; Nickel atomic spectroscopy standard concentrate 10.00 g Ni, 10.00 g/L, for 1L standard solution, analytical standard; Nickel metal,powder; Raney (R) nickel; nickel(1+) ion; Ra-Ni; Nickel on silica/alumina; Skeletal Nickel Catalyst; Activated Nickel Catalyst; Epitope ID:113234; EC 231-111-4; nickel sponge metal catalyst; Ni(+); Nickel ~60wt% on kieselguhr; Nickel, p.a., 99.8%; DTXSID2020925; CHEBI:30399; CTK0H9626; HSDB 6933; DTXSID20872443; Nickel powder, APS 3-7 micron; AMPERIT? 175.001; AMPERIT? 176.001; Nickel and certain nickel compounds; BCP27597; KS-00000ET8; ANW-36471; Nickel Compounds and Metallic Nickel; AKOS005259071; LS-3208; TRA-0176039; BP-12712; Nickel Ultrathin foil, 1.0 micron thick; SC-27143; AB1003639; Nickel, rod, 50mm, diameter 30mm, 99%; Nickel, rod, 50mm, diameter 40mm, 99%; FT-0703645; Nickel, foil, thickness 1.0 mm, 99.98%; Nickel, rod, 100mm, diameter 30mm, 99%; Nickel, rod, 100mm, diameter 40mm, 99%; Nickel, rod, 200mm, diameter 30mm, 99%; Nickel, rod, 200mm, diameter 40mm, 99%; S0487; Nickel, foil, thickness 1.0 mm, 99.995%; Nickel, rod, 100mm, diameter 3.0mm, 99%; Nickel, rod, 100mm, diameter 9.5mm, 99%; Nickel, rod, 200mm, diameter 3.0mm, 99%; Nickel, rod, 200mm, diameter 9.5mm, 99%; Nickel, rod, 500mm, diameter 3.0mm, 99%; Nickel, rod, 500mm, diameter 9.5mm, 99%; Nickel, wire, diam. 0.25 mm, >=99.9%; C00291; Nickel, rod, 1000mm, diameter 3.0mm, 99%; Nickel, rod, 1000mm, diameter 9.5mm, 99%; Nickel, rod, 100mm, diameter 12.0mm, 99%; Nickel, rod, 100mm, diameter 20.0mm, 99%; Nickel, rod, 100mm, diameter 6.35mm, 99%; Nickel, rod, 200mm, diameter 12.0mm, 99%; Nickel, rod, 200mm, diameter 20.0mm, 99%; Nickel, rod, 200mm, diameter 6.35mm, 99%; Nickel, rod, 500mm, diameter 12.0mm, 99%; Nickel, rod, 500mm, diameter 20.0mm, 99%; Nickel, rod, 500mm, diameter 6.35mm, 99%; Nickel isotopic standard, NIST(R) SRM(R) 986; Nickel, foil, thickness 0.125 mm, >=99.9%; Nickel, rod, 1000mm, diameter 12.0mm, 99%; Nickel, rod, 1000mm, diameter 20.0mm, 99%; Nickel, rod, 1000mm, diameter 6.35mm, 99%; Nickel, rod, 50mm, diameter 16mm, 99.99+%; A838111; Nickel, 99.995%, (trace metal basis), powder; Nickel, foil, 50x50mm, thickness 1.6mm, 99%; Nickel, rod, 100mm, diameter 16mm, 99.99+%; Nickel, rod, 200mm, diameter 16mm, 99.99+%; Nickel, rod, 50mm, diameter 25.4mm, 99.98%; Nickel, rod, 50mm, diameter 3.3mm, 99.99+%; Nickel, rod, 50mm, diameter 5.0mm, 99.99+%; Nickel, foil, 100x100mm, thickness 1.6mm, 99%; Nickel, foil, 150x150mm, thickness 1.6mm, 99%; Nickel, foil, 1m coil, thickness 0.02mm, 99.9%; Nickel, foil, 1m coil, thickness 0.03mm, 99.9%; Nickel, foil, 1m coil, thickness 0.05mm, 99.9%; Nickel, foil, 2m coil, thickness 0.02mm, 99.9%; Nickel, foil, 2m coil, thickness 0.03mm, 99.9%; Nickel, foil, 2m coil, thickness 0.05mm, 99.9%; Nickel, foil, 300x300mm, thickness 1.6mm, 99%; Nickel, pellets, 20g, max. size 5mm, 99.99+%; Nickel, pellets, 50g, max. size 5mm, 99.99+%; Nickel, powder, <1 mum, 99.8% trace metals basis; Nickel, rod, 100mm, diameter 1.5mm, 99.99+%; Nickel, rod, 100mm, diameter 12.7mm, 99.98%; Nickel, rod, 100mm, diameter 2.0mm, 99.99+%; Nickel, rod, 100mm, diameter 25.4mm, 99.98%; Nickel, rod, 100mm, diameter 3.3mm, 99.99+%; Nickel, rod, 100mm, diameter 5.0mm, 99.99+%; Nickel, rod, 200mm, diameter 1.5mm, 99.99+%; Nickel, rod, 200mm, diameter 12.7mm, 99.98%; Nickel, rod, 200mm, diameter 2.0mm, 99.99+%; Nickel, rod, 200mm, diameter 25.4mm, 99.98%; Nickel, rod, 200mm, diameter 3.3mm, 99.99+%; Nickel, rod, 200mm, diameter 5.0mm, 99.99+%; Nickel, rod, 500mm, diameter 1.5mm, 99.99+%; Nickel, rod, 500mm, diameter 12.7mm, 99.98%; Nickel, rod, 500mm, diameter 2.0mm, 99.99+%; Nickel, rod, 500mm, diameter 3.3mm, 99.99+%; Nickel, rod, 50mm, diameter 10.0mm, 99.99+%; Nickel, rod, 50mm, diameter 25.4mm, 99.99+%; Nickel Powder, 99.9+% (metal basis, O<10%) Nano; Nickel, foil, 1m coil, thickness 0.015mm, 99.9%; Nickel, foil, 1m coil, thickness 0.01mm, 99.95%; Nickel, foil, 1m coil, thickness 0.025mm, 99.9%; Nickel, foil, 1m coil, thickness 0.038mm, 99.9%; Nickel, foil, 2m coil, thickness 0.015mm, 99.9%; Nickel, foil, 2m coil, thickness 0.01mm, 99.95%; Nickel, foil, 2m coil, thickness 0.025mm, 99.9%; Nickel, foil, 2m coil, thickness 0.038mm, 99.9%; Nickel, foil, 4mm disks, thickness 0.02mm, 99.9%; Nickel, foil, 4mm disks, thickness 0.03mm, 99.9%; Nickel, foil, 4mm disks, thickness 0.05mm, 99.9%; Nickel, foil, 5m coil, thickness 0.01mm, 99.95%; Nickel, foil, 6mm disks, thickness 0.02mm, 99.9%; Nickel, foil, 6mm disks, thickness 0.03mm, 99.9%; Nickel, foil, 6mm disks, thickness 0.05mm, 99.9%; Nickel, foil, 8mm disks, thickness 0.02mm, 99.9%; Nickel, foil, 8mm disks, thickness 0.03mm, 99.9%; Nickel, foil, 8mm disks, thickness 0.05mm, 99.9%; Nickel, pellets, 100g, max. size 10mm, 99.99+%; Nickel, pellets, 100g, max. size 10mm, 99.999%; Nickel, pellets, 100g, max. size 15mm, 99.99+%; Nickel, pellets, 100g, max. size 20mm, 99.99+%; Nickel, pellets, 100g, max. size 5mm, 99.99+%; Nickel, pellets, 20g, max. size 10mm, 99.99+%; Nickel, pellets, 20g, max. size 10mm, 99.999%; Nickel, pellets, 20g, max. size 15mm, 99.99+%; Nickel, pellets, 20g, max. size 20mm, 99.99+%; Nickel, pellets, 50g, max. size 10mm, 99.99+%; Nickel, pellets, 50g, max. size 10mm, 99.999%; Nickel, pellets, 50g, max. size 15mm, 99.99+%; Nickel, pellets, 50g, max. size 20mm, 99.99+%; Nickel, powder, <50 mum, 99.7% trace metals basis; Nickel, rod, 1000mm, diameter 1.5mm, 99.99+%; Nickel, rod, 1000mm, diameter 12.7mm, 99.98%; Nickel, rod, 1000mm, diameter 2.0mm, 99.99+%; Nickel, rod, 100mm, diameter 10.0mm, 99.99+%; Nickel, rod, 100mm, diameter 2.0mm, annealed, 99%; Nickel, rod, 100mm, diameter 25.4mm, 99.99+%; Nickel, rod, 200mm, diameter 10.0mm, 99.99+%; Nickel, rod, 200mm, diameter 2.0mm, annealed, 99%; Nickel, rod, 200mm, diameter 25.4mm, 99.99+%; Nickel, rod, 500mm, diameter 2.0mm, annealed, 99%; Q27113549; N012000000; Nickel, foil, 0.5m coil, thickness 0.015mm, 99.9%; Nickel, foil, 0.5m coil, thickness 0.01mm, 99.95%; Nickel, foil, 0.5m coil, thickness 0.025mm, 99.9%; Nickel, foil, 0.5m coil, thickness 0.02mm, 99.9%; Nickel, foil, 0.5m coil, thickness 0.038mm, 99.9%; Nickel, foil, 0.5m coil, thickness 0.03mm, 99.9%; Nickel, foil, 0.5m coil, thickness 0.05mm, 99.9%; Nickel, foil, 10m coil, thickness 0.01mm, 99.95%; Nickel, foil, 10mm disks, thickness 0.015mm, 99.9%; Nickel, foil, 10mm disks, thickness 0.01mm, 99.95%; Nickel, foil, 10mm disks, thickness 0.025mm, 99.9%; Nickel, foil, 10mm disks, thickness 0.02mm, 99.9%; Nickel, foil, 10mm disks, thickness 0.038mm, 99.9%; Nickel, foil, 10mm disks, thickness 0.03mm, 99.9%; Nickel, foil, 10mm disks, thickness 0.05mm, 99.9%; Nickel, foil, 15mm disks, thickness 0.015mm, 99.9%; Nickel, foil, 15mm disks, thickness 0.01mm, 99.95%; Nickel, foil, 15mm disks, thickness 0.025mm, 99.9%; Nickel, foil, 15mm disks, thickness 0.02mm, 99.9%; Nickel, foil, 15mm disks, thickness 0.038mm, 99.9%; Nickel, foil, 15mm disks, thickness 0.03mm, 99.9%; Nickel, foil, 15mm disks, thickness 0.05mm, 99.9%; Nickel, foil, 1m coil, thickness 0.0025mm, 99.95%; Nickel, foil, 1m coil, thickness 0.003mm, 99.95%; Nickel, foil, 1m coil, thickness 0.004mm, hard, 99%; Nickel, foil, 1m coil, thickness 0.0075mm, 99.9%; Nickel, foil, 1m coil, thickness 0.0075mm, 99.95%; Nickel, foil, 1m coil, thickness 0.0125mm, 99.9%; Nickel, foil, 25mm disks, thickness 0.015mm, 99.9%; Nickel, foil, 25mm disks, thickness 0.01mm, 99.95%; Nickel, foil, 25mm disks, thickness 0.025mm, 99.9%; Nickel, foil, 25mm disks, thickness 0.02mm, 99.9%; Nickel, foil, 25mm disks, thickness 0.038mm, 99.9%; Nickel, foil, 25mm disks, thickness 0.03mm, 99.9%; Nickel, foil, 25mm disks, thickness 0.05mm, 99.9%; Nickel, foil, 2m coil, thickness 0.0025mm, 99.95%; Nickel, foil, 2m coil, thickness 0.003mm, 99.95%; Nickel, foil, 2m coil, thickness 0.0075mm, 99.9%; Nickel, foil, 2m coil, thickness 0.0075mm, 99.95%; Nickel, foil, 2m coil, thickness 0.0125mm, 99.9%; Nickel, foil, 4mm disks, thickness 0.003mm, 99.95%; Nickel, foil, 4mm disks, thickness 0.004mm, 99.95%; Nickel, foil, 4mm disks, thickness 0.0075mm, 99.9%; Nickel, foil, 4mm disks, thickness 0.007mm, 99.95%; Nickel, foil, 4mm disks, thickness 0.008mm, 99.95%; Nickel, foil, 4mm disks, thickness 0.009mm, 99.95%; Nickel, foil, 4mm disks, thickness 0.0125mm, 99.9%; Nickel, foil, 4mm disks, thickness 0.015mm, 99.9%; Nickel, foil, 4mm disks, thickness 0.01mm, 99.95%; Nickel, foil, 4mm disks, thickness 0.025mm, 99.9%; Nickel, foil, 4mm disks, thickness 0.038mm, 99.9%; Nickel, foil, 50mm disks, thickness 0.015mm, 99.9%; Nickel, foil, 50mm disks, thickness 0.01mm, 99.95%; Nickel, foil, 50mm disks, thickness 0.025mm, 99.9%; Nickel, foil, 50mm disks, thickness 0.02mm, 99.9%; Nickel, foil, 50mm disks, thickness 0.038mm, 99.9%; Nickel, foil, 50mm disks, thickness 0.03mm, 99.9%; Nickel, foil, 50mm disks, thickness 0.05mm, 99.9%; Nickel, foil, 5m coil, thickness 0.0025mm, 99.95%; Nickel, foil, 5m coil, thickness 0.003mm, 99.95%; Nickel, foil, 5m coil, thickness 0.0075mm, 99.95%; Nickel, foil, 5m coil, thickness 0.0125mm, 99.9%; Nickel, foil, 6mm disks, thickness 0.003mm, 99.95%; Nickel, foil, 6mm disks, thickness 0.004mm, 99.95%; Nickel, foil, 6mm disks, thickness 0.0075mm, 99.9%; Nickel, foil, 6mm disks, thickness 0.007mm, 99.95%; Nickel, foil, 6mm disks, thickness 0.008mm, 99.95%; Nickel, foil, 6mm disks, thickness 0.009mm, 99.95%; Nickel, foil, 6mm disks, thickness 0.0125mm, 99.9%; Nickel, foil, 6mm disks, thickness 0.015mm, 99.9%; Nickel, foil, 6mm disks, thickness 0.01mm, 99.95%; Nickel, foil, 6mm disks, thickness 0.025mm, 99.9%; Nickel, foil, 6mm disks, thickness 0.038mm, 99.9%; Nickel, foil, 8mm disks, thickness 0.003mm, 99.95%; Nickel, foil, 8mm disks, thickness 0.004mm, 99.95%; Nickel, foil, 8mm disks, thickness 0.0075mm, 99.9%; Nickel, foil, 8mm disks, thickness 0.007mm, 99.95%; Nickel, foil, 8mm disks, thickness 0.008mm, 99.95%; Nickel, foil, 8mm disks, thickness 0.009mm, 99.95%; Nickel, foil, 8mm disks, thickness 0.0125mm, 99.9%; Nickel, foil, 8mm disks, thickness 0.015mm, 99.9%; Nickel, foil, 8mm disks, thickness 0.01mm, 99.95%; Nickel, foil, 8mm disks, thickness 0.025mm, 99.9%; Nickel, foil, 8mm disks, thickness 0.038mm, 99.9%; Nickel, powder, <150 mum, 99.99% trace metals basis; Nickel, rod, 1000mm, diameter 2.0mm, annealed, 99%; Nickel, wire reel, 1m, diameter 1.0mm, as drawn, 99%; Nickel, wire reel, 5m, diameter 0.5mm, annealed, 99%; Nickel, wire reel, 5m, diameter 0.5mm, as drawn, 99%; Nickel, wire reel, 5m, diameter 1.0mm, as drawn, 99%; Nickel, foil, 0.2m coil, thickness 0.004mm, hard, 99%; Nickel, foil, 0.5m coil, thickness 0.0025mm, 99.95%; Nickel, foil, 0.5m coil, thickness 0.003mm, 99.95%; Nickel, foil, 0.5m coil, thickness 0.004mm, hard, 99%; Nickel, foil, 0.5m coil, thickness 0.0075mm, 99.9%; Nickel, foil, 0.5m coil, thickness 0.0075mm, 99.95%; Nickel, foil, 0.5m coil, thickness 0.0125mm, 99.9%; Nickel, foil, 0.5m coil, thickness 0.1mm, annealed, 99%; Nickel, foil, 0.5m coil, thickness 0.3mm, annealed, 99%; Nickel, foil, 0.5m coil, thickness 1.0mm, annealed, 99%; Nickel, foil, 10mm disks, thickness 0.0025mm, 99.95%; Nickel, foil, 10mm disks, thickness 0.003mm, 99.95%; Nickel, foil, 10mm disks, thickness 0.004mm, 99.95%; Nickel, foil, 10mm disks, thickness 0.004mm, hard, 99%; Nickel, foil, 10mm disks, thickness 0.0075mm, 99.9%; Nickel, foil, 10mm disks, thickness 0.0075mm, 99.95%; Nickel, foil, 10mm disks, thickness 0.007mm, 99.95%; Nickel, foil, 10mm disks, thickness 0.008mm, 99.95%; Nickel, foil, 10mm disks, thickness 0.009mm, 99.95%; Nickel, foil, 10mm disks, thickness 0.0125mm, 99.9%; Nickel, foil, 15mm disks, thickness 0.0025mm, 99.95%; Nickel, foil, 15mm disks, thickness 0.003mm, 99.95%; Nickel, foil, 15mm disks, thickness 0.004mm, 99.95%; Nickel, foil, 15mm disks, thickness 0.004mm, hard, 99%; Nickel, foil, 15mm disks, thickness 0.0075mm, 99.9%; Nickel, foil, 15mm disks, thickness 0.0075mm, 99.95%; Nickel, foil, 15mm disks, thickness 0.007mm, 99.95%; Nickel, foil, 15mm disks, thickness 0.008mm, 99.95%; Nickel, foil, 15mm disks, thickness 0.009mm, 99.95%; Nickel, foil, 15mm disks, thickness 0.0125mm, 99.9%; Nickel, foil, 1m coil, thickness 0.025mm, annealed, 99%; Nickel, foil, 1m coil, thickness 0.05mm, annealed, 99%; Nickel, foil, 1m coil, thickness 0.075mm, annealed, 99%; Nickel, foil, 1m coil, thickness 0.125mm, annealed, 99%; Nickel, foil, 1m coil, thickness 0.15mm, annealed, 99%; Nickel, foil, 1m coil, thickness 0.1mm, annealed, 99%; Nickel, foil, 1m coil, thickness 0.20mm, annealed, 99%; Nickel, foil, 1m coil, thickness 0.25mm, annealed, 99%; Nickel, foil, 1m coil, thickness 0.3mm, annealed, 99%; Nickel, foil, 1m coil, thickness 0.50mm, annealed, 99%; Nickel, foil, 1m coil, thickness 1.0mm, annealed, 99%; Nickel, foil, 25mm disks, thickness 0.0025mm, 99.95%; Nickel, foil, 25mm disks, thickness 0.003mm, 99.95%; Nickel, foil, 25mm disks, thickness 0.004mm, 99.95%; Nickel, foil, 25mm disks, thickness 0.004mm, hard, 99%; Nickel, foil, 25mm disks, thickness 0.0075mm, 99.9%; Nickel, foil, 25mm disks, thickness 0.0075mm, 99.95%; Nickel, foil, 25mm disks, thickness 0.007mm, 99.95%; Nickel, foil, 25mm disks, thickness 0.008mm, 99.95%; Nickel, foil, 25mm disks, thickness 0.009mm, 99.95%; Nickel, foil, 25mm disks, thickness 0.0125mm, 99.9%; Nickel, foil, 25x25mm, thickness 0.15mm, annealed, 99%; Nickel, foil, 25x25mm, thickness 0.1mm, annealed, 99%; Nickel, foil, 25x25mm, thickness 0.20mm, annealed, 99%; Nickel, foil, 25x25mm, thickness 0.25mm, annealed, 99%; Nickel, foil, 25x25mm, thickness 0.3mm, annealed, 99%; Nickel, foil, 25x25mm, thickness 0.50mm, annealed, 99%; Nickel, foil, 25x25mm, thickness 1.0mm, annealed, 99%; Nickel, foil, 25x25mm, thickness 2.0mm, annealed, 99%; Nickel, foil, 2m coil, thickness 0.025mm, annealed, 99%; Nickel, foil, 2m coil, thickness 0.05mm, annealed, 99%; Nickel, foil, 2m coil, thickness 0.075mm, annealed, 99%; Nickel, foil, 2m coil, thickness 0.125mm, annealed, 99%; Nickel, foil, 2m coil, thickness 0.15mm, annealed, 99%; Nickel, foil, 2m coil, thickness 0.1mm, annealed, 99%; Nickel, foil, 2m coil, thickness 0.20mm, annealed, 99%; Nickel, foil, 2m coil, thickness 0.25mm, annealed, 99%; Nickel, foil, 2m coil, thickness 0.3mm, annealed, 99%; Nickel, foil, 2m coil, thickness 0.50mm, annealed, 99%; Nickel, foil, 4mm disks, thickness 0.0025mm, 99.95%; Nickel, foil, 4mm disks, thickness 0.004mm, hard, 99%; Nickel, foil, 4mm disks, thickness 0.0075mm, 99.95%; Nickel, foil, 4mm disks, thickness 0.0125mm, 99.99+%; Nickel, foil, 4mm disks, thickness 0.1mm, annealed, 99%; Nickel, foil, 4mm disks, thickness 0.3mm, annealed, 99%; Nickel, foil, 50mm disks, thickness 0.0025mm, 99.95%; Nickel, foil, 50mm disks, thickness 0.003mm, 99.95%; Nickel, foil, 50mm disks, thickness 0.004mm, 99.95%; Nickel, foil, 50mm disks, thickness 0.004mm, hard, 99%; Nickel, foil, 50mm disks, thickness 0.0075mm, 99.9%; Nickel, foil, 50mm disks, thickness 0.0075mm, 99.95%; Nickel, foil, 50mm disks, thickness 0.0125mm, 99.9%; Nickel, foil, 50x50mm, thickness 0.15mm, annealed, 99%; Nickel, foil, 50x50mm, thickness 0.1mm, annealed, 99%; Nickel, foil, 50x50mm, thickness 0.20mm, annealed, 99%; Nickel, foil, 50x50mm, thickness 0.25mm, annealed, 99%; Nickel, foil, 50x50mm, thickness 0.3mm, annealed, 99%; Nickel, foil, 50x50mm, thickness 0.50mm, annealed, 99%; Nickel, foil, 50x50mm, thickness 1.0mm, annealed, 99%; Nickel, foil, 50x50mm, thickness 2.0mm, annealed, 99%; Nickel, foil, 5m coil, thickness 0.025mm, annealed, 99%; Nickel, foil, 5m coil, thickness 0.05mm, annealed, 99%; Nickel, foil, 5m coil, thickness 0.075mm, annealed, 99%; Nickel, foil, 5m coil, thickness 0.1mm, annealed, 99%; Nickel, foil, 6mm disks, thickness 0.0025mm, 99.95%; Nickel, foil, 6mm disks, thickness 0.004mm, hard, 99%; Nickel, foil, 6mm disks, thickness 0.0075mm, 99.95%; Nickel, foil, 6mm disks, thickness 0.0125mm, 99.99+%; Nickel, foil, 6mm disks, thickness 0.1mm, annealed, 99%; Nickel, foil, 6mm disks, thickness 0.3mm, annealed, 99%; Nickel, foil, 8mm disks, thickness 0.0025mm, 99.95%; Nickel, foil, 8mm disks, thickness 0.004mm, hard, 99%; Nickel, foil, 8mm disks, thickness 0.0075mm, 99.95%; Nickel, foil, 8mm disks, thickness 0.0125mm, 99.99+%; Nickel, foil, 8mm disks, thickness 0.1mm, annealed, 99%; Nickel, foil, 8mm disks, thickness 0.3mm, annealed, 99%; Nickel, Oil based standard solution, Specpure, Ni 5000g/g; Nickel, powder, <150 mum, 99.995% trace metals basis; Nickel, rod, 50 mm diameter, length 100 mm, purity 99%; Nickel, rod, 50 mm diameter, length 25 mm, purity 99%; Nickel, rod, 50 mm diameter, length 50 mm, purity 99%; Nickel, spheres, 6-16 mm, >=99.95% trace metals basis; Nickel, wire reel, 100m, diameter 0.4mm, as drawn, 99%; Nickel, wire reel, 100m, diameter 0.5mm, annealed, 99%; Nickel, wire reel, 100m, diameter 0.5mm, as drawn, 99%; Nickel, wire reel, 100m, diameter 0.5mm, hard, 99.98%; Nickel, wire reel, 100m, diameter 1.0mm, as drawn, 99%; Nickel, wire reel, 10m, diameter 0.05mm, as drawn, 99%; Nickel, wire reel, 10m, diameter 0.15mm, as drawn, 99%; Nickel, wire reel, 10m, diameter 0.25mm, annealed, 99%; Nickel, wire reel, 10m, diameter 0.25mm, as drawn, 99%; Nickel, wire reel, 10m, diameter 0.25mm, hard, 99.98%; Nickel, wire reel, 10m, diameter 0.4mm, as drawn, 99%; Nickel, wire reel, 10m, diameter 0.5mm, annealed, 99%; Nickel, wire reel, 10m, diameter 0.5mm, as drawn, 99%; Nickel, wire reel, 10m, diameter 0.5mm, hard, 99.98%; Nickel, wire reel, 10m, diameter 0.75mm, as drawn, 99%; Nickel, wire reel, 10m, diameter 1.0mm, as drawn, 99%; Nickel, wire reel, 10m, diameter 1.0mm, hard, 99.98%; Nickel, wire reel, 10m, diameter 2.0mm, hard, 99.98%; Nickel, wire reel, 1m, diameter 0.75mm, as drawn, 99%; Nickel, wire reel, 1m, diameter 1.0mm, hard, 99.98%; Nickel, wire reel, 1m, diameter 2.0mm, hard, 99.98%; Nickel, wire reel, 200m, diameter 0.4mm, as drawn, 99%; Nickel, wire reel, 200m, diameter 0.5mm, annealed, 99%; Nickel, wire reel, 20m, diameter 0.05mm, as drawn, 99%; Nickel, wire reel, 20m, diameter 0.15mm, as drawn, 99%; Nickel, wire reel, 20m, diameter 0.25mm, hard, 99.98%; Nickel, wire reel, 20m, diameter 0.4mm, as drawn, 99%; Nickel, wire reel, 20m, diameter 0.5mm, as drawn, 99%; Nickel, wire reel, 20m, diameter 0.5mm, hard, 99.98%; Nickel, wire reel, 20m, diameter 1.0mm, hard, 99.98%; Nickel, wire reel, 20m, diameter 2.0mm, hard, 99.98%; Nickel, wire reel, 25m, diameter 0.5mm, annealed, 99%; Nickel, wire reel, 2m, diameter 0.5mm, hard, 99.98%; Nickel, wire reel, 500m, diameter 0.4mm, as drawn, 99%; Nickel, wire reel, 500m, diameter 0.5mm, as drawn, 99%; Nickel, wire reel, 50m, diameter 0.05mm, as drawn, 99%; Nickel, wire reel, 50m, diameter 0.25mm, annealed, 99%; Nickel, wire reel, 50m, diameter 0.25mm, as drawn, 99%; Nickel, wire reel, 50m, diameter 0.25mm, hard, 99.98%; Nickel, wire reel, 50m, diameter 0.4mm, as drawn, 99%; Nickel, wire reel, 50m, diameter 0.5mm, annealed, 99%; Nickel, wire reel, 50m, diameter 0.5mm, as drawn, 99%; Nickel, wire reel, 50m, diameter 0.5mm, hard, 99.98%; Nickel, wire reel, 50m, diameter 0.75mm, as drawn, 99%; Nickel, wire reel, 50m, diameter 1.0mm, as drawn, 99%; Nickel, wire reel, 50m, diameter 1.0mm, hard, 99.98%; Nickel, wire reel, 50m, diameter 2.0mm, hard, 99.98%; Nickel, wire reel, 5m, diameter 0.25mm, annealed, 99%; Nickel, wire reel, 5m, diameter 0.25mm, as drawn, 99%; Nickel, wire reel, 5m, diameter 0.5mm, hard, 99.98%; Nickel, wire reel, 5m, diameter 0.75mm, as drawn, 99%; Nickel, wire reel, 5m, diameter 1.0mm, hard, 99.98%; Nickel, wire reel, 5m, diameter 2.0mm, hard, 99.98%; Nickel, wire, 1.0 mm diameter, length 1 m, purity 99%; Nickel, wire, 1.0 mm diameter, length 5 m, purity 99%; Nickel, wire, 1.0 mm diameter, length 50 m, purity 99%; Nickel, wire, diam. 0.5 mm, >=99.9% trace metals basis; Nickel, wire, length 10 m, 1.0 mm diameter, purity 99%; Nickel, 99.97%, (trace metal basis), spheres, 5 to 11 mm; Nickel, foil, 0.2m coil, thickness 0.004mm, hard, 99.98%; Nickel, foil, 0.5m coil, thickness 0.004mm, hard, 99.98%; Nickel, foil, 0.5m coil, thickness 0.0125mm, annealed, 99%; Nickel, foil, 0.5m coil, thickness 0.025mm, annealed, 99%; Nickel, foil, 0.5m coil, thickness 0.05mm, annealed, 99%; Nickel, foil, 0.5m coil, thickness 0.075mm, annealed, 99%; Nickel, foil, 0.5m coil, thickness 0.125mm, annealed, 99%; Nickel, foil, 0.5m coil, thickness 0.15mm, annealed, 99%; Nickel, foil, 0.5m coil, thickness 0.20mm, annealed, 99%; Nickel, foil, 0.5m coil, thickness 0.25mm, annealed, 99%; Nickel, foil, 0.5m coil, thickness 0.50mm, annealed, 99%; Nickel, foil, 0.5m coil, thickness 0.5mm, annealed, 99.98%; Nickel, foil, 0.5m coil, thickness 1.0mm, annealed, 99.98%; Nickel, foil, 100x100mm, thickness 0.125mm, annealed, 99%; Nickel, foil, 100x100mm, thickness 0.15mm, annealed, 99%; Nickel, foil, 100x100mm, thickness 0.1mm, annealed, 99%; Nickel, foil, 100x100mm, thickness 0.20mm, annealed, 99%; Nickel, foil, 100x100mm, thickness 0.25mm, annealed, 99%; Nickel, foil, 100x100mm, thickness 0.3mm, annealed, 99%; Nickel, foil, 100x100mm, thickness 0.50mm, annealed, 99%; Nickel, foil, 100x100mm, thickness 1.0mm, annealed, 99%; Nickel, foil, 100x100mm, thickness 2.0mm, annealed, 99%; Nickel, foil, 10mm disks, thickness 0.004mm, hard, 99.98%; Nickel, foil, 10mm disks, thickness 0.0125mm, 99.99+%; Nickel, foil, 10mm disks, thickness 0.025mm, annealed, 99%; Nickel, foil, 10mm disks, thickness 0.05mm, annealed, 99%; Nickel, foil, 10mm disks, thickness 0.075mm, annealed, 99%; Nickel, foil, 10mm disks, thickness 0.125mm, annealed, 99%; Nickel, foil, 10mm disks, thickness 0.15mm, annealed, 99%; Nickel, foil, 10mm disks, thickness 0.1mm, annealed, 99%; Nickel, foil, 10mm disks, thickness 0.20mm, annealed, 99%; Nickel, foil, 10mm disks, thickness 0.25mm, annealed, 99%; Nickel, foil, 10mm disks, thickness 0.3mm, annealed, 99%; Nickel, foil, 10mm disks, thickness 0.3mm, as rolled, 100%; Nickel, foil, 10mm disks, thickness 0.50mm, annealed, 99%; Nickel, foil, 10mm disks, thickness 0.5mm, as rolled, 100%; Nickel, foil, 150x150mm, thickness 0.125mm, annealed, 99%; Nickel, foil, 150x150mm, thickness 0.15mm, annealed, 99%; Nickel, foil, 150x150mm, thickness 0.1mm, annealed, 99%; Nickel, foil, 150x150mm, thickness 0.20mm, annealed, 99%; Nickel, foil, 150x150mm, thickness 0.25mm, annealed, 99%; Nickel, foil, 150x150mm, thickness 0.3mm, annealed, 99%; Nickel, foil, 150x150mm, thickness 0.50mm, annealed, 99%; Nickel, foil, 150x150mm, thickness 1.0mm, annealed, 99%; Nickel, foil, 150x150mm, thickness 2.0mm, annealed, 99%; Nickel, foil, 15mm disks, thickness 0.004mm, hard, 99.98%; Nickel, foil, 15mm disks, thickness 0.0125mm, 99.99+%; Nickel, foil, 15mm disks, thickness 0.025mm, annealed, 99%; Nickel, foil, 15mm disks, thickness 0.05mm, annealed, 99%; Nickel, foil, 15mm disks, thickness 0.075mm, annealed, 99%; Nickel, foil, 15mm disks, thickness 0.125mm, annealed, 99%; Nickel, foil, 15mm disks, thickness 0.15mm, annealed, 99%; Nickel, foil, 15mm disks, thickness 0.1mm, annealed, 99%; Nickel, foil, 15mm disks, thickness 0.20mm, annealed, 99%; Nickel, foil, 15mm disks, thickness 0.25mm, annealed, 99%; Nickel, foil, 15mm disks, thickness 0.3mm, annealed, 99%; Nickel, foil, 15mm disks, thickness 0.3mm, as rolled, 100%; Nickel, foil, 15mm disks, thickness 0.50mm, annealed, 99%; Nickel, foil, 15mm disks, thickness 0.5mm, as rolled, 100%; Nickel, foil, 1m coil, thickness 0.004mm, hard, 99.98%; Nickel, foil, 1m coil, thickness 0.005mm, as rolled, 99.9%; Nickel, foil, 1m coil, thickness 0.0125mm, annealed, 99%; Nickel, foil, 1m coil, thickness 0.05mm, annealed, 99.98%; Nickel, foil, 1m coil, thickness 0.05mm, as rolled, 99.98%; Nickel, foil, 1m coil, thickness 0.125mm, annealed, 99.98%; Nickel, foil, 1m coil, thickness 0.25mm, annealed, 99.98%; Nickel, foil, 1m coil, thickness 0.30mm, as rolled, 99.98%; Nickel, foil, 1m coil, thickness 0.5mm, annealed, 99.98%; Nickel, foil, 1m coil, thickness 1.0mm, annealed, 99.98%; Nickel, foil, 200x200mm, thickness 0.1mm, annealed, 99%; Nickel, foil, 200x300mm, thickness 0.15mm, annealed, 99%; Nickel, foil, 200x300mm, thickness 0.25mm, annealed, 99%; Nickel, foil, 25mm disks, thickness 0.004mm, hard, 99.98%; Nickel, foil, 25mm disks, thickness 0.0125mm, 99.99+%; Nickel, foil, 25mm disks, thickness 0.025mm, annealed, 99%; Nickel, foil, 25mm disks, thickness 0.05mm, annealed, 99%; Nickel, foil, 25mm disks, thickness 0.075mm, annealed, 99%; Nickel, foil, 25mm disks, thickness 0.125mm, annealed, 99%; Nickel, foil, 25mm disks, thickness 0.15mm, annealed, 99%; Nickel, foil, 25mm disks, thickness 0.1mm, annealed, 99%; Nickel, foil, 25mm disks, thickness 0.20mm, annealed, 99%; Nickel, foil, 25mm disks, thickness 0.25mm, annealed, 99%; Nickel, foil, 25mm disks, thickness 0.3mm, annealed, 99%; Nickel, foil, 25mm disks, thickness 0.3mm, as rolled, 100%; Nickel, foil, 25mm disks, thickness 0.50mm, annealed, 99%; Nickel, foil, 25x25mm, thickness 0.125mm, annealed, 99%; Nickel, foil, 25x25mm, thickness 0.25mm, annealed, 99.98%; Nickel, foil, 25x25mm, thickness 0.5mm, annealed, 99.98%; Nickel, foil, 25x25mm, thickness 1.0mm, annealed, 99.98%; Nickel, foil, 2m coil, thickness 0.0125mm, annealed, 99%; Nickel, foil, 2m coil, thickness 0.05mm, annealed, 99.98%; Nickel, foil, 2m coil, thickness 0.05mm, as rolled, 99.98%; Nickel, foil, 2m coil, thickness 0.125mm, annealed, 99.98%; Nickel, foil, 2m coil, thickness 0.25mm, annealed, 99.98%; Nickel, foil, 2m coil, thickness 0.30mm, as rolled, 99.98%; Nickel, foil, 2m coil, thickness 0.5mm, annealed, 99.98%; Nickel, foil, 300x300mm, thickness 0.125mm, annealed, 99%; Nickel, foil, 300x300mm, thickness 2.0mm, annealed, 99%; Nickel, foil, 4mm disks, thickness 0.004mm, hard, 99.98%; Nickel, foil, 4mm disks, thickness 0.0125mm, annealed, 99%; Nickel, foil, 4mm disks, thickness 0.025mm, annealed, 99%; Nickel, foil, 4mm disks, thickness 0.05mm, annealed, 99%; Nickel, foil, 4mm disks, thickness 0.05mm, as rolled, 100%; Nickel, foil, 4mm disks, thickness 0.075mm, annealed, 99%; Nickel, foil, 4mm disks, thickness 0.125mm, annealed, 99%; Nickel, foil, 4mm disks, thickness 0.15mm, annealed, 99%; Nickel, foil, 4mm disks, thickness 0.20mm, annealed, 99%; Nickel, foil, 4mm disks, thickness 0.25mm, annealed, 99%; Nickel, foil, 4mm disks, thickness 0.25mm, as rolled, 100%; Nickel, foil, 4mm disks, thickness 0.3mm, as rolled, 100%; Nickel, foil, 4mm disks, thickness 0.50mm, annealed, 99%; Nickel, foil, 4mm disks, thickness 0.5mm, annealed, 99.98%; Nickel, foil, 4mm disks, thickness 0.5mm, as rolled, 100%; Nickel, foil, 50mm disks, thickness 0.004mm, hard, 99.98%; Nickel, foil, 50mm disks, thickness 0.0125mm, 99.99+%; Nickel, foil, 50mm disks, thickness 0.025mm, annealed, 99%; Nickel, foil, 50mm disks, thickness 0.05mm, annealed, 99%; Nickel, foil, 50mm disks, thickness 0.075mm, annealed, 99%; Nickel, foil, 50mm disks, thickness 0.125mm, annealed, 99%; Nickel, foil, 50mm disks, thickness 0.15mm, annealed, 99%; Nickel, foil, 50mm disks, thickness 0.1mm, annealed, 99%; Nickel, foil, 50mm disks, thickness 0.20mm, annealed, 99%; Nickel, foil, 50mm disks, thickness 0.25mm, annealed, 99%; Nickel, foil, 50mm disks, thickness 0.3mm, annealed, 99%; Nickel, foil, 50mm disks, thickness 0.50mm, annealed, 99%; Nickel, foil, 50x50mm, thickness 0.125mm, annealed, 99%; Nickel, foil, 50x50mm, thickness 0.25mm, annealed, 99.98%; Nickel, foil, 50x50mm, thickness 0.5mm, annealed, 99.98%; Nickel, foil, 50x50mm, thickness 1.0mm, annealed, 99.98%; Nickel, foil, 5m coil, thickness 0.0125mm, annealed, 99%; Nickel, foil, 5m coil, thickness 0.05mm, annealed, 99.98%; Nickel, foil, 5m coil, thickness 0.125mm, annealed, 99.98%; Nickel, foil, 6mm disks, thickness 0.004mm, hard, 99.98%; Nickel, foil, 6mm disks, thickness 0.0125mm, annealed, 99%; Nickel, foil, 6mm disks, thickness 0.025mm, annealed, 99%; Nickel, foil, 6mm disks, thickness 0.05mm, annealed, 99%; Nickel, foil, 6mm disks, thickness 0.05mm, as rolled, 100%; Nickel, foil, 6mm disks, thickness 0.075mm, annealed, 99%; Nickel, foil, 6mm disks, thickness 0.125mm, annealed, 99%; Nickel, foil, 6mm disks, thickness 0.15mm, annealed, 99%; Nickel, foil, 6mm disks, thickness 0.20mm, annealed, 99%; Nickel, foil, 6mm disks, thickness 0.25mm, annealed, 99%; Nickel, foil, 6mm disks, thickness 0.25mm, as rolled, 100%; Nickel, foil, 6mm disks, thickness 0.3mm, as rolled, 100%; Nickel, foil, 6mm disks, thickness 0.50mm, annealed, 99%; Nickel, foil, 6mm disks, thickness 0.5mm, annealed, 99.98%; Nickel, foil, 6mm disks, thickness 0.5mm, as rolled, 100%; Nickel, foil, 8mm disks, thickness 0.004mm, hard, 99.98%; Nickel, foil, 8mm disks, thickness 0.0125mm, annealed, 99%; Nickel, foil, 8mm disks, thickness 0.025mm, annealed, 99%; Nickel, foil, 8mm disks, thickness 0.05mm, annealed, 99%; Nickel, foil, 8mm disks, thickness 0.05mm, as rolled, 100%; Nickel, foil, 8mm disks, thickness 0.075mm, annealed, 99%; Nickel, foil, 8mm disks, thickness 0.125mm, annealed, 99%; Nickel, foil, 8mm disks, thickness 0.15mm, annealed, 99%; Nickel, foil, 8mm disks, thickness 0.20mm, annealed, 99%; Nickel, foil, 8mm disks, thickness 0.25mm, annealed, 99%; Nickel, foil, 8mm disks, thickness 0.25mm, as rolled, 100%; Nickel, foil, 8mm disks, thickness 0.3mm, as rolled, 100%; Nickel, foil, 8mm disks, thickness 0.50mm, annealed, 99%; Nickel, foil, 8mm disks, thickness 0.5mm, annealed, 99.98%; Nickel, foil, 8mm disks, thickness 0.5mm, as rolled, 100%; Nickel, foil, diameter 10 mm, thickness 0.6 mm, purity 99%; Nickel, foil, diameter 25 mm, thickness 0.7 mm, purity 99%; Nickel, foil, thickness 0.1 mm, 99.98% trace metals basis; Nickel, foil, thickness 0.125 mm, 4 mm diameter, purity 99%; Nickel, foil, thickness 0.125 mm, diameter 8 mm, purity 99%; Nickel, foil, thickness 0.125 mm, length 0.5 m, purity 99%; Nickel, foil, thickness 0.125 mm, purity 99%, diameter 6 mm; Nickel, foil, thickness 0.25 mm, 99.995% trace metals basis; Nickel, foil, thickness 0.5 mm, 99.98% trace metals basis; Nickel, foil, thickness 0.50 mm, 10 mm diameter, purity 99%; Nickel, foil, thickness 0.50 mm, 15 mm diameter, purity 99%; Nickel, foil, thickness 0.50 mm, 25 mm diameter, purity 99%; Nickel, foil, thickness 0.50 mm, 50 mm diameter, purity 99%; Nickel, foil, thickness 0.50 mm, 6 mm diameter, purity 99%; Nickel, foil, thickness 0.50 mm, diameter 4 mm, purity 99%; Nickel, foil, thickness 0.50 mm, diameter 8 mm, purity 99%; Nickel, foil, thickness 0.6 mm, 15 mm diameter, purity 99%; Nickel, foil, thickness 0.6 mm, 4 mm diameter, purity 99%; Nickel, foil, thickness 0.6 mm, 50 mm diameter, purity 99%; Nickel, foil, thickness 0.6 mm, 6 mm diameter, purity 99%; Nickel, foil, thickness 0.6 mm, 8 mm diameter, purity 99%; Nickel, foil, thickness 0.6 mm, diameter 25 mm, purity 99%; Nickel, foil, thickness 0.7 mm, 10 mm diameter, purity 99%; Nickel, foil, thickness 0.7 mm, 15 mm diameter, purity 99%; Nickel, foil, thickness 0.7 mm, 50 mm diameter, purity 99%; Nickel, foil, thickness 0.7 mm, 6 mm diameter, purity 99%; Nickel, foil, thickness 0.7 mm, 8 mm diameter, purity 99%; Nickel, foil, thickness 0.7 mm, diameter 4 mm, purity 99%; Nickel, foil, thickness 0.8 mm, 10 mm diameter, purity 99%; Nickel, foil, thickness 0.8 mm, 15 mm diameter, purity 99%; Nickel, foil, thickness 0.8",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "Ni",
            "molecular_weight": "58.693",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "935",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0144",
            "name": "BADGE",
            "synonyms": "BISPHENOL A DIGLYCIDYL ETHER; 1675-54-3; 2,2-Bis(4-glycidyloxyphenyl)propane; Epoxide A; Epophen EL 5; Dian diglycidyl ether; BADGE; Diglycidyl bisphenol A; epi-Rez 510; Bpdge; DGEBA; Diglycidyl ether of bisphenol A; Diomethane diglycidyl ether; Dian-bis-glycidylether; Diglycidyl bisphenol A ether; Epi-Rez 508; 2,2-Bis(p-glycidyloxyphenyl)propane; Oligomer 340; DGEBPA; 2,2-Bis(4'-glycidyloxyphenyl)propane; Diglycidyl diphenylolpropane ether; 4,4'-Isopropylidenediphenol diglycidyl ether; Bis(4-glycidyloxyphenyl)dimethylmethane; ERL-2774; EP 274; D.E.R. 332; Diglycidyl ether of 4,4'-isopropylidenediphenol; Epotuf 37-140; Bis(4-hydroxyphenyl)dimethylmethane diglycidyl ether; Diglycidyl ether of 2,2-bis(4-hydroxyphenyl)propane; Diglycidyl ether of 2,2-bis(p-hydroxyphenyl)propane; NSC 5022; 4,4'-Dihydroxydiphenyldimethylmethane diglycidyl ether; p,p'-Dihydroxydiphenyldimethylmethane diglycidyl ether; 2,2-Bis(phenyl-4-glycidoxy)propane; Oxirane, 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis-; 2,2-Bis(4-hydroxyphenyl)propane diglycidyl ether; CCRIS 1965; Dian-bis-glycidylether [Czech]; HSDB 331; 4,4'-Bis(2,3-epoxypropoxy)diphenyldimethylmethane; 2,2-Bis(p-(2,3-epoxypropoxy)phenyl)propane; 2,2-Bis[4-(2,3-epoxypropoxy)phenyl]propane; EINECS 216-823-5; 2,2-Bis(4-(2,3-epoxypropyloxy)phenyl)propane; 2,2-Bis(4-hydroxyphenyl)propane, diglycidyl ether; 2,2-Bis(p-hydroxyphenyl)propane, diglycidyl ether; Propane, 2,2-bis(4-(2,3-epoxypropoxy)phenyl)-; GY 6010; 2,2-Bis[4-(glycidyloxy)phenyl]propane; 4,4'-Isopropylidenebis(1-(2,3-epoxypropoxy)benzene); BISPHENOLFDIGLYCIDYLETHER; CHEMBL258558; 2,2-Bis[p-(2,3-epoxypropoxy)phenyl]propane; CHEBI:34578; LCFVJGUPQDGYKZ-UHFFFAOYSA-N; 2,2'-((1-Methylethylidene)bis(4,1-phenyleneoxymethylene))bisoxirane; 2,2-Bis(p-hydroxyphenyl)propane diglycidyl ether; Propane, 2,2-bis (p-(2,3-epoxypropoxy)phenyl); Propane, 2,2-bis(p-(2,3-epoxypropoxy)phenyl)-; Propane, 2,2-bis[p-(2,3-epoxypropoxy)phenyl]-; MFCD00080480; 2,2-bis-(4-Glycidyloxyphenyl)propane; DSSTox_CID_4624; Oxirane, 2,2'-((1-methylethylidene)bis(4,1-phenyleneoxymethylene))bis-; 2,2-bis(4-(2,3-epoxypropoxy)phenyl)propane; 2,2-Bis[4-(2,3-epoxypropyloxy)phenyl]propane; DSSTox_RID_77472; DSSTox_GSID_24624; W-107909; 4,4'-Isopropylidenebis[1-(2,3-epoxypropoxy)benzene]; 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane; 2-[[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenoxy]methyl]oxirane; 2,2'-(((Propane-2,2-diylbis(4,1-phenylene))bis(oxy))bis(methylene))bis(oxirane); CAS-1675-54-3; 2,2-bis(4-(2,3-epoxypropoxy)phenyl)-propane; 2,2-Bis(p-(2,3-epoxypropoxy)phenyl)-Propane; 2,2-Bis[4-(2,3-epoxypropoxy)phenyl]-Propane; 2,2-Bis[p-(2,3-epoxypropoxy)phenyl]-Propane; SR-01000597404; Bisphenol A, diglycidyl ether; 2,2'-[propane-2,2-diylbis(4,1-phenyleneoxymethylene)]dioxirane; 2-((4-(2-(4-(oxiran-2-ylmethoxy)phenyl)propan-2-yl)phenoxy)methyl)oxirane; hexyloxypropylamine; 2, diglycidyl ether; ACMC-209dwr; Spectrum5_001987; Bisphenol-A diglycidylether; 4,3-epoxypropoxy)benzene]; D.E.R.trade mark 332; 11391red; bisphenol-a diglycidyl ether; isphenol a, diglycidyl ether; SCHEMBL22121; BSPBio_001468; KBioGR_000188; KBioSS_000188; Bis(4-glycidyloxyphenyl)propane; diglycidyl ether of bisphenol-A; 1-Propanamine, 3-(hexyloxy)-; 2,3-epoxypropoxy)phenyl]propane; DTXSID6024624; BCBcMAP01_000157; CTK3J3495; KBio2_000188; KBio2_002756; KBio2_005324; KBio3_000375; KBio3_000376; NSC5022; 2,3-epoxypropyloxy)phenyl]propane; Bio1_000378; Bio1_000867; Bio1_001356; Bio2_000188; Bio2_000668; HMS1361J10; HMS1791J10; HMS1989J10; HMS3267P05; HMS3402J10; HMS3414L19; HMS3649C20; HMS3678L17; WLN: T3OTJ B1OR D- 2X; BISPHENOLADIGLYCIDYLETHERRESIN; KS-00000UP7; NSC-5022; 2,2-bis(4-glycidyloxypheny)propane; Tox21_202141; Tox21_303315; 1642AH; ANW-22297; BDBM50241439; BS0034; LS-924; 2, 2-Bis(4-glycidyloxyphenyl)propane; 2, 2-Bis(p-glycidyloxyphenyl)propane; AKOS003609360; Bis(4-glycidyloxyphenyl)dimethyamethane; MCULE-9203373672; RTR-007262; 2, 2-Bis(4'-glycidyloxyphenyl)propane; 2,2-[Bis(4-glycidyloxyphenyl)]propane; 4,3-epoxypropoxy)diphenyldimethylmethane; IDI1_033938; NCGC00025114-02; NCGC00025114-03; NCGC00025114-04; NCGC00025114-05; NCGC00025114-06; NCGC00025114-07; NCGC00025114-08; NCGC00257039-01; NCGC00259690-01; 500008-19-5; AS-33346; TR-007262; FT-0609175; ST50826240; 4, 4'-Isopropylidenediphenol diglycidyl ether; D.E.R.(TM) 332, used as embedding medium; Propane,2-bis[(p-2,3-epoxypropoxy)phenyl]-; Propane,2-bis[4-(2,3-epoxypropoxy)phenyl]-; Propane,2-bis[p-(2,3-epoxypropoxy)phenyl]-; 2,2-Bis[(p-2,3-epoxypropoxy)phenyl]-Propane; Bis[4-(2,3-epoxypropoxy)phenyl]-(2)-propane; C14348; 4,4'-Isopropylidene diphenol, diglycidyl ether-; Bisphenol A diglycidyl ether, analytical standard; Diglycidyl ether of 4, 4'-isopropylidenediphenol; 2, 2-Bis(4-hydroxyphenyl)propane diglycidyl ether; 2, 2-Bis(p-hydroxyphenyl)propane diglycidyl ether; 2, 2-Bis(p-hydroxyphenyl)propane, diglycidyl ether; 4,4'-Bis(2, 3-epoxypropoxy)diphenyldimethylmethane; Q2080808; SR-01000597404-1; SR-01000597404-3; SR-01000597404-4; BRD-A16694057-001-01-9; Diglycidyl ether of 2, 2-bis(4-hydroxyphenyl)propane; Diglycidyl ether of 2, 2-bis(p-hydroxyphenyl)propane; diglycidyl ether of 2,2-bis(p-hydroxyphenyl)-propane; 4, 4'-Dihydroxydiphenyldimethylmethane diglycidyl ether; 2,2'-[(1-Methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane, 9CI; 2,2'-{Propane-2,2-diylbis[(4,1-phenylene)oxymethylene]}bis(oxirane); 2-(4-{2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl}phenoxymethyl)oxirane; Oxirane,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis-; 2,2''-(4,4''-(propane-2,2-diyl)bis(4,1-phenylene))bis(oxy)bis(methylene)dioxirane; 2,2-(((Propane-2,2-diylbis(4,1-phenylene))bis(oxy))bis(methylene))bis(oxirane); 2-[(4-(1-Methyl-1-[4-(2-oxiranylmethoxy)phenyl]ethyl)phenoxy)methyl]oxirane #; 4-{1-methyl-1-[4-(oxiran-2-ylmethoxy)phenyl]ethyl}-1-(oxiran-2-ylmethoxy)benze ne",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C21H24O4",
            "molecular_weight": "340.4",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "2286",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [
                "F02010203"
            ],
            "references": [
                "RC01299",
                "RC01313"
            ]
        },
        {
            "compound_ID": "D0145",
            "name": "Fenpyroximate",
            "synonyms": "Fenpyroximate; 134098-61-6; (Z)-Fenpyroximate; Fenpyroximate [ISO]; UNII-9W557V4RYA; FENPYROXYMATE; NNI 850; 111812-58-9; 9W557V4RYA; CHEBI:5011; (E)-Fenpyroximate; fenperoximate; t-Butyl (E)-alpha-(1,3-dimethyl-5-phenoxypyrazol-4-ylmethyleneaminooxy)-p-toluate (IUPAC); tert-butyl 4-[({[(1E)-(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoate; Assault; Danitron; Acari; Kendo; Ortus; FujiMite; Naja; DL-Fenpyroximate; Fenpyroximate (Z,E); t-butyl (E)-alpha-(1,3-dimethyl-5-phenoxypyrazol-4-ylmethyleneaminooxy)-p-toluate; Fenpyroximate, DL; Benzoic acid, 4-(((((1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene)amino)oxy)methyl)-, 1,1-dimethylethyl ester, (E)-; Benzoic acid, 4-((((E)-((1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene)amino)oxy)methyl)-, 1,1-dimethylethyl ester; HSDB 7943; tert-butyl 4-[[(E)-(1,3-dimethyl-5-phenoxypyrazol-4-yl)methylideneamino]oxymethyl]benzoate; (Z,E)-Fenpyroximate; DSSTox_CID_12550; DSSTox_RID_78979; DSSTox_GSID_32550; SCHEMBL74176; CHEMBL365100; DTXSID7032557; YYJNOYZRYGDPNH-MFKUBSTISA-; YYJNOYZRYGDPNH-MYYYXRDXSA-N; Tox21_300898; ZINC25763821; AKOS015895778; KS-5364; NCGC00163915-01; NCGC00163915-02; NCGC00163915-03; NCGC00163915-04; NCGC00163915-05; NCGC00163915-06; NCGC00254802-01; Benzoic acid, 4-(1,3-dimethyl-5-phenoxy-1H-pyrazol-4- yl)methyleneaminooxymethyl-, 1,1-dimethylethyl ester; LS-37235; SC-12556; CAS-111812-58-9; F1195; (E)-Fenpyroximate 100 microg/mL in Methanol; (E)-Fenpyroximate 10 microg/mL in Cyclohexane; C11098; K-4223; (E)-Fenpyroximate 10 microg/mL in Acetonitrile; (E)-Fenpyroximate 100 microg/mL in Cyclohexane; Fenpyroximate, PESTANAL(R), analytical standard; 098F616; A806730; Q27265074; tert-Butyl 4-({[(E)-1,3-dimethyl-5-phenoxypyrazol-4-yl]methyl}aminooxymethyl)benzoate; tert-butyl 4-[[[1,3-dimethyl-5-(phenoxy)pyrazol-4-yl]methylideneamino]oxymethyl]; 4-[[(E)-(1,3-dimethyl-5-phenoxy-4-pyrazolyl)methylideneamino]oxymethyl]benzoic acid tert-butyl ester; 4-[[[(E)-[(1,3-Dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino]oxy]methyl]benzoic Acid tert-Butyl Ester; Benzoic acid,4-[[[(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino]oxy]methyl]-, 1,1-dimethylethyl ester; InChI=1/C24H27N3O4/c1-17-21(22(27(5)26-17)30-20-9-7-6-8-10-20)15-25-29-16-18-11-13-19(14-12-18)23(28)31-24(2,3)4/h6-15H,16H2,1-5H3/b25-15+; Pesticide4_Fenpyroximate_C24H27N3O4_tert-Butyl 4-[({[(1E)-(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylidene]amino}oxy)methyl]benzoate; tert-butyl 4-[[(E)-(1,3-dimethyl-5-phenoxy-pyrazol-4-yl)methylideneamino]oxymethyl]benzoate; tert-Butyl 4-[[[(E)-[(1,3-Dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino]oxy]methyl]benzoate",
            "trade_name": "",
            "abbrev_name": "",
            "description": "acaricide/insecticide; inhibits mitochondrial electron transport at the NADH-coenzyme Q oxidoreductase (complex I)",
            "molecular_formula": "C24H27N3O4",
            "molecular_weight": "421.5",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "9576412",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [
                "T001"
            ],
            "function": [
                "F020103",
                "F020403"
            ],
            "references": [
                "RC01377",
                "RC01378",
                "RC04932"
            ]
        },
        {
            "compound_ID": "D0146",
            "name": "Benzene",
            "synonyms": "benzene; benzol; Cyclohexatriene; 71-43-2; benzole; Pyrobenzole; Benzine; Benzen; Phenyl hydride; Pyrobenzol; Phene; Mineral naphtha; Coal naphtha; Bicarburet of hydrogen; Benzolene; Benzin; [6]Annulene; Motor benzol; Carbon oil; Benzeen; Benzolo; Fenzen; Nitration benzene; (6)Annulene; Benzol 90; Benzeen [Dutch]; Benzen [Polish]; Fenzen [Czech]; Rcra waste number U019; Benzolo [Italian]; Benzine (Obs.); Benzin (Obs.); NCI-C55276; Caswell No. 077; Benzol diluent; Benzene, pure; CCRIS 70; NSC 67315; HSDB 35; UN 1114; CHEBI:16716; UNII-J64922108F; EINECS 200-753-7; UN1114; EPA Pesticide Chemical Code 008801; Benzene (including benzene from gasoline); AI3-00808; CHEMBL277500; UHOVQNZJYSORNB-UHFFFAOYSA-N; MFCD00003009; J64922108F; BNZ; 2,5-cyclohexadien-1,4-ylene; Benzene 100 microg/mL in Methanol; Benzene, ACS reagent, >=99.0%; 54682-86-9; 1,3,5-cyclohexatriene; Benzinum; Benzolum; Aromatic alkane; p-benzene; benzene solution; benzene-; 1hyz; 1swi; Benzene, anhydrous; [6]-annulene; Benzene ACS Grade; Benzene, for HPLC; {[6]Annulene}; Benzene, HPLC Grade; Ph-H; 2z9g; 4i7j; ACMC-209snd; Benzene + aniline combo; DSSTox_CID_135; Benzene, labeled with carbon-14 and tritium; WLN: RH; Epitope ID:116867; Benzene, purification grade; EC 200-753-7; Benzene, analytical standard; DSSTox_RID_79433; Benzene, LR, >=99%; DSSTox_GSID_39242; ghl.PD_Mitscher_leg0.503; 26181-88-4; Benzene, anhydrous, 99.8%; Benzene, AR, >=99.5%; DTXSID3039242; 3,4-DNH; Benzene, Spectrophotometric Grade; 1l83; 220l; 223l; Benzene 10 microg/mL in Methanol; ZINC967532; trans-N-Methylphenylcyclopropylamine; ACT02832; Benzene, for HPLC, >=99.8%; Benzene, for HPLC, >=99.9%; KS-00000X1X; NSC67315; Tox21_202487; 1,3-Cyclohexadiene-5,6-diylradical; ANW-41399; BDBM50167939; BM 613; NSC-67315; STL264205; Benzene 1000 microg/mL in Methanol; Benzene 5000 microg/mL in Methanol; Benzene, purum, >=99.0% (GC); AKOS008967253; LS-1605; MCULE-4899719484; RTR-002195; Benzene [UN1114] [Flammable liquid]; Benzene, SAJ first grade, >=99.0%; Benzene,SpectrophotometricGrade,99.5+%; CAS-71-43-2; Benzene [UN1114] [Flammable liquid]; Benzene, JIS special grade, >=99.5%; erythro-Phenyl-2-piperidyl-carbinol,(-); NCGC00090744-01; NCGC00090744-02; NCGC00163890-01; NCGC00163890-02; NCGC00260036-01; trans-N, N-Dimethylphenylcyclopropylamine; Cc-34,(+/-); RNG; SC-74481; AB1007259; DS-002542; B0020; FT-0080146; FT-0622636; FT-0622667; FT-0657604; Q0038; Q2270; 3945-EP0930075A1; 3945-EP1441224A2; 3945-EP2269977A2; 3945-EP2269978A2; 3945-EP2269985A2; 3945-EP2269986A1; 3945-EP2269987A1; 3945-EP2269988A2; 3945-EP2269989A1; 3945-EP2269990A1; 3945-EP2269991A2; 3945-EP2269993A1; 3945-EP2269995A1; 3945-EP2270000A1; 3945-EP2270006A1; 3945-EP2270008A1; 3945-EP2270010A1; 3945-EP2270113A1; 3945-EP2270114A1; 3945-EP2272516A2; 3945-EP2272537A2; 3945-EP2272813A2; 3945-EP2272817A1; 3945-EP2272822A1; 3945-EP2272825A2; 3945-EP2272828A1; 3945-EP2272832A1; 3945-EP2272839A1; 3945-EP2272840A1; 3945-EP2272841A1; 3945-EP2272849A1; 3945-EP2272935A1; 3945-EP2272972A1; 3945-EP2272973A1; 3945-EP2275395A2; 3945-EP2275401A1; 3945-EP2275404A1; 3945-EP2275407A1; 3945-EP2275410A1; 3945-EP2275411A2; 3945-EP2275414A1; 3945-EP2275417A2; 3945-EP2275418A1; 3945-EP2275427A1; 3945-EP2275469A1; 3945-EP2277858A1; 3945-EP2277862A2; 3945-EP2277867A2; 3945-EP2277871A1; 3945-EP2277872A1; 3945-EP2277874A1; 3945-EP2277875A2; 3945-EP2277878A1; 3945-EP2277881A1; 3945-EP2279750A1; 3945-EP2280000A1; 3945-EP2280001A1; 3945-EP2280003A2; 3945-EP2280005A1; 3945-EP2280007A1; 3945-EP2280009A1; 3945-EP2280011A1; 3945-EP2281559A1; 3945-EP2281563A1; 3945-EP2281810A1; 3945-EP2281817A1; 3945-EP2281818A1; 3945-EP2281821A1; 3945-EP2282636A2; 3945-EP2284150A2; 3945-EP2284151A2; 3945-EP2284152A2; 3945-EP2284153A2; 3945-EP2284155A2; 3945-EP2284156A2; 3945-EP2284157A1; 3945-EP2284159A1; 3945-EP2284162A2; 3945-EP2284163A2; 3945-EP2284164A2; 3945-EP2284169A1; 3945-EP2284174A1; 3945-EP2284178A2; 3945-EP2284920A1; 3945-EP2286811A1; 3945-EP2286812A1; 3945-EP2287140A2; 3945-EP2287141A1; 3945-EP2287147A2; 3945-EP2287148A2; 3945-EP2287150A2; 3945-EP2287152A2; 3945-EP2287153A1; 3945-EP2287154A1; 3945-EP2287161A1; 3945-EP2287162A1; 3945-EP2287165A2; 3945-EP2287166A2; 3945-EP2287940A1; 3945-EP2289509A2; 3945-EP2289518A1; 3945-EP2289868A1; 3945-EP2289871A1; 3945-EP2289876A1; 3945-EP2289879A1; 3945-EP2289884A1; 3945-EP2289887A2; 3945-EP2289888A2; 3945-EP2289892A1; 3945-EP2289965A1; 3945-EP2292227A2; 3945-EP2292231A1; 3945-EP2292576A2; 3945-EP2292589A1; 3945-EP2292590A2; 3945-EP2292592A1; 3945-EP2292593A2; 3945-EP2292595A1; 3945-EP2292597A1; 3945-EP2292599A1; 3945-EP2292606A1; 3945-EP2292611A1; 3945-EP2292612A2; 3945-EP2292615A1; 3945-EP2292617A1; 3945-EP2292620A2; 3945-EP2292630A1; 3945-EP2295399A2; 3945-EP2295402A2; 3945-EP2295406A1; 3945-EP2295409A1; 3945-EP2295411A1; 3945-EP2295412A1; 3945-EP2295413A1; 3945-EP2295414A1; 3945-EP2295415A1; 3945-EP2295418A1; 3945-EP2295419A2; 3945-EP2295421A1; 3945-EP2295422A2; 3945-EP2295424A1; 3945-EP2295425A1; 3945-EP2295426A1; 3945-EP2295427A1; 3945-EP2295429A1; 3945-EP2295432A1; 3945-EP2295433A2; 3945-EP2295438A1; 3945-EP2295439A1; 3945-EP2295441A2; 3945-EP2295503A1; 3945-EP2298729A1; 3945-EP2298731A1; 3945-EP2298732A1; 3945-EP2298735A1; 3945-EP2298745A1; 3945-EP2298746A1; 3945-EP2298747A1; 3945-EP2298750A1; 3945-EP2298753A1; 3945-EP2298756A1; 3945-EP2298763A1; 3945-EP2298767A1; 3945-EP2298768A1; 3945-EP2298770A1; 3945-EP2298772A1; 3945-EP2298774A1; 3945-EP2298777A2; 3945-EP2298778A1; 3945-EP2298783A1; 3945-EP2298828A1; 3945-EP2300430A1; 3945-EP2301534A1; 3945-EP2301627A1; 3945-EP2301911A1; 3945-EP2301912A2; 3945-EP2301913A1; 3945-EP2301914A1; 3945-EP2301916A2; 3945-EP2301918A1; 3945-EP2301919A1; 3945-EP2301921A1; 3945-EP2301922A1; 3945-EP2301924A1; 3945-EP2301926A1; 3945-EP2301928A1; 3945-EP2301933A1; 3945-EP2301934A1; 3945-EP2301936A1; 3945-EP2301937A1; 3945-EP2302003A1; 3945-EP2305219A1; 3945-EP2305250A1; 3945-EP2305625A1; 3945-EP2305627A1; 3945-EP2305636A1; 3945-EP2305637A2; 3945-EP2305640A2; 3945-EP2305641A1; 3945-EP2305642A2; 3945-EP2305647A1; 3945-EP2305648A1; 3945-EP2305649A1; 3945-EP2305650A1; 3945-EP2305651A1; 3945-EP2305655A2; 3945-EP2305658A1; 3945-EP2305668A1; 3945-EP2305672A1; 3945-EP2305676A1; 3945-EP2305679A1; 3945-EP2305683A1; 3945-EP2305687A1; 3945-EP2305769A2; 3945-EP2305825A1; 3945-EP2308510A1; 3945-EP2308562A2; 3945-EP2308812A2; 3945-EP2308828A2; 3945-EP2308832A1; 3945-EP2308838A1; 3945-EP2308839A1; 3945-EP2308844A2; 3945-EP2308845A2; 3945-EP2308846A2; 3945-EP2308848A1; 3945-EP2308849A1; 3945-EP2308850A1; 3945-EP2308851A1; 3945-EP2308852A1; 3945-EP2308853A1; 3945-EP2308854A1; 3945-EP2308855A1; 3945-EP2308857A1; 3945-EP2308863A1; 3945-EP2308865A1; 3945-EP2308868A1; 3945-EP2308869A1; 3945-EP2308872A1; 3945-EP2308874A1; 3945-EP2308876A1; 3945-EP2308877A1; 3945-EP2308882A1; 3945-EP2308926A1; 3945-EP2309564A1; 3945-EP2309584A1; 3945-EP2311451A1; 3945-EP2311464A1; 3945-EP2311796A1; 3945-EP2311797A1; 3945-EP2311798A1; 3945-EP2311799A1; 3945-EP2311802A1; 3945-EP2311803A1; 3945-EP2311804A2; 3945-EP2311807A1; 3945-EP2311808A1; 3945-EP2311811A1; 3945-EP2311813A1; 3945-EP2311814A1; 3945-EP2311820A1; 3945-EP2311825A1; 3945-EP2311827A1; 3945-EP2311828A1; 3945-EP2311829A1; 3945-EP2311830A1; 3945-EP2311839A1; 3945-EP2311840A1; 3945-EP2311842A2; 3945-EP2314558A1; 3945-EP2314576A1; 3945-EP2314577A1; 3945-EP2314579A1; 3945-EP2314581A1; 3945-EP2314583A1; 3945-EP2314584A1; 3945-EP2314585A1; 3945-EP2314586A1; 3945-EP2314587A1; 3945-EP2314589A1; 3945-EP2314593A1; 3945-EP2315303A1; 3945-EP2315502A1; 3945-EP2316450A1; 3945-EP2316459A1; 3945-EP2316826A1; 3945-EP2316829A1; 3945-EP2316831A1; 3945-EP2316832A1; 3945-EP2316833A1; 3945-EP2316836A1; 3945-EP2316837A1; 3945-EP2371795A1; 3945-EP2371810A1; 3945-EP2371811A2; 3945-EP2371812A1; 3945-EP2371831A1; 3945-EP2372804A1; 3945-EP2374787A1; 3945-EP2374790A1; 3945-EP2377610A2; 3945-EP2377611A2; 3945-EP2377847A1; 3945-EP2377849A2; 3945-EP2378585A1; 3945-EP2379677A2; 3945-EP2380568A1; 3945-EP2380867A1; 3945-EP2380873A1; 3945-EP2380874A2; Benzene, ACS spectrophotometric grade, >=99%; C01407; 77823-EP2272846A1; 77823-EP2277862A2; 77823-EP2277868A1; 77823-EP2277869A1; 77823-EP2277870A1; 77823-EP2287158A1; 77823-EP2292608A1; 77823-EP2292625A1; 77823-EP2295422A2; 77823-EP2295436A1; 77823-EP2298749A1; 77823-EP2298769A1; 77823-EP2300430A1; 77823-EP2305033A1; 77823-EP2308866A1; 77823-EP2379677A2; TRANSGENIC MODEL EVALUATION II (BENZENE); 142077-EP2270010A1; 142077-EP2292593A2; Benzene, ReagentPlus(R), thiophene free, >=99%; InChI=1/C6H6/c1-2-4-6-5-3-1/h1-6; Benzene, puriss. p.a., Reag. Ph. Eur., >=99.7%; Q26841227; Z57120059; Benzene, for residue analysis, suitable for 5000 per JIS; Benzene, suitable for 300 per JIS, >=99.5%, for residue analysis; Benzene, Pharmaceutical Secondary Standard; Certified Reference Material; Benzene, suitable for 1000 per JIS, >=99.5%, for residue analysis; Benzene, puriss., absolute, over molecular sieve (H2O <=0.005%), >=99.5% (GC)",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C6H6",
            "molecular_weight": "78.11",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "241",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0147",
            "name": "Benzo(A)Pyrene",
            "synonyms": "benzo[a]pyrene; 50-32-8; benzo[pqr]tetraphene; 3,4-Benzopyrene; BENZO(A)PYRENE; 3,4-Benzpyrene; Benzpyrene; benzo[def]chrysene; 6,7-Benzopyrene; Benz[a]pyrene; 3,4-BP; 3,4-Benz[a]pyrene; 3,4-Benzopirene; 3,4-Benzpyren; Benzo[d,e,f]chrysene; Benz(a)pyrene; (B(a)P); B(a)P; BP; 3,4 Benzpyrene; RCRA waste number U022; 3,4-Benz(a)pyrene; Benzo(d,e,f)chrysene; NSC 21914; 3,4-Benzo(a)pyrene; B[a]p; 3,4-Benzpyren [German]; Benzo[A]-Pyrene; CCRIS 76; Benzo(def)chrysene; 3,4-benzylpyrene; 3,4-Benzopirene [Italian]; UNII-3417WMA06D; CHEBI:29865; HSDB 2554; FMMWHPNWAFZXNH-UHFFFAOYSA-N; EINECS 200-028-5; RCRA waste no. U022; CHEMBL31184; AI3-50461; 3417WMA06D; Coal tar pitch volatiles: benzo(a)pyrene; Benzo(a)pyrene [Polycyclic aromatic compounds]; Benzo(a)pyrene [Polycyclic aromatic hydrocarbons]; 3,4 Benzopyrene; Benzo[a]pyrene (BaP); Benzo(a)pyrene radical cation; 3,4-Benzypyrene; Benzo(a)pyrene, radical ion(1+); Benzo(a)pyrene, radical ion(1-); Benzo[d,f]chrysene; Benzo(a)pyrene, labeled with tritium; Benzo Pyrene[BAP]; Benzo(3,4)pyrene, radical ion(1+); Spectrum_001871; ACMC-209sok; SpecPlus_000953; DSSTox_CID_139; Spectrum2_001081; Spectrum3_001695; Spectrum4_000609; Spectrum5_001824; Epitope ID:117721; DSSTox_RID_75392; DSSTox_GSID_20139; BSPBio_003250; KBioGR_001138; KBioSS_002390; KSC269M1J; MLS002695983; BIDD:ER0497; DivK1c_007049; SPBio_001122; 3,4-Benzopyrene (carcinogen); DTXSID2020139; CTK1G9614; KBio1_001993; KBio2_002385; KBio2_004953; KBio2_007521; KBio3_002470; HMS3089C04; HMS3746C17; NSC21914; ZINC1530818; Benzo[a]pyrene, >=96% (HPLC); Tox21_200710; ANW-41442; BDBM50137506; CCG-39759; LS-139; MFCD00003602; NSC-21914; SBB061395; AKOS015907666; 3,4-Benzopyrene(purifiedbysublimation); AM61580; CB-1807; CS-7789; MCULE-1109963029; RTR-017988; CAS-50-32-8; WLN: L D6 B6666 2AB TJ; NCGC00178185-01; NCGC00178185-02; NCGC00258264-01; 34505-58-3; 42299-33-2; 6699-27-0; AK-49838; BR-49838; CC-24344; EN002216; NCI60_001824; SC-08054; SMR000393676; SY048151; Benzo(a)pyrene 100 microg/mL in Methanol; AX8115689; DB-071166; HY-107377; TR-017988; 4CH-007056; B0085; Benzo[a]pyrene 10 microg/mL in Acetonitrile; FT-0614185; ST24030136; ST45022245; W6563; Benzo[a]pyrene 100 microg/mL in Acetonitrile; Benzo[a]pyrene 100 microg/mL in Cyclohexane; MFCD00003602 (95%); 4809-EP2270014A1; 4809-EP2270895A2; 4809-EP2272517A1; 4809-EP2277880A1; 4809-EP2277898A2; 4809-EP2278637A1; 4809-EP2284157A1; 4809-EP2292088A1; 4809-EP2292610A1; 4809-EP2292630A1; 4809-EP2295424A1; 4809-EP2295428A2; 4809-EP2298735A1; 4809-EP2298744A2; 4809-EP2298780A1; 4809-EP2302015A1; 4809-EP2305250A1; 4809-EP2305689A1; 4809-EP2305825A1; 4809-EP2308852A1; 4809-EP2311820A1; 4809-EP2316827A1; 4809-EP2316836A1; 4809-EP2316937A1; 4809-EP2371805A1; 4809-EP2374895A1; C07535; J10073; S-4361; A828066; A828067; Benzo[a]pyrene, vial of 1 g, analytical standard; C-29981; Q306051; BRD-K09668667-001-02-0; Benzo[a]pyrene, certified reference material, TraceCERT(R); UNII-0TNN3Q0D4D component FMMWHPNWAFZXNH-UHFFFAOYSA-N; Benzo[a]pyrene, analytical standard, for environmental analysis; BENZO(A)PYRENE (SEE ALSO: BENZO(E)PYRENE (CAS 192-97-2)); Benzo[a]pyrene solution, 100 mug/mL in cyclohexane, analytical standard; Benzo[a]pyrene solution, certified reference material, 100 mug/mL in methylene chloride; Benzo[a]pyrene solution, certified reference material, TraceCERT(R), 1000 mug/mL in acetone; Benzo[a]pyrene solution, certified reference material, TraceCERT(R), 200 mug/mL in methylene chloride; pentacyclo[10.6.2.0(2),?.0?,(1)?.0(1)?,(2)?]icosa-1,3,5,7,9,11,13,15,17,19-decaene",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C20H12",
            "molecular_weight": "252.3",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "2336",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F02010203",
                "F02010204",
                "F02010205",
                "F02010207"
            ],
            "references": [
                "RC01259",
                "RC01260",
                "RC01261",
                "RC01262",
                "RC01263",
                "RC01264"
            ]
        },
        {
            "compound_ID": "D0149",
            "name": "Bisphenol A",
            "synonyms": "Bisphenol A; 80-05-7; 2,2-Bis(4-hydroxyphenyl)propane; 4,4'-Isopropylidenediphenol; Bisphenol; Diphenylolpropane; Diano; 4,4'-(propane-2,2-diyl)diphenol; 4,4'-Bisphenol A; Biphenol A; DIAN; Parabis A; Rikabanol; p,p'-Bisphenol A; p,p'-Isopropylidenebisphenol; 2,2-Bis(p-hydroxyphenyl)propane; 2,2-Di(4-phenylol)propane; Bisferol A; Phenol, 4,4'-(1-methylethylidene)bis-; Ipognox 88; Pluracol 245; 4,4'-Dihydroxydiphenylpropane; 4-[2-(4-hydroxyphenyl)propan-2-yl]phenol; Bisphenol-A; Dimethylmethylene-p,p'-diphenol; p,p'-Isopropylidenediphenol; Bis(4-hydroxyphenyl)propane; Ucar bisphenol A; 2,2-Di(4-hydroxyphenyl)propane; 4,4'-propane-2,2-diyldiphenol; p,p'-Dihydroxydiphenylpropane; BPA; Ucar bisphenol HP; 4,4'-Isopropylidene diphenol; 2,2-Bis(hydroxyphenyl)propane; p,p'-Dihydroxydiphenyldimethylmethane; 4,4'-(1-Methylethylidene)bisphenol; 4,4'-Isopropylidenebisphenol; Bis(4-hydroxyphenyl)dimethylmethane; Isopropylidenebis(4-hydroxybenzene); Bis(4-hydroxyphenyl) dimethylmethane; Bisphenol A.; 4,4'-Dihydroxy-2,2-diphenylpropane; 4,4'-Dihydroxydiphenyldimethylmethane; 2,2-Bis-4'-hydroxyfenylpropan; 2,2-(4,4'-Dihydroxydiphenyl)propane; Phenol, 4,4'-isopropylidenedi-; Phenol, (1-methylethylidene)bis-; Dimethylbis(p-hydroxyphenyl)methane; NCI-C50635; 2,2-Bis(4'-hydroxyphenyl)propane; 4,4' Isopropylidinediphenol; Bisferol A [Czech]; Dimethyl bis(p-hydroxyphenyl)methane; 2,2-Bis (4-hydroxyphenol) propane; beta-di-p-hydroxyphenylpropane; 4,4'-Dihydroxydiphenyl-2,2-propane; 4-[1-(4-hydroxyphenyl)-1-methylethyl]phenol; Bis(p-hydroxyphenyl)propane; Phenol, 4,4'-dimethylmethylenedi-; CCRIS 95; 4,4[-Isopropylidenediphenol; Propane, 2,2-bis(p-hydroxyphenyl)-; beta,beta'-Bis(p-hydroxyphenyl)propane; UNII-MLT3645I99; 4,4'-Dimethylmethylenediphenol; HSDB 513; 4,4'-Isopropylidenebis[phenol]; Bisphenol A (BPA); 2,2-bis[4-Hydroxyphenyl]propane; 4,4-ISOPROPYLIDENEDIPHENOL; 2,2-bis(4-hydroxyphenyl) propane; NSC 1767; EINECS 201-245-8; beta,beta-di-(p-hydroxyphenyl)propane; BRN 1107700; 2,2-Bis-4'-hydroxyfenylpropan [Czech]; 4,4'-Dihydroxdiphenylpropane; Noname; 4,4'-(1-Methylethane-1,1-diyl)diphenol; AI3-04009; DTXSID7020182; CHEBI:33216; bisphenol A, disodium salt; IISBACLAFKSPIT-UHFFFAOYSA-N; di-2,2-(4-Hydroxyphenyl)propane; MLT3645I99; 2, 2-Bis(4-hydroxyphenyl)propane; 4,4'-ISOPROPYLIDENEDIPHENOL (BISPHENOL A); Polycarbonate; 4,2-propane; 2,2-(4,4-Dihydroxydiphenyl)propane; 2,2-di-(4'-Hydroxyphenyl)-propane; 4,2-diphenylpropane; MFCD00002366; 2,2-Bis(4,4'-hydroxyphenyl)propane; bis(4-hyd roxyphenyl) dimethylmethane; NCGC00090952-07; .beta.,.beta.'-Bis(p-hydroxyphenyl)propane; DSSTox_CID_182; DSSTox_RID_75420; Phenol,4'-isopropylidenedi-; DSSTox_GSID_20182; Phenol,4'-dimethylmethylenedi-; 2,4'-Dihydroxydiphenyl)propane; WLN: QR DX1&1&R DQ; Propane,2-bis(p-hydroxyphenyl)-; .beta.-Di-(p-hydroxyphenyl)propane; 4,4'-Isopropylidenediphenol, 97%; Phenol,4'-(1-methylethylidene)bis-; CAS-80-05-7; 4-[1-(4-hydroxyphenyl)-isopropyl]phenol; bisphenol A, sodium salt; bis-phenol-a; bis-phenol A; Bis Phenol A; Millad HBPA; 2OH; 4,4'-ISOPROPYLIDENE-DIPHENOL; Phenol, 4,4'-(1-methylethylidene)bis-, homopolymer; 4,4'-bisphenol-A; Bisphenol A, 97%; PubChem22174; 2e2r; 2p7g; 4, 4'-Bisphenol A; Bisphenol A, >=99%; EC 201-245-8; 4,4'-(1-Methylethylidene)bisphenol homopolymer; Bisphenol a(ring 13c12); Poly(Bisphenol A carbonate); BIDD:PXR0120; Oprea1_215541; p, p'-Isopropylidenediphenol; SCHEMBL15062; bis(4-hydroxyphenyl)-propane; 27100-33-0; 4-06-00-06717 (Beilstein Handbook Reference); KSC448A9R; MLS001055461; BIDD:ER0208; 4,4'-Isopropylidenedi-Phenol; p, p'-Dihydroxydiphenylpropane; (1-methylethylidene)bis-Phenol; 2, 2-Di(4-phenylol)propane; 4,4'-Isopropylidenediphenol B; ACMC-20977c; CHEMBL418971; GTPL7865; 4, 4'-Dihydroxydiphenylpropane; 2, 2-Bis(hydroxyphenyl)propane; .beta.-di-p-hydroxyphenylpropane; 4,4'-Dimethylmethylenedi-Phenol; BDBM29608; beta-Di-(p-hydroxyphenyl)propane; CTK3E8098; ZINC56434; BPA 157; NSC1767; 2,2-bis(p-hydroxyphenyl)-propane; Bisphenol A - Polycarbonate Grade; HMS2866B07; HMS3749E11; KUC105370N; 2,2'-Bis(4-hydroxyphenyl)propane; 2,2-di(p-hydroxy-phenyl-)propane; 4,4'-Isopropylidenediphenol, 8CI; 2,2-bis-(p-hydroxyphenyl)-propane; CS-B1737; NSC-1767; NSC17959; 2,2-bis-(4-hydroxy phenyl)propane; 2,2-bis-(4-hydroxyphenyl) propane; 2,2-bis-(4-hydroxyphenyl)-propane; Tox21_202992; Tox21_400088; ANW-13606; BBL010647; dimethyl bis(p-hydroxyphenyl)methane; KSC-7-199; NSC-17959; SBB012432; STK801675; 2,2-bis-(4- hydroxyphenyl)-propane; p, p'-Dihydroxydiphenyldimethylmethane; 4,4'-(1-methylethylidene)bis-phenol; 4,4'-dihydroxy diphenyl-2,2-propane; AKOS000119022; 4, 4'-Dihydroxydiphenyl-2,2-propane; 4, 4'-Dihydroxydiphenyldimethylmethane; CCG-214370; DB06973; LS-1788; MCULE-1016303245; NE10183; RTR-025374; beta, beta'-Bis(p-hydroxyphenyl)propane; UPCMLD0ENAT5883875:001; NCGC00090952-01; NCGC00090952-02; NCGC00090952-03; NCGC00090952-04; NCGC00090952-05; NCGC00090952-06; NCGC00090952-08; NCGC00090952-09; NCGC00260537-01; O169; SC-62333; SMR000315090; ST065685; VS-02603; 4,4'-(1-Methylethylidene)bisphenol, 9CI; TR-025374; 1,1'-(1-Methylethylidene)bisphenylol, 9CI; B0494; FT-0609178; ST24042488; C13624; 4,4'-Isopropylidenediphenol, analytical standard; A839823; AE-848/01247026; Q271980; SR-01000596928; SR-01000596928-1; BRD-K41494493-001-04-7; Bisphenol A, certified reference material, TraceCERT(R); F1284-0895; Z256709694; Bisphenol A, United States Pharmacopeia (USP) Reference Standard; InChI=1/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C15H16O2",
            "molecular_weight": "228.29",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "6623",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [
                "F0108"
            ],
            "references": [
                "RC01810",
                "RC02431",
                "RC03052"
            ]
        },
        {
            "compound_ID": "D0150",
            "name": "BPDE",
            "synonyms": "55097-80-8; BPDE; 7,8,8a,9a-tetrahydrobenzo[1,12]tetrapheno[10,11-b]oxirene-7,8-diol; Benzo(a)pyrene diolepoxide I; Benzo(a)pyrene diol epoxide; 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; BP 7,8-Diol-9,10-epoxide 2; Benzo(a)pyrene 7,8-dihydrodiol 9,10-epoxide; benzo[a]pyrene diol epoxide I; 7,8-Dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene; CHEBI:30614; 7,8,8a,9a-Tetrahydrobenzo[1,12]tetrapheno-[10,11-b]oxirene-7,8-diol; Benzo[A]Pyrene Diol Epoxide (Bpde); BDPE; 7,8-Dihydro-7,8-dihydroxybenzo[a]pyrene 9,10-oxide; Benzo[a]pyrene-7,8-dihydrodiol-9,10-oxide; benzo(a)pyrene diol epoxide 1; 7,8,8a,9a-Tetrahydrobenzo[10,11]chryseno[3,4-b]oxirene-7,8-diol; Anti BaPDE; Anti-BaPDE; 7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene; 7,8-BaP-9,10-Diol Epoxide; Benzo(a)pyrene-7,8-diol 9,10-Epoxide; Benzo(a)pyrene diolepoxide; Benzo(a)pyrene diolepoxide 1; SCHEMBL6299813; Benzopyrene Related Compound 10; CHEMBL1743211; DTXSID9036779; (+/-)-trans-Benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide; DQEPMTIXHXSFOR-UHFFFAOYSA-N; 7,8,9,10-Tetrahydro-7,8-dihydroxybenzo(a)pyrene 9,10-epoxide; 8022AB; Benzo(10,11)chryseno(3,4-b)oxirene-7,8-diol, 7,8,8a,9a-tetrahydro-; AX8238577; C14853; (+- )-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide; Q26840771; 1,2-Epoxy-3,4-dihydroxycyclohexano[a]pyrene, (3s,4s-); 9,10-Epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene-7,8-diol; 7,8,9,10-Tetrahydrobenzo(a)pyrene-7,8-diol 9,10-epoxide; 7,8,8a,9a-Tetrahydrobenzo[10,11]chryseno[3,4-b]oxirene-7,8-diol #; BENZO(a)PYRENE, 7,8-DIHYDRO-7,8-DIHYDROXY-9,10-EPOXY-, trans-; 4-oxahexacyclo[11.6.2.0^{2,8.0^{3,5.0^{10,20.0^{17,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-6,7-diol",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C20H14O3",
            "molecular_weight": "302.3",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "41322",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0151",
            "name": "Diepoxybutane",
            "synonyms": "2,2'-Bioxirane; Diepoxybutane; 1,3-Butadiene diepoxide; 1464-53-5; Butadiene diepoxide; Dioxybutadiene; Butadiene dioxide; Bioxirane; Butane diepoxide; 1,2:3,4-DIEPOXYBUTANE; Bioxiran; 1,2,3,4-Diepoxybutane; Butadiendioxyd; 1,2:3,4-Butadiene diepoxide; Butane, 1,2:3,4-diepoxy-; D,L-Diepoxybutane; RCRA waste number U085; 1,1'-Bi(ethylene oxide); 1,1'-Bi[ethylene oxide]; Butadiendioxyd [German]; CB 1181; NSC 629; Threitol, 1,2:3,4-dianhydro-; R 181; ENT-26592; CCRIS 234; M 8838; D,L-1,2:3,4-Diepoxybutane; HSDB 4046; EINECS 215-979-1; RCRA waste no. U085; BRN 0079833; 1,2,3,4-Diepoxybutane DL; AI3-26592; CHEBI:23704; ZFIVKAOQEXOYFY-UHFFFAOYSA-N; Diepoxybutane, dl-; dl-Butadiene dioxide; UNII-60OB65YNAB; 2-(oxiran-2-yl)oxirane; J-503880; J-640017; CCRIS 2782; 1,2:3,4-Dianhydro-DL-threitol; (+-)-1,2:3,4-Diepoxybutane; EINECS 206-060-6; 2,2'-Bioxirane, (2R,2'R)-rel-; Butane, (+-)-1,2:3,4-diepoxy-; (R*,R*)-(+-)-2,2'-Bioxirane; Butane,2:3,4-diepoxy-; meso-1,2,3,4-Diepoxybutane; CCRIS 5879; WLN: T3OTJ B- BT3OTJ; Erythritol, 1,2:3,4-dianhydro-; Butane, meso-1,2:3,4-diepoxy-; NSC 32607; Butane, 1,2:3,4-diepoxy-, meso-; 2,2'-Bioxirane, (2R,2'S)-rel-; BRN 0079832; 1,4-Diepoxybutane; 2,4-Diepoxybutane; 2,2'-Bioxirane, (theta,theta)-(+/-)-; 2,2'-Bioxirane, (R*,R*)-(.+/-.)-; 1,3,4-Diepoxybutane; 1,2:3,4-dianhydrothreitol; Threitol,2:3,4-dianhydro-; 5-19-01-00185 (Beilstein Handbook Reference); NSC629; CHEMBL1964283; DTXSID0041307; 1,3-Butadiene diepoxide, 97%; CTK0H5398; ZFIVKAOQEXOYFY-UHFFFAOYSA-; NSC-629; 2,2'-Bioxirane, (R*,S*)-; 5-(DimEtNmEt)furfuryl alcohol HCl; 1,2:3,4-Diepoxybutane, (DL)-; MFCD00005120; AKOS017342854; FCH1118637; LS-1144; VA10447; KS-0000124K; CC-25276; LS-45689; LS-45691; NCI60_009412; 1,3-Butadiene diepoxide, analytical standard; B0234; D3410; FT-0606590; 1,3-Butadiene diepoxide, 98+%, AcroSeal(R); Butane, 1,2:3,4-diepoxy-, (.+/-.)-; C-00085; J-800012; Q5274970; ERYTHRITHOL ANHYDRIDE (OLD NAME); 1,3-BUTADIENE DIEPOXIDE; InChI=1/C4H6O2/c1-3(5-1)4-2-6-4/h3-4H,1-2H2; 1,2,3,4-DIEPOXYBUTANE DL ( (SEE ALSO: 1,2,3,4-DIEPOXYBUTANE, CAS 564-00-1))",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C4H6O2",
            "molecular_weight": "86.09",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "11254",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0152",
            "name": "Cadmium",
            "synonyms": "Cadmium; 7440-43-9; Cadmium compounds; Kadmium; Colloidal cadmium; Cadmium, elemental; Kadmium [German]; UNII-00BH33GNGH; CCRIS 112; HSDB 282; Cd; EINECS 231-152-8; MFCD00010914; 00BH33GNGH; C I 77180; C.I. 77180; Cadmium [Cadmium and cadmium compounds]; Cadmium [Cadmium and certain cadmium compounds]; cadmio; Cadmium, Reference Standard Solution; Cadmium, mass of 135; CD135; Cadmium, p.a.; Cadmium powder 325 mesh; 48Cd; Cadmium, >=99.9%; EC 231-152-8; Cadmium powder - 100mesh; Cadmium, thermovacuum aerosol; Aerosol of thermovacuum cadmium; DTXSID1023940; NIOSH/EV3380000; CHEBI:22977; CTK2H7447; BDOSMKKIYDKNTQ-UHFFFAOYSA-N; 8234AF; AKOS015902734; LS-1639; RTR-024044; KS-0000117H; TRA-0188395; 81271-94-5; LS-48525; Cadmium, granular, >=99%, 5-20 mesh; Cadmium, granular, 30-80 mesh, >=99%; Cadmium, purum p.a., for filling reductors; TR-024044; Cadmium rod, 8mm (0.3in) dia, Puratronic; EV33800000; Q1091; C01413; Cadmium, rod, 25mm, diameter 40mm, 99.9%; Cadmium, rod, 50mm, diameter 40mm, 99.9%; Cadmium, rod, 100mm, diameter 40mm, 99.9%; Cadmium wire, 0.64mm (0.025in) dia, Puratronic; Cadmium, rod, 50mm, diameter 10.0mm, 99.999%; Cadmium, shot, 3 mm, 99.999% trace metals basis; Cadmium foil, 0.025mm (0.001in) thick, Puratronic; Cadmium, rod, 100mm, diameter 10.0mm, 99.999%; Cadmium, rod, 200mm, diameter 10.0mm, 99.999%; Cadmium, foil, 4mm disks, thickness 0.01mm, 99.7+%; Cadmium, foil, 6mm disks, thickness 0.01mm, 99.7+%; Cadmium, foil, 8mm disks, thickness 0.01mm, 99.7+%; Cadmium, powder, -100 mesh, 99.5% trace metals basis; Cadmium, foil, 10mm disks, thickness 0.005mm, 99.7+%; Cadmium, foil, 10mm disks, thickness 0.015mm, 99.7+%; Cadmium, foil, 10mm disks, thickness 0.01mm, 99.7+%; Cadmium, foil, 10mm disks, thickness 0.025mm, 99.7+%; Cadmium, foil, 15mm disks, thickness 0.005mm, 99.7+%; Cadmium, foil, 15mm disks, thickness 0.015mm, 99.7+%; Cadmium, foil, 15mm disks, thickness 0.01mm, 99.7+%; Cadmium, foil, 15mm disks, thickness 0.025mm, 99.7+%; Cadmium, foil, 4mm disks, thickness 0.005mm, 99.7+%; Cadmium, foil, 4mm disks, thickness 0.015mm, 99.7+%; Cadmium, foil, 4mm disks, thickness 0.025mm, 99.7+%; Cadmium, foil, 6mm disks, thickness 0.005mm, 99.7+%; Cadmium, foil, 6mm disks, thickness 0.015mm, 99.7+%; Cadmium, foil, 6mm disks, thickness 0.025mm, 99.7+%; Cadmium, foil, 8mm disks, thickness 0.005mm, 99.7+%; Cadmium, foil, 8mm disks, thickness 0.015mm, 99.7+%; Cadmium, foil, 8mm disks, thickness 0.025mm, 99.7+%; Cadmium, rod, diam. 4.0 mm, 99.999% trace metals basis; Cadmium, wire reel, 1m, diameter 0.5mm, hard, 99.95+%; Cadmium, wire reel, 1m, diameter 0.5mm, hard, 99.99+%; Cadmium, wire reel, 1m, diameter 1.0mm, hard, 99.999%; Cadmium, wire reel, 2m, diameter 0.5mm, hard, 99.95+%; Cadmium, wire reel, 2m, diameter 0.5mm, hard, 99.99+%; Cadmium, wire reel, 5m, diameter 0.5mm, hard, 99.95+%; Cadmium, wire reel, 5m, diameter 0.5mm, hard, 99.99+%; Cadmium, foil, 0.5m coil, thickness 0.5mm, as rolled, 100%; Cadmium, foil, 10mm disks, thickness 1.0mm, as rolled, 100%; Cadmium, foil, 15mm disks, thickness 1.0mm, as rolled, 100%; Cadmium, foil, 1m coil, thickness 0.5mm, as rolled, 100%; Cadmium, foil, 25mm disks, thickness 1.0mm, as rolled, 100%; Cadmium, foil, 2m coil, thickness 0.5mm, as rolled, 100%; Cadmium, foil, 4mm disks, thickness 1.0mm, as rolled, 100%; Cadmium, foil, 50mm disks, thickness 1.0mm, as rolled, 100%; Cadmium, foil, 50x50mm, thickness 3.0mm, as rolled, 99.9%; Cadmium, foil, 6mm disks, thickness 1.0mm, as rolled, 100%; Cadmium, foil, 8mm disks, thickness 1.0mm, as rolled, 100%; Cadmium, purum p.a., for metal reduction, 99.99%, granular; Cadmium, rod, 1000mm, diameter 5.0mm, as drawn, 99.99+%; Cadmium, rod, 100mm, diameter 5.0mm, as drawn, 99.99+%; Cadmium, rod, 150mm, diameter 10.0mm, as drawn, 99.99+%; Cadmium, rod, 200mm, diameter 5.0mm, as drawn, 99.99+%; Cadmium, rod, 300mm, diameter 10.0mm, as drawn, 99.99+%; Cadmium, rod, 500mm, diameter 5.0mm, as drawn, 99.99+%; Cadmium, wire reel, 0.1m, diameter 0.25mm, hard, 99.99+%; Cadmium, wire reel, 0.1m, diameter 0.5mm, hard, 99.95+%; Cadmium, wire reel, 0.1m, diameter 0.5mm, hard, 99.99+%; Cadmium, wire reel, 0.1m, diameter 1.0mm, hard, 99.999%; Cadmium, wire reel, 0.1m, diameter 2.0mm, hard, 99.99+%; Cadmium, wire reel, 0.2m, diameter 0.25mm, hard, 99.99+%; Cadmium, wire reel, 0.2m, diameter 0.5mm, hard, 99.95+%; Cadmium, wire reel, 0.2m, diameter 0.5mm, hard, 99.99+%; Cadmium, wire reel, 0.2m, diameter 1.0mm, hard, 99.999%; Cadmium, wire reel, 0.2m, diameter 2.0mm, hard, 99.99+%; Cadmium, wire reel, 0.5m, diameter 0.25mm, hard, 99.99+%; Cadmium, wire reel, 0.5m, diameter 0.5mm, hard, 99.95+%; Cadmium, wire reel, 0.5m, diameter 0.5mm, hard, 99.99+%; Cadmium, wire reel, 0.5m, diameter 1.0mm, hard, 99.999%; Cadmium, wire reel, 0.5m, diameter 2.0mm, hard, 99.99+%; Cadmium, wire reel, 10m, diameter 0.25mm, hard, 99.99+%; Cadmium, wire reel, 1m, diameter 0.125mm, as drawn, 99.9%; Cadmium, wire reel, 1m, diameter 0.25mm, hard, 99.99+%; Cadmium, wire reel, 1m, diameter 1.2mm, as drawn, 99.99+%; Cadmium, wire reel, 2m, diameter 0.125mm, as drawn, 99.9%; Cadmium, wire reel, 2m, diameter 1.2mm, as drawn, 99.99+%; Cadmium, wire reel, 5m, diameter 0.125mm, as drawn, 99.9%; Cadmium, wire reel, 5m, diameter 0.25mm, hard, 99.99+%; Cadmium, wire, diam. 1.0 mm, 99.999% trace metals basis; Cadmium, foil, 100x100mm, thickness 0.25mm, as rolled, 99.99%; Cadmium, foil, 100x100mm, thickness 0.5mm, as rolled, 99.95%; Cadmium, foil, 100x100mm, thickness 1.0mm, as rolled, 99.99%; Cadmium, foil, 100x100mm, thickness 2.0mm, as rolled, 99.99%; Cadmium, foil, 100x100mm, thickness 3.0mm, as rolled, 99.9%; Cadmium, foil, 10mm disks, thickness 0.05mm, as rolled, 99.99+%; Cadmium, foil, 10mm disks, thickness 0.125mm, as rolled, 99.95%; Cadmium, foil, 10mm disks, thickness 0.25mm, as rolled, 99.9%; Cadmium, foil, 10mm disks, thickness 0.25mm, as rolled, 99.95%; Cadmium, foil, 10mm disks, thickness 0.25mm, as rolled, 99.99+%; Cadmium, foil, 10mm disks, thickness 0.5mm, as rolled, 99.95%; Cadmium, foil, 10mm disks, thickness 1.0mm, as rolled, 99.95%; Cadmium, foil, 150x150mm, thickness 0.25mm, as rolled, 99.95%; Cadmium, foil, 150x150mm, thickness 0.5mm, as rolled, 99.99%; Cadmium, foil, 150x150mm, thickness 1.0mm, as rolled, 99.95%; Cadmium, foil, 150x150mm, thickness 3.0mm, as rolled, 99.9%; Cadmium, foil, 15mm disks, thickness 0.05mm, as rolled, 99.99+%; Cadmium, foil, 15mm disks, thickness 0.125mm, as rolled, 99.95%; Cadmium, foil, 15mm disks, thickness 0.25mm, as rolled, 99.9%; Cadmium, foil, 15mm disks, thickness 0.25mm, as rolled, 99.95%; Cadmium, foil, 15mm disks, thickness 0.25mm, as rolled, 99.99+%; Cadmium, foil, 15mm disks, thickness 0.5mm, as rolled, 99.95%; Cadmium, foil, 15mm disks, thickness 1.0mm, as rolled, 99.95%; Cadmium, foil, 195x200mm, thickness 1.0mm, as rolled, 99.95%; Cadmium, foil, 200x200mm, thickness 0.5mm, as rolled, 99.99%; Cadmium, foil, 200x200mm, thickness 1.0mm, as rolled, 99.99%; Cadmium, foil, 25mm disks, thickness 0.05mm, as rolled, 99.99+%; Cadmium, foil, 25mm disks, thickness 0.125mm, as rolled, 99.95%; Cadmium, foil, 25mm disks, thickness 0.25mm, as rolled, 99.9%; Cadmium, foil, 25mm disks, thickness 0.25mm, as rolled, 99.95%; Cadmium, foil, 25mm disks, thickness 0.25mm, as rolled, 99.99+%; Cadmium, foil, 25mm disks, thickness 0.5mm, as rolled, 99.95%; Cadmium, foil, 25mm disks, thickness 1.0mm, as rolled, 99.95%; Cadmium, foil, 25x25mm, thickness 0.125mm, as rolled, 99.99+%; Cadmium, foil, 25x25mm, thickness 0.25mm, as rolled, 99.9%; Cadmium, foil, 25x25mm, thickness 0.25mm, as rolled, 99.99+%; Cadmium, foil, 25x25mm, thickness 0.5mm, as rolled, 99.999%; Cadmium, foil, 25x25mm, thickness 1.0mm, as rolled, 99.999%; Cadmium, foil, 300x1000mm, thickness 2.0mm, as rolled, 99.99%; Cadmium, foil, 300x300mm, thickness 0.25mm, as rolled, 99.95%; Cadmium, foil, 300x300mm, thickness 0.5mm, as rolled, 99.99%; Cadmium, foil, 300x300mm, thickness 2.0mm, as rolled, 99.99%; Cadmium, foil, 30x100mm, thickness 0.5mm, as rolled, 99.999%; Cadmium, foil, 30x150mm, thickness 0.5mm, as rolled, 99.999%; Cadmium, foil, 30x50mm, thickness 0.5mm, as rolled, 99.999%; Cadmium, foil, 4mm disks, thickness 0.05mm, as rolled, 99.99+%; Cadmium, foil, 4mm disks, thickness 0.125mm, as rolled, 99.95%; Cadmium, foil, 4mm disks, thickness 0.125mm, as rolled, 99.99+%; Cadmium, foil, 4mm disks, thickness 0.25mm, as rolled, 99.9%; Cadmium, foil, 4mm disks, thickness 0.25mm, as rolled, 99.95%; Cadmium, foil, 4mm disks, thickness 0.25mm, as rolled, 99.99+%; Cadmium, foil, 4mm disks, thickness 0.5mm, as rolled, 99.95%; Cadmium, foil, 4mm disks, thickness 1.0mm, as rolled, 99.95%; Cadmium, foil, 50mm disks, thickness 0.05mm, as rolled, 99.99+%; Cadmium, foil, 50mm disks, thickness 0.125mm, as rolled, 99.95%; Cadmium, foil, 50mm disks, thickness 0.25mm, as rolled, 99.95%; Cadmium, foil, 50mm disks, thickness 0.5mm, as rolled, 99.95%; Cadmium, foil, 50x100mm, thickness 1.0mm, as rolled, 99.999%; Cadmium, foil, 50x200mm, thickness 1.0mm, as rolled, 99.999%; Cadmium, foil, 50x50mm, thickness 0.125mm, as rolled, 99.95%; Cadmium, foil, 50x50mm, thickness 0.125mm, as rolled, 99.99+%; Cadmium, foil, 50x50mm, thickness 0.25mm, as rolled, 99.9%; Cadmium, foil, 50x50mm, thickness 0.25mm, as rolled, 99.99+%; Cadmium, foil, 50x50mm, thickness 1.0mm, as rolled, 99.95%; Cadmium, foil, 50x50mm, thickness 1.0mm, as rolled, 99.999%; Cadmium, foil, 50x50mm, thickness 2.0mm, as rolled, 99.99%; Cadmium, foil, 6mm disks, thickness 0.05mm, as rolled, 99.99+%; Cadmium, foil, 6mm disks, thickness 0.125mm, as rolled, 99.95%; Cadmium, foil, 6mm disks, thickness 0.125mm, as rolled, 99.99+%; Cadmium, foil, 6mm disks, thickness 0.25mm, as rolled, 99.9%; Cadmium, foil, 6mm disks, thickness 0.25mm, as rolled, 99.95%; Cadmium, foil, 6mm disks, thickness 0.25mm, as rolled, 99.99+%; Cadmium, foil, 6mm disks, thickness 0.5mm, as rolled, 99.95%; Cadmium, foil, 6mm disks, thickness 1.0mm, as rolled, 99.95%; Cadmium, foil, 71x179mm, thickness 1.0mm, as rolled, 99.95%; Cadmium, foil, 75x100mm, thickness 0.5mm, as rolled, 99.99%; Cadmium, foil, 8mm disks, thickness 0.05mm, as rolled, 99.99+%; Cadmium, foil, 8mm disks, thickness 0.125mm, as rolled, 99.95%; Cadmium, foil, 8mm disks, thickness 0.125mm, as rolled, 99.99+%; Cadmium, foil, 8mm disks, thickness 0.25mm, as rolled, 99.9%; Cadmium, foil, 8mm disks, thickness 0.25mm, as rolled, 99.95%; Cadmium, foil, 8mm disks, thickness 0.25mm, as rolled, 99.99+%; Cadmium, foil, 8mm disks, thickness 0.5mm, as rolled, 99.95%; Cadmium, foil, 8mm disks, thickness 1.0mm, as rolled, 99.95%; Cadmium, foil, 95x100mm, thickness 0.5mm, as rolled, 99.99%; Cadmium, foil, light tested, 25x25mm, thickness 0.01mm, 99.7+%; Cadmium, foil, light tested, 50x50mm, thickness 0.01mm, 99.7+%; Cadmium, foil, thickness 0.5 mm, >=99.99% trace metals basis; Cadmium, lump, 5 mm max. lump size, weight 50 g, purity 99.99+%; Cadmium, stick, thickness 10 mm, >=99.999% trace metals basis; Cadmium, wire reel, 0.1m, diameter 0.125mm, as drawn, 99.9%; Cadmium, wire reel, 0.1m, diameter 0.70mm, as drawn, 99.99+%; Cadmium, wire reel, 0.1m, diameter 1.2mm, as drawn, 99.99+%; Cadmium, wire reel, 0.2m, diameter 0.125mm, as drawn, 99.9%; Cadmium, wire reel, 0.2m, diameter 0.70mm, as drawn, 99.99+%; Cadmium, wire reel, 0.2m, diameter 1.2mm, as drawn, 99.99+%; Cadmium, wire reel, 0.5m, diameter 0.125mm, as drawn, 99.9%; Cadmium, wire reel, 0.5m, diameter 0.70mm, as drawn, 99.99+%; Cadmium, wire reel, 0.5m, diameter 1.2mm, as drawn, 99.99+%; Cadmium, wire reel, 1m, diameter 0.70mm, as drawn, 99.99+%; Cadmium, wire reel, 2m, diameter 0.70mm, as drawn, 99.99+%; AQUANAL(TM)-plus cadmium (Cd) 0.02-1.2 mg/L, refill pack for 37432; Cadmium standard for IC, ready-to-use, traceable to BAM, in nitric acid; Cadmium, foil, 100x100mm, thickness 0.125mm, as rolled, 99.95%; Cadmium, foil, 100x100mm, thickness 0.125mm, as rolled, 99.99+%; Cadmium, foil, 100x100mm, thickness 0.25mm, as rolled, 99.99+%; Cadmium, foil, 100x200mm, thickness 0.125mm, as rolled, 99.95%; Cadmium, foil, 100x300mm, thickness 0.125mm, as rolled, 99.95%; Cadmium, foil, 10mm disks, thickness 0.125mm, as rolled, 99.99+%; Cadmium, foil, 15mm disks, thickness 0.125mm, as rolled, 99.99+%; Cadmium, foil, 25mm disks, thickness 0.125mm, as rolled, 99.99+%; Cadmium, foil, 50mm disks, thickness 0.125mm, as rolled, 99.99+%; Cadmium, foil, light tested, 100x100mm, thickness 0.015mm, 99.7+%; Cadmium, foil, light tested, 100x100mm, thickness 0.025mm, 99.7+%; Cadmium, foil, light tested, 25x25mm, thickness 0.005mm, 99.7+%; Cadmium, foil, light tested, 25x25mm, thickness 0.015mm, 99.7+%; Cadmium, foil, light tested, 25x25mm, thickness 0.025mm, 99.7+%; Cadmium, foil, light tested, 50x50mm, thickness 0.015mm, 99.7+%; Cadmium, foil, light tested, 50x50mm, thickness 0.025mm, 99.7+%; Cadmium, foil, not light tested, 100x100mm, thickness 0.005mm, 99.7+%; Cadmium, foil, not light tested, 100x100mm, thickness 0.015mm, 99.7+%; Cadmium, foil, not light tested, 100x100mm, thickness 0.01mm, 99.7+%; Cadmium, foil, not light tested, 100x100mm, thickness 0.025mm, 99.7+%; Cadmium, foil, not light tested, 25x25mm, thickness 0.001mm, 99.7+%; Cadmium, foil, not light tested, 25x25mm, thickness 0.002mm, 99.7+%; Cadmium, foil, not light tested, 25x25mm, thickness 0.005mm, 99.7+%; Cadmium, foil, not light tested, 25x25mm, thickness 0.015mm, 99.7+%; Cadmium, foil, not light tested, 25x25mm, thickness 0.01mm, 99.7+%; Cadmium, foil, not light tested, 25x25mm, thickness 0.025mm, 99.7+%; Cadmium, foil, not light tested, 50x50mm, thickness 0.002mm, 99.7+%; Cadmium, foil, not light tested, 50x50mm, thickness 0.005mm, 99.7+%; Cadmium, foil, not light tested, 50x50mm, thickness 0.015mm, 99.7+%; Cadmium, foil, not light tested, 50x50mm, thickness 0.01mm, 99.7+%; Cadmium, lump, 100 mm max. lump size, weight 100 g, purity 99.99%; Cadmium, lump, 100 mm max. lump size, weight 1000 g, purity 99.99%; Cadmium, lump, 100 mm max. lump size, weight 200 g, purity 99.99%; Cadmium, lump, 100 mm max. lump size, weight 500 g, purity 99.99%; Cadmium, lump, 5 mm max. lump size, weight 100 g, purity 99.99+%; Cadmium, lump, 5 mm max. lump size, weight 200 g, purity 99.99+%; AQUANAL(TM)-plus cadmium (Cd) 0.02-1.2 mg/L, test set with color comparator; Cadmium, foil, light tested, 100x100mm, thickness 0.05mm, as rolled, 99.99+%; Cadmium, foil, light tested, 25x25mm, thickness 0.05mm, as rolled, 99.99+%; Cadmium, foil, light tested, 50x50mm, thickness 0.05mm, as rolled, 99.99+%; Cadmium, powder, max. particle size 60 micron, weight 100 g, purity 99.9%; Cadmium, powder, max. particle size 60 micron, weight 1000 g, purity 99.9%; Cadmium, powder, max. particle size 60 micron, weight 200 g, purity 99.9%; Cadmium, powder, max. particle size 60 micron, weight 500 g, purity 99.9%; 72172-64-6; AQUANAL(TM)-plus cadmium (Cd) 0.02-1.2 mg/L, check solution for 37432 (calibrated standard (Cd = 0.015 mg/mL)); Cadmium single crystal, 15mm (0.59in) dia, 50mm (2.0in) long, (111) orientation, +/-2 degrees; Cadmium standard solution, suitable for atomic absorption spectrometry, 1 mg/mL Cd+2, 1000 ppm Cd+2; Cadmium, tube, 1000mm, outside diameter 2.29mm, inside diameter 1.27mm, wall thickness 0.51mm, 99.95+%; Cadmium, tube, 100mm, outside diameter 2.29mm, inside diameter 1.27mm, wall thickness 0.51mm, 99.95+%; Cadmium, tube, 200mm, outside diameter 2.29mm, inside diameter 1.27mm, wall thickness 0.51mm, 99.95+%; Cadmium, tube, 500mm, outside diameter 2.29mm, inside diameter 1.27mm, wall thickness 0.51mm, 99.95+%",
            "trade_name": "",
            "abbrev_name": "Cd",
            "description": "chemical element; stable metal",
            "molecular_formula": "Cd",
            "molecular_weight": "112.41",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "23973",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [
                "F01",
                "F0201",
                "F020403",
                "F0308",
                "F05",
                "F0701"
            ],
            "references": [
                "RC03706",
                "RC03930",
                "RC03931",
                "RC03932",
                "RC05058",
                "RC05059",
                "RC05060",
                "RC05061"
            ]
        },
        {
            "compound_ID": "D0153",
            "name": "Tebufenpyrad",
            "synonyms": "Tebufenpyrad; 119168-77-3; Pyranica; Comanche; MK239; Tebufenpyrad [ISO]; UNII-IRU3P7ZB3F; MK 239; N-(4-(tert-Butyl)benzyl)-4-chloro-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide; AC 801757; HSDB 7271; 4-Chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide; IRU3P7ZB3F; N-(4-t-Butylbenzyl)-4-chloro-3-ethyl-1-methylpyrazole-5-carboxamide; 1H-Pyrazole-5-carboxamide, 4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-; CHEBI:9422; ZZYSLNWGKKDOML-UHFFFAOYSA-N; N-(4-tert-butylbenzyl)-4-chloro-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide; N-[(4-tert-butylphenyl)methyl]-4-chloro-5-ethyl-2-methylpyrazole-3-carboxamide; 1H-Pyrazole-5-carboxamide, 4-chloro-N-[[4-(1,1-dimethylethyl)phenyl]methyl]-3-ethyl-1-methyl-; DSSTox_CID_14223; DSSTox_RID_79126; DSSTox_GSID_34223; SCHEMBL26848; CHEMBL1897070; DTXSID0034223; ZZYSLNWGKKDOML-UHFFFAOYSA-; ZINC967721; Tox21_301038; AKOS015895772; NCGC00168338-01; NCGC00168338-02; NCGC00254940-01; AS-12374; Tebufenpyrad 10 microg/mL in Cyclohexane; Tebufenpyrad 10 microg/mL in Acetonitrile; Tebufenpyrad 100 microg/mL in Cyclohexane; AB0011825; AX8152491; LS-128147; TR-022882; TR-022926; CAS-119168-77-3; FT-0603186; C11126; K-1355; Tebufenpyrad, PESTANAL(R), analytical standard; 168T773; A804212; Q285594; N-(p-tert-butylbenzyl)-4-chloro-3-ethyl-1-methylpyrazole-5-carboxamide; N-[(4-tert-butylphenyl)methyl]-4-chloranyl-5-ethyl-2-methyl-pyrazole-3-carboxamide; N-[(4-tert-butylphenyl)methyl]-4-chloro-5-ethyl-2-methyl-3-pyrazolecarboxamide; InChI=1/C18H24ClN3O/c1-6-14-15(19)16(22(5)21-14)17(23)20-11-12-7-9-13(10-8-12)18(2,3)4/h7-10H,6,11H2,1-5H3,(H,20,23); Pesticide4_Tebufenpyrad_C18H24ClN3O_1H-Pyrazole-5-carboxamide, 4-chloro-N-[[4-(1,1-dimethylethyl)phenyl]methyl]-3-ethyl-1-methyl-",
            "trade_name": "",
            "abbrev_name": "",
            "description": "insecticide and acaricide",
            "molecular_formula": "C18H24ClN3O",
            "molecular_weight": "333.9",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "86354",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [
                "T001"
            ],
            "function": [
                "F020103",
                "F020403"
            ],
            "references": [
                "RC01379",
                "RC04958"
            ]
        },
        {
            "compound_ID": "D0154",
            "name": "Carbon Monoxide",
            "synonyms": "carbon monoxide; carbon monooxide; Carbonic oxide; carbon(II) oxide; 630-08-0; Carbon oxide (CO); Exhaust gas; Flue gas; Kohlenoxyd [German]; Koolmonoxyde [Dutch]; Kohlenmonoxid [German]; Wegla tlenek [Polish]; Oxyde de carbone [French]; Carbone (oxyde de) [French]; UNII-7U1EE4V452; HSDB 903; Carbonio (ossido di) [Italian]; Carbon monoxide [USAN]; EINECS 211-128-3; NA9202; UN1016; [CO]; CHEBI:17245; 7U1EE4V452; Carbon monoxide 10% by volume or more; Carbon monoxide (USAN); monoxide; C#O; .carbon monoxide; Carboneum oxygenisatum; ACMC-1B3LA; Carbon monoxide, compressed; EC 211-128-3; CHEMBL1231840; DTXSID5027273; CTK0I2914; c0369; DB11588; LS-52213; LS-187194; TC-167536; Q2025; C00237; D09706; Carbon monoxide, compressed [UN1016] [Poison gas]; Carbon monoxide, compressed [UN1016] [Poison gas]; Carbon monoxide, refrigerated liquid (cryogenic liquid); Carbon monoxide, refrigerated liquid (cryogenic liquid) [NA9202] [Poison gas]; Carbon monoxide, refrigerated liquid (cryogenic liquid) [NA9202] [Poison gas]",
            "trade_name": "",
            "abbrev_name": "CO",
            "description": "colorless, odorless, and tasteless flammable gas",
            "molecular_formula": "CO",
            "molecular_weight": "28.01",
            "state": "gas",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "Binds with very high affinity to hemoglobin in humans [L2549].",
            "half_life": "\nThe half-life of carbon monoxide at room air temperature is 3-4 hours. 100% oxygen reduces the half-life to 30-90 minutes; hyperbaric oxygen at 2.5 atm (atmosphere units) with 100% oxygen reduces it to 15-23 minutes [L2552].",
            "absorption": "Although CO is not one of the respiratory gases, the similarity of physico-chemical properties of CO and oxygen (O2) permits an extension of the findings of studies on the kinetics of transport of O2 to those of CO. The rate of formation and elimination of COHb, its concentration in blood, and its catabolism is controlled by numerous physical factors and physiological mechanisms [L2546]. \n\nThe absorption of carbon monoxide from the consumption treated food products is not significant. Risk of CO toxicity from the packaging process or from consumption of CO-treated meats is negligible [A32745].",
            "cid": "281",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T005",
                "T016"
            ],
            "function": [
                "F020103"
            ],
            "references": [
                "RC01164",
                "RC03716"
            ]
        },
        {
            "compound_ID": "D0155",
            "name": "Leucinostatin",
            "synonyms": "Paecilotoxin; LEUCINOSTATIN; Antibiotic A 20668; A 20668 (antibiotic); 39405-64-6; LS-87870",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C58H102N10O13",
            "molecular_weight": "1147.5",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "6450280",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [
                "T019"
            ],
            "function": [
                "F020103"
            ],
            "references": [
                "RC01417",
                "RC01418",
                "RC01419"
            ]
        },
        {
            "compound_ID": "D0156",
            "name": "CCCP",
            "synonyms": "cccp; 555-60-2; Carbonyl cyanide 3-chlorophenylhydrazone; Carbonyl cyanide m-chlorophenylhydrazone; (3-Chlorophenyl)hydrazonomalononitrile; Carbonylcyanide-3-chlorophenylhydrazone; Carbonyl cyanide m-chlorophenyl hydrazone; [(3-chlorophenyl)hydrazono]malononitrile; m-Chlorophenyl carbonylcyanide hydrazone; (3-Chlorophenyl)carbonohydrazonoyl dicyanide; NSC 88124; Propanedinitrile, [(3-chlorophenyl)hydrazono]-; CHEBI:3259; Carbonyl cyanide, (3-chlorophenyl)hydrazone; EINECS 209-103-7; C9H5ClN4; Carbonyl cyanide Chlorophenylhydrazone; Propanedinitrile, ((3-chlorophenyl)hydrazono)-; Carbonylcyanide-m-chlorophenylhydrazone; Mesoxalonitrile 3-chlorophenylhydrazone; Carbonyl cyanide-m-chlorophenylhydrazone; BRN 1842102; Mesoxalonitrile, (m-chlorophenyl)hydrazone; ((3-Chlorophenyl)hydrazono)propanedinitrile; UGTJLJZQQFGTJD-UHFFFAOYSA-N; 2-[(3-Chlorophenyl)hydrazinylidene]propanedinitrile; MFCD00001848; Carbonylcyanide m-chlorophenylhydrazone; ((3-Chlorophenyl)hydrazono)malononitrile; Carbonyl cyanide, 3-chlorophenylhydrazone; Carbonyl cyanide (m-chlorophenyl)hydrazone; [(3-chlorophenyl)hydrazono]propanedinitrile; 2-[(3-chlorophenyl)-hydrazono]malononitrile; Buttpark 91\\04-41; N'-(3-chlorophenyl)carbonohydrazonoyl dicyanide; Propanedinitrile, 2-[2-(3-chlorophenyl)hydrazinylidene]-; Carbonyl cyanide 3-chlorophenylhydrazone, 98%; m-Cl-CCP; Propanedinitrile, 2-(2-(3-chlorophenyl)hydrazinylidene)-; ACMC-1ATQC; MolMap_000008; WLN: NCYCN&NUNR CG; WLN: NCYCN&UNMR CG; DSSTox_CID_20990; DSSTox_RID_79610; DSSTox_GSID_40990; SCHEMBL379195; CHEMBL224214; DTXSID7040990; CTK7C4864; UGTJLJZQQFGTJD-UHFFFAOYSA-; HMS3266A14; ZINC161387; NSC88124; Tox21_302066; BDBM50198893; BS0046; NSC-88124; SBB003506; AKOS003238387; CS-7660; FCH1316788; MCULE-3322388801; OR51909; KS-0000180Y; NCGC00092273-01; NCGC00092273-02; NCGC00255699-01; AK324695; CAS-555-60-2; LS-52241; 2-[(3-Chlorophenyl)hydrazono]malononitrile; HY-100941; TC-167534; (3-Chlorophenyl);carbonohydrazonoyl dicyanide; B5003; FT-0623480; 2-[(3-Chlorophenyl)hydrazono]malononitrile #; 2-[(3-chlorophenyl)hydrazono]propanedinitrile; C11164; Mesoxalonitrile, (m-chlorophenyl)hydrazone (8CI); [2-(3-chlorophenyl)hydrazinylidene]propanedinitrile; Q2720515; BRD-K15616905-001-01-5; N-(3-chlorophenyl)-1-cyanomethanecarbohydrazonoyl cyanide; Carbonyl cyanide 3-chlorophenylhydrazone, >=97% (TLC), powder; {[(3-chlorophenyl)amino]azamethylene}methane-1,1-dicarbonitrile; InChI=1/C9H5ClN4/c10-7-2-1-3-8(4-7)13-14-9(5-11)6-12/h1-4,13H",
            "trade_name": "",
            "abbrev_name": "CCCP; m-Cl-CCP",
            "description": "inhibitor of oxidative phosphorylation; nitrile; hydrazone; protonophore; uncoupler;",
            "molecular_formula": "C9H5ClN4",
            "molecular_weight": "204.61",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "2603",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [
                "T001"
            ],
            "function": [
                "F0105",
                "F0108",
                "F020103",
                "F020403",
                "F0308",
                "F030801",
                "F0401"
            ],
            "references": [
                "RC00910",
                "RC00964",
                "RC01404",
                "RC01841",
                "RC02462",
                "RC03083",
                "RC03594",
                "RC03596",
                "RC03711",
                "RC03722",
                "RC04919"
            ]
        },
        {
            "compound_ID": "D0157",
            "name": "Chlorpyrifos",
            "synonyms": "chlorpyrifos; 2921-88-2; Chlorpyriphos; Dursban; Lorsban; Trichlorpyrphos; Brodan; Chlorpyrifos-ethyl; Piridane; Coroban; Equity; Lentrek; Pyrinex; Stipend; Lock-On; Killmaster; Bonidel; Danusban; Geodinfos; Spannit; Tafaban; Dowco 179; Durmet; Radar; Terial; Zidil; Suscon blue; Suscon green; suSCon; Dursban F; Dursban R; Dursban 4E; Chlorpyriphos-ethyl; Ethyl chlorpyriphos; Dursban 10CR; Chlorpyrifos (Dursban); Phosphorothioic acid, O,O-diethyl O-(3,5,6-trichloro-2-pyridinyl) ester; Detmol U.A.; Chloropyrifos; Clorpyrifos; Dhanusban; Grofo; Detmol ua; Chlorpyrifos ethyl; Radar (fungicide); Dursban 44; Lorsban 50SL; Empire 20; Terial 40L; Chlorpyrifos [BAN]; Chloropyriphos; Chlorpyrofos; Chlorpyrophos; Pageant; Silrifos; Caswell No. 219AA; m-Chlorpyrifos; XRM 429; O,O-Diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate; C9H11Cl3NO3PS; OMS-0971; XRM 5160; Dursban 2E; Chlorpyriphos [ISO-French]; UNII-JCS58I644W; ENT 27311; CCRIS 7144; HSDB 389; Chlorpyrifos [ANSI:BSI:ISO]; EINECS 220-864-4; O,O-Diethyl O-(3,5,6-trichloro-2-pyridinyl)phosphorothioate; EPA Pesticide Chemical Code 059101; BRN 1545756; Phosphorothioic acid, O,O-diethyl O-(3,5,6-trichloro-2-pyridyl) ester; AI3-27311; MLS001065609; JCS58I644W; O,O-Diaethyl-O-3,5,6-trichlor-2-pyridylmonothiophosphat; O,O-diethyl O-(3,5,6-trichloropyridin-2-yl) thiophosphate; CHEBI:34631; SBPBAQFWLVIOKP-UHFFFAOYSA-N; diethoxy-sulfanylidene-(3,5,6-trichloropyridin-2-yl)oxyphosphorane; 2-Pyridinol, 3,5,6-trichloro-, O-ester with O,O-diethyl phosphorothioate; Chlorpyrifos (BAN); O,O-Diethyl O-(3,5,6-trichloro-2-pyridyl) phsophorothioate; SMR000568474; DSSTox_CID_458; O,O-Diaethyl-O-3,5,6-trichlor-2-pyridylmonothiophosphat [German]; DSSTox_RID_75603; DSSTox_GSID_20458; o,o-Diethyl-o-(3,5,6-trichloro-2-pyridyl)phosphorothioate; O,O-Diethyl O-(3,5,6-Trichloro-2-pyridyl) phosphorothioate; O,O-Diethyl-O-(3,5,6-trichloro-2-pyridyl)phosphorothiolate; O,O-diethyl O-(3,5,6-trichloropyridin-2-yl) phosphorothioate; diethoxy-sulfanylidene-[(3,5,6-trichloro-2-pyridinyl)oxy]phosphorane; CAS-2921-88-2; pridane; Chlorpyritos; Warhawk; Bolton; Detmol; Tricel; Nufos; diethoxy-sulfanylidene-(3,5,6-trichloropyridin-2-yl)oxy-?^{5}-phosphane; detmol u. a; Detmol U.A; Zodiac (TN); Spectrum_001897; SpecPlus_000518; Spectrum2_001230; Spectrum3_000849; Spectrum4_000689; Spectrum5_002014; C7H7Cl3NO3PS; cid_2730; Dursban, analytical standard; BIDD:PXR0044; SCHEMBL21680; BSPBio_002437; KBioGR_001157; KBioSS_002427; SPECTRUM330058; DivK1c_006614; SPBio_001080; CHEMBL463210; DTXSID4020458; BDBM74063; CTK8E8187; KBio1_001558; KBio2_002421; KBio2_004989; KBio2_007557; KBio3_001937; SBPBAQFWLVIOKP-UHFFFAOYSA-; OMS 971; HMS3039C03; HMS3264O03; Pharmakon1600-00330058; ZINC608250; Tox21_202383; Tox21_300148; AC-993; CCG-39144; NSC755891; AKOS015891656; Phosphorothioic acid O,O-diethyl O-(3,5,6-trichloro-2-pyridinyl) ester; Chlorpyrifos 100 microg/mL in Acetone; ENT 27,311; KS-5372; LS-1137; NSC-755891; Chlorpyrifos 1000 microg/mL in Toluene; NCGC00091472-01; NCGC00091472-02; NCGC00091472-03; NCGC00091472-04; NCGC00091472-05; NCGC00091472-06; NCGC00091472-07; NCGC00091472-08; NCGC00091472-09; NCGC00253974-01; NCGC00259932-01; CC-25729; Chlorpyrifos 10 microg/mL in Cyclohexane; O799; SC-47023; Chlorpyrifos 100 microg/mL in Cyclohexane; SBI-0052543.P002; Chlorpyrifos 100 microg/mL in Acetonitrile; TR-036379; FT-0602970; C14322; D07688; M-1133; 26848-EP2274983A1; 26848-EP2275422A1; 26848-EP2280002A1; 26848-EP2280009A1; 26848-EP2292608A1; 26848-EP2305662A1; 26848-EP2308857A1; 26848-EP2308858A1; 26848-EP2311816A1; 26848-EP2311817A1; 26848-EP2314583A1; 88579-EP2298076A1; 88579-EP2298077A1; 88579-EP2301353A1; 88579-EP2305031A1; 88579-EP2305034A1; 88579-EP2305035A1; 88579-EP2305662A1; AB00053051_06; Chlorpyrifos, PESTANAL(R), analytical standard; 921C882; A819822; C-20634; Q414915; SR-01000854727; J-017440; SR-01000854727-2; BRD-K08303368-001-02-7; BRD-K08303368-001-06-8; Chlorpyrifos, certified reference material, TraceCERT(R); Diethyl O-(3,5,6-trichloro-2-pyridyl) phosphorothioate; O,O-Diethyl O-3,5,6-trichloro-2-pyridylphosphorothioate; diethoxy-thioxo-[(3,5,6-trichloro-2-pyridyl)oxy]phosphorane; O,O-Diethyl o-(3,5,6-trichloro-2-pyridinyl) thiophosphate #; diethoxy-sulfanylidene-(3,5,6-trichloropyridin-2-yl)oxy--phosphane; ethyl 3,5,6-trichloropyridin-2-yl ethoxy(sulfanylidene)phosphonite; O,O-diethyl O-(3,5,6-trichloro-2-pyridinyl) phosphorothioic acid; O,O-DIETHYL O-3,5,6-TRICHLOROPYRIDIN-2-YL PHOSPHOROTHIOATE; diethoxy-sulfanylidene-[3,5,6-tris(chloranyl)pyridin-2-yl]oxy--phosphane; Chlorpyrifos solution, 100 mug/mL in acetonitrile, PESTANAL(R), analytical standard; diethoxy-sulfanylidene-[3,5,6-tris(chloranyl)pyridin-2-yl]oxy-$l^{5}-phosphane; Chlorpyrifos solution, certified reference material, TraceCERT(R), 1000 mug/mL in methyl tert-butyl ether, ampule of 1 mL; InChI=1/C9H11Cl3NO3PS/c1-3-14-17(18,15-4-2)16-9-7(11)5-6(10)8(12)13-9/h5H,3-4H2,1-2H3",
            "trade_name": "",
            "abbrev_name": "CPS",
            "description": "organophosphate pesticide; It acts on the nervous systems of insects by inhibiting the acetylcholinesterase enzyme.",
            "molecular_formula": "C9H11Cl3NO3PS",
            "molecular_weight": "350.6",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "2730",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [
                "T489"
            ],
            "function": [
                "F020603",
                "F0308",
                "F030804"
            ],
            "references": [
                "RC03646",
                "RC03647",
                "RC03709"
            ]
        },
        {
            "compound_ID": "D0159",
            "name": "phenanthrene",
            "synonyms": "PHENANTHRENE; 85-01-8; Phenanthren; Phenanthrin; Phenanthracene; Ravatite; Phenanthren [German]; Phenanthrene, pure; UNII-448J8E5BST; CCRIS 1233; HSDB 2166; EINECS 201-581-5; NSC 26256; CHEMBL46730; AI3-00790; 448J8E5BST; CHEBI:28851; YNPNZTXNASCQKK-UHFFFAOYSA-N; MFCD00001168; NSC-26256; Phenanthrene, 97%; Coal tar pitch volatiles: phenanthrene; Phenantrin; DSSTox_CID_4254; DSSTox_RID_77342; DSSTox_GSID_24254; CAS-85-01-8; PEY; Phenanthrenato; phenanthroline;; 9-Phenanthrene; phenanthrene-ring; Phenanthrene, 98%; ACMC-20ajxi; Phenanthrene-[U-13C]; 9,10-Dehydrophenanthrene; bmse000560; KSC146C5L; MLS002454437; WLN: L B666J; DTXSID6024254; HMS2268O22; ZINC967819; HY-B1727; KS-00000F9Y; NSC26256; Tox21_201638; Tox21_300573; BDBM50159266; SBB058516; STL453632; AKOS008967330; EBD2205101; LS-1845; MCULE-8033936622; RTR-037980; TRA0005896; TRA0047947; Phenanthrene 100 microg/mL in Methanol; Phenanthrene, zone-refined, >=99.5%; NCGC00091177-01; NCGC00091177-02; NCGC00091177-03; NCGC00091177-04; NCGC00254398-01; NCGC00259187-01; Phenanthrene, sublimed grade, >=99.5%; AC-11346; AK113960; AS-12847; Phenanthrene 10 microg/mL in Cyclohexane; SC-18157; SMR000112025; Phenanthrene 10 microg/mL in Acetonitrile; DB-043112; Phenanthrene 100 microg/mL in Acetonitrile; ST2413660; TR-037980; CS-0013733; FT-0631391; P0079; P0331; P1310; ST50827630; C11422; A841054; Q422037; W-104097; Phenanthrene, certified reference material, TraceCERT(R); Phenanthrene, purum, for fluorescence, >=97.0% (HPLC); UNII-0TNN3Q0D4D component YNPNZTXNASCQKK-UHFFFAOYSA-N; Phenanthrene, analytical standard, for environmental analysis; Phenanthrene solution, 100 mug/mL in cyclohexane, analytical standard; InChI=1/C14H10/c1-3-7-13-11(5-1)9-10-12-6-2-4-8-14(12)13/h1-10; Phenanthrene solution, certified reference material, 200 mug/mL in dichloromethane; Phenanthrene solution, certified reference material, 5000 mug/mL in methanol",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C14H10",
            "molecular_weight": "178.23",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "995",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F02010203",
                "F02010204",
                "F02010205",
                "F02010207"
            ],
            "references": [
                "RC01265",
                "RC01266",
                "RC01267",
                "RC01268",
                "RC01269",
                "RC01270"
            ]
        },
        {
            "compound_ID": "D0160",
            "name": "fluoranthene",
            "synonyms": "FLUORANTHENE; 206-44-0; Idryl; 1,2-Benzacenaphthene; Benzo(jk)fluorene; Benzo[jk]fluorene; RCRA waste number U120; 1,2-(1,8-Naphthylene)benzene; Benzene, 1,2-(1,8-naphthalenediyl)-; NSC 6803; 1,2-(1,8-Naphthalenediyl)benzene; Benzene, 1,2-(1,8-naphthylene)-; UNII-360UOL779Z; CCRIS 1034; Fluoranthene, 98%; HSDB 5486; EINECS 205-912-4; RCRA waste no. U120; CHEBI:33083; GVEPBJHOBDJJJI-UHFFFAOYSA-N; 360UOL779Z; DSSTox_CID_4104; DSSTox_RID_77290; DSSTox_GSID_24104; W-107604; Fluoranthene, analytical standard; Benzacenaphthylene; Benzo[j,k]fluorene; CAS-206-44-0; Fluoranthrene; Fluroanthene; ClusterCarbon; ACMC-1CBEU; 1,8-Naphthylene)benzene; KSC203I3F; MLS002177805; CHEMBL355014; DTXSID3024104; 1,2-(1,8-Naphthalene)benzene; Benzene,2-(1,8-naphthylene)-; CTK1A3432; NSC6803; HMS2268M14; NSC-6803; WLN: L C6566 1A PJ; ZINC8585874; Benzene,2-(1,8-naphthalenediyl)-; Tox21_201835; Tox21_300480; CCG-50891; STL570455; AKOS003617663; MCULE-8741992230; RTR-009648; TRA0118487; KS-00000V10; 1,2 - (1,8 - napthalenediyl)benzene; NCGC00090998-01; NCGC00090998-02; NCGC00090998-03; NCGC00090998-04; NCGC00254498-01; NCGC00259384-01; 76774-50-0; AS-39328; CC-28476; Fluoranthene 10 microg/mL in Cyclohexane; LS-69112; SB 00542; SC-47055; SMR000112026; Fluoranthene 10 microg/mL in Acetonitrile; Fluoranthene 100 microg/mL in Acetonitrile; TR-009648; 4CH-007323; F0016; FT-0626446; ST24030711; C19425; EN300-177281; A814763; C-34897; Fluoranthene, BCR(R) certified Reference Material; Q423462; SR-01000640231-1; F0074-0087; Fluoranthene, certified reference material, TraceCERT(R); 1D41162B-880B-494F-9960-6EEAC8E4EEE3; UNII-0TNN3Q0D4D component GVEPBJHOBDJJJI-UHFFFAOYSA-N; Fluoranthene solution, 5000 mug/mL in methanol, analytical standard; Fluoranthene solution, certified reference material, 200 mug/mL in methylene chloride; InChI=1/C16H10/c1-2-8-13-12(7-1)14-9-3-5-11-6-4-10-15(13)16(11)14/h1-10",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C16H10",
            "molecular_weight": "202.25",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "9154",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F02010203",
                "F02010204",
                "F02010205",
                "F02010207"
            ],
            "references": [
                "RC01271",
                "RC01272",
                "RC01273",
                "RC01274"
            ]
        },
        {
            "compound_ID": "D0161",
            "name": "Clofilium Tosylate",
            "synonyms": "Clofilium tosylate; 92953-10-1; UNII-13ZVF1051K; clofilium tosylateclofilium tosylate; N-(4-(4-Chlorophenyl)butyl)-N,N-diethylheptan-1-aminium 4-methylbenzenesulfonate; 13ZVF1051K; NCGC00017142-01; CAS-92953-10-1; DSSTox_CID_25601; DSSTox_RID_80994; DSSTox_GSID_45601; Benzenebutanaminium, 4-chloro-N,N-diethyl-N-heptyl-, salt with 4-methylbenzenesulfonicacid (1:1); A1-01947; MLS002154263; 4-Chloro-N,N-Diethyl-N-Heptyl-Benzenebutanaminiusaltwith4-Methylbenzenes; GNF-Pf-3889; SMR001233522; Prestwick_682; 4-Chloro-N,N-diethyl-N-heptylbenzenebutanaminium tosylate; ACMC-20ei9v; SCHEMBL467251; CHEMBL598270; DTXSID7045601; CTK8E7407; Clofilium tosylate, >97%, solid; HMS1568P20; HMS2095P20; HMS2234L09; HMS3374A08; HMS3712P20; BCP08356; CS-D0394; Tox21_110799; MFCD00069233; AKOS024257841; Tox21_110799_1; API0008443; CCG-220319; TRA0051317; NCGC00168464-04; AK325998; AS-30960; HY-33350; LS-29306; TX-017493; FT-0747981; C-54142; SR-01000838821; SR-01000838821-2; Q27251555",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C28H44ClNO3S",
            "molecular_weight": "510.2",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "175533",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0162",
            "name": "1,9-benz-10-anthrone",
            "synonyms": "BENZANTHRONE; 82-05-3; 7H-Benz[de]anthracen-7-one; Benzanthrenone; 7H-benzo[de]anthracen-7-one; MS-Benzanthrone; DYE, benzanthrone; Benzoanthrone; Mesobenzanthrone; 1,9-Benz-10-anthrone; benzo[a]phenalen-7-one; 7-Oxobenz[de]anthracene; 1,9-Benzanthrone; 7H-Benz(de)anthracen-7-one; 7-Oxobenz(de)anthracene; Naphthanthrone (VAN); 7H-Benz(de)anthracene-7-one; 7H-Benzo(de)anthracen-7-one; UNII-LP5P3RR8QN; NSC 5189; NSC 631641; CCRIS 3173; HSDB 5245; benz[de]anthracen-7-one; Benz(de)anthracen-7-one; EINECS 201-393-3; LP5P3RR8QN; HUKPVYBUJRAUAG-UHFFFAOYSA-N; NSC631641; 7H-Benz[de]anthracene-7-one; W-104190; 7-benzo[a]phenalenone; Spectrum2_000766; Spectrum3_001680; SCHEMBL23838; BSPBio_003499; MLS002207268; SPECTRUM1505272; SPBio_000812; ACMC-20977j; CHEMBL1607517; DTXSID8052566; CHEBI:93350; CTK3E8594; KBio3_002719; KS-00000UEF; NSC5189; NSC-5189; ZINC3860207; 7H-Benz[de]anthracen-7-one, 98%; ANW-13613; CCG-38994; MFCD00003585; SBB057877; STK662686; WLN: L C6666 1A Q IVJ; AKOS002319374; MCULE-6216392978; NSC-631641; NCGC00095343-01; NCGC00095343-02; NCGC00178030-01; AK317468; AS-56358; LS-27945; SMR001306791; ST028631; AB1003202; TR-025695; 7H-Benzo(de)anthracen-7-one (Benzanthrone); B0019; FT-0621414; A840240; Q2075398; BRD-K76872913-001-02-8; F0001-2103",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C17H10O",
            "molecular_weight": "230.26",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "6697",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F02010203",
                "F02010204",
                "F02010205"
            ],
            "references": [
                "RC01278",
                "RC01282",
                "RC01284"
            ]
        },
        {
            "compound_ID": "D0163",
            "name": "Cyanide",
            "synonyms": "cyanide; CYANIDE ION; Cyanide anion; Isocyanide; 57-12-5; Cyanide ions; Nitrile anion; Cyanure [French]; Cyanide(1-) ion; Cyanide(1-); Cyanide (anion); UNII-OXN4E7L11K; RCRA waste number P030; Cyanide (CN(sup 1-)); Carbon nitride ion (CN1-); Hydrocyanic acid, ion(1-)-; Carbon nitride ion (CN(sup 1-)); UN1935; RCRA waste no. P030; BRN 1900509; OXN4E7L11K; CN-; Cyanides (soluble salts and complexes) not otherwise specified; Cyanure; Cyanide, free; iminomethanide; isonitrile; Prussiate; Zyanid; Cyano; nitridocarbonate(1-); Cyanide with potassium salt; Cyanide solutions, n.o.s.; CHEMBL186374; DTXSID6023991; BDBM26984; CHEBI:17514; CTK1G9863; XFXPMWWXUTWYJX-UHFFFAOYSA-N; CN(-); CN(-1); VZ36346; NCGC00188964-01; LS-55777; C00177; Q185076; Cyanide solutions, n.o.s. [UN1935] [Poison, Keep away from food]; Cyanide solutions, n.o.s. [UN1935] [Poison, Keep away from food]",
            "trade_name": "",
            "abbrev_name": "",
            "description": "Classical respiratory inhibitors",
            "molecular_formula": "CN-",
            "molecular_weight": "26.017",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "5975",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [
                "T016"
            ],
            "function": [
                "F020103",
                "F020403"
            ],
            "references": [
                "RC01166",
                "RC04957"
            ]
        },
        {
            "compound_ID": "D0164",
            "name": "cycloheximide",
            "synonyms": "cycloheximide; 66-81-9; ACTIDIONE; Cicloheximide; NARAMYCIN A; Kaken; Actidion; Actidone; Hizarocin; Naramycin; Neocycloheximide; Acti-Aid; Actispray; Actidione PM; Cicloheximida; Cicloheximidum; Cycloheximid; Zykloheximid; Acti-Dione; Actidione BR; Actidione TGF; Aktidion [Czech]; NSC 185; Cycloheximide [USAN]; Caswell No. 270A; C15H23NO4; NSC-185; Acti-dione BR; 4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione; Cicloheximidum [INN-Latin]; Cicloheximida [INN-Spanish]; CCRIS 937; U-4527; CBC 500046; NSC185; HSDB 1552; TCMDC-125838; 3-((R)-2-((1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)glutarimide; EINECS 200-636-0; U 4527; UNII-98600C0908; Cycloheximide [BSI:ISO]; EPA Pesticide Chemical Code 043401; BRN 0088868; Aktidion; 4-[(2R)-2-[(1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione; AI3-15541; CHEMBL123292; TZA; CHEBI:27641; GNF-PF-5118; 3-(2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)glutarimide; 3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide; beta-(2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)glutarimide; 3-(2R)-2-((1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethylglutarimide; Cicloheximide (INN); Cicloheximide [INN]; Cycloheximide, 95%; (1S-(1alpha(S*),3alpha,5beta))-4-(2-(3,5-Dimethyl-2-oxo-cyclohexyl))-2-hydroxyethyl-2,6-piperidinedione; 2,6-Piperidinedione, 4-(2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)-, (1S-(1alpha(S*),3alpha,5beta))-; CX; Cycloheximide (USAN); DSSTox_CID_4882; 4-((2R)-2-((1S,3S,5S)-(3,5-Dimethyl-2-oxocyclohexyl))-2-hydroxyethyl)piperidine-2,6-dione; 4-((R)-2-((1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)piperidine-2,6-dione; DSSTox_RID_77565; Cyclohemimide; Cyclohexamide; DSSTox_GSID_24882; 98600C0908; .beta.-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide; 4-[2-(3,5-Dimethyl-2-oxo-cyclohexyl)-2-hydroxyethyl]-2,6-piperidinedione; 4-[(2R)-2-((1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]azaperhydro ine-2,6-dione; SMR000686067; Glutarimide, 3-(2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)-; SR-01000597484; SR-05000001596; Cycloheximide, High Purity; NM-MCD 80; Acti-dione PM; Acti-dione TGF; CAS-66-81-9; NCGC00024910-01; Prestwick_976; Spectrum_001344; FT 3422-2; Prestwick0_000790; Prestwick1_000790; Prestwick2_000790; Prestwick3_000790; Spectrum2_000900; Spectrum3_001510; Spectrum4_000914; Spectrum5_001635; cid_6197; SCHEMBL26617; BSPBio_000900; BSPBio_003159; KBioGR_001408; KBioSS_001824; 5-21-13-00434 (Beilstein Handbook Reference); ksc-8-190; MLS001055333; MLS002154001; DivK1c_000050; SPECTRUM1502112; SPBio_000720; SPBio_002839; 4-[2-(3,6-piperidinedione; BPBio1_000990; GTPL5433; 4-(2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)-2,6-piperidinedione; DTXSID6024882; HMS500C12; KBio1_000050; KBio2_001824; KBio2_004392; KBio2_006960; KBio3_002659; NINDS_000050; YPHMISFOHDHNIV-FSZOTQKASA-N; ZX-AFC000592; HMS1570M22; HMS1921L04; HMS2092D10; HMS2097M22; HMS3714M22; KUC105858N; Pharmakon1600-01502112; Cycloheximide, Streptomyces griseus; 2,6-Piperidinedione, 4-((2R)-2-((1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)-; ZINC3872170; Tox21_113580; Tox21_201158; Tox21_303652; BDBM50080528; BI2521; CCG-39902; Cycloheximide, >=93.0% (HPLC); MFCD00082346; NSC758187; SBB005972; AKOS024282670; Tox21_113580_1; CC-2256; CS-4985; LS-1558; NSC-758187; 4-[(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxo-cyclohexyl]-2-hydroxy-ethyl]piperidine-2,6-dione; IDI1_000050; NCGC00017363-05; NCGC00017363-06; NCGC00017363-07; NCGC00017363-08; NCGC00017363-10; NCGC00024910-02; NCGC00024910-03; NCGC00024910-04; NCGC00024910-05; NCGC00024910-06; NCGC00169964-05; NCGC00257430-01; NCGC00258710-01; AS-14624; BP-12396; CC-26065; HY-12320; L918; NCI60_001540; SC-19304; ST057527; SBI-0051732.P002; WLN: T6VMVTJ E1YQ- BL6VTJ D1 F1; Cycloheximide, from microbial, >=94% (TLC); C-9217; C06685; Cycloheximide solution, 0.1%, for microbiology; D03625; M01527; AB00052279_08; Cycloheximide, PESTANAL(R), analytical standard; 082C346; C-17728; Cycloheximide, Biotechnology Performance Certified; Q412895; Cycloheximide, Antibiotic for Culture Media Use Only; SR-01000597484-1; SR-01000597484-4; SR-05000001596-1; SR-05000001596-3; SR-05000001596-4; BRD-K36055864-001-05-1; BRD-K36055864-001-07-7; BRD-K36055864-001-09-3; BRD-K36055864-001-16-8; [1S-[1.alpha.(S*),3.alpha.,5.beta.]]-4-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-2,6-piperidinedione; 2, 4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-, [1S-[1.alpha.(S*),3.alpha.,5.beta.]]-; 4-[(2R)-2-[(1S,3S,5R)-3,5-dimethyl-2-oxo-cyclohexyl]-2-hydroxy-ethyl]piperidine-2,6-dione; Cycloheximide solution, Ready-Made Solution, microbial, 100 mg/mL in DMSO, 0.2 mum filtered",
            "trade_name": "",
            "abbrev_name": "CHX",
            "description": "fungicide; potent, reversible and specific inhibitor of eukaryotic cytosolic translation; direct binding to the ribosome, inhibiting eEF2-mediated translocation of the nascent protein; blocking eukaryotic translational elongation",
            "molecular_formula": "C15H23NO4",
            "molecular_weight": "281.35",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "6197",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F0702"
            ],
            "references": [
                "RC03666"
            ]
        },
        {
            "compound_ID": "D0165",
            "name": "Phenanthrenequinone",
            "synonyms": "Phenanthrene-9,10-dione; 9,10-Phenanthrenequinone; 84-11-7; Phenanthrenequinone; 9,10-PHENANTHRENEDIONE; 9,10-Phenanthraquinone; Phenanthraquinone; 9,10-Phenanthroquinone; 9-10 Phenanthrene quinone; UNII-42L7BZ8H74; CCRIS 7615; HSDB 4489; Phenanthrene, 9,10-dihydro-9,10-dioxo-; EINECS 201-515-5; MFCD00001163; NSC 10446; phenanthrene-9,10-quinone; BRN 0608838; SMR000150826; CHEMBL51931; AI3-23739; MLS000571180; MLS000881132; CHEBI:37454; YYVYAPXYZVYDHN-UHFFFAOYSA-N; 42L7BZ8H74; 9,10-dihydrophenanthrene-9,10-dione; AK-96664; Phenanthrenequinone, 95%; Q-201551; W-104124; WLN: L B666 HVVJ; Phenanthrene,10-dihydro-9,10-dioxo-; SR-01000512656; phenanthrenchinon; Phenanthroquinone; Phenanthrene chinone; 9,10-phenanthrquinone; Opera_ID_1159; Phenanthrene-9,10 dione; cid_6763; REGID_for_CID_6763; SCHEMBL43050; 4-07-00-02565 (Beilstein Handbook Reference); KSC908S3D; ACMC-20977q; DTXSID3058901; BDBM22857; CTK8A8931; NSC7389; 1,2-Dione-Based Compound, 14; 9,10-Phenanthrenequinone, 95%; HMS2231F24; KUC103886N; EBD42196; KS-00000F8Q; NSC-7389; NSC10446; ZINC1529614; 9,10-Phenanthrenequinone, >=99%; ANW-13620; CX1139; KSC-1-127; NSC-10446; SBB058783; STK793149; AKOS000120609; CS-W015223; MCULE-9308842057; RTR-026056; NCGC00246089-01; AS-14257; BP-13416; CC-23472; K501; OR322078; SC-17706; AX8105395; BC4124307; DB-005403; LS-102685; ST2413662; ST4022387; TR-026056; FT-0621602; P0080; P1136; 84P117; A-8615; C03243; A840718; AF-936/31262009; C-10589; SR-01000512656-1; SR-01000512656-4; Q25103737; Z56943754; 9,10-Phenanthrenequinone, Vetec(TM) reagent grade, 94%; 2-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)-N-[2-(2-thienyl)ethyl]acetamide",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C14H8O2",
            "molecular_weight": "208.21",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "6763",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F02010204",
                "F02010205"
            ],
            "references": [
                "RC01275",
                "RC01279"
            ]
        },
        {
            "compound_ID": "D0166",
            "name": "Decarbamoyl Mitomycin C",
            "synonyms": "Decarbamoylmitomycin C; 26909-37-5; 10-Decarbamoylmitomycin C; Decarbamylmitomycin C; DCMC; Decarbamoyl mitomycin C; 10-Decarbamoyl mitomycin C; CCRIS 5160; BRN 5608775; 6-Amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione; DCMMC; Azirino(2',3'-3,4)pyrrolo(1,2-alpha)indole-4,7-dione, 1,1a,2,8,8a,8b-hexahydro-6-amino-8-(hydroxymethyl)-8a-methoxy-5-methyl-, (1aR-(1a-alpha,8-beta,8a-alpha,8b-alpha))-; Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methyl-",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C14H17N3O4",
            "molecular_weight": "291.3",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "10424358",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0167",
            "name": "DEHP",
            "synonyms": "Bis(2-ethylhexyl) phthalate; 117-81-7; DEHP; Di(2-ethylhexyl) phthalate; Di(2-ethylhexyl)phthalate; Diethylhexyl phthalate; BIS(2-ETHYLHEXYL)PHTHALATE; Di-sec-octyl phthalate; Octyl phthalate; Fleximel; Octoil; Ethylhexyl phthalate; Palatinol AH; Celluflex DOP; Vestinol AH; Bisoflex DOP; Kodaflex DOP; Staflex DOP; Truflex DOP; 2-Ethylhexyl phthalate; Flexol DOP; Vinicizer 80; Bisoflex 81; Eviplast 80; Eviplast 81; Hercoflex 260; Etalon; RC plasticizer DOP; Compound 889; Witcizer 312; Platinol dop; Di-2-ethylhexyl phthalate; Nuoplaz dop; Platinol ah; Hatcol dop; Reomol dop; Pittsburgh PX-138; Sansocizer DOP; Ergoplast FDO; Monocizer DOP; Plasthall DOP; Flexol plasticizer DOP; Mollan O; Jayflex DOP; Sicol 150; Ergoplast FDO-S; Di(2-ethylhexyl)orthophthalate; Good-rite gp 264; Reomol D 79P; Sconamoll DOP; Diacizer DOP; Kodaflex DEHP; Di(ethylhexyl) phthalate; Bis(ethylhexyl) phthalate; Rcra waste number U028; Px-138; Phthalic acid dioctyl ester; NCI-C52733; Etalon (plasticizer); Di(2-ethylhexyl) o-phthalate; Sansocizer R 8000; Bis(2-ethylhexyl) benzene-1,2-dicarboxylate; Caswell No. 392K; 1,2-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester; Behp; Di-2-ethylhexylphthalate; DOF [Russian plasticizer]; Bis(2-ethylhexyl) 1,2-benzenedicarboxylate; DOP; Phthalic acid di(2-ethylhexyl) ester; CCRIS 237; Di-(2-ethylhexyl) phthalate; Bis(2-ethylhexyl) o-phthalate; Phthalic acid, bis(2-ethylhexyl) ester; Ethyl hexyl phthalate; HSDB 339; Di(2-ethylhexyl) orthophthalate; CHEBI:17747; 1,2-Benzenedicarboxylic acid bis(2-ethylhexyl) ester; EINECS 204-211-0; MFCD00009493; NSC 17069; RCRA waste no. U028; Union carbide flexol 380; EPA Pesticide Chemical Code 295200; Phthalic Acid Bis(2-ethylhexyl) Ester; BRN 1890696; Bis-(2-ethylhexyl)ester kyseliny ftalove; AI3-04273; DAF 68; 1,2-Benzenedicarboxylic acid, 1,2-bis(2-ethylhexyl) ester; DTXSID5020607; BJQHLKABXJIVAM-UHFFFAOYSA-N; Benzenedicarboxylic acid, bis(2-ethylhexyl) ester; Bis-(2-ethylhexyl)ester kyseliny ftalove [Czech]; NCGC00091499-05; 15495-94-0; BIS-(2-ETHYLHEXYL) PHTHALATE; Phthalic acid, bis-2-ethylhexyl ester; SMR000777878; Bis-(2-ethylhexyl)ester kyseliny ftalove (czech); 2-ethylhexyl 2-[(2-ethylhexyl)oxycarbonyl]benzoate; Diethylhexylphthalate (Bis-(2-ethylhexyl) Phthalate); Dioctylphthalate; ergoplas t fdo; octyl ph thalate; Palatinol DOP; Polycizer DOP; Merrol DOP; Palatinol AH-L; Hatco DOP; Vinycizer 80; Di(2-ethylhexyl)phthalate (DEHP); N-Dioctyl phthalate; Corflex 400; ACMC-1BUXH; Dioctyl phthalate, 99%; DSSTox_CID_607; 1, bis(ethylhexyl) ester; Epitope ID:140107; EC 204-211-0; WLN: 8OVR BVO8; Di(2-Ethylhexyl phthalate); DSSTox_RID_75688; Union carbide flexo l 380; DSSTox_GSID_20607; SCHEMBL20271; 14C -DEHP; MLS001333173; MLS001333174; MLS002454397; bis (2-Etheylexyl) Phthalate; Dioctyl phthalate, >=99.5%; 1,2-Benzenedicarboxylic acid, bis-(1-ethylhexyl) ester; CHEMBL1242017; CTK4B0443; HMS2233C15; HMS3374J09; HY-B1945; NSC17069; Tox21_400084; ANW-17048; Bis(2-ethylhexyl)ester phthalic acid; LS-592; NSC-17069; SBB061417; AKOS024318875; MCULE-4692716107; RTR-003119; TRA0089624; NCGC00091499-01; NCGC00091499-02; NCGC00091499-04; NCGC00091499-06; NCGC00091499-07; 8033-53-2; AK116900; CAS-117-81-7; I887; TR-003119; Bis(2-ethylhexyl) 1, 2-benzenedicarboxylate; bis-(2-ethylhexyl) 1,2-benzenedicarboxylate; CS-0014050; FT-0624576; P0297; ST24030385; ST50406397; WLN: 4Y2 & 1OVR BVO1Y4 & 2; bis-(2-ethylhexyl) 1,2-benzenedicar boxylate; Bis(2-ethylhexyl) phthalate, Selectophore(TM); C03690; Bis (2-Ethylhexyl) Phthalate (Dioctyl phthalate); Q418492; 1,2-Benzenedicarboxylic acid bis-(1-ethylhexyl) ester; benzene-1,2-dicarboxylic acid bis(2-ethylhexyl) ester; BRD-A89471977-001-05-2; Bis(2-ethylhexyl) phthalate 100 microg/mL in Methanol; Bis(2-ethylhexyl) phthalate 5000 microg/mL in Methanol; F0001-0292; Bis(2-ethylhexyl) phthalate, SAJ first grade, >=98.0%; Bis(2-ethylhexyl) phthalate, PESTANAL(R), analytical standard; DI(2-ETHYLHEXYL) PHTHALATE (SEE ALSO CAS 103-23-1); Phthalic acid, bis-2-ethylhexyl ester 10 microg/mL in Cyclohexane; Phthalic acid, bis-2-ethylhexyl ester 100 microg/mL in Acetonitrile; Plastic additive 01, European Pharmacopoeia (EP) Reference Standard; TRANSGENIC MODEL EVALUATION (DI(2-ETHYLHEXYL) PHTHALATE); Bis(2-ethylhexyl) phthalate, certified reference material, TraceCERT(R); Plastic additive 14, United States Pharmacopeia (USP) Reference Standard; 1,2-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester, labeled with carbon-14; 50885-87-5; 82208-43-3; InChI=1/C24H38O4/c1-5-9-13-19(7-3)17-27-23(25)21-15-11-12-16-22(21)24(26)28-18-20(8-4)14-10-6-2/h11-12,15-16,19-20H,5-10,13-14,17-18H2,1-4H",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C24H38O4",
            "molecular_weight": "390.6",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "8343",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0168",
            "name": "Dibenzofuran",
            "synonyms": "dibenzofuran; Dibenzo[b,d]furan; 132-64-9; diphenylene oxide; Dibenzofurans; 2,2'-Biphenylene oxide; 2,2'-Biphenylylene oxide; Dibenzo(b,d)furan; Dibenzol(b,d)furan; dibenzofurane; (1,1'-Biphenyl)-2,2'-diyl oxide; [1,1'-Biphenyl]-2,2'-diyl oxide; UNII-8U54U639VI; CCRIS 1436; HSDB 2163; NSC 1245; EINECS 205-071-3; AI3-00039; CHEBI:28145; TXCDCPKCNAJMEE-UHFFFAOYSA-N; 8U54U639VI; DSSTox_CID_1993; DSSTox_RID_76446; DSSTox_GSID_21993; 8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaene; CAS-132-64-9; Dibenzo[b]furan; Dibenzofuran, 98%; PubChem7058; [1,2'-diyl oxide; Industry fluorene oxide; ACMC-1BNIJ; bmse000548; SCHEMBL8207; KSC154C7P; CHEMBL277497; DTXSID2021993; Dibenzofuran, analytical standard; NSC1245; EBD29106; NSC-1245; ZINC3861058; Tox21_202116; Tox21_300052; ANW-19449; BDBM50408362; LS-757; MFCD00004968; SBB060835; STL185574; AKOS000120971; CS-W017802; MCULE-9430669072; NE10370; PS-5378; RTR-004456; TRA0064754; KS-0000016U; NCGC00164102-01; NCGC00164102-02; NCGC00164102-03; NCGC00254221-01; NCGC00259665-01; AC-19766; AK112050; I961; SC-47120; DB-042123; TR-004456; D0147; FT-0624634; ST24033149; ST50824932; C07729; Q419513; Q-101160; Z57127512; Dibenzo[b,d]furan, BCR(R) certified Reference Material; 8-oxatricyclo[7.4.0.0(2),]trideca-1(9),2(7),3,5,10,12-hexaene; 8-oxatricyclo[7.4.0.0?,?]trideca-1(9),2(7),3,5,10,12-hexaene; InChI=1/C12H8O/c1-3-7-11-9(5-1)10-6-2-4-8-12(10)13-11/h1-8; 1IT",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C12H8O",
            "molecular_weight": "168.19",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "568",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0170",
            "name": "benz(a)anthracene-7,12-dione",
            "synonyms": "1,2-Benzanthraquinone; 2498-66-0; Tetraphene-7,12-dione; Benzanthraquinone; Benz[a]anthracene-7,12-dione; Sirius Yellow G; BENZ(A)ANTHRACENE-7,12-DIONE; Benzanthracene-7,12-dione; 7,12-Benz(a)anthraquinone; 1,2-Benzoanthraquinone; 1,2-Benzanthrachinon; 1,2-Benzo-9,10-anthraquinone; Benz[a]anthracene-7,12-quinone; Sirius Yellow G (VAN); UNII-BL89U5YZBK; NSC 7961; C.I. 59000; Benz(a)anthra-7,12-quinone; Benzo[a]anthracene-7,12-dione; Benz(a)anthracene-7,12-quinone; EINECS 219-693-8; BL89U5YZBK; BRN 2052941; Benz[a]anthra-7,12-quinone; benzo[b]phenanthrene-7,12-dione; zlchem 21; 4-07-00-02644 (Beilstein Handbook Reference); SCHEMBL183078; Benz-A-Anthracene-7,12-Dione; DTXSID8051916; CTK1A2542; NSC7961; ZLB0008; LHMRXAIRPKSGDE-UHFFFAOYSA-N; Benzo[a]anthracene-7,12-dione #; ACT05743; NSC-7961; ZINC3861589; 7,12-dihydrotetraphene-7,12-dione; ANW-73357; SBB069412; AKOS016008512; ACM2498660; MCULE-7106275012; VZ20384; KS-0000167O; AK-81863; AS-57440; LS-27769; U868; AX8016792; TC-162102; B0018; FT-0606277; ST24031893; ST50826757; A817591; C-16071; 1,2-BenzanthraquinoneBenz(a)anthracene-7,12-dione; J-015761; Q27274742",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C18H10O2",
            "molecular_weight": "258.3",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "17253",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F02010204",
                "F02010205"
            ],
            "references": [
                "RC01276",
                "RC01281"
            ]
        },
        {
            "compound_ID": "D0171",
            "name": "Diethylaminoethoxy Hexestrol",
            "synonyms": "diethylaminoethoxyhexestrol; Coralgil; 2691-45-4; 69-14-7; 2,2'-[(1,2-diethylethylene)bis(p-phenyleneoxy)]bis(triethyl)amine; 2,2'-[3,4-Hexanediylbis(4,1-phenyleneoxy)]-bis(N,N-diethylethanamine); Hexestrol bis(diethylaminoethyl ether); 2,2'-((1,2-Diethylethylene)bis(p-phenyleneoxy))bis(triethyl)amine; EINECS 220-261-6; hexestrol bis(beta-diethylaminoethyl ether); Hexestrol-4,4'-bis(2-diethylaminoethylether); ARONIS24375; SCHEMBL317407; CHEMBL1615358; CTK5C9147; BBC/535; CHEBI:135759; SBB080788; AKOS000280972; N,N,N',N'-Tetraethyl-N,N'-(2,2'-(4,4'-(1,2-diethylethylen)diphenoxy)diethyl)diamin; BB 0259580; FT-0683014; Q27291006; {2-[4-(2-{4-[2-(diethylamino)ethoxy]phenyl}-1-ethylbutyl)phenoxy]ethyl}diethyl amine",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C30H48N2O2",
            "molecular_weight": "468.7",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "66143",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0172",
            "name": "Diethylstilbestrol",
            "synonyms": "cis-Diethyl Stilbestrol; 6898-97-1; 4-[4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol; (Z,E)-Diethylstilbestrol; Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-; 4,4'-hex-3-ene-3,4-diyldiphenol; cis-Diethylstilbestrol; DSSTox_CID_20770; DSSTox_RID_79594; DSSTox_GSID_40770; CCRIS 9140; 22610-99-7; 4,4'-(Hex-3-ene-3,4-diyl)diphenol; CAS-6898-97-1; AI3-17297; C18H20O2; NCGC00090749-04; Diethylstilbestrol BP; 4,4'-(3-HEXENE-3,4-DIYL)DIPHENOL; Diethylstilbestrol,(S); Spectrum_000940; Prestwick0_000756; Prestwick1_000756; Spectrum2_000148; Spectrum3_000391; Spectrum4_000512; ACMC-209o5h; Oprea1_042748; KBioGR_001083; KBioSS_001420; KSC491C7P; DivK1c_000519; cpd w/o stereochem designation; SPBio_000256; SPBio_002711; CHEMBL2135534; DTXSID3040770; CTK3J1177; CTK6C6263; CTK8F8699; KBio1_000519; KBio2_001420; KBio2_003988; KBio2_006556; KBio3_001421; NINDS_000519; HMS3655E18; HMS3746G09; KS-00000G1O; Tox21_111005; ANW-35571; AKOS025401352; Tox21_111005_1; DB00255; MCULE-1184803692; KS-0000113R; KS-000046H0; NCGC00090749-11; NCGC00090749-12; NCGC00188969-02; AC-12170; AK113608; Diethylstilbestrol,mixture of cis and trans; DB-052931; LS-176713; (Z)-4,4'-(hex-3-ene-3,4-diyl)diphenol; FT-0603236; FT-0624909; FT-0666798; A23912; Q27164556; Z2197067559",
            "trade_name": "",
            "abbrev_name": "DES, stilbestrol, stilboestrol",
            "description": "nonsteroidal estrogen medication",
            "molecular_formula": "C18H20O2",
            "molecular_weight": "268.3",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "3054",
            "classification": "G; L",
            "indications": "",
            "side_effects": "",
            "atc_codes": "G03CB02; L02AA04; G03CC05; L02AA01",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T019"
            ],
            "function": [
                "F0108",
                "F020103",
                "F020403"
            ],
            "references": [
                "RC01433",
                "RC01434",
                "RC01889",
                "RC02200",
                "RC02510",
                "RC02821",
                "RC03131",
                "RC04926"
            ]
        },
        {
            "compound_ID": "D0174",
            "name": "Dimethylnitrosamine",
            "synonyms": "N-NITROSODIMETHYLAMINE; Dimethylnitrosamine; 62-75-9; Dimethylnitrosoamine; N-Methyl-N-nitrosomethanamine; N,N-Dimethylnitrosamine; Nitrosodimethylamine; Methanamine, N-methyl-N-nitroso-; DMNA; N,N-dimethylnitrous amide; Dimethylnitrosamin; N-Nitroso-N,N-dimethylamine; Dimethylamine, N-nitroso-; N-Nitroaodimethylamine; N-Dimethyl-nitrosamine; RCRA waste number P082; nitrous dimethylamide; NSC 23226; Nitrosamine, dimethyl-; N-methyl-N-nitroso-methanamine; Dimethylnitrosamin [German]; DMN; UNII-M43H21IO8R; CCRIS 261; 1,1-Dimethyl-2-oxohydrazine; N-dimethylnitrosoamine; dimethyl(nitroso)amine; Methanamine,N-methyl-N-nitroso-; HSDB 1667; n-nitroso-dimethylamine; EINECS 200-549-8; RCRA waste no. P082; BRN 1738979; (CH3)2NNO; AI3-25308; MLS001065602; M43H21IO8R; Methamine, N-methyl-N-nitroso-; CHEBI:35807; UMFJAHHVKNCGLG-UHFFFAOYSA-N; SMR000568479; DSSTox_CID_1029; Dimethylnitrosamin (german); DSSTox_RID_75914; DSSTox_GSID_21029; CAS-62-75-9; N Nitrosodimethylamine; InChI=1/C2H6N2O/c1-4(2)3-5/h1-2H; NDMA Nitrosodimethylamine; Nitrosodimethylamine, NDMA; dimethyl-nitrosamine; N, N-Dimethylnitrosamine; N,N-dimethyl nitrous amide; N,N-dimethyl-nitrous amide; cid_6124; N, N-dimethyl nitrous amide; N-N-Dimethyl N Nitrosoamine; N-Methyl-N-nitroso-Methamine; BIDD:ER0584; WLN: ONN1&1; N-Nitrosodimethylamine (NDMA); CHEMBL117311; DTXSID7021029; 1,1-Dimethyl-2-oxohydrazine #; BDBM73982; CTK5B5914; EBD71417; NSC23226; ZINC4658628; N-Methyl-N-nitrosomethanamine, 9CI; Tox21_201663; Tox21_302873; 6868AF; NSC-23226; AKOS016000499; LS-1482; MCULE-1157726226; NCGC00091431-01; NCGC00091431-02; NCGC00091431-03; NCGC00256498-01; NCGC00259212-01; N-Nitrosodimethylamine, analytical standard; D0761; FT-0658538; N-Nitrosodimethylamine 0.2 mg/ml in Methanol; C14704; A833977; N-Nitroso-dimethylamine 10 microg/mL in Methanol; N-Nitroso-dimethylamine 100 microg/mL in Methanol; N-nitrosodimethylamine 1000 microg/mL in Methanol; Q409367; N-Nitrosodimethylamine 1000 microg/mL in Dichloromethane; N-Nitrosodimethylamine (NDMA) 5000 microg/mL in Methanol; N-nitrosodimethylamine 1000 microg/mL in Methanol, Second Source",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C2H6N2O",
            "molecular_weight": "74.08",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "6124",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0175",
            "name": "9,10-anthraquinone",
            "synonyms": "ANTHRAQUINONE; 84-65-1; anthracene-9,10-dione; 9,10-Anthraquinone; 9,10-Anthracenedione; Anthradione; Hoelite; 9,10-Dioxoanthracene; Corbit; Morkit; 9,10-Anthrachinon; Anthra-9,10-quinone; Anthrapel; 9,10-quinone; Az-Q; Anthrachinon; Caswell No. 052A; Anthraquinone [BSI:ISO]; UNII-030MS0JBDO; Bis-alkylamino anthraquinone; NSC 7957; 9,10-Anthrachinon [Czech]; CCRIS 649; 9,10-Anthracendion; Anthracene, 9,10-dihydro-9,10-dioxo-; CHEBI:40448; HSDB 2074; EINECS 201-549-0; EPA Pesticide Chemical Code 122701; 030MS0JBDO; CHEMBL55659; AI3-09073; DTXSID3020095; RZVHIXYEVGDQDX-UHFFFAOYSA-N; 9,10-dihydroanthracene-9,10-dione; MFCD00001188; Anthraquinone, 98%; NCGC00094960-03; DSSTox_CID_95; DSSTox_RID_75364; DSSTox_GSID_20095; CAS-84-65-1; Anthracene-9,10-quinone; Anthracenequinone; 9,10-dihydro-9,10-dioxoanthracene; 9,10-Anthraguinone; Anthraquinone, 97%; Spectrum_001527; SpecPlus_000645; Spectrum2_000405; Spectrum3_001501; Spectrum4_000907; Spectrum5_001897; ACMC-209pw0; Anthra-9,10-quinone #; Epitope ID:116191; EC 201-549-0; SCHEMBL14943; BSPBio_003141; KBioGR_001374; KBioSS_002007; KSC362C5J; DivK1c_006741; SPECTRUM1502103; SPBio_000330; KBio1_001685; KBio2_002007; KBio2_004575; KBio2_007143; KBio3_002641; NSC7957; Anthraquinone, analytical standard; HMS1921J14; HY-N0354; NSC-7957; ZINC3847491; Tox21_111369; ANW-37822; BBL003001; BDBM50094892; CCG-39966; s5168; SBB060613; STK398385; Anthracene,10-dihydro-9,10-dioxo-; AKOS000282964; Tox21_111369_1; DS-4810; LS-1837; MCULE-4655011423; RTR-031315; TRA0074021; NCGC00094960-01; NCGC00094960-02; NCGC00094960-04; NCGC00094960-06; AC-12719; AK117080; K513; SC-46775; Anthraquinone, purum, >=99.0% (HPLC); DB-005409; TR-031315; A0502; Anthraquinone 100 microg/mL in Acetonitrile; CS-0008907; FT-0622417; ST24024605; ST50410412; T8216; Anthraquinone, Vetec(TM) reagent grade, 97%; C16207; Anthraquinone, PESTANAL(R), analytical standard; AB-131/40003277; Q423174; SR-01000944707; SR-01000944707-1; BRD-K15957397-001-03-4; Melting point standard 283-286C, analytical standard; F0001-2133; 1,4-bis-[2-(2-hydroxy-ethylamino)-ethylamino]-anthraquinone; 9,10-anthraquinone;9,10-anthracenedione;anthraquinone;anthracene-9,10-dione;9,10-anthraquinone 9,10-anthracenedione anthraquinone anthracene-9,10-dione; 9TA; InChI=1/C14H8O2/c15-13-9-5-1-2-6-10(9)14(16)12-8-4-3-7-11(12)13/h1-8",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C14H8O2",
            "molecular_weight": "208.21",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "6780",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F02010203",
                "F02010205"
            ],
            "references": [
                "RC01277",
                "RC01283"
            ]
        },
        {
            "compound_ID": "D0176",
            "name": "Epibromohydrin",
            "synonyms": "Epibromohydrin; 1-Bromo-2,3-epoxypropane; 3132-64-7; Epibromohydrine; Epibromhydrin; 2-(Bromomethyl)oxirane; (Bromomethyl)oxirane; Oxirane, (bromomethyl)-; (Bromomethyl)ethylene oxide; 1,2-Epoxy-3-bromopropane; 3-Bromo-1,2-epoxypropane; 3-bromopropylene oxide; ALPHA-EPIBROMOHYDRIN; Epibromhydrine; Propane, 1-bromo-2,3-epoxy-; Epibromhydrine [French]; Propane, 3-bromo-1,2-epoxy-; Epibromhidrina [Spanish]; NSC 630; Oxirane, 2-(bromomethyl)-; CCRIS 2620; HSDB 2717; (RS)-3-bromo-1,2-epoxypropane; EINECS 221-525-3; UN2558; BRN 0079786; AI3-03546; CHEBI:18718; GKIPXFAANLTWBM-UHFFFAOYSA-N; Epibromhidrina; 2-bromomethyloxiran; Propane,2-epoxy-; 2-bromomethyloxirane; 2-bromomethyl-oxirane; racemic epibromohydrine; Epibromohydrin, 98%; PubChem21362; (+/-)-epibromohydrin; ACMC-209sjk; 2,3-epoxypropyl bromide; 2-(bromomethyl) oxirane; 2-(bromomethyl)-oxirane; DSSTox_CID_5237; WLN: T3OTJ B1E; DSSTox_RID_77711; OXIRANYLMETHYL BROMIDE; 1-bromo-2,3-epoxypropane-; DSSTox_GSID_25237; SCHEMBL78600; (r/s)-2-bromomethyl-oxirane; NSC630; CHEMBL3183066; DTXSID5025237; (.+/-.)-(Bromomethyl)oxirane; CTK3J2367; KS-00000XDR; Tox21_202607; ANW-41262; BR1167; Epibromohydrin [UN2558] [Poison]; MFCD00005130; AKOS002664702; AKOS016043519; Epibromohydrin [UN2558] [Poison]; LS-1175; RTR-013326; UN 2558; Propane, 1-bromo-2,3-epoxy- (8CI); NCGC00260155-01; BC004634; BP-21061; Epibromohydrin, purum, >=97.5% (GC); SC-25640; CAS-3132-64-7; (+/-)-3-BROMO-1,2-EPOXYPROPANE; TR-013326; E0011; FT-0622147; 51663-EP2280008A2; 51663-EP2311824A1; W-106908; Q27109087",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C3H5BrO",
            "molecular_weight": "136.98",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "18430",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0177",
            "name": "Epichlorohydrin",
            "synonyms": "EPICHLOROHYDRIN; 2-(Chloromethyl)oxirane; Epichlorhydrin; 106-89-8; 1-Chloro-2,3-epoxypropane; Glycidyl chloride; Oxirane, (chloromethyl)-; Epichlorhydrine; Chloromethyloxirane; 1,2-Epoxy-3-chloropropane; 2,3-Epoxypropyl chloride; Chloropropylene oxide; 3-Chloro-1,2-epoxypropane; Glycerol epichlorhydrin; Epichloorhydrine; Glycerol epichlorohydrin; 3-Chloropropylene oxide; (CHLOROMETHYL)OXIRANE; Epicloridrina; 3-Chloro-1,2-propylene oxide; Epichlorohydryna; Epichlorophydrin; (Chloromethyl)ethylene oxide; alpha-Epichlorohydrin; epi-Chlorohydrin; 3-Chloropropene-1,2-oxide; SKEKhG; Oxirane, 2-(chloromethyl); Epoxypropyl chloride; gamma-Chloropropylene oxide; Propane, 1-chloro-2,3-epoxy-; 1-Chlor-2,3-epoxy-propan; 1-Cloro-2,3-epossipropano; 2-Chloromethyl-oxirane; 1-Chloor-2,3-epoxy-propaan; (+/-)-Epichlorohydrin; Rcra waste number U041; (+/-)-2-(Chloromethyl)oxirane; Allyl chloride oxide; DL-a-Epichlorohydrin; Epoxy-3-chloropropane; Caswell No. 424; (chloromethyl)-Oxirane; Chloropropylene; .alpha.-Epichlorohydrin; epichlorohydrine; Epicloridrina [Italian]; Epichloorhydrine [Dutch]; Epichlorhydrine [French]; Epichlorohydryna [Polish]; (RS)-3-chloro-1,2-epoxypropane; NSC 6747; Alyl chloride oxide; Chloropropyl epoxide; .gamma.-Chloropropylene oxide; CCRIS 277; HSDB 39; (DL)-.alpha.-Epichlorohydrin; 3-Chloropropyl epoxide; Epichlorohydrin, 99%; BRLQWZUYTZBJKN-UHFFFAOYSA-N; NCI-C07001; Oxirane,(chloromethyl)-; Chloro-1,2-epoxypropane; Chloro-2,3-epoxypropane; Chloropropene-1,2-oxide; 3-Chloro-propylene oxide; 2-(chloromethyl)-oxirane; EINECS 203-439-8; UN2023; 1-Chlor-2,3-epoxy-propan [German]; RCRA waste no. U041; 1-Chloor-2,3-epoxy-propaan [Dutch]; 1-Cloro-2,3-epossipropano [Italian]; EPA Pesticide Chemical Code 097201; BRN 0079785; Chloro-1,2-propylene oxide; oxirane, 2-(chloromethyl)-; (chloromethyl) Ethylene oxide; 1-chloro-2,3-epoxy-propane; 1-Chloro-2,3-epoxy propone; AI3-03545; CHEBI:37144; NCGC00091792-01; DSSTox_CID_566; Epichlorohydrin, >=99%; DSSTox_RID_75662; DSSTox_GSID_20566; 56227-39-5; ECH; EPI; Polidexide; Oxirane, (chloromethyl)-, (R)-; Epichlorohydrin, 99%, AcroSeal(R); Polidexidi sulfas; 9009-12-5; CAS-106-89-8; C3H5ClO; Sulfate de polidexide; Sulfato de polidexido; 5-17-01-00020 (Beilstein Handbook Reference); CCRIS 6387; epichiorohydrin; Polidexidi sulfas [INN-Latin]; epi-chlorohydrine; a-Epichlorohydrin; Epichloro hydrine; BRN 1420785; Sulfate de polidexide [INN-French]; Sulfato de polidexido [INN-Spanish]; (rs)-epichlorohydrin; (+) epichlorohydrin; (-) epichlorohydrin; 2-chloromethyloxirane; chloromethyl) Oxirane; (rac)-epichlorohydrin; Cardolite NC-513; racemic epichlorohydrin; beta-epoxypropylchloride; racemic epichlorohydrine; Epoxy-3-chlor opropane; 3-Chloropro pylene Oxide; 2-(chloromethyl) Oxirane; bmse000722; UNII-61TTR6T3SE; EC 203-439-8; WLN: T3OTJ B1G; (DL)-alpha-Epichlorohydrin; (RS)-(chloromethyl)oxirane; 3-chloro-1,2-epoxypropene; 61TTR6T3SE; Epichlorohydrin Reagent Grade; CHEMBL1421613; DTXSID1020566; CTK5A4812; NSC6747; KS-00000V0U; NSC-6747; Tox21_111167; Tox21_200276; 6660AH; BBL012223; LS-409; MFCD00005132; STL163564; (+/-)-1-Chloro-2,3-epoxypropane; Epichlorohydrin [UN2023] [Poison]; AKOS000118974; AKOS016039400; Epichlorohydrin [UN2023] [Poison]; MCULE-9759519789; TRA0067700; UN 2023; NCGC00091792-02; NCGC00091792-03; NCGC00257830-01; 13403-37-7; BP-31004; SC-47193; (+/-)-Epichlorohydrin, analytical standard; DB-018066; Epichlorhydrin 1000 microg/mL in Methanol; LS-101030; E0012; Epichlorhydrin 100 microg/mL in Cyclohexane; FT-0625672; (+/-)-Epichlorohydrin, purum, >=99% (GC); 5717-EP2269977A2; 5717-EP2270011A1; 5717-EP2272817A1; 5717-EP2272839A1; 5717-EP2272840A1; 5717-EP2272841A1; 5717-EP2275418A1; 5717-EP2277874A1; 5717-EP2277878A1; 5717-EP2280001A1; 5717-EP2280009A1; 5717-EP2280010A2; 5717-EP2284159A1; 5717-EP2284169A1; 5717-EP2287161A1; 5717-EP2287162A1; 5717-EP2292227A2; 5717-EP2292592A1; 5717-EP2292596A2; 5717-EP2292628A2; 5717-EP2295407A1; 5717-EP2295426A1; 5717-EP2295427A1; 5717-EP2295434A2; 5717-EP2295437A1; 5717-EP2298312A1; 5717-EP2298734A2; 5717-EP2298736A1; 5717-EP2298750A1; 5717-EP2298774A1; 5717-EP2298775A1; 5717-EP2301921A1; 5717-EP2301924A1; 5717-EP2301926A1; 5717-EP2301929A1; 5717-EP2301934A1; 5717-EP2301935A1; 5717-EP2301936A1; 5717-EP2301937A1; 5717-EP2301939A1; 5717-EP2305219A1; 5717-EP2305649A1; 5717-EP2305658A1; 5717-EP2305674A1; 5717-EP2305682A1; 5717-EP2308828A2; 5717-EP2308857A1; 5717-EP2308858A1; 5717-EP2308861A1; 5717-EP2308873A1; 5717-EP2308875A1; 5717-EP2308877A1; 5717-EP2308879A1; 5717-EP2311808A1; 5717-EP2311816A1; 5717-EP2311817A1; 5717-EP2311822A1; 5717-EP2311829A1; 5717-EP2311831A1; 5717-EP2311846A1; 5717-EP2314558A1; 5717-EP2314583A1; 5717-EP2314584A1; 5717-EP2314585A1; 5717-EP2316824A1; 5717-EP2316836A1; 5717-EP2371810A1; 5717-EP2371831A1; 5717-EP2372804A1; 5717-EP2374454A1; 5717-EP2378585A1; C14449; 23287-EP2270113A1; 23287-EP2270114A1; 23287-EP2272935A1; 23287-EP2275417A2; 23287-EP2277867A2; 23287-EP2280003A2; 23287-EP2280008A2; 23287-EP2280012A2; 23287-EP2284146A2; 23287-EP2284147A2; 23287-EP2284162A2; 23287-EP2284163A2; 23287-EP2285791A1; 23287-EP2286811A1; 23287-EP2292597A1; 23287-EP2295438A1; 23287-EP2298776A1; 23287-EP2301941A1; 23287-EP2305666A1; 23287-EP2308862A1; 23287-EP2308865A1; 23287-EP2314584A1; 204282-EP2277867A2; 204282-EP2280003A2; Q423083; (+/-)-Epichlorohydrin, puriss., >=99.5% (GC); Q-201062; F0001-0128; Z955123632; Starch, 2-(diethylamino)ethyl 2-((2-(diethylamino)ethyl)diethylammonio)ethyl ether, chloride, hydrochloride, polymer with (chloromethyl)oxirane",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C3H5ClO",
            "molecular_weight": "92.52",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "7835",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0178",
            "name": "Ethanol",
            "synonyms": "ethanol; ethyl alcohol; alcohol; Methylcarbinol; grain alcohol; 64-17-5; Ethyl hydroxide; Ethyl hydrate; EtOH; Algrain; Alkohol; Anhydrol; Tecsol; etanol; Hydroxyethane; Jaysol S; Potato alcohol; Cologne Spirit; Absolute ethanol; Alcool ethylique; Ethanol 200 proof; Molasses alcohol; Spirits of wine; Aethylalkohol; Denatured alcohol; Denatured ethanol; Aethanol; Alcohols; 1-Hydroxyethane; Fermentation alcohol; Alcohol, diluted; Tecsol C; Alcool etilico; Etanolo; Jaysol; Etylowy alkohol; absolute alcohol; Ethanol solution; Alcohol, ethyl; Alcohol dehydrated; Alkoholu etylowego; Dehydrated ethanol; Ethyl alcohol usp; Alcohol, anhydrous; Synasol; Ethyl alcohol anhydrous; Denatured alcohol CD-5; Denatured alcohol SD-1; Distilled spirits; Denatured alcohol CD-5a; Denatured alcohol SD-3a; Denatured alcohol CD-10; Denatured alcohol SD-17; Denatured alcohol SD-28; Denatured alcohol SD-30; Denatured alcohol SD-13a; Denatured alcohol SD-23a; Denatured alcohol SD-39b; Denatured alcohol SD-39c; Denatured alcohol SD-40m; Ethylalcohol; Spirit; SD Alchol 23-hydrogen; Ethanol Absolute; Dehydrated alcohol; Alkohol [German]; Aethanol [German]; Etanolo [Italian]; Ethyl alcohol & water, 5%; Thanol; Ethanol, undenatured; Spirt; Alcare Hand Degermer; Ethyl alcohol & water, 10%; Ethyl alcohol & water, 20%; Ethyl alcohol & water, 30%; Ethyl alcohol & water, 40%; Ethyl alcohol & water, 50%; Ethyl alcohol & water, 60%; Ethyl alcohol & water, 70%; Ethyl alcohol & water, 80%; Ethyl alcohol & water, 95%; Ethyl alcohol & water, 96%; Ethyl alc; Ethylalcohol [Dutch]; Alcohol anhydrous; Ethyl alcohol and water; Alcohol (ethyl alcohol); Alcohol, dehydrated; Alcohol [USP]; Ethicap; Hinetoless; alcohol etilico; Cologne spirits; spiritus vini; Caswell No. 430; Reagent Alcohol; Infinity Pure; NCI-C03134; Aethylalkohol [German]; Desinfektol EL; Anhydrous alcohol; Ethyl alcohol in alcoholic beverages; FEMA Number 2419; Alcool etilico [Italian]; Etylowy alkohol [Polish]; Ethyl alcohol, undenatured; Alcool ethylique [French]; C2H5OH; Ethanol [JAN]; Alkoholu etylowego [Polish]; HSDB 82; SDM No. 37; AI3-01706; CCRIS 945; FEMA No. 2419; Ethanol Vapor; SD alcohol 23-hydrogen; Ru-Tuss Hydrocodone Liquid; C2H6O; NSC 85228; Alcohol (USP); EPA Pesticide Chemical Code 001501; Absolute ethyl alcohol; UNII-3K9958V90M; Punctilious ethyl alcohol; ALCOHOL 5% IN DEXTROSE 5%; EINECS 200-578-6; Cologne spirits (alcohol); CHEBI:16236; LFQSCWFLJHTTHZ-UHFFFAOYSA-N; Ethanol, denatured; Ethanol, Anhydrous; MFCD00003568; 3K9958V90M; Ethanol, CDA 19; Ethanol, 200 Proof; Ethyl Alcohol Denatured; Ethylol; Alcohols, C1-3; Alcohols, C6-9; Ethanol Anhydrous; EOH; Alcohols, C>30; Sekundasprit; (C6-C9)Alkyl alcohol; Lux; SY Fresh M; Esumiru WK 88; Ethanol (9CI); Ethanol, silent spirit; Anhydrol PM 4085; Ethyl alcohol, anhydrous; Higher alcohol distillate; SDA 3A; Athylalkohol; Athanol; silent spirit; diluted Alcohol; ethanol-; 100C.NPA; ALCOHOL 5% IN D5-W; CDA 19; IMS 99; Alcohol denatured; Alcohol (ethyl); Alcohol, denatured; undenatured Ethanol; AHD 2000; Hamamelis virginiana; SDA 40-2; VANILLA Powder; EINECS 270-649-4; Eosin Y, Alcoholic; fermentation alcohol; CDA 19-200; Ethyl Alcohol 40%; Ethyl Alcohol 70%; Ethyl Alcohol 75%; Ethyl Alcohol 80%; Ethyl Alcohol 90%; Ethyl alcohol,absolute; WITCH HAZEL; Ethanol, 99.8%; Ethanol, technical grade; Fatty Alcohol C8-10; Reagent Alcohol, 70%; Reagent Alcohol, 80%; Reagent Alcohol, 95%; CH3CH2OH; Dehydrated ethanol (TN); Ethyl Alcohol 47.5%; DSSTox_CID_584; Ethanol, standard for GC; ACMC-1AT5A; bmse000297; CHEMBL545; EC 200-578-6; Ethanol, >=99.5%; Aerosol&trade; OT Solution; Anhydrous ethanol (JP17); Reagent Alcohol, for HPLC; Ethanol, analytical standard; DSSTox_RID_75674; SD 3A; DSSTox_GSID_20584; Ethanol, for UV Spectrocopy; Ru-Tuss Liquid (Salt/Mix); Ethanol, USP, 99.5%; WLN: Q2; 68475-56-9; 71076-86-3; 71329-38-9; Ethanol, anhydrous, denatured; Ethanol, for residue analysis; KSC353A0H; Reagent Alcohol, ACS reagent; Duplicating Fluid 100C.NPA; Ethanol, p.a., 99.8%; Reagent Alcohol, reagent grade; SDM No. 37 (Salt/Mix); GTPL2299; Alcohol dehydrated, >=85.0%; DTXSID4028331; DTXSID9020584; Ethanol, technical grade, 93%; Ethanol, technical grade, 99%; CHEBI:17246; CTK2F3003; Ethanol, 95.1-96.9%; KS-00000WFI; poly(vinyl alcohol) macromolecule; Ru-Tuss Expectorant (Salt/Mix); Ethyl alcohol (6CI,7CI,8CI); Ethanol, technical grade, 93.8%; Ethanol, technical grade, 99.5%; Ethanol, >=99.5%, for HPLC; NSC85228; Ethyl Alcohol 95% ACS/USP Grade; Tox21_202510; 6869AF; ALCOHOL 5% AND DEXTROSE 5%; ANW-42207; NSC-85228; STL264245; Ethanol 2000 microg/mL in Methanol; Ethanol, 95.0%, (190 proof); Ethanol, p.a., ACS reagent, 96%; Ethanol, tested according to Ph.Eur.; Ethanol, USP, 70.0-72.0%; Ethanol, USP, 94.9-96.0%; AKOS009104571; Ethanol, Reagent (Denatured SDA 3A); ALCOHOL 10% AND DEXTROSE 5%; DB00898; Ethanol 10000 microg/mL in Methanol; Ethanol, absolute, >=99.8% (GC); Ethanol, UV HPLC spectroscopic, 95%; LS-1539; MCULE-8818474596; RTR-022011; UN 1170; CAS-64-17-5; Ethanol, denatured, (UK IDA standard); Ethanol, SAJ first grade, >=99.5%; Ethyl Alcohol Absolute, ACS/USP Grade; Ethanol, JIS special grade, >=99.5%; Ethanol, p.a., ACS reagent, 95.0%; Ethanol, technical grade, 92.6-93.8; NCGC00091458-01; NCGC00091458-02; NCGC00260059-01; Reagent Alcohol, spectrophotometric grade; SC-25298; Ethanol, absolute, for HPLC, >=99.8%; Ethyl Alcohol 95% (Synthetic) FCC Grade; Ethanol, ACS reagent, 99.8, 200 proof; Ethanol, JIS first grade, 94.8-95.8%; Ethyl Alcohol Absolute (Organic) USP Grade; TR-022011; 113-EP0930075A1; 113-EP1441224A2; 113-EP2269610A2; 113-EP2269977A2; 113-EP2269978A2; 113-EP2269983A1; 113-EP2269984A1; 113-EP2269985A2; 113-EP2269986A1; 113-EP2269989A1; 113-EP2269990A1; 113-EP2269991A2; 113-EP2269994A1; 113-EP2269995A1; 113-EP2270000A1; 113-EP2270004A1; 113-EP2270005A1; 113-EP2270006A1; 113-EP2270008A1; 113-EP2270009A1; 113-EP2270010A1; 113-EP2270011A1; 113-EP2270012A1; 113-EP2270013A1; 113-EP2270014A1; 113-EP2270017A1; 113-EP2270101A1; 113-EP2270113A1; 113-EP2270114A1; 113-EP2270505A1; 113-EP2272516A2; 113-EP2272517A1; 113-EP2272813A2; 113-EP2272817A1; 113-EP2272822A1; 113-EP2272825A2; 113-EP2272832A1; 113-EP2272834A1; 113-EP2272835A1; 113-EP2272839A1; 113-EP2272840A1; 113-EP2272841A1; 113-EP2272843A1; 113-EP2272844A1; 113-EP2272847A1; 113-EP2272848A1; 113-EP2272849A1; 113-EP2272935A1; 113-EP2272972A1; 113-EP2272973A1; 113-EP2274983A1; 113-EP2275102A1; 113-EP2275105A1; 113-EP2275398A1; 113-EP2275401A1; 113-EP2275404A1; 113-EP2275409A1; 113-EP2275410A1; 113-EP2275411A2; 113-EP2275412A1; 113-EP2275413A1; 113-EP2275414A1; 113-EP2275417A2; 113-EP2275418A1; 113-EP2275420A1; 113-EP2275421A1; 113-EP2275424A1; 113-EP2275427A1; 113-EP2275469A1; 113-EP2277507A1; 113-EP2277848A1; 113-EP2277861A1; 113-EP2277862A2; 113-EP2277867A2; 113-EP2277872A1; 113-EP2277874A1; 113-EP2277876A1; 113-EP2277877A1; 113-EP2277878A1; 113-EP2277879A1; 113-EP2277881A1; 113-EP2280001A1; 113-EP2280003A2; 113-EP2280004A1; 113-EP2280005A1; 113-EP2280008A2; 113-EP2280009A1; 113-EP2280010A2; 113-EP2280012A2; 113-EP2280020A1; 113-EP2280021A1; 113-EP2281816A1; 113-EP2281817A1; 113-EP2281818A1; 113-EP2281820A2; 113-EP2281823A2; 113-EP2281899A2; 113-EP2284146A2; 113-EP2284147A2; 113-EP2284148A1; 113-EP2284149A1; 113-EP2284150A2; 113-EP2284151A2; 113-EP2284152A2; 113-EP2284153A2; 113-EP2284154A1; 113-EP2284155A2; 113-EP2284156A2; 113-EP2284157A1; 113-EP2284158A1; 113-EP2284160A1; 113-EP2284162A2; 113-EP2284163A2; 113-EP2284164A2; 113-EP2284165A1; 113-EP2284169A1; 113-EP2284170A1; 113-EP2284171A1; 113-EP2284172A1; 113-EP2284174A1; 113-EP2286795A1; 113-EP2286811A1; 113-EP2286812A1; 113-EP2286915A2; 113-EP2287140A2; 113-EP2287141A1; 113-EP2287147A2; 113-EP2287148A2; 113-EP2287150A2; 113-EP2287152A2; 113-EP2287153A1; 113-EP2287154A1; 113-EP2287155A1; 113-EP2287156A1; 113-EP2287159A1; 113-EP2287161A1; 113-EP2287162A1; 113-EP2287163A1; 113-EP2287165A2; 113-EP2287166A2; 113-EP2287167A1; 113-EP2287940A1; 113-EP2289509A2; 113-EP2289510A1; 113-EP2289518A1; 113-EP2289868A1; 113-EP2289871A1; 113-EP2289879A1; 113-EP2289880A1; 113-EP2289882A1; 113-EP2289883A1; 113-EP2289884A1; 113-EP2289887A2; 113-EP2289888A2; 113-EP2289890A1; 113-EP2289892A1; 113-EP2289894A2; 113-EP2289897A1; 113-EP2289965A1; 113-EP2292088A1; 113-EP2292228A1; 113-EP2292231A1; 113-EP2292233A2; 113-EP2292576A2; 113-EP2292590A2; 113-EP2292592A1; 113-EP2292593A2; 113-EP2292597A1; 113-EP2292606A1; 113-EP2292612A2; 113-EP2292614A1; 113-EP2292615A1; 113-EP2292617A1; 113-EP2292620A2; 113-EP2292622A1; 113-EP2292628A2; 113-EP2292629A1; 113-EP2295399A2; 113-EP2295401A2; 113-EP2295406A1; 113-EP2295408A1; 113-EP2295410A1; 113-EP2295411A1; 113-EP2295412A1; 113-EP2295413A1; 113-EP2295414A1; 113-EP2295415A1; 113-EP2295416A2; 113-EP2295417A1; 113-EP2295418A1; 113-EP2295419A2; 113-EP2295420A1; 113-EP2295422A2; 113-EP2295423A1; 113-EP2295426A1; 113-EP2295427A1; 113-EP2295430A2; 113-EP2295431A2; 113-EP2295433A2; 113-EP2295434A2; 113-EP2295438A1; 113-EP2295439A1; 113-EP2295550A2; 113-EP2298312A1; 113-EP2298313A1; 113-EP2298728A1; 113-EP2298729A1; 113-EP2298731A1; 113-EP2298732A1; 113-EP2298735A1; 113-EP2298743A1; 113-EP2298745A1; 113-EP2298746A1; 113-EP2298748A2; 113-EP2298750A1; 113-EP2298751A2; 113-EP2298753A1; 113-EP2298754A1; 113-EP2298755A1; 113-EP2298758A1; 113-EP2298759A1; 113-EP2298761A1; 113-EP2298763A1; 113-EP2298767A1; 113-EP2298768A1; 113-EP2298770A1; 113-EP2298772A1; 113-EP2298776A1; 113-EP2298778A1; 113-EP2298779A1; 113-EP2298783A1; 113-EP2299326A1; 113-EP2301533A1; 113-EP2301534A1; 113-EP2301909A1; 113-EP2301912A2; 113-EP2301913A1; 113-EP2301914A1; 113-EP2301916A2; 113-EP2301918A1; 113-EP2301919A1; 113-EP2301924A1; 113-EP2301928A1; 113-EP2301929A1; 113-EP2301930A1; 113-EP2301931A1; 113-EP2301933A1; 113-EP2301935A1; 113-EP2301936A1; 113-EP2301939A1; 113-EP2301983A1; 113-EP2302003A1; 113-EP2302382A2; 113-EP2302383A2; 113-EP2305250A1; 113-EP2305257A1; 113-EP2305260A1; 113-EP2305625A1; 113-EP2305627A1; 113-EP2305629A1; 113-EP2305633A1; 113-EP2305636A1; 113-EP2305637A2; 113-EP2305640A2; 113-EP2305643A1; 113-EP2305646A1; 113-EP2305648A1; 113-EP2305652A2; 113-EP2305660A1; 113-EP2305664A1; 113-EP2305666A1; 113-EP2305667A2; 113-EP2305668A1; 113-EP2305671A1; 113-EP2305672A1; 113-EP2305673A1; 113-EP2305674A1; 113-EP2305675A1; 113-EP2305676A1; 113-EP2305678A1; 113-EP2305679A1; 113-EP2305680A2; 113-EP2305681A1; 113-EP2305682A1; 113-EP2305683A1; 113-EP2305684A1; 113-EP2305687A1; 113-EP2305695A2; 113-EP2305696A2; 113-EP2305697A2; 113-EP2305698A2; 113-EP2305808A1; 113-EP2305825A1; 113-EP2308492A1; 113-EP2308509A1; 113-EP2308510A1; 113-EP2308562A2; 113-EP2308828A2; 113-EP2308832A1; 113-EP2308833A2; 113-EP2308838A1; 113-EP2308839A1; 113-EP2308840A1; 113-EP2308841A2; 113-EP2308844A2; 113-EP2308845A2; 113-EP2308846A2; 113-EP2308848A1; 113-EP2308849A1; 113-EP2308851A1; 113-EP2308857A1; 113-EP2308861A1; 113-EP2308863A1; 113-EP2308864A1; 113-EP2308865A1; 113-EP2308867A2; 113-EP2308870A2; 113-EP2308871A1; 113-EP2308872A1; 113-EP2308874A1; 113-EP2308875A1; 113-EP2308877A1; 113-EP2308879A1; 113-EP2308882A1; 113-EP2308926A1; 113-EP2309564A1; 113-EP2309584A1; 113-EP2311451A1; 113-EP2311464A1; 113-EP2311796A1; 113-EP2311797A1; 113-EP2311798A1; 113-EP2311799A1; 113-EP2311801A1; 113-EP2311802A1; 113-EP2311803A1; 113-EP2311805A1; 113-EP2311806A2; 113-EP2311807A1; 113-EP2311808A1; 113-EP2311810A1; 113-EP2311811A1; 113-EP2311815A1; 113-EP2311818A1; 113-EP2311820A1; 113-EP2311821A1; 113-EP2311822A1; 113-EP2311823A1; 113-EP2311824A1; 113-EP2311825A1; 113-EP2311827A1; 113-EP2311828A1; 113-EP2311829A1; 113-EP2311830A1; 113-EP2311832A1; 113-EP2311833A1; 113-EP2311834A1; 113-EP2311835A1; 113-EP2311838A1; 113-EP2311839A1; 113-EP2311840A1; 113-EP2311841A1; 113-EP2311842A2; 113-EP2311846A1; 113-EP2311850A1; 113-EP2314295A1; 113-EP2314558A1; 113-EP2314575A1; 113-EP2314576A1; 113-EP2314581A1; 113-EP2314583A1; 113-EP2314584A1; 113-EP2314585A1; 113-EP2314586A1; 113-EP2314587A1; 113-EP2314588A1; 113-EP2314589A1; 113-EP2314591A1; 113-EP2314593A1; 113-EP2315303A1; 113-EP2316450A1; 113-EP2316452A1; 113-EP2316457A1; 113-EP2316458A1; 113-EP2316824A1; 113-EP2316825A1; 113-EP2316826A1; 113-EP2316827A1; 113-EP2316828A1; 113-EP2316829A1; 113-EP2316831A1; 113-EP2316835A1; 113-EP2316837A1; 113-EP2316974A1; 113-EP2371805A1; 113-EP2371809A1; 113-EP2371811A2; 113-EP2371814A1; 113-EP2372017A1; 113-EP2374454A1; 113-EP2374526A1; 113-EP2374780A1; 113-EP2374781A1; 113-EP2374783A1; 113-EP2374786A1; 113-EP2374787A1; 113-EP2374790A1; 113-EP2374792A1; 113-EP2375479A1; 113-EP2377510A1; 113-EP2377841A1; 113-EP2377848A1; 113-EP2380568A1; 113-EP2380661A2; 113-EP2380871A1; 113-EP2380872A1; 113-EP2380873A1; 139-EP0930075A1; 139-EP1441224A2; 139-EP2269610A2; 139-EP2269651A2; 139-EP2269977A2; 139-EP2269978A2; 139-EP2269985A2; 139-EP2269986A1; 139-EP2269987A1; 139-EP2269988A2; 139-EP2269989A1; 139-EP2269990A1; 139-EP2269991A2; 139-EP2269992A1; 139-EP2269993A1; 139-EP2269994A1; 139-EP2269995A1; 139-EP2269996A1; 139-EP2269999A1; 139-EP2270000A1; 139-EP2270001A1; 139-EP2270002A1; 139-EP2270004A1; 139-EP2270006A1; 139-EP2270008A1; 139-EP2270009A1; 139-EP2270010A1; 139-EP2270011A1; 139-EP2270012A1; 139-EP2270013A1; 139-EP2270014A1; 139-EP2270017A1; 139-EP2270101A1; 139-EP2270113A1; 139-EP2270114A1; 139-EP2270505A1; 139-EP2270895A2; 139-EP2272516A2; 139-EP2272517A1; 139-EP2272537A2; 139-EP2272813A2; 139-EP2272817A1; 139-EP2272822A1; 139-EP2272825A2; 139-EP2272826A1; 139-EP2272827A1; 139-EP2272828A1; 139-EP2272830A1; 139-EP2272832A1; 139-EP2272834A1; 139-EP2272835A1; 139-EP2272837A1; 139-EP2272839A1; 139-EP2272840A1; 139-EP2272841A1; 139-EP2272843A1; 139-EP2272844A1; 139-EP2272846A1; 139-EP2272847A1; 139-EP2272848A1; 139-EP2272849A1; 139-EP2272935A1; 139-EP2272972A1; 139-EP2272973A1; 139-EP2274983A1; 139-EP2275102A1; 139-EP2275105A1; 139-EP2275398A1; 139-EP2275401A1; 139-EP2275403A1; 139-EP2275404A1; 139-EP2275409A1; 139-EP2275411A2; 139-EP2275412A1; 139-EP2275413A1; 139-EP2275414A1; 139-EP2275419A2; 139-EP2275420A1; 139-EP2275421A1; 139-EP2275422A1; 139-EP2275423A1; 139-EP2275424A1; 139-EP2275425A1; 139-EP2275427A1; 139-EP2275469A1; 139-EP2277507A1; 139-EP2277565A2; 139-EP2277566A2; 139-EP2277567A1; 139-EP2277568A2; 139-EP2277569A2; 139-EP2277570A2; 139-EP2277848A1; 139-EP2277858A1; 139-EP2277861A1; 139-EP2277865A1; 139-EP2277866A1; 139-EP2277867A2; 139-EP2277868A1; 139-EP2277869A1; 139-EP2277870A1; 139-EP2277872A1; 139-EP2277874A1; 139-EP2277875A2; 139-EP2277876A1; 139-EP2277878A1; 139-EP2277879A1; 139-EP2277880A1; 139-EP2277881A1; 139-EP2277898A2; 139-EP2278637A1; 139-EP2279741A2; 139-EP2279750A1; 139-EP2279751A2; 139-EP2280000A1; 139-EP2280001A1; 139-EP2280003A2; 139-EP2280004A1; 139-EP2280005A1; 139-EP2280006A1; 139-EP2280007A1; 139-EP2280008A2; 139-EP2280010A2; 139-EP2280011A1; 139-EP2280012A2; 139-EP2280013A1; 139-EP2280014A2; 139-EP2280020A1; 139-EP2280021A1; 139-EP2281563A1; 139-EP2281810A1; 139-EP2281812A1; 139-EP2281813A1; 139-EP2281815A1; 139-EP2281817A1; 139-EP2281818A1; 139-EP2281819A1; 139-EP2281820A2; 139-EP2281821A1; 139-EP2281822A1; 139-EP2281823A2; 139-EP2281824A1; 139-EP2281861A2; 139-EP2281899A2; 139-EP2283811A1; 139-EP2283898A1; 139-EP2284146A2; 139-EP2284147A2; 139-EP2284149A1; 139-EP2284150A2; 139-EP2284151A2; 139-EP2284152A2; 139-EP2284153A2; 139-EP2284154A1; 139-EP2284155A2; 139-EP2284156A2; 139-EP2284157A1; 139-EP2284158A1; 139-EP2284159A1; 139-EP2284160A1; 139-EP2284161A1; 139-EP2284164A2; 139-EP2284165A1; 139-EP2284166A1; 139-EP2284167A2; 139-EP2284168A2; 139-EP2284169A1; 139-EP2284170A1; 139-EP2284171A1; 139-EP2284172A1; 139-EP2284174A1; 139-EP2284178A2; 139-EP2284179A2; 139-EP2284920A1; 139-EP2286795A1; 139-EP2286811A1; 139-EP2286812A1; 139-EP2286915A2; 139-EP2287140A2; 139-EP2287141A1; 139-EP2287147A2; 139-EP2287148A2; 139-EP2287150A2; 139-EP2287152A2; 139-EP2287153A1; 139-EP2287154A1; 139-EP2287155A1; 139-EP2287156A1; 139-EP2287158A1; 139-EP2287159A1; 139-EP2287160A1; 139-EP2287161A1; 139-EP2287162A1; 139-EP2287163A1; 139-EP2287164A1; 139-EP2287165A2; 139-EP2287166A2; 139-EP2287167A1; 139-EP2287168A2; 139-EP2287940A1; 139-EP2289483A1; 139-EP2289509A2; 139-EP2289510A1; 139-EP2289868A1; 139-EP2289871A1; 139-EP2289876A1; 139-EP2289877A1; 139-EP2289879A1; 139-EP2289881A1; 139-EP2289882A1; 139-EP2289883A1; 139-EP2289884A1; 139-EP2289885A1; 139-EP2289887A2; 139-EP2289888A2; 139-EP2289890A1; 139-EP2289892A1; 139-EP2289893A1; 139-EP2289894A2; 139-EP2289896A1; 139-EP2289897A1; 139-EP2289965A1; 139-EP2292088A1; 139-EP2292227A2; 139-EP2292228A1; 139-EP2292233A2; 139-EP2292234A1; 139-EP2292280A1; 139-EP2292586A2; 139-EP2292589A1; 139-EP2292590A2; 139-EP2292592A1; 139-EP2292593A2; 139-EP2292596A2; 139-EP2292597A1; 139-EP2292601A1; 139-EP2292602A1; 139-EP2292603A1; 139-EP2292606A1; 139-EP2292607A2; 139-EP2292608A1; 139-EP2292609A1; 139-EP2292610A1; 139-EP2292612A2; 139-EP2292613A1; 139-EP2292614A1; 139-EP2292615A1; 139-EP2292616A1; 139-EP2292617A1; 139-EP2292618A1; 139-EP2292619A1; 139-EP2292620A2; 139-EP2292621A1; 139-EP2292622A1; 139-EP2292625A1; 139-EP2292628A2; 139-EP2292629A1; 139-EP2292630A1; 139-EP2293650A1; 139-EP2295053A1; 139-EP2295055A2; 139-EP2295061A1; 139-EP2295399A2; 139-EP2295406A1; 139-EP2295407A1; 139-EP2295408A1; 139-EP2295409A1; 139-EP2295410A1; 139-EP2295411A1; 139-EP2295412A1; 139-EP2295413A1; 139-EP2295414A1; 139-EP2295415A1; 139-EP2295416A2; 139-EP2295417A1; 139-EP2295418A1; 139-EP2295419A2; 139-EP2295420A1; 139-EP2295421A1; 139-EP2295422A2; 139-EP2295423A1; 139-EP2295424A1; 139-EP2295425A1; 139-EP2295426A1; 139-EP2295427A1; 139-EP2295428A2; 139-EP2295429A1; 139-EP2295430A2; 139-EP2295431A2; 139-EP2295432A1; 139-EP2295433A2; 139-EP2295434A2; 139-EP2295435A1; 139-EP2295436A1; 139-EP2295437A1; 139-EP2295438A1; 139-EP2295439A1; 139-EP2295550A2; 139-EP2298305A1; 139-EP2298312A1; 139-EP2298313A1; 139-EP2298728A1; 139-EP2298729A1; 139-EP2298731A1; 139-EP2298732A1; 139-EP2298734A2; 139-EP2298735A1; 139-EP2298736A1; 139-EP2298737A1; 139-EP2298738A1; 139-EP2298739A1; 139-EP2298740A1; 139-EP2298741A1; 139-EP2298742A1; 139-EP2298743A1; 139-EP2298744A2; 139-EP2298745A1; 139-EP2298746A1; 139-EP2298747A1; 139-EP2298748A2; 139-EP2298749A1; 139-EP2298750A1; 139-EP2298751A2; 139-EP2298752A1; 139-EP2298753A1; 139-EP2298754A1; 139-EP2298755A1; 139-EP2298756A1; 139-EP2298757A2; 139-EP2298758A1; 139-EP2298759A1; 139-EP2298760A1; 139-EP2298761A1; 139-EP2298763A1; 139-EP2298764A1; 139-EP2298765A1; 139-EP2298766A1; 139-EP2298767A1; 139-EP2298768A1; 139-EP2298769A1; 139-EP2298770A1; 139-EP2298771A2; 139-EP2298772A1; 139-EP2298773A1; 139-EP2298774A1; 139-EP2298775A1; 139-EP2298776A1; 139-EP2298778A1; 139-EP2298779A1; 139-EP2298783A1; 139-EP2298828A1; 139-EP2299509A1; 139-EP2299510A1; 139-EP2301533A1; 139-EP2301534A1; 139-EP2301536A1; 139-EP2301538A1; 139-EP2301540A1; 139-EP2301544A1; 139-EP2301627A1; 139-EP2301909A1; 139-EP2301911A1; 139-EP2301912A2; 139-EP2301913A1; 139-EP2301914A1; 139-EP2301916A2; 139-EP2301919A1; 139-EP2301920A1; 139-EP2301921A1; 139-EP2301922A1; 139-EP2301923A1; 139-EP2301925A1; 139-EP2301928A1; 139-EP2301929A1; 139-EP2301931A1; 139-EP2301933A1; 139-EP2301934A1; 139-EP2301935A1; 139-EP2301936A1; 139-EP2301937A1; 139-EP2301938A1; 139-EP2301939A1; 139-EP2301940A1; 139-EP2301941A1; 139-EP2301983A1; 139-EP2302003A1; 139-EP2305033A1; 139-EP2305219A1; 139-EP2305243A1; 139-EP2305250A1; 139-EP2305254A1; 139-EP2305257A1; 139-EP2305260A1; 139-EP2305625A1; 139-EP2305627A1; 139-EP2305629A1; 139-EP2305633A1; 139-EP2305637A2; 139-EP2305640A2; 139-EP2305641A1; 139-EP2305642A2; 139-EP2305643A1; 139-EP2305644A1; 139-EP2305647A1; 139-EP2305648A1; 139-EP2305649A1; 139-EP2305651A1; 139-EP2305652A2; 139-EP2305654A1; 139-EP2305655A2; 139-EP2305657A2; 139-EP2305658A1; 139-EP2305659A1; 139-EP2305660A1; 139-EP2305662A1; 139-EP2305663A1; 139-EP2305664A1; 139-EP2305666A1; 139-EP2305667A2; 139-EP2305668A1; 139-EP2305669A1; 139-EP2305671A1; 139-EP2305672A1; 139-EP2305673A1; 139-EP2305674A1; 139-EP2305675A1; 139-EP2305676A1; 139-EP2305677A1; 139-EP2305678A1; 139-EP2305679A1; 139-EP2305680A2; 139-EP2305681A1; 139-EP2305682A1; 139-EP2305683A1; 139-EP2305684A1; 139-EP2305685A1; 139-EP2305686A1; 139-EP2305687A1; 139-EP2305688A1; 139-EP2305695A2; 139-EP2305696A2; 139-EP2305697A2; 139-EP2305698A2; 139-EP2305769A2; 139-EP2305808A1; 139-EP2305825A1; 139-EP2308471A1; 139-EP2308479A2; 139-EP2308492A1; 139-EP2308509A1; 139-EP2308510A1; 139-EP2308562A2; 139-EP2308812A2; 139-EP2308828A2; 139-EP2308832A1; 139-EP2308833A2; 139-EP2308838A1; 139-EP2308839A1; 139-EP2308840A1; 139-EP2308841A2; 139-EP2308842A1; 139-EP2308848A1; 139-EP2308849A1; 139-EP2308850A1; 139-EP2308851A1; 139-EP2308852A1; 139-EP2308853A1; 139-EP2308854A1; 139-EP2308855A1; 139-EP2308857A1; 139-EP2308858A1; 139-EP2308861A1; 139-EP2308863A1; 139-EP2308864A1; 139-EP2308865A1; 139-EP2308866A1; 139-EP2308867A2; 139-EP2308868A1; 139-EP2308869A1; 139-EP2308870A2; 139-EP2308871A1; 139-EP2308872A1; 139-EP2308873A1; 139-EP2308874A1; 139-EP2308875A1; 139-EP2308876A1; 139-EP2308877A1; 139-EP2308878A2; 139-EP2308879A1; 139-EP2308880A1; 139-EP2308882A1; 139-EP2308883A1; 139-EP2308926A1; 139-EP2309505A1; 139-EP2309564A1; 139-EP2309584A1; 139-EP2311451A1; 139-EP2311453A1; 139-EP2311455A1; 139-EP2311464A1; 139-EP2311494A1; 139-EP2311796A1; 139-EP2311797A1; 139-EP2311798A1; 139-EP2311799A1; 139-EP2311801A1; 139-EP2311802A1; 139-EP2311803A1; 139-EP2311805A1; 139-EP2311806A2; 139-EP2311807A1; 139-EP2311808A1; 139-EP2311810A1; 139-EP2311811A1; 139-EP2311812A1; 139-EP2311814A1; 139-EP2311815A1; 139-EP2311816A1; 139-EP2311817A1; 139-EP2311818A1; 139-EP2311820A1; 139-EP2311821A1; 139-EP2311822A1; 139-EP2311823A1; 139-EP2311824A1; 139-EP2311825A1; 139-EP2311826A2; 139-EP2311827A1; 139-EP2311828A1; 139-EP2311829A1; 139-EP2311830A1; 139-EP2311831A1; 139-EP2311832A1; 139-EP2311833A1; 139-EP2311834A1; 139-EP2311835A1; 139-EP2311836A1; 139-EP2311837A1; 139-EP2311838A1; 139-EP2311839A1; 139-EP2311840A1; 139-EP2311842A2; 139-EP2311850A1; 139-EP2314295A1; 139-EP2314298A1; 139-EP2314558A1; 139-EP2314571A2; 139-EP2314575A1; 139-EP2314576A1; 139-EP2314577A1; 139-EP2314578A1; 139-EP2314579A1; 139-EP2314581A1; 139-EP2314582A1; 139-EP2314583A1; 139-EP2314584A1; 139-EP2314585A1; 139-EP2314586A1; 139-EP2314587A1; 139-EP2314588A1; 139-EP2314589A1; 139-EP2314590A1; 139-EP2314591A1; 139-EP2314593A1; 139-EP2315303A1; 139-EP2315502A1; 139-EP2316450A1; 139-EP2316452A1; 139-EP2316457A1; 139-EP2316458A1; 139-EP2316459A1; 139-EP2316470A2; 139-EP2316825A1; 139-EP2316826A1; 139-EP2316827A1; 139-EP2316828A1; 139-EP2316829A1; 139-EP2316830A2; 139-EP2316831A1; 139-EP2316832A1; 139-EP2316833A1; 139-EP2316835A1; 139-EP2316836A1; 139-EP2316837A1; 139-EP2316905A1; 139-EP2316906A2; 139-EP2316937A1; 139-EP2371797A1; 139-EP2371798A1; 139-EP2371800A1; 139-EP2371806A1; 139-EP2371807A1; 139-EP2371810A1; 139-EP2371811A2; 139-EP2371813A1; 139-EP2371814A1; 139-EP2371823A1; 139-EP2371831A1; 139-EP2372017A1; 139-EP2372804A1; 139-EP2374454A1; 139-EP2374538A1; 139-EP2374780A1; 139-EP2374781A1; 139-EP2374783A1; 139-EP2374788A1; 139-EP2374790A1; 139-EP2374791A1; 139-EP2374792A1; 139-EP2374895A1; 139-EP2377510A1; 139-EP2377841A1; 139-EP2377845A1; 139-EP2377847A1; 139-EP2378585A1; 139-EP2380568A1; 139-EP2380872A1; 139-EP2380873A1; 139-EP2380874A2; E1510; Ethanol solution, EP, BP, 69.5-70.4%; Ethanol, JIS special grade, 94.8-95.8%; FT-0625728; Ethanol, >=99.5%, SAJ super special grade; Reagent Alcohol, anhydrous, <=0.003% water; Reagent Alcohol, anhydrous, <=0.005% water; 1037-EP2269996A1; 1037-EP2270002A1; 1037-EP2270006A1; 1037-EP2272848A1; 1037-EP2274983A1; 1037-EP2275411A2; 1037-EP2277565A2; 1037-EP2277566A2; 1037-EP2277567A1; 1037-EP2277568A2; 1037-EP2277569A2; 1037-EP2277570A2; 1037-EP2277862A2; 1037-EP2277866A1; 1037-EP2277867A2; 1037-EP2280003A2; 1037-EP2280008A2; 1037-EP2280010A2; 1037-EP2281563A1; 1037-EP2284160A1; 1037-EP2284169A1; 1037-EP2284172A1; 1037-EP2287152A2; 1037-EP2287160A1; 1037-EP2287161A1; 1037-EP2287162A1; 1037-EP2289868A1; 1037-EP2289893A1; 1037-EP2292227A2; 1037-EP2292280A1; 1037-EP2295055A2; 1037-EP2295402A2; 1037-EP2295408A1; 1037-EP2295410A1; 1037-EP2295416A2; 1037-EP2295437A1; 1037-EP2295439A1; 1037-EP2298734A2; 1037-EP2298735A1; 1037-EP2298748A2; 1037-EP2298770A1; 1037-EP2298775A1; 1037-EP2301939A1; 1037-EP2302382A2; 1037-EP2302383A2; 1037-EP2305243A1; 1037-EP2305254A1; 1037-EP2305679A1; 1037-EP2305684A1; 1037-EP2305689A1; 1037-EP2308479A2; 1037-EP2308861A1; 1037-EP2308872A1; 1037-EP2308873A1; 1037-EP2308875A1; 1037-EP2311453A1; 1037-EP2311809A1; 1037-EP2311814A1; 1037-EP2311821A1; 1037-EP2311824A1; 1037-EP2311831A1; 1037-EP2311832A1; 1037-EP2311833A1; 1037-EP2311837A1; 1037-EP2311840A1; 1037-EP2311842A2; 1037-EP2314584A1; 1037-EP2316459A1; 1037-EP2316470A2; 1037-EP2316829A1; 1037-EP2316831A1; 1037-EP2316832A1; 1037-EP2316833A1; 1037-EP2316834A1; 1037-EP2316835A1; 1037-EP2316836A1; 1037-EP2374454A1; 4260-EP2269977A2; 4260-EP2269988A2; 4260-EP2269996A1; 4260-EP2270000A1; 4260-EP2270001A1; 4260-EP2270002A1; 4260-EP2270003A1; 4260-EP2270006A1; 4260-EP2270008A1; 4260-EP2270010A1; 4260-EP2270011A1; 4260-EP2270012A1; 4260-EP2270013A1; 4260-EP2270015A1; 4260-EP2270018A1; 4260-EP2272510A1; 4260-EP2272825A2; 4260-EP2272826A1; 4260-EP2272839A1; 4260-EP2272840A1; 4260-EP2272848A1; 4260-EP2275102A1; 4260-EP2275412A1; 4260-EP2275413A1; 4260-EP2277848A1; 4260-EP2277867A2; 4260-EP2277874A1; 4260-EP2277875A2; 4260-EP2277877A1; 4260-EP2279741A2; 4260-EP2280003A2; 4260-EP2280006A1; 4260-EP2280008A2; 4260-EP2280010A2; 4260-EP2281563A1; 4260-EP2281812A1; 4260-EP2281813A1; 4260-EP2281819A1; 4260-EP2281822A1; 4260-EP2281861A2; 4260-EP2284157A1; 4260-EP2284174A1; 4260-EP2286811A1; 4260-EP2287156A1; 4260-EP2287159A1; 4260-EP2287165A2; 4260-EP2287166A2; 4260-EP2287167A1; 4260-EP2289509A2; 4260-EP2289881A1; 4260-EP2289883A1; 4260-EP2289893A1; 4260-EP2289894A2; 4260-EP2292589A1; 4260-EP2292593A2; 4260-EP2292612A2; 4260-EP2292617A1; 4260-EP2292620A2; 4260-EP2292628A2; 4260-EP2295055A2; 4260-EP2295401A2; 4260-EP2295402A2; 4260-EP2295409A1; 4260-EP2295411A1; 4260-EP2295412A1; 4260-EP2295413A1; 4260-EP2295416A2; 4260-EP2295417A1; 4260-EP2295426A1; 4260-EP2295427A1; 4260-EP2295428A2; 4260-EP2295429A1; 4260-EP2295432A1; 4260-EP2295433A2; 4260-EP2295435A1; 4260-EP2295437A1; 4260-EP2295441A2; 4260-EP2295503A1; 4260-EP2298312A1; 4260-EP2298734A2; 4260-EP2298735A1; 4260-EP2298743A1; 4260-EP2298744A2; 4260-EP2298748A2; 4260-EP2298750A1; 4260-EP2298761A1; 4260-EP2298762A2; 4260-EP2298770A1; 4260-EP2298775A1; 4260-EP2298776A1; 4260-EP2298780A1; 4260-EP2301536A1; 4260-EP2301538A1; 4260-EP2301544A1; 4260-EP2301627A1; 4260-EP2301923A1; 4260-EP2301928A1; 4260-EP2301930A1; 4260-EP2301934A1; 4260-EP2301939A1; 4260-EP2305250A1; 4260-EP2305644A1; 4260-EP2305648A1; 4260-EP2305652A2; 4260-EP2305660A1; 4260-EP2305671A1; 4260-EP2305676A1; 4260-EP2305681A1; 4260-EP2305682A1; 4260-EP2305684A1; 4260-EP2305687A1; 4260-EP2305689A1; 4260-EP2305695A2; 4260-EP2305696A2; 4260-EP2305697A2; 4260-EP2305698A2; 4260-EP2305769A2; 4260-EP2305808A1; 4260-EP2308833A2; 4260-EP2308840A1; 4260-EP2308841A2; 4260-EP2308844A2; 4260-EP2308845A2; 4260-EP2308846A2; 4260-EP2308848A1; 4260-EP2308849A1; 4260-EP2308850A1; 4260-EP2308851A1; 4260-EP2308852A1; 4260-EP2308861A1; 4260-EP2308867A2; 4260-EP2308870A2; 4260-EP2308872A1; 4260-EP2308873A1; 4260-EP2308875A1; 4260-EP2308876A1; 4260-EP2308879A1; 4260-EP2311453A1; 4260-EP2311455A1; 4260-EP2311802A1; 4260-EP2311803A1; 4260-EP2311806A2; 4260-EP2311807A1; 4260-EP2311808A1; 4260-EP2311821A1; 4260-EP2311824A1; 4260-EP2311825A1; 4260-EP2311826A2; 4260-EP2311829A1; 4260-EP2311830A1; 4260-EP2311831A1; 4260-EP2311838A1; 4260-EP2311840A1; 4260-EP2311842A2; 4260-EP2314295A1; 4260-EP2314576A1; 4260-EP2314586A1; 4260-EP2314593A1; 4260-EP2315502A1; 4260-EP2316452A1; 4260-EP2316824A1; 4260-EP2316827A1; 4260-EP2316829A1; 4260-EP2316831A1; 4260-EP2316835A1; 4260-EP2316836A1; 4260-EP2316905A1; 4260-EP2316906A2; 4260-EP2371813A1; 4260-EP2374454A1; 4260-EP2374790A1; 4260-EP2377845A1; 4260-EP2377849A2; 4260-EP2380874A2; C00469; D00068; Ethanol, >=99.5%, suitable for fluorescence; Ethyl Alcohol 95% (Grain Derived) FCC Grade; Ethyl Alcohol 95% (Synthetic) ACS/USP Grade; InChI=1/C2H6O/c1-2-3/h3H,2H2,1H; 28147-EP2277868A1; 28147-EP2277869A1; 28147-EP2277870A1; 28147-EP2295422A2; 28147-EP2298305A1; 28147-EP2298769A1; 28147-EP2308852A1; 28147-EP2308878A2; 28147-EP2313400A1; 28147-EP2371823A1; 48516-EP2311824A1; 48516-EP2311828A1; 48516-EP2380568A1; Ethyl Alcohol Absolute (Synthetic) ACS/USP Grade; SR-01000944357; Ethanol, 95+%, pure, denat. with 5% wood spirit; Ethanol, puriss. p.a., absolute, >=99.8% (GC); SR-01000944357-1; Ethanol, 99.5%, Extra Dry, absolute, AcroSeal(R); Ethanol, denatured (5 % IPA, 5 % n-propylacetate); Reagent Alcohol, used for histology tissue preparation; Ethyl alcohol, Pure, 190 proof, for molecular biology; Ethyl alcohol, Pure, 200 proof, anhydrous, >=99.5%; Ethyl alcohol, Pure, 200 proof, for molecular biology; Ethanol, absolute, >=99.8% (GC), sales not in Germany; Ethyl Alcohol Absolute (Dehydrated) USP, BP/EP, JP Grade; Ethyl alcohol, Pure, 200 proof, ACS reagent, >=99.5%; Reagent Alcohol, 70%, used for histology tissue preparation; Reagent Alcohol, 80%, used for histology tissue preparation; 1E37B0D2-6209-4B03-A57D-500F3223C2DA; Alcohol, United States Pharmacopeia (USP) Reference Standard; Ethanol, >=99.5%, suitable for absorption spectrum analysis; Ethanol-water solutions, NIST(R) SRM(R) 1828b, six levels; Ethyl alcohol, Pure, 200 proof, HPLC/spectrophotometric grade; Reagent Alcohol, 95%, Used for histology tissue preparation; Ethanol solution, NIST(R) SRM(R) 2897a, nominal mass fraction 2%; Ethanol solution, NIST(R) SRM(R) 2898a, nominal mass fraction 6%; Ethanol solution, NIST(R) SRM(R) 2899a, nominal 25% by mass; Ethanol, 95+%, pure, anhydrous, denat. with up to 5% v/v ether; Ethanol, p.a., ACS reagent, reag. ISO, reag. Ph. Eur., 99.9%; Ethanol, suitable for 300 per JIS, >=99.5%, for residue analysis; Ethyl alcohol, Pure, 190 proof, meets USP testing specifications; Ethyl alcohol, Pure, 200 proof, anhydrous, ZerO2(TM), >=99.5%; Ethyl alcohol, Pure, 200 proof, meets USP testing specifications; Specially Denatured Alcohol, 190 proof, SDA 23A, contains Acetone; Specially Denatured Alcohol, 190 proof, SDA 2B-3, contains Toluene; Specially Denatured Alcohol, 190 proof, SDA 30, contains Methanol; Specially Denatured Alcohol, 190 proof, SDA 3A, contains Methanol; Specially Denatured Alcohol, 200 proof, SDA 23A, contains Acetone; Specially Denatured Alcohol, 200 proof, SDA 2B-3, contains Toluene; Specially Denatured Alcohol, 200 proof, SDA 30, contains Methanol; Specially Denatured Alcohol, 200 proof, SDA 3A, contains Methanol; Alcohol, Pharmaceutical Secondary Standard; Certified Reference Material; Dehydrated Alcohol, United States Pharmacopeia (USP) Reference Standard; Ethanol Fixative 80% v/v, suitable for fixing solution (blood films); Ethanol solution, certified reference material, 2000 mug/mL in methanol; Ethanol standards 10% (v/v), 10 % (v/v) in H2O, analytical standard; Ethanol, absolute, for gradient elution, sales not in Germany, >=99.9%; Ethanol, absolute, for HPLC, sales not in Germany1, >=99.8% (GC); Ethanol, absolute, semiconductor grade PURANAL(TM) (Honeywell 17826); Ethanol, suitable for 1000 per JIS, >=99.5%, for residue analysis; Ethanol-water solution, NIST(R) SRM(R) 2894, nominal mass fraction 0.1%; Ethanol-water solution, NIST(R) SRM(R) 2895, nominal mass fraction 0.2%; Ethanol-water solution, NIST(R) SRM(R) 2896, nominal mass fraction 0.3%; Ethanol-water solution, NIST(R) SRM(R) 2900, nominal 95.6% by mass; Ethyl Alcohol Absolute (Dehydrated, Synthetic) USP, BP/EP, JP Grade; Ethyl alcohol, Pure, 140 proof, Excise Tax-free, Permit for use required; Ethyl alcohol, Pure, 160 proof, Excise Tax-free, Permit for use required; Ethyl alcohol, Pure, 190 proof, ACS spectrophotometric grade, 95.0%; Specially Denatured Alcohol, 190 proof, SDA 2B-4, contains Heptanes; Specially Denatured Alcohol, 190 proof, SDA 2B-4, contains n-Heptane; Specially Denatured Alcohol, 190 proof, SDA 2B-5, contains n-Hexane; Specially Denatured Alcohol, 190 proof, SDA 35A, contains Ethyl acetate; Specially Denatured Alcohol, 190 proof, SDA 3C, contains Isopropanol; Specially Denatured Alcohol, 200 proof, SDA 2B-4, contains Heptanes; Specially Denatured Alcohol, 200 proof, SDA 2B-4, contains n-Heptane; Specially Denatured Alcohol, 200 proof, SDA 2B-5, contains n-Hexane; Specially Denatured Alcohol, 200 proof, SDA 35A, contains Ethyl acetate; Specially Denatured Alcohol, 200 proof, SDA 3C, contains Isopropanol; Alcohol Determination-Alcohol, United States Pharmacopeia (USP) Reference Standard; Dehydrated Alcohol, Pharmaceutical Secondary Standard; Certified Reference Material; Ethanol Calibration Kit, ampule of 10 x 1.2 mL, certified reference material; Ethanol, a",
            "trade_name": "",
            "abbrev_name": "",
            "description": "organic chemical compound",
            "molecular_formula": "C2H6O",
            "molecular_weight": "46.07",
            "state": "liquid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "Rapidly absorbed.",
            "cid": "702",
            "classification": "D; V",
            "indications": "",
            "side_effects": "",
            "atc_codes": "V03AB16; D08AX08; V03AZ01",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [
                "F030604",
                "F05"
            ],
            "references": [
                "RC03669",
                "RC03903",
                "RC03904"
            ]
        },
        {
            "compound_ID": "D0179",
            "name": "Ethidium Bromide",
            "synonyms": "ETHIDIUM BROMIDE; Homidium bromide; 1239-45-8; Dromilac; EtBr; 3,8-Diamino-5-ethyl-6-phenylphenanthridinium bromide; Ethydium bromide; 3,8-Diamino-5-ethyl-6-phenylphenanthridin-5-ium bromide; 2,7-Diamino-10-ethyl-9-phenylphenanthridinium bromide; 2,7-Diamino-9-phenyl-10-ethylphenanthridinium bromide; UNII-059NUO2Z1L; MFCD00011724; 2,7-Diamino-9-phenylphenanthridine ethobromide; Homidium bromide [INN:BAN]; Phenanthridinium, 3,8-diamino-5-ethyl-6-phenyl-, bromide; Homidii bromidum [INN-Latin]; CCRIS 1017; 3,8-Diamino-1-ethyl-6-phenylphenantridinium bromide; HSDB 7297; Bromure d'homidium [INN-French]; Bromuro de homidio [INN-Spanish]; EINECS 214-984-6; NSC 268986; RD 1572; AI3-62997; MLS002702536; 059NUO2Z1L; CHEBI:4883; NSC268986; NCGC00091387-01; NCGC00095070-01; DSSTox_CID_5258; E-4000; DSSTox_RID_77719; DSSTox_GSID_25258; Ethidium bromide, 95%, pure; ethidium-bromide; Homidii bromidum; CHEMBL284328; Bromure d'homidium; Bromuro de homidio; CAS-1239-45-8; 2,7-Diamino-9-Phenyl-10-Ethylphenanthridiniumbromide; 5-ethyl-6-phenylphenanthridine-3,8-diamine, bromide; Ethidium bromide, 98%; SCHEMBL20520; SPECTRUM1503806; Ethidium bromide, >=95.0%; SCHEMBL1505620; DTXSID8025258; CTK3J2116; HMS502O22; ZMMJGEGLRURXTF-UHFFFAOYSA-N; ZX-AFC000512; ZX-AFC003107; HMS1922I08; Pharmakon1600-01503806; Ethidium bromide, ~95% (HPLC); KS-000000YI; Tox21_111123; Tox21_111410; Tox21_202511; ANW-41701; BI4663; CCG-39365; GT1710; LS-688; NSC758630; Ethidium bromide solution 1% in H2O; Ethidium bromide solution, 10 mg/mL; AKOS015904050; Tox21_111410_1; AM84361; MCULE-8684380812; NSC-268986; NSC-758630; RTR-003732; Ethidium bromide, for biochemistry, 98%; NCGC00091387-08; NCGC00095070-02; NCGC00260060-01; AK114459; SMR001566146; AX8127683; DB-062201; TR-003732; E0370; FT-0614786; ST24041300; ST50308645; C11161; Ethidium bromide, Vetec(TM) reagent grade, 95%; SR-01000872761; SR-01000872761-1; Ethidium bromide, for fluorescence, >=95.0% (HPLC); Phenanthridinium,8-diamino-5-ethyl-6-phenyl-, bromide; Ethidium bromide solution, for fluorescence, ~1% in H2O; WLN: T B666 HKJ EJ H2 IR& LZ &E &9/26; Ethidium bromide, ~10 mg/tablet ethidium bromide, tablet; Ethidium bromide, BioReagent, for molecular biology, powder; J Mol Biol 13: 269 (1965); 27: 87 (1967); Phenanthridinium, 3,8-diamino-5-ethyl-6-phenyl-, bromide (1:1); Ethidium bromide solution, BioReagent, for molecular biology, 10 mg/mL in H2O; Ethidium bromide solution, BioReagent, for molecular biology, 500 mug/mL in H2O",
            "trade_name": "",
            "abbrev_name": "",
            "description": "intercalating agent",
            "molecular_formula": "C21H20BrN3",
            "molecular_weight": "394.3",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "14710",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F030604"
            ],
            "references": [
                "RC03900"
            ]
        },
        {
            "compound_ID": "D0181",
            "name": "FCCP",
            "synonyms": "FCCP; 370-86-5; Carbonyl cyanide p-trifluoromethoxyphenylhydrazone; Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone; EINECS 206-730-8; BRN 4693268; CHEBI:75458; trifluoromethoxy carbonylcyanide phenylhydrazone; 2-{2-[4-(Trifluoromethoxy)phenyl]hydrazono}malononitrile; Propanedinitrile, ((4-(trifluoromethoxy)phenyl)hydrazono)-; Propanedinitrile, [[4-(trifluoromethoxy)phenyl]hydrazono]-; Carbonyl cyanide 4-trifluoromethoxyphenylhydrazone; Carbonyl cyanide, 4-trifluoromethoxyphenylhydrazone; ((4-(Trifluoromethoxy)phenyl)hydrazono)malononitrile; {[4-(Trifluoromethoxy)phenyl]-hydrazono}malononitrile; Mesoxalonitrile, (p-(trifluoromethoxy)phenyl)hydrazone; 2-[2-[4-(Trifluoromethoxy)phenyl]hydrazono]malononitrile; {[4-(trifluoromethoxy)phenyl]hydrazono}malononitrile; (4-(trifluoromethoxy)phenyl)carbonohydrazonoyl dicyanide; [4-(Trifluoromethoxy)phenyl]carbonohydrazonoyl Dicyanide; 2-(2-[4-(TRIFLUOROMETHOXY)PHENYL]HYDRAZONO)MALONONITRILE; C10H5F3N4O; Cyto10H8; 2-[[4-(trifluoromethoxy)phenyl]hydrazinylidene]propanedinitrile; Maybridge1_007693; BSPBio_001069; KBioGR_000409; KBioSS_000409; SCHEMBL345231; CHEMBL457504; CTK7C4861; HMS563F15; KBio2_000409; KBio2_002977; KBio2_005545; KBio3_000777; KBio3_000778; CARBONYL CYANIDE p-TRIFLUOROMETHOXYPHENYL HYDRAZONE; DTXSID40190494; BMZRVOVNUMQTIN-UHFFFAOYSA-N; Bio1_000432; Bio1_000921; Bio1_001410; Bio2_000365; Bio2_000845; HMS1362E11; HMS1792E11; HMS1990E11; HMS3266A16; HMS3403E11; ZINC110861; BCP29558; EX-A2029; ZX-AP008931; 1-cyano-N-[4-(trifluoromethoxy)phenyl]methanecarbohydrazonoyl cyanide; ACM370865; BS0078; CCG-56026; PC0578; s8276; SBB101377; AKOS004121079; CS-5732; MCULE-4712161118; IDI1_002120; QTL1_000036; NCGC00092274-01; NCGC00092274-02; NCGC00092274-03; NCGC00092274-04; AK546688; LS-52242; PS-10973; HY-100410; B5004; C3463; FT-0610900; [4-(Trifluoromethoxy)phenylhydrazono]malononitrile; C-15732; Carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone; Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone; Q1649579; SR-01000645014-1; SR-01000645014-2; BRD-K14821540-001-02-1; BRD-K14821540-001-03-9; Carbonyl cyanide, 4-(trifluoromethoxy)phenylhydrazone; F9995-2716; 2-([4-(Trifluoromethoxy)phenyl]hydrazono)malononitrile #; N-(4-(trifluoromethoxy)phenyl)carbonohydrazonoyl dicyanide; Mesoxalonitrile, (p-(trifluoromethoxy)phenyl)hydrazone (8CI); Propanedinitrile, ((4-(trifluoromethoxy)phenyl)hydrazono)- (9CI); ({[4-(trifluoromethoxy)phenyl]amino}azamethylene)methane-1,1-dicarbonitrile; Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone, >=98% (TLC), powder; Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazon;Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone; (4-(Trifluoromethoxy)phenyl)hydrazonopropanedinitrile; Carbonyl Cyanide para Trifluoromethoxyphe",
            "trade_name": "Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone",
            "abbrev_name": "",
            "description": "ionophore; uncoupling agent; a nitrile and hydrazone",
            "molecular_formula": "C10H5F3N4O",
            "molecular_weight": "254.17",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "3330",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F0105",
                "F02010202",
                "F02040101",
                "F020403",
                "F0308"
            ],
            "references": [
                "RC00520",
                "RC00521",
                "RC00965",
                "RC03712",
                "RC04928"
            ]
        },
        {
            "compound_ID": "D0182",
            "name": "FOSAA",
            "synonyms": "perfluorooctane sulfonamidoacetic acid; 2806-24-8; SCHEMBL7887621; CHEBI:83505; CTK0J2227; DTXSID40440941; N-(Heptadecafluorooctylsulfonyl)glycine; N-[(heptadecafluorooctyl)sulfonyl]glycine; Glycine, N-[(heptadecafluorooctyl)sulfonyl]-; Q27156887; N-[(1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-Heptadecafluorooctyl)sulfonyl]glycine; N-[(1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-Heptadecafluorooctyl)sulfonyl]glycine (Perfluorooctane sulfonamidoacetic acid)",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C10H4F17NO4S",
            "molecular_weight": "557.18",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "10507011",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0183",
            "name": "H2O2",
            "synonyms": "hydrogen peroxide; 7722-84-1; oxydol; perhydrol; Superoxol; Interox; Hydrogen dioxide; hydroperoxide; Inhibine; Peroxaan; Albone; Hioxyl; Kastone; Albone 35; Albone DS; Dihydrogen dioxide; T-Stuff; Lensept; Elawox; Perone; Albone 50; Albone 70; Perone 50; Albone 35CG; Albone 50CG; Albone 70CG; H2O2; Hydrogen peroxide (H2O2); Peroxide; Peroxan; Hydrogen peroxide, 30%; Hydrogen dioxide solution; Hydrogen peroxide, 90%; Perone 30; Perone 35; Hydrogen peroxide, solution; Waterstofperoxyde; Hydrogen peroxide, 3%; Wasserstoffperoxid; Caswell No. 486AAA; Hydrogen peroxide solution; Peroxyde d'hydrogene; Perossido di idrogeno; Asepticper; Baquashock; Crystacide; Peroxclean; CCRIS 1060; Dentasept; HSDB 547; Hybrite; Metrokur; Mirasept; Oxigenal; Oxyfull; Oxysept; Pegasyl; Puresept; Hipox; Select Bleach; Hydrogen peroxide, solution, 3%; Hydrogen peroxide solution (DOT); Waterstofperoxyde [Dutch]; Xtra White; Hydrogen peroxide (conc > 52%); Oxysept I; Hydrogen peroxide solutions; Hydrogen peroxide, solution, 30%; Hydrogen peroxide, solution, 35%; Lensan A; Odosat D; UNII-BBX060AN9V; Adeka Super EL; Wasserstoffperoxid [German]; Crestal Whitestrips; UN2014; UN2015; UN2984; EPA Pesticide Chemical Code 000595; Peroxyde d'hydrogene [French]; Anti-Keim 50; Perossido di idrogeno [Italian]; Hydrogen peroxide, 8% to 20%; Hydrogen peroxide, 20% to 60%; Hydrogen peroxide (> 52% conc.); Hydrogen peroxide [USP]; EINECS 231-765-0; MFCD00011333; NSC 19892; UN 2015 (>52%); BBX060AN9V; UN 2984 (8%-20%); UN 2014 (20%-52%); CHEBI:16240; Hydrogen peroxide (conc >52%); Hydrogen peroxide solutions (over 8% but not over 60%); Hydrogen peroxide solutions (over 60% but not over 70%); Hydrogen peroxide (USP); PEO; dioxidane; hydrogenperoxide; Accel Concentrate; Astri-UC; HTP [peroxide]; High Test Peroxide; CIX; Hydrogen peroxide, aqueous solutions with >40% but not >60% hydrogen peroxide (stabilized as necessary) [UN2014] [Oxidizer]; Hydrogen peroxide, aqueous solutions with not <20% but not >40% hydrogen peroxide (stabilized as necessary) [UN2014] [Oxidizer]; Hydrogen peroxide, aqueous solutions with not <8% but <20% hydrogen peroxide (stabilized as necessary) [UN2984] [Oxidizer]; Hydrogen peroxide, stabilized or hydrogen peroxide aqueous solutions, stabilized with >60% hydrogen peroxide [UN2015] [Oxidizer]; Teat dip HP 5; Pre milk HP 0.5; Pre milk HP 1.0; Hydrogen peroxide 35%; Hydrogen peroxide, 3 wt.% solution in water, stabilized; Pre milk HP 0.5 10; Whitespeed; Eskata; Hydrogen peroxide, pure, 50 wt% solution in water, stabilized; Hioxy; Magic Bleaching; Clarigel Gold; Lase Peroxide; Quasar Brite; Opalescence Xtra; Whiteness HP; Hydrogen peroxide, ACS reagent, 30 wt% solution in water, nonstabilized; Deslime LP; hydrogen per oxide; dihydrogen peroxide; dihydrogen(peroxide); Oxyfull (TN); HOOH; hydrogen hydroperoxide; ACMC-20akqy; Nite White Excel 2; Oxydol (JP17); Hydrogen peroxide 50%; HYDROGEN-PEROXIDE; HYDROGEN PEROXIDE; Hydrogen Peroxide, 50%; Hydrogen peroxide (8CI); MolMap_000025; bis(hydridooxygen)(O--O); EC 231-765-0; 30 %Hydrogen peroxide(aq); CHEMBL71595; [OH(OH)]; DTXSID2020715; Hydrogen peroxide, 6% in water; CTK2H7501; MHAJPDPJQMAIIY-UHFFFAOYSA-N; Hydrogen peroxide (H2O2) (9CI); NSC19892; WLN: H2 O2 90%; Hydrogen Peroxide [Topical Solution]; NSC-19892; AKOS015856794; DB11091; LS-2428; QTL1_000041; 8007-30-5; TR-037767; FT-0627133; C00027; D00008; Hydrogen peroxide solution, 3%, for microbiology; Hydrogen peroxide solution, for ultratrace analysis; Q171877; Q1088474; Hydrogen peroxide solution, extra pure, 30.0-32.0%; Hydrogen peroxide solution, purum p.a., >=30% (RT); Hydrogen peroxide solution, purum p.a., >=35% (RT); Hydrogen peroxide solution, >=30%, for trace analysis; Hydrogen peroxide solution, SAJ first grade, >=30.0%; Hydrogen peroxide solution, tested according to Ph.Eur.; Hydrogen peroxide solution, 50 wt. % in H2O, stabilized; Hydrogen peroxide solution, JIS special grade, 30.0-35.5%; Hydrogen peroxide solution, 30 % (w/w) in H2O, contains stabilizer; Hydrogen peroxide solution, contains inhibitor, 35 wt. % in H2O; Hydrogen peroxide solution, p.a., ACS reagent, reag. ISO, 30.0%; Hydrogen peroxide, technical, 35 wt% solution in water, stabilized; Hydrogen Peroxide Solution, 30% (w/w), puriss. p.a., reag. ISO, reag. Ph. Eur.; Hydrogen peroxide solution, AR, contains sodium pyrophosphate as stabilizer, >=30 % (w/v); Hydrogen peroxide solution, contains ~200 ppm acetanilide as stabilizer, 3 wt. % in H2O; Hydrogen peroxide solution, contains inhibitor, 30 wt. % in H2O, ACS reagent; Hydrogen peroxide solution, LR, contains sodium pyrophosphate as stabilizer, >=30 % (w/v); Hydrogen peroxide solution, LR, contains sodium pyrophosphate as stabilizer, >=50 % (w/v); Hydrogen peroxide solution, meets analytical specification of Ph. Nord., 34.5-36.5%; Hydrogen peroxide solution, puriss. p.a., ACS reagent, not stabilized, >=30% (RT); Hydrogen peroxide solution, semiconductor grade MOS PURANAL(TM) (Honeywell 17937), >=30%; Hydrogen peroxide solution, semiconductor grade PURANAL(TM) (Honeywell 17948), >=30%; Hydrogen peroxide solution, semiconductor grade ULSI PURANAL(TM) (Honeywell 17024), >=30%; Hydrogen peroxide solution, semiconductor grade VLSI PURANAL(TM) (Honeywell 17606), >=30%; Hydrogen peroxide solution, contains inhibitor, 30 wt. % in H2O, meets USP testing specifications; Hydrogen peroxide solution, contains potassium stannate as inhibitor, 30-32 wt. % in water, semiconductor grade, 99.999% trace metals basis; Hydrogen peroxide, aqueous solutions with >40% but not >60% hydrogen peroxide (stabilized as necessary); Hydrogen peroxide, aqueous solutions with >40% but not >60% hydrogen peroxide (stabilized as necessary) [UN2014] [Oxidizer]; Hydrogen peroxide, aqueous solutions with not <20% but not >40% hydrogen peroxide (stabilized as necessary); Hydrogen peroxide, aqueous solutions with not <20% but not >40% hydrogen peroxide (stabilized as necessary) [UN2014] [Oxidizer]; Hydrogen peroxide, aqueous solutions with not <8% but <20% hydrogen peroxide (stabilized as necessary); Hydrogen peroxide, aqueous solutions with not <8% but <20% hydrogen peroxide (stabilized as necessary) [UN2984] [Oxidizer]; Hydrogen peroxide, stabilized or hydrogen peroxide aqueous solutions, stabilized with >60% hydrogen peroxide; Hydrogen peroxide, stabilized or hydrogen peroxide aqueous solutions, stabilized with >60% hydrogen peroxide [UN2015] [Oxidizer]",
            "trade_name": "",
            "abbrev_name": "",
            "description": "the simplest peroxide; reactive oxygen species; used as an oxidizer, bleaching agent, and antiseptic;",
            "molecular_formula": "H2O2",
            "molecular_weight": "34.015",
            "state": "liquid",
            "clearance": "",
            "volume_of_distribution": "Target organs affected by hydrogen peroxide include the lungs, intestine, thymus, liver, and kidney [L2024].",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "It is reported that hydrogen peroxide is decomposed before absorption in the intestine. Solutions of hydrogen peroxide displays poor penetration when applied to tissue [L2024].",
            "cid": "784",
            "classification": "S; A; D",
            "indications": "",
            "side_effects": "",
            "atc_codes": "S02AA06; D11AX25; A01AB02; D08AX01",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [
                "F030603",
                "F030604",
                "F0402"
            ],
            "references": [
                "RC03603",
                "RC03898",
                "RC03917"
            ]
        },
        {
            "compound_ID": "D0184",
            "name": "xanthone",
            "synonyms": "XANTHONE; 9H-Xanthen-9-one; 90-47-1; Xanthen-9-one; 9-Xanthenone; Benzophenone oxide; 9-Oxoxanthene; Genicide; Xanthenone; 9-Xanthone; Diphenylene ketone oxide; Dibenzo-gamma-pyrone; Xanthene, 9-oxo-; 9H-Xanthene, 9-oxo-; Caswell No. 905; UNII-9749WEV0CA; NSC 14978; Dibenzo-.gamma.-pyrone; EINECS 201-997-7; EPA Pesticide Chemical Code 086503; AI3-00077; 9749WEV0CA; CHEMBL186784; E 6; CHEBI:37647; JNELGWHKGNBSMD-UHFFFAOYSA-N; NSC14978; ST024714; diphenyline ketone oxide; xanthene-9-one; MFCD00005060; Xanthone (Genicide); Xanthone, 97%; Spectrum2_000052; Spectrum3_001884; DSSTox_CID_1795; ACMC-209r6d; DSSTox_RID_76331; DSSTox_GSID_21795; SCHEMBL41161; BSPBio_003388; SPECTRUM200523; KSC486O8J; MLS002207109; SPBio_000203; ghl.PD_Mitscher_leg0.1212; DTXSID6021795; CTK3I6784; KBio3_002891; KS-00000UQW; WLN: T C666 BO IVJ; HMS3651G22; BCP21155; HY-N0126; STR05546; ZINC3860823; Tox21_301151; ANW-39491; BDBM50155411; CCG-38356; NSC-14978; s2372; SBB069491; STK372481; AKOS001213782; MCULE-8122570588; NE10375; RTR-028437; SDCCGMLS-0066462.P001; TRA0014485; CAS-90-47-1; NCGC00095484-01; NCGC00095484-02; NCGC00095484-03; NCGC00255049-01; R895; SC-75486; SMR000112239; LS-162426; TR-028437; CS-0007833; FT-0645039; SW219800-1; A10993; A843557; AC-907/21098006; Q421789; SR-05000002437; SR-05000002437-1; W-100331; F8889-9282; Xanthone, United States Pharmacopeia (USP) Reference Standard; InChI=1/C13H8O2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1-8; N-methyl-1-[5-({[(4-methylbenzyl)amino]carbonyl}amino)pyridin-2-yl]piperidine-4-carboxamide",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C13H8O2",
            "molecular_weight": "196.2",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "7020",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F02010203",
                "F02010204"
            ],
            "references": [
                "RC01280",
                "RC01285"
            ]
        },
        {
            "compound_ID": "D0185",
            "name": "(+)-win 55,212-2 mesylate",
            "synonyms": "131543-23-2; WIN 55212-2 mesylate; WIN 55,212-2 MESYLATE; (R)-(5-Methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1-yl)methanone methanesulfonate; ( R)-(+)-WIN 55,212-2 mesylate; (R)-(+)-WIN 55212; WIN 55,212-2 (Mesylate); UNII-2J851TP7VJ; WIN-55212-2 Mesylate; 2J851TP7VJ; J-502109; SR-01000076200; (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone mesylate; Methanone, ((3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo(1,2,3-de)-1,4-benzoxazin-6-yl)-1-naphthalenyl-, methanesulfonate (1:1); Methanone, [(3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenyl-, methanesulfonate (1:1); NCGC00016210-01; Lopac-W-102; (R)-(+)-WIN 55,212-2 mesylate salt; WIN55,212-2mesylate; WIN55212-2 mesylate; WIN-55212-2 mesilate; MLS000860027; BML2-C07; SCHEMBL1517636; CHEMBL1222317; WIN 55,212-2 mesylate/; 1-naphthalenyl)methanone mesylate; CTK8B6572; AOB4577; DTXSID50424974; C27H26N2O3.CH4O3S; HMS2236O05; HMS3267A16; HMS3402M20; HMS3650K10; (R)-(5-Methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino-[2,3,4-hi]indol-6-yl)(naphthalen-1-yl)methanone methanesulfonate; BCP02715; ABP000804; ANW-53681; AKOS015998626; CS-0517; LP01278; (+)-WIN 55,212-2 (mesylate); (R)-(+)-Win 55212-2 mesylate; NCGC00094513-01; AC-27750; AS-75227; HY-13291; SC-85572; SMR000326885; AX8001899; ST2402538; TC-142426; EU-0101278; FT-0643154; W-102; Y0477; A11932; S-7696; 543W232; C-23063; SR-01000076200-1; SR-01000076200-4; WIN 55,212-2 MESYLATE in Methanol (1000ug/ml); (R)-(+)-WIN 55,212-2 mesylate salt, >=98% (HPLC); (11R)-2-methyl-11-[(morpholin-4-yl)methyl]-3-(naphthalene-1-carbonyl)-9-oxa-1-azatricyclo[6.3.1.0?,(1)(2)]dodeca-2,4,6,8(12)-tetraene; methanesulfonic acid; (R)-(+)-(2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo(1,2,3-de)-1,4-benzoxazin-6-yl)-1-napthalenylmethanone; (R)-(+)-[2,3-Dihydro-5-methyl-3[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(; (R)-(5-methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1-yl)methanone mesylate; (R)-5-Methyl-3-(morpholinomethyl)-6-(1-naphthylcarbonyl)-2,3-dihydro-[1,4]oxazino[2,3,4-hi]indole Methanesulfonate; Methanesulfonic acid--{(3R)-5-methyl-3-[(morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl}(naphthalen-1-yl)methanone (1/1)",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C28H30N2O6S",
            "molecular_weight": "522.6",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "6604176",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F02010203"
            ],
            "references": [
                "RC01290",
                "RC01304"
            ]
        },
        {
            "compound_ID": "D0186",
            "name": "Hippuristanol",
            "synonyms": "SCHEMBL21358104",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C28H46O5",
            "molecular_weight": "462.7",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "9981822",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0187",
            "name": "IQ",
            "synonyms": "76180-96-6; 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine; 2-Amino-3-methylimidazo(4,5-f)quinoline; 2-Amino-3-methyl-3H-imidazo[4,5-f]quinoline; 2-Amino-3-methylimidazo[4,5-f]quinoline; N3-IQ; IQ; 2-AMINO-3-METHYL-3H-IMIDAZO(4,5-F)QUINOLINE; UNII-30GL3D3T0G; 3-Methyl-3H-imidazo(4,5-f)quinolin-2-amine; CCRIS 1767; HSDB 7085; 2-Amino-3-methylimidazo(4,5-f)-quinoline; BRN 5014055; 30GL3D3T0G; CHEBI:42725; 3H-Imidazo(4,5-f)quinolin-2-amine, 3-methyl-; 3H-Imidazo(4,5-f)quinoline, 2-amino-3-methyl-; GIQ; 3-methylimidazo[4,5-f]quinolin-2-amine; 2-AMIQ; 2-amino-3-methylimidazolo(4,5-f)quinoline; DSSTox_CID_745; 2-amino-3-methylimidazo(4,5-f)- quinoline; DSSTox_RID_75766; DSSTox_GSID_20745; SCHEMBL605923; 2-amino-3-methylimidazo(4,5-f)quinoline hydrobromide; 2-AMINO-3-METHYL-3H-IMIDAZO-[4,5-f]-QUINOLINE; CHEMBL1233049; DTXSID4020745; CTK2H9492; OR1650T; ARZWATDYIYAUTA-UHFFFAOYSA-N; KS-00002A2C; ZX-AT000582; Tox21_200693; ZINC13282307; AKOS026675474; LS-7161; PS-3912; NCGC00248800-01; NCGC00258247-01; CAS-76180-96-6; FT-0611062; C19180; 2-Amino-3-methyl-imidazo[4,5-f]quinoline (IQ); Q27120486; (3-methyl-3H-pyrido[3,2-e]benzoimidazol-2-yl)-amine; 2-Amino-3-methyl-3H-imidazo[4 pound not5-f]quinoline; 2-Amino-3-methyl-3H-imidazo[4,5-f]quinoline 10 microg/mL in Acetonitrile",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C11H10N4",
            "molecular_weight": "198.22",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "53462",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0189",
            "name": "4-diethylaminobenz-aldehyde",
            "synonyms": "4-(Diethylamino)benzaldehyde; 120-21-8; 4-Diethylaminobenzaldehyde; Benzaldehyde, 4-(diethylamino)-; p-(Diethylamino)benzaldehyde; p-Formyl-N,N-diethylaniline; 4-(N,N-Diethylamino)benzaldehyde; 4-(Diethylamino)-Benzaldehyde; Benzaldehyde, p-(diethylamino)-; NSC 8782; UNII-S640XWL10H; p-N,N-diethylaminobenzaldehyde; p-DIETHYLAMINOBENZALDEHYDE; CHEBI:86194; EINECS 204-377-4; MFCD00003382; AI3-05886; S640XWL10H; CHEMBL3416563; MNFZZNNFORDXSV-UHFFFAOYSA-N; 4-(N,N-diethylamino)-benzaldehyde; 4-(Diethylamino)benzaldehyde, 99%; ST093335; PubChem22031; p-Diethylaminobenzaldhyde; DSSTox_CID_1963; p-diethylamino benzaldehyde; p-diethylamino-benzaldehyde; 4-diethylamino benzaldehyde; ACMC-209a6r; DSSTox_GSID_21963; KSC490K9N; 4-(diethylamino) benzaldehyde; SCHEMBL195135; 4-n,n-diethylaminobenzaldehyde; 4-N,N-Diethylamino benzaldehyde; DTXSID0021963; CTK3J0596; 4-Diethylaminobenzaldehyde, 99%; NSC8782; 4-(N,N-diethyl)aminobenzaldehyde; BENZALDEHYDE,4-DIETHYLAMINO; ZINC157147; KS-00000VB2; NSC-8782; Tox21_303895; ANW-17473; BBL009749; BDBM50076742; SBB040233; STK187548; AKOS000118909; CS-W017361; HY-W016645; MCULE-4810264892; PS-6119; RTR-030884; TRA0073478; Benzaldehyde, p-(diethylamino)- (8CI); NCGC00357151-01; BP-21432; CAS-120-21-8; L574; LS-24998; SC-77220; DB-041543; TR-030884; D0463; FT-0618338; ST24028804; K-1427; A804467; W-108483; Q27158973; F2190-0606; InChI=1/C11H15NO/c1-3-12(4-2)11-7-5-10(9-13)6-8-11/h5-9H,3-4H2,1-2H; 54337-10-9",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C11H15NO",
            "molecular_weight": "177.24",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "67114",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F02010203"
            ],
            "references": [
                "RC01292",
                "RC01306"
            ]
        },
        {
            "compound_ID": "D0190",
            "name": "Lead",
            "synonyms": "Lead; 7439-92-1; Plumbum; Blei; Lead metal; Lead cation Pb4+; Glover; Lead element; Lead flake; Lead, elemental; Omaha & grant; C.I. Pigment Metal 4; Olow [Polish]; Rough lead bullion; CI pigment metal 4; Lead S2; Lead S 2; Lead ion (1 ); Lead, ion (Pb4+); Lead, inorganic; Pb; SSO 1; UNII-7Y62STE4M2; CCRIS 1581; HSDB 231; KS-4; lead(0); Pb-S 100; UNII-2P299V784P; C.I. 77575; EINECS 231-100-4; CI 77575; 7Y62STE4M2; Trimethyl Lead Ion; MFCD00134050; 2P299V784P; Lead, elemental and inorganic compounds; plomo; Lead, 99+%, powder; Lead, 99+%, granular; 54076-28-7; plomb; Olow; Plumbum metallicum; Lead and compounds; Lead and compounds (inorganic); LEAD COMPOUNDS; Lead and lead compounds; Lead 240; Lead isotope of mass 240; 240Pb; lead atom; Lead, p.a.; ACMC-1BLMK; 82Pb; EC 231-100-4; KSC271O5H; Pb(0); DTXSID2024161; CHEBI:25016; CHEBI:27889; CHEBI:30180; CTK1H1753; HSDB 6923; Pb(4+); DTXSID50274754; DTXSID70872438; 8973AF; AKOS028108231; LS-1638; RTR-031604; TRA0068821; KS-0000117A; Bullet lead, NIST(R) SRM(R) C2416; TR-031604; Lead granules, approximately 3mm (0.12in); High-purity lead, NIST(R) SRM(R) C2418; C06696; Lead, rod, 50mm, diameter 50mm, 99.95%; Lead, rod, 100mm, diameter 50mm, 99.95%; Lead, rod, 200mm, diameter 50mm, 99.95%; Lead, shot, <2 mm, 99.9% trace metals basis; Lead, rod, 1000mm, diameter 3.2mm, 99.95%; Lead, rod, 100mm, diameter 12.7mm, 99.95%; Lead, rod, 100mm, diameter 19.0mm, 99.95%; Lead, rod, 100mm, diameter 6.35mm, 99.95%; Lead, rod, 200mm, diameter 12.7mm, 99.95%; Lead, rod, 200mm, diameter 19.0mm, 99.95%; Lead, rod, 200mm, diameter 6.35mm, 99.95%; Lead, rod, 500mm, diameter 12.7mm, 99.95%; Lead, rod, 500mm, diameter 19.0mm, 99.95%; Lead, rod, 500mm, diameter 3.2mm, 99.95%; Lead, rod, 500mm, diameter 6.35mm, 99.95%; Lead, rod, 1000mm, diameter 12.7mm, 99.95%; Lead, rod, 1000mm, diameter 19.0mm, 99.95%; Lead, rod, 1000mm, diameter 6.35mm, 99.95%; Lead, shot, 1-3 mm, 99.995% trace metals basis; Common lead isotopic standard, NIST(R) SRM(R) 981; Lead, plasma standard solution, Specpure, Pb 10g/ml; Lead, powder, -325 mesh, >=99% trace metals basis; Lead, shot, 1-3 mm, 99.9995% trace metals basis; Q27110449; Q27882203; L007100000; Lead, foil, 10mm disks, thickness 0.01mm, 99.99+%; Lead, foil, 10mm disks, thickness 0.02mm, 99.99+%; Lead, foil, 10mm disks, thickness 0.03mm, 99.99+%; Lead, foil, 10mm disks, thickness 0.04mm, 99.99+%; Lead, foil, 10mm disks, thickness 0.05mm, 99.99+%; Lead, foil, 15mm disks, thickness 0.01mm, 99.99+%; Lead, foil, 15mm disks, thickness 0.02mm, 99.99+%; Lead, foil, 15mm disks, thickness 0.03mm, 99.99+%; Lead, foil, 15mm disks, thickness 0.04mm, 99.99+%; Lead, foil, 15mm disks, thickness 0.05mm, 99.99+%; Lead, foil, 25mm disks, thickness 0.02mm, 99.99+%; Lead, foil, 25mm disks, thickness 0.03mm, 99.99+%; Lead, foil, 25mm disks, thickness 0.04mm, 99.99+%; Lead, foil, 25mm disks, thickness 0.05mm, 99.99+%; Lead, foil, 4mm disks, thickness 0.006mm, 99.99+%; Lead, foil, 4mm disks, thickness 0.007mm, 99.99+%; Lead, foil, 4mm disks, thickness 0.008mm, 99.99+%; Lead, foil, 4mm disks, thickness 0.009mm, 99.99+%; Lead, foil, 4mm disks, thickness 0.015mm, 99.99+%; Lead, foil, 4mm disks, thickness 0.01mm, 99.99+%; Lead, foil, 4mm disks, thickness 0.025mm, 99.99+%; Lead, foil, 4mm disks, thickness 0.02mm, 99.99+%; Lead, foil, 4mm disks, thickness 0.03mm, 99.99+%; Lead, foil, 4mm disks, thickness 0.04mm, 99.99+%; Lead, foil, 4mm disks, thickness 0.05mm, 99.99+%; Lead, foil, 6mm disks, thickness 0.006mm, 99.99+%; Lead, foil, 6mm disks, thickness 0.007mm, 99.99+%; Lead, foil, 6mm disks, thickness 0.008mm, 99.99+%; Lead, foil, 6mm disks, thickness 0.009mm, 99.99+%; Lead, foil, 6mm disks, thickness 0.015mm, 99.99+%; Lead, foil, 6mm disks, thickness 0.01mm, 99.99+%; Lead, foil, 6mm disks, thickness 0.025mm, 99.99+%; Lead, foil, 6mm disks, thickness 0.02mm, 99.99+%; Lead, foil, 6mm disks, thickness 0.03mm, 99.99+%; Lead, foil, 6mm disks, thickness 0.04mm, 99.99+%; Lead, foil, 6mm disks, thickness 0.05mm, 99.99+%; Lead, foil, 8mm disks, thickness 0.006mm, 99.99+%; Lead, foil, 8mm disks, thickness 0.007mm, 99.99+%; Lead, foil, 8mm disks, thickness 0.008mm, 99.99+%; Lead, foil, 8mm disks, thickness 0.009mm, 99.99+%; Lead, foil, 8mm disks, thickness 0.015mm, 99.99+%; Lead, foil, 8mm disks, thickness 0.01mm, 99.99+%; Lead, foil, 8mm disks, thickness 0.025mm, 99.99+%; Lead, foil, 8mm disks, thickness 0.02mm, 99.99+%; Lead, foil, 8mm disks, thickness 0.03mm, 99.99+%; Lead, foil, 8mm disks, thickness 0.04mm, 99.99+%; Lead, foil, 8mm disks, thickness 0.05mm, 99.99+%; Lead, powder, -100 mesh, 99.95% trace metals basis; Lead, wire, diam. 1.0 mm, 99.99% trace metals basis; Lead, foil, 10mm disks, thickness 0.006mm, 99.99+%; Lead, foil, 10mm disks, thickness 0.007mm, 99.99+%; Lead, foil, 10mm disks, thickness 0.008mm, 99.99+%; Lead, foil, 10mm disks, thickness 0.009mm, 99.99+%; Lead, foil, 10mm disks, thickness 0.0125mm, 99.99+%; Lead, foil, 10mm disks, thickness 0.015mm, 99.99+%; Lead, foil, 10mm disks, thickness 0.025mm, 99.99+%; Lead, foil, 15mm disks, thickness 0.006mm, 99.99+%; Lead, foil, 15mm disks, thickness 0.007mm, 99.99+%; Lead, foil, 15mm disks, thickness 0.008mm, 99.99+%; Lead, foil, 15mm disks, thickness 0.009mm, 99.99+%; Lead, foil, 15mm disks, thickness 0.0125mm, 99.99+%; Lead, foil, 15mm disks, thickness 0.015mm, 99.99+%; Lead, foil, 15mm disks, thickness 0.025mm, 99.99+%; Lead, foil, 1m coil, thickness 1.0mm, as rolled, 99.5%; Lead, foil, 25mm disks, thickness 0.025mm, 99.99+%; Lead, foil, 2m coil, thickness 1.0mm, as rolled, 99.5%; Lead, foil, 4mm disks, thickness 0.0125mm, 99.99+%; Lead, foil, 6mm disks, thickness 0.0125mm, 99.99+%; Lead, foil, 8mm disks, thickness 0.0125mm, 99.99+%; Lead, Oil based standard solution, Specpure, Pb 5000g/g; Lead, foil, 0.5m coil, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 0.5m coil, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 0.5m coil, thickness 1.0mm, as rolled, 99.5%; Lead, foil, 0.5m coil, thickness 1.0mm, as rolled, 99.95%; Lead, foil, 0.5m coil, thickness 2.0mm, as rolled, 99.95%; Lead, foil, 100x100mm, thickness 1.0mm, as rolled, 99.5%; Lead, foil, 10m coil, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 10m coil, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 10mm disks, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 10mm disks, thickness 0.55mm, as rolled, 100%; Lead, foil, 10mm disks, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 150x150mm, thickness 1.0mm, as rolled, 99.5%; Lead, foil, 15mm disks, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 15mm disks, thickness 0.55mm, as rolled, 100%; Lead, foil, 15mm disks, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 1m coil, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 1m coil, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 1m coil, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 1m coil, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 1m coil, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 1m coil, thickness 1.0mm, as rolled, 99.95%; Lead, foil, 1m coil, thickness 2.0mm, as rolled, 99.95%; Lead, foil, 25mm disks, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 25mm disks, thickness 0.55mm, as rolled, 100%; Lead, foil, 25mm disks, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 25x25mm, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 25x25mm, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 25x25mm, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 25x25mm, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 25x25mm, thickness 0.5mm, as rolled, 99.99+%; Lead, foil, 25x25mm, thickness 1.0mm, as rolled, 99.5%; Lead, foil, 25x25mm, thickness 1.0mm, as rolled, 99.95%; Lead, foil, 25x25mm, thickness 1.0mm, as rolled, 99.99+%; Lead, foil, 25x25mm, thickness 1.5mm, as rolled, 99.99+%; Lead, foil, 25x25mm, thickness 2.0mm, as rolled, 99.95%; Lead, foil, 25x25mm, thickness 3.0mm, as rolled, 99.99+%; Lead, foil, 2m coil, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 2m coil, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 2m coil, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 2m coil, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 2m coil, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 2m coil, thickness 1.0mm, as rolled, 99.95%; Lead, foil, 300x300mm, thickness 1.0mm, as rolled, 99.5%; Lead, foil, 4mm disks, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 4mm disks, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 4mm disks, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 4mm disks, thickness 0.55mm, as rolled, 100%; Lead, foil, 4mm disks, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 4mm disks, thickness 0.5mm, as rolled, 99.99+%; Lead, foil, 4mm disks, thickness 1.0mm, as rolled, 99.99+%; Lead, foil, 50mm disks, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 50mm disks, thickness 0.55mm, as rolled, 100%; Lead, foil, 50mm disks, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 50x50mm, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 50x50mm, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 50x50mm, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 50x50mm, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 50x50mm, thickness 0.5mm, as rolled, 99.99+%; Lead, foil, 50x50mm, thickness 1.0mm, as rolled, 99.5%; Lead, foil, 50x50mm, thickness 1.0mm, as rolled, 99.95%; Lead, foil, 50x50mm, thickness 1.0mm, as rolled, 99.99+%; Lead, foil, 50x50mm, thickness 1.5mm, as rolled, 99.99+%; Lead, foil, 50x50mm, thickness 2.0mm, as rolled, 99.95%; Lead, foil, 50x50mm, thickness 2.7mm, as rolled, 99.95%; Lead, foil, 50x50mm, thickness 3.0mm, as rolled, 99.95%; Lead, foil, 50x50mm, thickness 3.0mm, as rolled, 99.99+%; Lead, foil, 50x50mm, thickness 6.0mm, as rolled, 99.99+%; Lead, foil, 5m coil, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 5m coil, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 5m coil, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 5m coil, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 6mm disks, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 6mm disks, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 6mm disks, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 6mm disks, thickness 0.55mm, as rolled, 100%; Lead, foil, 6mm disks, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 6mm disks, thickness 0.5mm, as rolled, 99.99+%; Lead, foil, 6mm disks, thickness 1.0mm, as rolled, 99.99+%; Lead, foil, 75x100mm, thickness 2.7mm, as rolled, 99.95%; Lead, foil, 8mm disks, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 8mm disks, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 8mm disks, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 8mm disks, thickness 0.55mm, as rolled, 100%; Lead, foil, 8mm disks, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 8mm disks, thickness 0.5mm, as rolled, 99.99+%; Lead, foil, 8mm disks, thickness 1.0mm, as rolled, 99.99+%; Lead, foil, thickness 0.20 mm, length 1 m, purity 99.95%; Lead, foil, thickness 0.20 mm, length 2 m, purity 99.95%; Lead, foil, thickness 0.20 mm, length 5 m, purity 99.95%; Lead, foil, thickness 0.40 mm, length 1 m, purity 99.95%; Lead, foil, thickness 0.40 mm, length 2 m, purity 99.95%; Lead, foil, thickness 0.40 mm, length 5 m, purity 99.95%; Lead, rod, 5.0 mm diameter, length 100 mm, purity 99.95%; Lead, rod, 5.0 mm diameter, length 1000 mm, purity 99.95%; Lead, rod, 5.0 mm diameter, length 200 mm, purity 99.95%; Lead, rod, length 500 mm, 5.0 mm diameter, purity 99.95%; Lead, wire reel, 0.1m, diameter 0.5mm, as drawn, 99.99+%; Lead, wire reel, 0.1m, diameter 0.5mm, as drawn, 99.999%; Lead, wire reel, 0.1m, diameter 1.0mm, as drawn, 99.99+%; Lead, wire reel, 0.1m, diameter 2.0mm, as drawn, 99.99+%; Lead, wire reel, 0.1m, diameter 3.0mm, as drawn, 99.99+%; Lead, wire reel, 0.5m, diameter 0.125mm, as drawn, 99.5%; Lead, wire reel, 0.5m, diameter 0.5mm, as drawn, 99.99+%; Lead, wire reel, 0.5m, diameter 0.5mm, as drawn, 99.999%; Lead, wire reel, 0.5m, diameter 1.0mm, as drawn, 99.99+%; Lead, wire reel, 0.5m, diameter 2.0mm, as drawn, 99.99+%; Lead, wire reel, 0.5m, diameter 3.0mm, as drawn, 99.99+%; Lead, wire reel, 10m, diameter 0.125mm, as drawn, 99.5%; Lead, wire reel, 10m, diameter 0.25mm, as drawn, 99.95%; Lead, wire reel, 10m, diameter 0.5mm, as drawn, 99.99+%; Lead, wire reel, 1m, diameter 0.125mm, as drawn, 99.5%; Lead, wire reel, 1m, diameter 0.25mm, as drawn, 99.95%; Lead, wire reel, 1m, diameter 0.5mm, as drawn, 99.99+%; Lead, wire reel, 1m, diameter 0.5mm, as drawn, 99.999%; Lead, wire reel, 1m, diameter 0.75mm, as drawn, 99.99+%; Lead, wire reel, 1m, diameter 1.0mm, as drawn, 99.99+%; Lead, wire reel, 1m, diameter 2.0mm, as drawn, 99.99+%; Lead, wire reel, 1m, diameter 3.0mm, as drawn, 99.99+%; Lead, wire reel, 20m, diameter 0.125mm, as drawn, 99.5%; Lead, wire reel, 20m, diameter 0.25mm, as drawn, 99.95%; Lead, wire reel, 2m, diameter 0.125mm, as drawn, 99.5%; Lead, wire reel, 2m, diameter 0.25mm, as drawn, 99.95%; Lead, wire reel, 2m, diameter 0.5mm, as drawn, 99.99+%; Lead, wire reel, 2m, diameter 0.5mm, as drawn, 99.999%; Lead, wire reel, 2m, diameter 0.75mm, as drawn, 99.99+%; Lead, wire reel, 2m, diameter 1.0mm, as drawn, 99.99+%; Lead, wire reel, 2m, diameter 2.0mm, as drawn, 99.99+%; Lead, wire reel, 2m, diameter 3.0mm, as drawn, 99.99+%; Lead, wire reel, 5m, diameter 0.125mm, as drawn, 99.5%; Lead, wire reel, 5m, diameter 0.25mm, as drawn, 99.95%; Lead, wire reel, 5m, diameter 0.5mm, as drawn, 99.99+%; Lead, wire reel, 5m, diameter 0.5mm, as drawn, 99.999%; Lead, wire reel, 5m, diameter 0.75mm, as drawn, 99.99+%; Lead, wire reel, 5m, diameter 1.0mm, as drawn, 99.99+%; Lead, wire reel, 5m, diameter 2.0mm, as drawn, 99.99+%; Lead, wire reel, 5m, diameter 3.0mm, as drawn, 99.99+%; Lead (impurities), manufactured by MBH Analytical Ltd (83X PR8); Lead, foil, 0.5m coil, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 0.5m coil, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 0.5m coil, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 1000x1000mm, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 100x100mm, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 100x100mm, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 100x100mm, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 100x100mm, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 100x100mm, thickness 0.25mm, as rolled, 99.99+%; Lead, foil, 100x100mm, thickness 0.55mm, as rolled, 99.999%; Lead, foil, 100x100mm, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 100x100mm, thickness 0.5mm, as rolled, 99.99+%; Lead, foil, 100x100mm, thickness 1.0mm, as rolled, 99.95%; Lead, foil, 100x100mm, thickness 1.0mm, as rolled, 99.99+%; Lead, foil, 100x100mm, thickness 1.5mm, as rolled, 99.99+%; Lead, foil, 100x100mm, thickness 2.0mm, as rolled, 99.95%; Lead, foil, 100x100mm, thickness 3.0mm, as rolled, 99.95%; Lead, foil, 100x100mm, thickness 3.0mm, as rolled, 99.99+%; Lead, foil, 100x100mm, thickness 6.0mm, as rolled, 99.99+%; Lead, foil, 10mm disks, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 10mm disks, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 10mm disks, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 10mm disks, thickness 0.25mm, as rolled, 99.99+%; Lead, foil, 10mm disks, thickness 0.5mm, as rolled, 99.99+%; Lead, foil, 10mm disks, thickness 1.0mm, as rolled, 99.99+%; Lead, foil, 150x150mm, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 150x150mm, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 150x150mm, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 150x150mm, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 150x150mm, thickness 0.55mm, as rolled, 99.999%; Lead, foil, 150x150mm, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 150x150mm, thickness 1.0mm, as rolled, 99.95%; Lead, foil, 150x150mm, thickness 2.0mm, as rolled, 99.95%; Lead, foil, 15mm disks, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 15mm disks, thickness 0.125mm, as rolled, 99.99+%; Lead, foil, 15mm disks, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 15mm disks, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 15mm disks, thickness 0.25mm, as rolled, 99.99+%; Lead, foil, 15mm disks, thickness 0.5mm, as rolled, 99.99+%; Lead, foil, 15mm disks, thickness 1.0mm, as rolled, 99.99+%; Lead, foil, 250x250mm, thickness 3.0mm, as rolled, 99.95%; Lead, foil, 25mm disks, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 25mm disks, thickness 0.125mm, as rolled, 99.99+%; Lead, foil, 25mm disks, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 25mm disks, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 25mm disks, thickness 0.25mm, as rolled, 99.99+%; Lead, foil, 25mm disks, thickness 1.0mm, as rolled, 99.99+%; Lead, foil, 25x25mm, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 25x25mm, thickness 0.125mm, as rolled, 99.99+%; Lead, foil, 25x25mm, thickness 0.25mm, as rolled, 99.99+%; Lead, foil, 25x25mm, thickness 0.55mm, as rolled, 99.999%; Lead, foil, 300x300mm, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 300x300mm, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 300x300mm, thickness 0.1mm, as rolled, 99.95%; Lead, foil, 300x300mm, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 300x300mm, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 300x300mm, thickness 1.0mm, as rolled, 99.95%; Lead, foil, 300x300mm, thickness 2.0mm, as rolled, 99.95%; Lead, foil, 4mm disks, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 4mm disks, thickness 0.125mm, as rolled, 99.99+%; Lead, foil, 4mm disks, thickness 0.25mm, as rolled, 99.99+%; Lead, foil, 500x1000mm, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 500x1000mm, thickness 1.0mm, as rolled, 99.95%; Lead, foil, 500x500mm, thickness 0.5mm, as rolled, 99.95%; Lead, foil, 500x500mm, thickness 1.0mm, as rolled, 99.95%; Lead, foil, 500x500mm, thickness 2.0mm, as rolled, 99.95%; Lead, foil, 500x500mm, thickness 3.0mm, as rolled, 99.95%; Lead, foil, 50mm disks, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 50mm disks, thickness 0.15mm, as rolled, 99.95%; Lead, foil, 50mm disks, thickness 0.25mm, as rolled, 99.95%; Lead, foil, 50x50mm, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 50x50mm, thickness 0.125mm, as rolled, 99.99+%; Lead, foil, 50x50mm, thickness 0.25mm, as rolled, 99.99+%; Lead, foil, 50x50mm, thickness 0.55mm, as rolled, 99.999%; Lead, foil, 6mm disks, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 6mm disks, thickness 0.25mm, as rolled, 99.99+%; Lead, foil, 8mm disks, thickness 0.125mm, as rolled, 99.95%; Lead, foil, 8mm disks, thickness 0.25mm, as rolled, 99.99+%; Lead, foil, light tested, 25x25mm, thickness 0.007mm, 99.99+%; Lead, foil, light tested, 25x25mm, thickness 0.008mm, 99.99+%; Lead, foil, light tested, 25x25mm, thickness 0.009mm, 99.99+%; Lead, foil, light tested, 25x25mm, thickness 0.015mm, 99.99+%; Lead, foil, light tested, 25x25mm, thickness 0.01mm, 99.99+%; Lead, foil, light tested, 25x25mm, thickness 0.025mm, 99.99+%; Lead, foil, light tested, 25x25mm, thickness 0.02mm, 99.99+%; Lead, foil, light tested, 25x25mm, thickness 0.03mm, 99.99+%; Lead, foil, light tested, 25x25mm, thickness 0.04mm, 99.99+%; Lead, foil, light tested, 25x25mm, thickness 0.05mm, 99.99+%; Lead, foil, light tested, 50x50mm, thickness 0.008mm, 99.99+%; Lead, foil, light tested, 50x50mm, thickness 0.009mm, 99.99+%; Lead, foil, light tested, 50x50mm, thickness 0.015mm, 99.99+%; Lead, foil, light tested, 50x50mm, thickness 0.01mm, 99.99+%; Lead, foil, light tested, 50x50mm, thickness 0.025mm, 99.99+%; Lead, foil, light tested, 50x50mm, thickness 0.02mm, 99.99+%; Lead, foil, light tested, 50x50mm, thickness 0.03mm, 99.99+%; Lead, foil, light tested, 50x50mm, thickness 0.04mm, 99.99+%; Lead, foil, light tested, 50x50mm, thickness 0.05mm, 99.99+%; Lead, foil, thickness 0.20 mm, 10 mm diameter, purity 99.95%; Lead, foil, thickness 0.20 mm, 15 mm diameter, purity 99.95%; Lead, foil, thickness 0.20 mm, 4 mm diameter, purity 99.95%; Lead, foil, thickness 0.20 mm, 50 mm diameter, purity 99.95%; Lead, foil, thickness 0.20 mm, 6 mm diameter, purity 99.95%; Lead, foil, thickness 0.20 mm, diameter 25 mm, purity 99.95%; Lead, foil, thickness 0.20 mm, diameter 8 mm, purity 99.95%; Lead, foil, thickness 0.20 mm, length 0.5 m, purity 99.95%; Lead, foil, thickness 0.20 mm, size 25 x 25 mm, purity 99.95%; Lead, foil, thickness 0.20 mm, size 50 x 50 mm, purity 99.95%; Lead, foil, thickness 0.40 mm, 15 mm diameter, purity 99.95%; Lead, foil, thickness 0.40 mm, 25 mm diameter, purity 99.95%; Lead, foil, thickness 0.40 mm, 4 mm diameter, purity 99.95%; Lead, foil, thickness 0.40 mm, 6 mm diameter, purity 99.95%; Lead, foil, thickness 0.40 mm, diameter 10 mm, purity 99.95%; Lead, foil, thickness 0.40 mm, diameter 50 mm, purity 99.95%; Lead, foil, thickness 0.40 mm, diameter 8 mm, purity 99.95%; Lead, foil, thickness 0.40 mm, length 0.5 m, purity 99.95%; Lead, foil, thickness 0.40 mm, size 25 x 25 mm, purity 99.95%; Lead, foil, thickness 0.40 mm, size 50 x 50 mm, purity 99.95%; Lead, foil, thickness 0.5 mm, size 500 x 500 mm, purity 99.5%; Lead, foil, thickness 1.0 mm, size 100 x 100 mm, tolerance 0.2; Lead, foil, thickness 1.0 mm, size 25 x 25 mm, tolerance 0.2; Lead, foil, thickness 1.0 mm, size 50 x 50 mm, tolerance 0.2; Lead, foil, thickness 1.0 mm, size 500 x 500 mm, purity 99.5%; Lead, foil, thickness 2.0 mm, size 90 x 125 mm, purity 99.95%; Lead, foil, thickness 6.0 mm, size 50 x 50 mm, purity 99.95%; Lead, wire reel, 0.1m, diameter 0.75mm, as drawn, 99.99+%; Lead, wire reel, 0.5m, diameter 0.75mm, as drawn, 99.99+%; Lead, wire, 0.6 mm diameter, length 1 m, high purity 99.999%; Lead, wire, 0.6 mm diameter, length 2 m, high purity 99.999%; Lead, wire, length 0.1 m, 0.6 mm diameter, high purity 99.999%; Lead, wire, length 0.5 m, 0.6 mm diameter, high purity 99.999%; Lead, foil, light tested, 100x100mm, thickness 0.025mm, 99.99+%; Lead, foil, light tested, 100x100mm, thickness 0.03mm, 99.99+%; Lead, foil, light tested, 100x100mm, thickness 0.04mm, 99.99+%; Lead, foil, light tested, 100x100mm, thickness 0.05mm, 99.99+%; Lead, foil, light tested, 25x25mm, thickness 0.0125mm, 99.99+%; Lead, foil, light tested, 50x50mm, thickness 0.0125mm, 99.99+%; Lead, foil, not light tested, 100x100mm, thickness 0.004mm, 99.99+%; Lead, foil, not light tested, 100x100mm, thickness 0.005mm, 99.99+%; Lead, foil, not light tested, 100x100mm, thickness 0.006mm, 99.99+%; Lead, foil, not light tested, 100x100mm, thickness 0.007mm, 99.99+%; Lead, foil, not light tested, 100x100mm, thickness 0.008mm, 99.99+%; Lead, foil, not light tested, 100x100mm, thickness 0.009mm, 99.99+%; Lead, foil, not light tested, 100x100mm, thickness 0.0125mm, 99.99+%; Lead, foil, not light tested, 100x100mm, thickness 0.01mm, 99.99+%; Lead, foil, not light tested, 100x100mm, thickness 0.025mm, 99.99+%; Lead, foil, not light tested, 100x100mm, thickness 0.02mm, 99.99+%; Lead, foil, not light tested, 100x100mm, thickness 0.03mm, 99.99+%; Lead, foil, not light tested, 100x100mm, thickness 0.04mm, 99.99+%; Lead, foil, not light tested, 150x150mm, thickness 0.025mm, 99.99+%; Lead, foil, not light tested, 150x150mm, thickness 0.02mm, 99.99+%; Lead, foil, not light tested, 150x150mm, thickness 0.03mm, 99.99+%; Lead, foil, not light tested, 150x150mm, thickness 0.04mm, 99.99+%; Lead, foil, not light tested, 150x150mm, thickness 0.05mm, 99.99+%; Lead, foil, not light tested, 25x25mm, thickness 0.003mm, 99.99+%; Lead, foil, not light tested, 25x25mm, thickness 0.004mm, 99.99+%; Lead, foil, not light tested, 25x25mm, thickness 0.006mm, 99.99+%; Lead, foil, not light tested, 25x25mm, thickness 0.007mm, 99.99+%; Lead, foil, not light tested, 25x25mm, thickness 0.008mm, 99.99+%; Lead, foil, not light tested, 25x25mm, thickness 0.009mm, 99.99+%; Lead, foil, not light tested, 25x25mm, thickness 0.0125mm, 99.99+%; Lead, foil, not light tested, 25x25mm, thickness 0.015mm, 99.99+%; Lead, foil, not light tested, 25x25mm, thickness 0.01mm, 99.99+%; Lead, foil, not light tested, 25x25mm, thickness 0.02mm, 99.99+%; Lead, foil, not light tested, 50x50mm, thickness 0.003mm, 99.99+%; Lead, foil, not light tested, 50x50mm, thickness 0.004mm, 99.99+%; Lead, foil, not light tested, 50x50mm, thickness 0.005mm, 99.99+%; Lead, foil, not light tested, 50x50mm, thickness 0.006mm, 99.99+%; Lead, foil, not light tested, 50x50mm, thickness 0.007mm, 99.99+%; Lead, foil, not light tested, 50x50mm, thickness 0.008mm, 99.99+%; Lead, foil, not light tested, 50x50mm, thickness 0.009mm, 99.99+%; Lead, foil, not light tested, 50x50mm, thickness 0.0125mm, 99.99+%; Lead, foil, not light tested, 50x50mm, thickness 0.015mm, 99.99+%; Lead, foil, not light tested, 50x50mm, thickness 0.01mm, 99.99+%; Lead, foil, not light tested, 50x50mm, thickness 0.025mm, 99.99+%; Lead, foil, not light tested, 50x50mm, thickness 0.02mm, 99.99+%; Lead, foil, not light tested, 50x50mm, thickness 0.03mm, 99.99+%; Lead, foil, thickness 0.0045 mm, size 25 x 25 mm, purity 99.99+%; Lead, foil, thickness 0.0045 mm, size 50 x 50 mm, purity 99.99+%; Lead, foil, thickness 0.20 mm, size 100 x 100 mm, purity 99.95%; Lead, foil, thickness 0.20 mm, size 150 x 150 mm, purity 99.95%; Lead, foil, thickness 0.20 mm, size 300 x 300 mm, purity 99.95%; Lead, foil, thickness 0.40 mm, size 100 x 100 mm, purity 99.95%; Lead, foil, thickness 0.40 mm, size 150 x 150 mm, purity 99.95%; Lead, foil, thickness 0.40 mm, size 300 x 300 mm, purity 99.95%; Lead, foil, thickness 0.5 mm, 25 mm diameter, high purity 99.99+%; Lead, foil, thickness 0.5 mm, size 1000 x 1000 mm, purity 99.5%; Lead, foil, thickness 0.5 mm, size 500 x 1000 mm, purity 99.5%; Lead, foil, thickness 0.75 mm, size 300 x 300 mm, temper as rolled; Lead, foil, thickness 1.0 mm, size 1000 x 1000 mm, purity 99.5%; Lead, foil, thickness 1.0 mm, size 500 x 1000 mm, purity 99.5%; Lead, foil, thickness 6.0 mm, size 100 x 100 mm, purity 99.95%; Lead, foil, thickness 6.0 mm, size 250 x 250 mm, purity 99.95%; Lead, granule, 3 mm nominal granule size, weight 10 g, purity 99.97%; Lead, lump, 10 mm max. lump size, weight 100 g, high purity 99.99+%; Lead, lump, 10 mm max. lump size, weight 200 g, high purity 99.99+%; Lead, lump, 10 mm max. lump size, weight 50 g, high purity 99.99+%; Lead, lump, 10 mm max. lump size, weight 500 g, high purity 99.99+%; Lead, lump, 5 mm max. lump size, weight 10 g, high purity 99.999%; Lead, lump, 5 mm max. lump size, weight 100 g, high purity 99.999%; Lead, lump, 5 mm max. lump size, weight 20 g, high purity 99.999%; Lead, lump, 5 mm max. lump size, weight 50 g, high purity 99.999%; Lead, Natural Pb, plasma standard solution, Specpure, Natural Pb 100g/ml; Lead, NIST Pb, plasma standard solution, Specpure, NIST Pb 100g/ml; Lead, powder, 150 max. part. size (micron), weight 200 g, purity 99.5%; Lead, powder, 150 max. part. size (micron), weight 500 g, purity 99.5%; Lead, powder, 45 max. part. size (micron), weight 1000 g, purity 99.5%; Lead, powder, 45 max. part. size (micron), weight 500 g, purity 99.5%; Lead, powder, max. particle size 150 micron, weight 100 g, purity 99.5%; Lead, powder, max. particle size 45 micron, weight 100 g, purity 99.5%; Lead, powder, max. particle size 45 micron, weight 200 g, purity 99.5%; Lead, powder, max. particle size 45 micron, weight 2000 g, purity 99.5%; Lead ribbon, 76.2mm (3.0in) wide, 0.15mm (0.006in) thick, low silver (<0.0001%),; Lead, foil, 0.5m coil, thickness 0.016mm, as rolled, 96% (sn 1.5%, sb 2.5%); Lead, foil, 0.5m coil, thickness 0.05mm, as rolled, 97% (sn 1.5%, sb 1.5%); Lead, foil, 10m coil, thickness 0.12mm, coil width 25.4mm, as rolled, 99.95%; Lead, foil, 1m coil, thickness 0.016mm, as rolled, 96% (sn 1.5%, sb 2.5%); Lead, foil, 1m coil, thickness 0.05mm, as rolled, 97% (sn 1.5%, sb 1.5%); Lead, foil, 1m coil, thickness 0.12mm, coil width 25.4mm, as rolled, 99.95%; Lead, foil, 20m coil, thickness 0.12mm, coil width 25.4mm, as rolled, 99.95%; Lead, foil, 2m coil, thickness 0.016mm, as rolled, 96% (sn 1.5%, sb 2.5%); Lead, foil, 2m coil, thickness 0.05mm, as rolled, 97% (sn 1.5%, sb 1.5%); Lead, foil, 2m coil, thickness 0.12mm, coil width 25.4mm, as rolled, 99.95%; Lead, foil, 5m coil, thickness 0.016mm, as rolled, 96% (sn 1.5%, sb 2.5%); Lead, foil, 5m coil, thickness 0.05mm, as rolled, 97% (sn 1.5%, sb 1.5%); Lead, foil, 5m coil, thickness 0.12mm, coil width 25.4mm, as rolled, 99.95%; Lead, foil, light tested, 25x25mm, thickness 0.05mm, as rolled, 99.99+%; Lead, foil, light tested, 50x50mm, thickness 0.05mm, as rolled, 99.99+%; Lead, foil, thickness 0.125 mm, size 100 x 100 mm, high purity 99.99+%; Lead, powder, max. particle size 150 micron, weight 1000 g, purity 99.5%; Lead, powder, max. particle size 150 micron, weight 2000 g, purity 99.5%; Lead atomic spectroscopy standard concentrate 1.00 g Pb, 1.00 g/L, for 1L standard solution, analytical standard; Lead atomic spectroscopy standard concentrate 10.00 g Pb, 10.00 g/L, for 1L standard solution, analytical standard; Lead standard solution, suitable for atomic absorption spectrometry, 1 mg/mL Pb, 1000 ppm Pb; Lead, foil, light tested, 100x100mm, thickness 0.016mm, as rolled, 96% (Sn 1.5%, Sb 2.5%); Lead, foil, light tested, 100x100mm, thickness 0.025mm, as rolled, 97% (Sn 1.5%, Sb 1.5%); Lead, foil, light tested, 100x100mm, thickness 0.05mm, as rolled, 97% (Sn 1.5%, Sb 1.5%); Lead, foil, light tested, 150x150mm, thickness 0.016mm, as rolled, 96% (Sn 1.5%, Sb 2.5%); Lead, foil, light tested, 150x150mm, thickness 0.05mm, as rolled, 97% (Sn 1.5%, Sb 1.5%); Lead, foil, light tested, 25x25mm, thickness 0.016mm, as rolled, 96% (Sn 1.5%, Sb 2.5%); Lead, foil, light tested, 25x25mm, thickness 0.025mm, as rolled, 97% (Sn 1.5%, Sb 1.5%); Lead, foil, light tested, 25x25mm, thickness 0.05mm, as rolled, 96% (Sn 1.5%, Sb 2.5%); Lead, foil, light tested, 25x25mm, thickness 0.05mm, as rolled, 97% (Sn 1.5%, Sb 1.5%); Lead, foil, light tested, 50x50mm, thickness 0.016mm, as rolled, 96% (Sn 1.5%, Sb 2.5%); Lead, foil, light tested, 50x50mm, thickness 0.025mm, as rolled, 97% (Sn 1.5%, Sb 1.5%); Lead, foil, light tested, 50x50mm, thickness 0.05mm, as rolled, 96% (Sn 1.5%, Sb 2.5%); Lead, foil, light tested, 50x50mm, thickness 0.05mm, as rolled, 97% (Sn 1.5%, Sb 1.5%); Lead, foil, not light tested, 150x150mm, thickness 0.05mm, as rolled, 96% (Sn 1.5%, Sb 2.5%); Lead, foil, not light tested, 150x150mm, thickness 0.05mm, as rolled, 97% (Sn 1.5%, Sb 1.5%); Lead, foil, not light tested, 250x300mm, thickness 0.025mm, as rolled, 97% (Sn 1.5%, Sb 1.5%); Lead, foil, not light tested, 25x25mm, thickness 0.001mm, temporary acrylic support, 99.99+%; Lead, foil, not light tested, 25x25mm, thickness 0.0025mm, temporary acrylic support, 99.99+%; Lead, foil, not light tested, 25x25mm, thickness 0.002mm, temporary acrylic support, 99.99+%; Lead, foil, not light tested, 300x300mm, thickness 0.016mm, as rolled, 96% (Sn 1.5%, Sb 2.5%); Lead, foil, not light tested, 300x300mm, thickness 0.05mm, as rolled, 97% (Sn 1.5%, Sb 1.5%); Lead, foil, not light tested, 50x50mm, thickness 0.001mm, temporary acrylic support, 99.99+%; Lead, foil, not light tested, 50x50mm, thickness 0.0025mm, temporary acrylic support, 99.99+%; Lead, microfoil, disks, 10mm, thinness 0.001mum, specific density 1.135mug/cm2, permanent mylar 3.5mum support, 99.99+%; Lead, microfoil, disks, 10mm, thinness 0.025mum, specific density 30.9mug/cm2, permanent mylar 3.5mum support, 99.99+%; Lead, microfoil, disks, 10mm, thinness 0.1mum, specific density 103.4mug/cm2, permanent mylar 3.5mum support, 99.99+%; Lead, microfoil, disks, 10mm, thinness 0.25mum, specific density 266.7mug/cm2, permanent mylar 3.5mum support, 99.99+%; Lead, microfoil, disks, 10mm, thinness 1.0mum, specific density 1047.8mug/cm2, permanent mylar 3.5mum support, 99.99+%; Lead, microfoil, disks, 25mm, thinness 0.25mum, specific density 266.7mug/cm2, permanent mylar 3.5mum support, 99.99+%; Lead, microfoil, disks, 25mm, thinness 1.0mum, specific density 1047.8mug/cm2, permanent mylar 3.5mum support, 99.99+%; Lead, tube, 1000mm, outside diameter 6.78mm, inside diameter 4.7mm, wall thickness 1.04mm, 99.9%; Lead, tube, 100mm, outside diameter 6.78mm, inside diameter 4.7mm, wall thickness 1.04mm, 99.9%; Lead, tube, 200mm, outside diameter 6.78mm, inside diameter 4.7mm, wall thickness 1.04mm, 99.9%; Lead, tube, 500mm, outside diameter 6.78mm, inside diameter 4.7mm, wall thickness 1.04mm, 99.9%; ZN7",
            "trade_name": "",
            "abbrev_name": "Pb",
            "description": "heavy metal",
            "molecular_formula": "Pb",
            "molecular_weight": "207",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "5352425",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F0201"
            ],
            "references": [
                "RC03656"
            ]
        },
        {
            "compound_ID": "D0191",
            "name": "Lipopolysaccharide",
            "synonyms": "Lipopolysaccharide; NCGC00188939-01; 127382-EP2295402A2",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C205H366N3O117P5",
            "molecular_weight": "4900",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "11970143",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0192",
            "name": "Manganese",
            "synonyms": "Manganese(2+); Manganese(II); Manganous ion; Manganese (Mn2+); Mn2+; Manganese ion(2+); Manganese cation; MANGANESE(II) ION; Manganese, ion (Mn2+); Manganese(2+)ions; Manganese cation (2+); UNII-H6EP7W5457; 16397-91-4; Mn(II); Mn++; Mn(2+); H6EP7W5457; 15365-82-9; manganese ion; Manganous cation; Manganese dication; Manganous dication; manganese (II); MnII; Manganese(2+) ion; Mn(II) (incorrect); ion (Mn2+); Manganese cation (Mn2+); at. no. 25; Hexaaquamanganese(2+) ion; CHEBI:29035; CTK4C7940; Manganese(2+), hexaaqua-, ion; DTXSID00167687; WAEMQWOKJMHJLA-UHFFFAOYSA-N; DB06757; LS-89223; C19610; Q27095727",
            "trade_name": "",
            "abbrev_name": "Mn",
            "description": "chemical element; transition metal",
            "molecular_formula": "Mn+2",
            "molecular_weight": "54.93804",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "27854",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001",
                "T002",
                "T400",
                "T408"
            ],
            "function": [
                "F0108",
                "F0201",
                "F0303",
                "F0308",
                "F050401",
                "F050501"
            ],
            "references": [
                "RC03657",
                "RC03658",
                "RC03707",
                "RC04084",
                "RC04208",
                "RC04332",
                "RC04456",
                "RC04580"
            ]
        },
        {
            "compound_ID": "D0193",
            "name": "MDMA",
            "synonyms": "MDMA; 3,4-methylenedioxymethamphetamine; Ecstasy; Methylenedioxymethamphetamine; 42542-10-9; Midomafetamine; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; DL-(3,4-Methylenedioxy)methamphetamine; (RS)-3,4-(methylenedioxy)methamphetamine; MDMA (unspecified); N,alpha-Dimethyl-1,3-benzodioxole-5-ethanamine; HSDB 6929; 1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine; CHEBI:1391; DEA No. 7405; (+-)-(3,4-Methylenedioxy)methamphetamine; (+-)-N-Methyl-3,4-(methylenedioxy)amphetamine; 1,3-Benzodioxole-5-ethanamine, N,alpha-dimethyl-; 1-(1,3-Benzodioxol-5-yl)-N-methyl-2-propanamine; Phenethylamine, N,alpha-dimethyl-3,4-methylenedioxy-; CHEMBL43048; 3,4-Methylenedioxy-N,alpha-dimethyl-beta-phenylethylamine; (+-)-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane; SHXWCVYOXRDMCX-UHFFFAOYSA-N; 69610-10-2; XTC; UNII-KE1SEN21RM; Ecstasy (Drug); XTC [Street Name]; Mandy [Street Name]; NCGC00168266-02; KE1SEN21RM; CCRIS 9277; Midomafetamine [USAN]; Epitope ID:178091; Midomafetamine (USAN/INN); (+/-)-3,4-METHYLENEDIOXYMETHAMPHETAMINE; SCHEMBL44210; Methylenedioxy Methamphetamine; DivK1c_000962; 3,4-MDMA; GTPL4574; CTK5D0599; KBio1_000962; DTXSID90860791; NINDS_000962; 3,4-methylenedioxymethylamphetamine; BDBM50010588; PDSP1_001522; PDSP2_001506; rac-3,4-Methylenedioxymethamphetamine; AKOS006283463; DB01454; IDI1_000962; NCGC00168266-01; LS-34695; LS-34696; (+/-)-(3,4-Methylenedioxy)methamphetamine; FT-0693477; 1,3-Benzodioxole-5-ethanamine,N,a-dimethyl-; 3,4-Methylenedioxy-N-methylamphetamine (MDMA); C07577; D11172; Q69488; [1-(2H-1,3-benzodioxol-5-yl)propan-2-yl](methyl)amine; rac-MDMA (rac-3,4-Methylenedioxymethamphetamine) 1.0 mg/ml in Methanol; (+/-)-MDMA solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; 54946-52-0",
            "trade_name": "ecstasy; Molly",
            "abbrev_name": "",
            "description": "psychoactive drug; increasing the activity of the neurotransmitters serotonin, dopamine and noradrenaline",
            "molecular_formula": "C11H15NO2",
            "molecular_weight": "193.24",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "renal",
            "protein_binding": "",
            "half_life": "6–10 (though duration of effects is typically actually 3–5 hours)",
            "absorption": "",
            "cid": "1615",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [
                "F0308"
            ],
            "references": [
                "RC03703"
            ]
        },
        {
            "compound_ID": "D0194",
            "name": "Menadione",
            "synonyms": "menadione; 58-27-5; Vitamin K3; 2-Methyl-1,4-naphthoquinone; Menaphthone; 2-methylnaphthalene-1,4-dione; 2-Methylnaphthoquinone; Thyloquinone; Kappaxin; Kayquinone; Klottone; Panosine; Kayklot; Kolklot; 2-Methyl-1,4-naphthalenedione; Menaphthon; Menadion; Kanone; Kipca; Aquinone; Kaergona; Kativ-G; Mitenone; Prokayvit; Aquakay; Hemodal; Karcon; Kareon; Kaykot; Koaxin; Mitenon; Synkay; K-Thrombyl; K-Vitan; Kipca-Oil Soluble; Juva-K; Vitamin K2(0); Vitamin K0; Menaquinone 0; 2-Methyl-1,4-naphthochinon; Menadionum; Menaphtone; Vitamin K 3; Memodol; Usaf ek-5185; 1,4-Naphthalenedione, 2-methyl-; 3-Methyl-1,4-naphthoquinone; Methylnaphthoquinone; Kappaxan (VAN); Menaphthene; Kaynone; 2-Methyl-1,4-naftochinon; 1,4-Naphthoquinone, 2-methyl-; Menaquinone O; Methyl-1,4-naphthoquinone; NSC 4170; 2-methyl-1,4-dihydronaphthalene-1,4-dione; 2-Methyl-1,4-naftochinon [Czech]; UNII-723JX6CXY5; 2-Methyl-1,4-naphthochinon [German]; NAPHTHOQUINONE, METHYL-; CCRIS 6672; HSDB 3354; C11H8O2; NSC4170; Menadione (Vitamin K3); EINECS 200-372-6; MFCD00001681; MNQ; CHEMBL590; 2-Methyl-1,4-naphthalendione; AI3-14700; MLS000069420; 723JX6CXY5; CHEBI:28869; MJVAVZPDRWSRRC-UHFFFAOYSA-N; VK3; CAS-58-27-5; Menadione semiquinone; NCGC00016258-02; SMR000059102; Vicasol; 1,4-Dihydro-2-methylnaphthalene-1,4-dione; DSSTox_CID_1715; DSSTox_RID_76289; DSSTox_GSID_21715; Q-201350; Menadione [USAN:BAN]; 2-Methyl-1,4-naphthoquinone, 98%; Menadione (USP); Kappaxin (TN); Kipca, oil soluble; Menadione [USP:BAN]; SR-01000712386; 2-Methyl-1,4-naphthodione; Methyl-1,4-naphthalenedione; Mendione; 2-methyl-1,4-naphthoquinone, 5; Menadione, 9; Menadione,(S); Prestwick_313; Menadione, 98%; Menadione, crystalline; PubChem14596; Spectrum_001228; ACMC-1BCKI; SpecPlus_000191; Opera_ID_1802; Prestwick0_000459; Prestwick1_000459; Prestwick2_000459; Prestwick3_000459; Spectrum2_001194; Spectrum4_000722; Spectrum5_001764; M0373; NCIMech_000105; cid_4055; 2-methyl-1,4-napthoquinone; SCHEMBL25970; BSPBio_000538; KBioGR_000984; KBioGR_002527; KBioSS_001708; KBioSS_002535; 2-methyl-1,4 naphthoquinone; 34524-96-4; KSC608C0H; MLS001148443; ARONIS24154; BIDD:ER0556; DivK1c_000080; DivK1c_006287; SPECTRUM1502254; SPBio_001267; SPBio_002477; 3-methyl-1,4-naphthalenedione; BPBio1_000592; ZINC1677; DTXSID4021715; 2-Methyl-[1,4]-naphthoquinone; BDBM24778; CTK5A8103; HMS500D22; KBio1_000080; KBio1_001231; KBio2_001708; KBio2_002527; KBio2_004276; KBio2_005095; KBio2_006844; KBio2_007663; KBio3_003005; WLN: L66 BV EVJ C1; cMAP_000077; NINDS_000080; Bio1_000471; Bio1_000960; Bio1_001449; HMS1569K20; HMS1921P06; HMS2092F12; HMS2096K20; HMS2232A09; HMS2234J16; HMS3371M08; HMS3373A12; HMS3655P03; Pharmakon1600-01502254; BB_NC-02319; BCP25699; HY-B0332; NSC-4170; STR01143; ZX-AS004517; ZX-AT006056; Tox21_110334; Tox21_301367; ANW-32906; BBL027351; BG0249; CCG-35354; Menadione (K3), analytical standard; NSC758200; s1949; SBB012369; STL377874; AKOS004910447; AKOS025244105; Tox21_110334_1; CS-2374; DB00170; FCH1114831; FS-2556; MCULE-2487773379; NSC-758200; RTR-037165; SB17255; TRA0064327; IDI1_000080; KS-00000C40; QTL1_000056; BENZOYL CHLORIDE,2,5-DIHYDROXY-; NCGC00016258-01; NCGC00016258-03; NCGC00016258-04; NCGC00016258-06; NCGC00016258-07; NCGC00016258-08; NCGC00094978-01; NCGC00094978-02; NCGC00255225-01; 72060-21-0; CC-30201; H500; LS-95653; LS-95654; NCI60_003945; SC-16348; SC-61015; SMR000653532; ST066885; SY018303; SBI-0051776.P002; AB2000387; Menadione, meets USP testing specifications; TR-037165; FT-0612893; SW219798-1; C05377; D02335; Z-3172; MFCD00001681 (97+%); 001M681; A831816; C-24481; Q192471; 1,4-Naphthalenedione, 2-methyl-, radical ion(1-); SR-01000712386-2; SR-01000712386-5; SR-01000712386-6; VITAMIN K3; 2-METHYL-1,4-NAPHTHALENEDIONE; BRD-K78126613-001-16-0; Vitamin K3; 2-Methyl-1,4-naphthoquinone; Menaphthone; Vitamin K3: 1,4-Dihydro-1,4-dioxo-2-methylnaphthalene; Menadione, European Pharmacopoeia (EP) Reference Standard; 03AAE1E9-B215-45AF-976C-91E61894A467; Menadione, United States Pharmacopeia (USP) Reference Standard; Menadione, Pharmaceutical Secondary Standard; Certified Reference Material; InChI=1/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H",
            "trade_name": "",
            "abbrev_name": "",
            "description": "an analog of 1,4-naphthoquinone; has vitamin K activity (sometimes called vitamin K3)",
            "molecular_formula": "C11H8O2",
            "molecular_weight": "172.18",
            "state": "solid",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "Variable and ranges from 10% to 80%",
            "cid": "4055",
            "classification": "B",
            "indications": "",
            "side_effects": "",
            "atc_codes": "B02BA02",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T234"
            ],
            "function": [
                "F010401",
                "F0105",
                "F010501",
                "F0109",
                "F020403",
                "F0402",
                "F05",
                "F0504",
                "F060102"
            ],
            "references": [
                "RC00597",
                "RC00934",
                "RC00935",
                "RC01007",
                "RC03602",
                "RC03504",
                "RC03799",
                "RC03993",
                "RC04889"
            ]
        },
        {
            "compound_ID": "D0195",
            "name": "Mercury",
            "synonyms": "Mercury; 7439-97-6; Hydrargyrum; Quicksilver; Metallic mercury; Liquid silver; Mercurio; Quecksilber; Mercure; Quick silver; Colloidal mercury; Mercury, elemental; Kwik; Rtec; Mercury vapor; elemental mercury; Mercury, metallic; Mercure [French]; RCRA waste number U151; Mercurio [Italian]; RTEC [Polish]; KWIK [Dutch]; Quecksilber [German]; Caswell No. 546; Hg; UNII-FXS1BY2PGL; Mercury, vapor; NCI-C60399; CCRIS 1578; UN 2024 (liquid compounds); HSDB 1208; Mercury vapor (as Hg); FXS1BY2PGL; EINECS 231-106-7; UN2809; RCRA waste no. U151; EPA Pesticide Chemical Code 052301; MFCD00011035; Mercury, elemental and inorganic forms; Mercury metal [Mercury and mercury compounds]; MERCURY COMPOUNDS; Mercurius vivus; Mercury and compounds; azogue; Marcero; Rathje; mercury atom; Mercury metal; mercury(0); Mercury, >=99%; 80Hg; EC 231-106-7; Mercury, 99.99+%; Mercury compounds, n.o.s.; Mercury and mercury compounds; Hg(0); Mercury, p.a., 99.9%; DTXSID1024172; CHEBI:16170; CHEBI:25195; CTK2H8868; HSDB 6943; Mercury [UN2809] [Corrosive]; QSHDDOUJBYECFT-UHFFFAOYSA-N; Mercury [UN2809] [Corrosive]; 8717AF; AKOS015902446; RTR-024018; UN 2809; Mercury, SAJ first grade, >=99.5%; Mercury, >=99.99% trace metals basis; Mercury, JIS special grade, >=99.5%; LS-89552; TR-024018; FT-0628223; C01319; TCLP Standard Solution 2, Specpure?, Hg 20?g/ml; Mercury, ACS reagent, 99.9995% trace metals basis; M032000000; Mercury, electronic grade, 99.9999% trace metals basis; Mercury, plasma standard solution, Specpure, Hg 10g/ml; Mercury, Oil based standard solution, Specpure, Hg 1000g/g; HG0; Mercury atomic spectroscopy standard concentrate 1.00 g Hg, 1.00 g/L, for 1L standard solution, analytical standard; Mercury standard solution, suitable for atomic absorption spectrometry, 1 mg/mL Hg, 1000 ppm Hg",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "Hg",
            "molecular_weight": "200.59",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "23931",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F01",
                "F0201",
                "F0701"
            ],
            "references": [
                "RC03933",
                "RC03934",
                "RC03935"
            ]
        },
        {
            "compound_ID": "D0196",
            "name": "AM 630",
            "synonyms": "164178-33-0; AM630; AM-630; (6-iodo-2-methyl-1-(2-morpholinoethyl)-1H-indol-3-yl)(4-methoxyphenyl)methanone; iodopravadoline; AM 630; 6-iodopravadoline; UNII-U1LNJ6NBKA; U1LNJ6NBKA; [6-iodo-2-methyl-1-(2-morpholin-4-ylethyl)indol-3-yl]-(4-methoxyphenyl)methanone; CHEMBL181633; 1-(2-(Morpholin-4-yl)ethyl)-2-methyl-3-(4-methoxybenzoyl)-6-iodoindole; Methanone, [6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)-; 1-[2-(morpholin-4-yl)ethyl]-2-methyl-3-(4-methoxybenzoyl)-6-iodoindole; Tocris-1120; Iodopravadoline (AM630); Iodopravadoline(AM-630); GTPL750; MLS006010265; SCHEMBL2545822; C23H25IN2O3; CHEBI:93112; CTK0I0704; DTXSID10167719; JHOTYHDSLIUKCJ-UHFFFAOYSA-N; BCPP000412; HMS3267M04; HMS3412K03; HMS3676K03; HMS3742K07; BCP02699; EX-A1547; KS-00000P7P; ABP000810; AM630/; ANW-45821; BDBM50160434; BN0067; ZINC28332661; AKOS015998968; BCP9000279; CS-0854; NCGC00025012-01; NCGC00025012-02; 4CA-0031; AM630, >=90% (HPLC); HY-15421; SMR004701337; AB0022666; AX8218742; RT-011262; ST2402495; W3580; A14993; W-5276; L000847; SR-01000597361; J-010122; Q4652499; SR-01000597361-1; BRD-K63533170-001-01-1; [6-Iodo-2-methyl-1-(2-morpholin-4-yl-ethyl)-1H-indol-3-yl]-(4-methoxy-phenyl)-methanone; {6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl}[4-(methyloxy)phenyl]methanone; 6-Iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)methanone; 6-iodo-3-(4-methoxybenzoyl)-2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indole; Methanone,[6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)-",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C23H25IN2O3",
            "molecular_weight": "504.4",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "4302963",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F02010203"
            ],
            "references": [
                "RC01298",
                "RC01312"
            ]
        },
        {
            "compound_ID": "D0197",
            "name": "Methoxychlor",
            "synonyms": "methoxychlor; 72-43-5; p,p'-Methoxychlor; DMDT; Dimethoxy-DDT; Methoxy-DDT; Methoxcide; Metox; Maralate; Marlate; Moxie; Dianisyl trichloroethane; Metoksychlor; Higalmetox; Mezox K; Methoxychlor 2 ec; Dianisyltrichlorethane; Methoxychlore; Dimethoxy-DT; Rcra waste number U247; NCI-C00497; Caswell No. 550; Metoksychlor [Polish]; 1,1,1-Trichloro-2,2-bis(p-anisyl)ethane; 2,2-Bis(p-anisyl)-1,1,1-trichloroethane; ENT 1,716; Methoxychlor, technical; Methoxo; p,p'-DMDT; 1,1,1-Trichloro-2,2-di(4-methoxyphenyl)ethane; OMS 466; 1,1,1-Trichloro-2,2-bis(p-methoxyphenyl)ethane; 2,2-Bis(p-methoxyphenyl)-1,1,1-trichloroethane; Methoxychlor [BSI:ISO]; MeOCl; UNII-RIA79UD69L; Double-M ec; Methoxychlore [ISO-French]; CCRIS 380; 2,2-Di-p-anisyl-1,1,1-trichloroethane; Ethane, 1,1,1-trichloro-2,2-bis(p-methoxyphenyl)-; HSDB 1173; Methoxychlor [95%]; 4,4-(2,2,2-Trichloroethylidene)dianisole; NSC 8945; Flo pro mcseed protectant; EINECS 200-779-9; p,p'-Dimethoxydiphenyltrichloroethane; Ethane, 2,2-bis(p-anisyl)-1,1,1-trichloro-; p,p'-Dwumetoksydwufenylotrojchloroetan; 1,1'-(2,2,2-trichloroethane-1,1-diyl)bis(4-methoxybenzene); 1,1,1-Trichloro-2,2-bis(4-methoxyphenyl)ethane; 1,1-Bis(p-methoxyphenyl)-2,2,2-trichloroethane; 2,2,2-Trichloro-1,1-bis(4-methoxyphenyl)ethane; RCRA waste no. U247; EPA Pesticide Chemical Code 034001; BRN 2057367; RIA79UD69L; 1,1'-(2,2,2-Trichloroethylidene)bis(4-methoxybenzene); Dimethoxydiphenyltrichloroethane; CHEBI:6842; Benzene, 1,1'-(2,2,2-trichloroethylidene)bis[4-methoxy-; p,p'-Dwumetoksydwufenylotrojchloroetan [Polish]; 2,2-Di(p-methoxyphenyl)-1,1,1-trichloroethane; 2,2-Di-(p-methoxyphenyl)-1,1,1-trichloroethane; 1,1,1-Trichlor-2,2-bis(4-methoxy-phenyl)-aethan; p,p'-(Dimethoxydiphenyl)trichloroethane; NCGC00090760-08; 1,1,1-Trichlor-2,2-bis(4-methoxy-phenyl)-aethan [German]; Benzene, 1,1'-(2,2,2-trichloroethylidene)bis(4-methoxy-; Di(p-methoxyphenyl)trichloromethyl methane; 1-Methoxy-4-[2,2,2-trichloro-1-(4-methoxyphenyl)ethyl]benzene; 1,1'-(2,2,2-trichloroethane-1,1-diyl)bis[4-(methyloxy)benzene]; SMR000568481; pMethoxychlor; Maxie; 4-methoxy-1-[2,2,2-trichloro-1-(4-methoxyphenyl)ethyl]benzene; Methoxy DDT; Mesox K; Chemform methoxychlor; dianisyltrichloroethane; Spectrum_001949; SpecPlus_000588; DSSTox_CID_827; Spectrum2_001890; Spectrum3_000864; Spectrum4_000704; Spectrum5_002050; DSSTox_RID_75813; 2,2-Bis(4-methoxyphenyl)-1,1,1-trichloroethane; BIDD:PXR0108; DSSTox_GSID_20827; BSPBio_002507; KBioGR_001227; KBioSS_002503; SPECTRUM330077; 1,1,1-Trichloro-2,2-bis-(p-methoxyphenyl)ethane; MLS001055458; MLS001065605; BIDD:ER0613; DivK1c_006684; SCHEMBL116390; SPBio_001800; CHEMBL362919; Dimethox ydiphenyltrichloroethane; DTXSID9020827; CTK5D6098; KBio1_001628; KBio2_002495; KBio2_005063; KBio2_007631; KBio3_002007; Methoxychlor, analytical standard; WLN: GXGGYR DO1&R DO1; NSC8945; IAKOZHOLGAGEJT-UHFFFAOYSA-N; PUBERTAL METHOXYCHLOR STUDY; HMS3039K10; ZINC155246; Marlate 300 flowable (Salt/Mix); NSC-8945; Tox21_400075; BDBM50410535; CCG-39337; MFCD00000803; SBB057311; p,p'-dimethoxydiphenyltrichl oroethane; AKOS001025493; Bis(p-anisyl)-1,1,1-trichloroethane; LS-1614; MCULE-1125841404; CAS-72-43-5; Methoxychlor 10 microg/mL in Isooctane; Methoxychlor 100 microg/mL in Methanol; 1,1-Trichloro-2,2-bis(p-anisyl)ethane; NCGC00090760-01; NCGC00090760-02; NCGC00090760-03; NCGC00090760-04; NCGC00090760-05; NCGC00090760-06; NCGC00090760-07; NCGC00090760-09; NCGC00090760-10; NCGC00090760-11; CC-26448; MXC; di(p-methoxyphenyl) trichloromethyl methane; Methoxychlor 10 microg/mL in Acetonitrile; Methoxychlor 100 microg/mL in Cyclohexane; 2,2-Di(p-anisyl)-1,1,1-trichloroethane; DB-055634; Ethane,2-bis(p-anisyl)-1,1,1-trichloro-; Bis(p-methoxyphenyl)-1,1,1-trichloroethane; EU-0084224; FT-0603090; M1736; ST50997635; 1,1-Trichloro-2,2-bis(p-methoxyphenyl)ethane; 1,1-Trichloro-2,2-di(4-methoxyphenyl)ethane; C11043; 1,2,2-Trichloroethylidene)bis(4-methoxybenzene); Methoxychlor, PESTANAL(R), analytical standard; 1,1-Bis(4-methoxyphenyl)-2,2,2-trichloroethane; 2,2-Bis (p-methoxyphenol)-1,1,1-trichloroethane; C-20487; Ethane,1,1-trichloro-2,2-bis(p-methoxyphenyl)-; Q411958; 2,2,2-t richloro-1,1-bis(4-methoxyphenyl)ethane; Benzene,1'-(2,2,2-trichloroethylidene)bis[4-methoxy-; 1,1'-(2,2,2-Trichloroethylidene)-bis[4-methoxybenzene]; 4,4'-(2,2,2-trichloroethane-1,1-diyl)bis(methoxybenzene); Benzene, 1,1'-(2,2,2-trichloroethylidene)bis*4-methoxy-; Benzene,1,1'-(2,2,2-trichloroethylidene)bis[4-methoxy-; KID PEST PROJECT (METHOXYCHLOR) (SEE ALSO METHOXYCHLOR); METHOXYCHLOR (SEE ALSO KID PEST PROJECT (METHOXYCHLOR)); 1-Methoxy-4-[2,2,2-trichloro-1-(4-methoxyphenyl)ethyl]benzene #; Benzene, 1,1'-(2,2,2-trichloroethylidene)bis(4-methoxy- (9CI); Methoxychlor solution, 200 mug/mL in isooctane, analytical standard; methoxychlor (MXC) (1,1,1-trichloro-2,2-bis(p-methoxyphenyl)ethane); ENDOCRINE DISRUPTOR (METHOXYCHLOR) (SEE ALSO METHOXYCHLOR (72-43-5); KIDPEST PROJECT); InChI=1/C16H15Cl3O2/c1-20-13-7-3-11(4-8-13)15(16(17,18)19)12-5-9-14(21-2)10-6-12/h3-10,15H,1-2H",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C16H15Cl3O2",
            "molecular_weight": "345.6",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "4115",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [
                "F0108"
            ],
            "references": [
                "RC02009",
                "RC02630",
                "RC03251"
            ]
        },
        {
            "compound_ID": "D0198",
            "name": "Methylazoxymethanol (MAM)",
            "synonyms": "METHYLAZOXYMETHANOL; UNII-JGG19N3YDQ; JGG19N3YDQ; (methyl-ONN-azoxy)methanol; CCRIS 1113; 590-96-5; Methanol, (methyl-ONN-azoxy)-; HSDB 3509; BRN 1921057; 1-Hydroxymethyl-2-methylditmide-2-oxide; MAM; methyl-ONN-azoxymethanol; CH3-N(O)=N-CH2OH; CHEBI:29323; C02390",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C2H6N2O2",
            "molecular_weight": "90.08",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "6433205",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0199",
            "name": "Methylene Blue",
            "synonyms": "methylene blue; 61-73-4; Basic blue 9; Methylthioninium chloride; Swiss Blue; Chromosmon; Methylene Blue N; Methylenium ceruleum; Urolene blue; Bleu de methylene; Methylene Blue chloride; Solvent blue 8; External Blue 1; Methylene Blue A; Methylene Blue B; Methylene Blue D; Methylene Blue G; C.I. Basic Blue 9; Methylene Blue anhydrous; Calcozine Blue ZF; Methylene Blue BB; Methylene Blue BD; Methylene Blue BP; Methylene Blue BX; Methylene Blue BZ; Methylene Blue FZ; Methylene Blue GZ; Methylene Blue NZ; Methylene Blue SG; Methylene Blue SP; Methylene Blue ZF; Methylene Blue ZX; Tetramethylene Blue; Methylene Blue 2B; Methylene Blue BBA; Methylene Blue BPC; Methylene Blue HGG; Methylene Blue IAD; Methylene Blue JFA; Sandocryl Blue BRL; Methylenblau; Methylene Blue 2BF; Methylene Blue 2BN; Methylene Blue 2BP; M-B Tabs; Tetramethylthionine chloride; Rember; 3,7-Bis(dimethylamino)phenothiazin-5-ium chloride; Mitsui Methylene Blue; Methylthionium chloride; Leather Pure Blue HB; Methylthionine chloride; Modr methylenova; Schultz No. 1038; Aizen Methylene Blue BH; Aizen Methylene Blue FZ; Methylene Blue polychrome; Methylene Blue Zinc Free; Ceruleum methylenum; Yamamoto Methylene Blue B; D And C Blue Number 1; Methylenum coeruleum; Methylene Blue (Medicinal); Yamamoto Methylene Blue ZF; CI Basic Blue 9; Ext D and C Blue No. 1; Caswell No. 567; Methylenblau [German]; Methylene Blue I (Medicinal); Methylthionini chloridum; Cloruro de metiltioninio; Methylene Blue NF (Medicinal); Methylthioninii chloridum; Hidaco Methylene Blue Salt Free; Methylene Blue BB (Zinc Free); Methylene Blue USP (Medicinal); D and C Blue No. 1; Modr Methylenova [Czech]; Modr Zasadita 9 [Czech]; Chlorure de methylthioninium; Methylene Blue USP XII (Medicinal); UNII-8NAP7826UB; Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride; 3,7-Bis(dimethylamino)phenazathionium chloride; CCRIS 833; Metiltioninio cloruro [DCIT]; Modr Rozpoustedlova 8 [Czech]; HSDB 1405; Methylene Blue Chloride (Biological stain); C.I. 52015; X 138; EINECS 200-515-2; Methylthioninii chloridum [INN-Latin]; EPA Pesticide Chemical Code 039505; NSC 215213; Cloruro de metiltioninio [INN-Spanish]; CI 52015; Chlorure de methylthioninium [INN-French]; 8NAP7826UB; CHEBI:6872; Methylene Blue (C.I. 52015); azul de metileno; CI-52015; Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride (1:1); DSSTox_CID_3296; N-[7-(dimethylamino)-3H-phenothiazin-3-ylidene]-N-methylmethanaminium chloride; DSSTox_RID_76963; DSSTox_GSID_23296; 3H-Phenothiazine, 3-methochloride; 3H-Phenothiazine, 7-(dimethylamino)-3-(methylimino)-, 3-methochloride; CHEMBL405110; Modr zasadita 9; CAS-61-73-4; N-(7-(dimethylamino)-3H-phenothiazin-3-ylidene)-N-methylmethanaminium chloride; NSC3089; Metiltioninio cloruro; MFCD00012111; Modr rozpoustedlova 8; NSC215213; NSC617593; C.I. 52 015; Methylene Blue, pure, certified, residual water; NCGC00167496-01; NCGC00167496-03; Phenothiazin-5-ium,7-bis(dimethylamino)-, chloride; WLN: T C666 BS EY INJ EUK1&1 MN1&1 &G &421; Provayblue; methylene-blue; [7-(dimethylamino)phenothiazin-3-ylidene]dimethylamine, chloride; Lowacryl blue 9; MethyleneBlueHydrate; Methylene Azure II; Prestwick_326; Ehrlichs reagent III; Loefflers Methylene Blue; Methylene Blue (anhydrous); Methylene Blue (Inhibitor); SCHEMBL1351; C16H20N3S.HCl; MLS000719838; DOG (COUCH) GRASS Powder; DTXSID0023296; Methylthioninium chloride [INN]; C.I. Basic Blue 9 (8CI); BIA4084; CXKWCBBOMKCUKX-UHFFFAOYSA-M; HMS2598O03; Pharmakon1600-01505444; CI NO 52015; KS-000013GW; NSC-3089; Tox21_112497; Tox21_302087; LS-268; NSC759135; s4535; SBB060907; STK018918; AKOS000486124; AKOS015916406; Tox21_112497_1; CS-2959; DB09241; MCULE-7744087830; NSC-215213; NSC-617593; NSC-759135; KS-00004B65; NCGC00255351-01; 105504-42-5; 12262-49-6; AC-15225; AK326199; AS-35256; Basic Blue 9;Tetramethylthionine chloride; HY-14536; SMR000304367; ST093058; A0574; FT-0622580; M0501; ST50406802; C00220; 3,7-Bis(dimethylamino)-5-phenothiazinium Chloride; Q422134; 3,7-bis(dimethylamino)-phenothiazin-5-ium chloride salt; [7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride; [7-(dimethylamino)dibenzo[b,e]1,4-thiazin-3-yl]dimethylamine, chloride; METHYLENE BLUE (METHYLENE BLUE, CHLORIDE:HYDRATE (7220-79-3)); 1341-90-8; 152071-32-4; 6476-03-5; 97130-83-1",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C16H18ClN3S",
            "molecular_weight": "319.9",
            "state": "solid",
            "clearance": "3.0 ± 0.7 L/min.",
            "volume_of_distribution": "10 mg/kg (in rats).",
            "route_of_elimination": "Excreted in urine and bile. About 75% of an oral dose excreted in urine, primarily as stabilized colorless leukomethylene blue.",
            "protein_binding": "Methylene blue was reported to bind strongly to rabbit plasma (71–77% of bound drug).",
            "half_life": "5–6.5 hours (after IV dose).",
            "absorption": "",
            "cid": "6099",
            "classification": "V",
            "indications": "",
            "side_effects": "",
            "atc_codes": "V03AB17; V04CG05",
            "group": "Drug",
            "drug_type": "",
            "target": [],
            "function": [
                "F0108"
            ],
            "references": [
                "RC02014",
                "RC02635",
                "RC03256"
            ]
        },
        {
            "compound_ID": "D0200",
            "name": "Methylmercury",
            "synonyms": "Methylmercury(1+); Methylmercury II; Methyl Mercury Ion; Methylmercury ion; Methyl mercury; METHYLMERCURY(II) CATION; Monomethylmercury cation; Methylmercury ion(1+); CH3Hg+; Mercury(1+), methyl-; Methyl mercury(II) cation; 22967-92-6; methylmercury(II); [HgMe](+); CH3Hg(+); Mercury(1+), methyl-, ion; [HgCH3](+); DTXSID9024198; CHEBI:49747; CTK8D8906; HSDB 3930; AKOS015903545; BRN 3902999; LS-89823; C18672; Q414075",
            "trade_name": "",
            "abbrev_name": "MeHg",
            "description": "organometallic cation; bioaccumulative environmental toxicant",
            "molecular_formula": "CH3Hg+",
            "molecular_weight": "215.63",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "6860",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [
                "T397"
            ],
            "function": [
                "F020403",
                "F0308",
                "F050401"
            ],
            "references": [
                "RC03661",
                "RC03662",
                "RC03708",
                "RC04938"
            ]
        },
        {
            "compound_ID": "D0201",
            "name": "Methylmethanesulfonate",
            "synonyms": "METHYL METHANESULFONATE; 66-27-3; Methyl mesylate; Methanesulfonic acid methyl ester; Methanesulfonic acid, methyl ester; methylmethane sulfonate; Methylmethansulfonat; Methyl methanesulphonate; as-Dimethyl sulfite; as-Dimethyl sulphite; Methyl methansulfonate; Methylmethanesulfonate; Methyl methansulphonate; Dimethylsulfonate; MMS; FDA 0092; Methyl ester of methanesulfonic acid; NSC-50256; CB 1540; Methylmethanesulphonate; CCRIS 396; HSDB 5103; Methanesulphonic acid methyl ester; Methyl methanesulfonic acid; Methyl ester of methanesulphonic acid; UNII-AT5C31J09G; C2H6O3S; Methylmethansulfonat [German]; AI3-50052; Methylester kyseliny methansulfonove; EINECS 200-625-0; BRN 1098586; Methyl methanesulfonate, 99%; AT5C31J09G; Methylester kyseliny methansulfonove [Czech]; DTXSID7020845; CHEBI:25255; MBABOKRGFJTBAE-UHFFFAOYSA-N; CB1540; methyl methylsulfonate; DSSTox_CID_845; DSSTox_RID_75824; DSSTox_GSID_20845; Methylmesilate; Methyl Methane Sulfonate; Mesilate, Methyl; CAS-66-27-3; Methyl Methylenesulfonate; methylmesylate; dimethylsulfonic acid; methylmethansulphonate; Spectrum_001850; ACMC-209nuh; Spectrum2_000917; Spectrum3_001166; Spectrum4_000776; Spectrum5_001652; Methanesulfonic acid methyl; SCHEMBL63290; BSPBio_002751; KBioGR_001192; KBioSS_002365; SPECTRUM330003; 4-04-00-00011 (Beilstein Handbook Reference); WLN: WS1&O1; SPBio_000794; CHEMBL313493; Methylsulfonic acid methyl ester; CTK3J2453; KBio2_002362; KBio2_004930; KBio2_007498; KBio3_002251; KS-00000GMU; Methylsulfonic acid, methyl ester; NSC50256; ZINC3861020; CDCT-C15100700; Tox21_202094; Tox21_300299; 0180AC; ANW-35175; CCG-39749; MFCD00007557; SBB058203; AKOS015900695; CS-W004702; LS-1557; MCULE-4411511042; RTR-022444; NCGC00090697-01; NCGC00090697-02; NCGC00090697-03; NCGC00090697-04; NCGC00090697-05; NCGC00090697-06; NCGC00253916-01; NCGC00259643-01; AS-10021; NCI60_004210; SC-52027; DB-054898; TR-022444; FT-0628902; M0369; ST24031195; ST51015459; C19181; InChI=1/C2H6O3S/c1-5-6(2,3)4/h1-2H; Q3077242; W-104766; Methanesulfonic acid, methyl ester (6CI,7CI,8CI,9CI); Methyl methanesulfonate, certified reference material, TraceCERT(R)",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C2H6O3S",
            "molecular_weight": "110.13",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "4156",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0202",
            "name": "Methylnitrosourea",
            "synonyms": "N-Methyl-N-nitrosourea; 1-Methyl-1-nitrosourea; 684-93-5; N-NITROSO-N-METHYLUREA; Methylnitrosourea; Urea, N-methyl-N-nitroso-; Methylnitrosouree; 1-Nitroso-1-methylurea; N-Nitroso-N-methylcarbamide; N-Nitroso-N-methyl urea; Methylnitroso-harnstoff; Urea, 1-methyl-1-nitroso-; NSC 23909; RCRA waste number U177; SRI 859; NMH [German]; Urea, methylnitroso-; N-Methyl-N-nitroso-harnstoff; N-Nitroso-N-methyl-harnstoff; NSC-23909; SKI 24464; Carbamide, N-methyl-N-nitroso-; UNII-W8KW4E3XSU; Methylnitrosouree [French]; 1-Methyl-1-nitrosomocovina; MNU; N-methylnitrosourea; CCRIS 404; NMH; NMU; Methylnitroso-harnstoff [German]; HSDB 5112; 1-Methyl-1-nitrosomocovina [Czech]; EINECS 211-678-4; W8KW4E3XSU; RCRA waste no. U177; N-Methyl-N-nitroso-harnstoff [German]; N-Nitroso-N-methyl-harnstoff [German]; O-Nitroso-N-methyl-harnstoff [German]; AI3-50583; CHEBI:50102; ZRKWMRDKSOPRRS-UHFFFAOYSA-N; 1-(Aminocarbonyl)-1-methyl-2-oxohydrazine; 28606-00-0; C2H5N3O2; O-Nitroso-N-methyl-harnstoff; NSC23909; N-methyl-nitrosourea; Methylnitrosoharnstoff; N-methyl-N-nitrosurea; N-methyl,N-nitrosourea; N-methyl-N-nitrosouree; N-nitroso-N-methyluree; N-Methyl N-Nitrosourea; N-methyl-N-nitroso-Urea; DSSTox_CID_1006; WLN: ZVN1&NO; N-methyl-N-nitrosocarbamide; N-Methyl-N-nitrosoharnstoff; N-Nitroso-N-methylharnstoff; N-Nitrosomethylurea - Carc; DSSTox_RID_75909; n-methyl-n-nitroso-carbamide; DSSTox_GSID_21006; N-nitroso- N-methylcarbamide; SCHEMBL38377; CHEMBL288958; DTXSID4021006; CTK2F3254; KS-000002IE; ZINC4202501; Tox21_302850; FCH916934; N-Nitroso-N-methylurea, ISOPAC(R); N-Nitroso-N-methylurea, Bulk package; Urea, 1-methyl-1-nitroso- (8CI); AKOS006228360; LS-1582; TRA0046051; NCGC00256586-01; AS-31175; CAS-684-93-5; SC-19817; DB-014949; LS-160476; TC-064506; FT-0659469; V2274; 1-(Aminocarbonyl)-1-methyl-2-oxohydrazine #; C14595; 139765-EP2292576A2; 684N935; C-42370; Q3023727; n-nitroso-n-methylurea (stabilized with 10% acetic acid); N-Nitroso-N-methylurea wet with 10% acetic acid solution",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "C2H5N3O2",
            "molecular_weight": "103.08",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "12699",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [],
            "function": [],
            "references": []
        },
        {
            "compound_ID": "D0203",
            "name": "MPP",
            "synonyms": "fenthion; 55-38-9; Mercaptophos; Baytex; Lebaycid; Fenthione; Phenthion; Queletox; Spotton; Talodex; Baycid; Entex; Sulfidophos; Figuron; Tiguvon; Fenthion-methyl; Bayer 29493; Fenthion 4E; MPP (pesticide); Bay-Bassa; Pro-Spot; Bayer 9007; Bayer S-1752; OMS 2; Caswell No. 456F; 4-Methylmercapto-3-methylphenyl dimethyl thiophosphate; Lebayeid; UNII-BL0L45OVKT; NCI-C08651; BAY 29493; Fenthion [BAN]; Mosquitocide 700; CCRIS 310; ENT 25,540; C10H15O3PS2; HSDB 1403; Fenthion [BSI:ISO]; EINECS 200-231-9; S 1752; BL0L45OVKT; B 29493; O,O-Dimethyl-O-4-(methylmercapto)-3-methylphenyl thiophosphate; EPA Pesticide Chemical Code 053301; O,O-Dimethyl O-4-(methylmercapto)-3-methylphenyl phosphorothioate; BRN 1974129; AI3-25540; O,O-Dimethyl O-(4-(methylthio)-m-tolyl) phosphorothioate; O,O-Dimethyl O-(4-methylthio-3-methylphenyl) thiophosphate; CHEBI:34761; O,O-Dimethyl O-(4-methylthio-3-methylphenyl) phosphorothioate; O,O-Dimethyl O-(3-methyl-4-methylmercaptophenyl)phosphorothioate; PNVJTZOFSHSLTO-UHFFFAOYSA-N; Fenthion (BAN); m-Cresol, 4-(methylthio)-, O-ester with O,O-dimethyl phosphorothioate; Phosphorothioic acid, O,O-dimethyl O-(3-methyl-4-(methylthio)phenyl) ester; Phosphorothioic acid, O,O-dimethyl O-[3-methyl-4-(methylthio)phenyl] ester; ENT 25540; O,O-Dimethyl O-4-methylthio-m-tolyl phosphorothioate; Dimethyl methylthiotolyl phosphorothioate; O,O-Dimetil-O-(3-metil-4-metiltio-fenil)-monotiofosfato; NCGC00091635-01; O,O-Dimethyl O-3-methyl-4-methylthiophenyl phosphorothioate; O,O-Dimethyl O-(3-methyl-4-(methylthio)phenyl)phosphorothioate; O,O-Dimethyl-O-(3-methyl-4-methylthio-fenyl)-monothiofosfaat; DSSTox_CID_620; O,O-Dimethyl O-(4-methylmercapto-3-methylphenyl) thionophosphate; O,O-Dimethyl-O-(3-methyl-4-methylmercaptophenyl)phosphorothioate; O,O-Dimethyl-O-4-(methylmercapto)-3-methylphenyl phosphorothioate; O,O-Dimetil-O-(3-metil-4-metiltio-fenil)-monotiofosfato [Italian]; O,O-Dimethyl O-(3-methyl-4-methylthio-fenyl)-monothiofosfaat [Dutch]; O,O-Dimethyl-O-(3-methyl-4-methylthio-fenyl)-monothiofosfaat [Dutch]; O,O-Dimethyl-O-(3-methyl-4-methylthio-phenyl)-thionophosphat [German]; O,O-Dimethyl-O-(3-methyl-4-methylthiophenyl)-monothiophosphat [German]; Thiophosphate de O,O-dimethyle et de O-(3-methyl-4-methylthiophenyle); Thiophosphate de O,O-dimethyle et de O-(3-methyl-4-methylthiophenyle) [French]; DSSTox_RID_75695; DSSTox_GSID_20620; Fenthion, analytical standard; Dimethyl O-(4-(methylthio)-m-tolyl) phosphorothioate; Dimethyl (3-methyl-4-(methylthio)phenyl) phosphorothionate; Dimethyl O-(3-methyl-4-(methylthio)phenyl) thiophosphate; O,O-dimethyl-O-[4-(methylthio)-m-tolyl] phosphorothioate; O,O-dimethyl O-[3-methyl-4-(methylthio)phenyl] thiophosphate; Phosphorothioic acid, O,O-dimethyl O-(4-(methylthio)-m-tolyl) ester; Phosphorothioic acid, O,O-dimethyl O-[4-(methylthio)-m-tolyl] ester; CAS-55-38-9; Fenthion [INN:BAN]; Spotten; o,o-Dimethyl o-[3-methyl-4-(methylthio)phenyl]phosphorothioate; Quel etox; dimethoxy-(3-methyl-4-methylsulfanylphenoxy)-sulfanylidene-?^{5}-phosphane; Lebaycid(R); Rid-a-Bird; Fenthion (MPP); MPP (Pestiide); Tiguvon (TN); Spectrum_001919; SpecPlus_000550; Spectrum2_001231; Spectrum3_000855; Spectrum4_000695; Spectrum5_002028; SCHEMBL26907; BSPBio_002469; KBioGR_001189; KBioSS_002461; SPECTRUM330064; MLS002695988; BIDD:ER0528; DivK1c_006646; SPBio_001102; BX-2; ZINC1443; CHEMBL1604375; DTXSID8020620; KBio1_001590; KBio2_002454; KBio2_005022; KBio2_007590; KBio3_001969; PNVJTZOFSHSLTO-UHFFFAOYSA-; HMS3091A22; HMS3264I08; O,O-Dimethyl O-(3-methyl-4-methylthio-fenyl)-monothiofosfaat; O,O-Dimethyl-O-(3-methyl-4-methylthio-phenyl)-thionophosphat; O,O-Dimethyl-O-(3-methyl-4-methylthiophenyl)-monothiophosphat; Pharmakon1600-00330064; Tox21_111157; Tox21_201595; Tox21_300658; CCG-39101; NSC755881; Fenthion 10 microg/mL in Cyclohexane; AKOS015889922; Tox21_111157_1; ACN-048892; LS-1355; NSC-755881; NCGC00091635-02; NCGC00091635-03; NCGC00091635-04; NCGC00091635-05; NCGC00091635-06; NCGC00091635-07; NCGC00091635-08; NCGC00091635-09; NCGC00254566-01; NCGC00259144-01; AC-16722; CC-28403; Dimethyl methylthiotolyl phosphorothioat e; SMR000777965; SBI-0052549.P002; Fenthion, PESTANAL(R), analytical standard; FT-0603232; C14420; D07950; AB00053057_04; C-17512; Q418354; SR-01000872733; SR-01000872733-1; BRD-K67217586-001-02-3; BRD-K67217586-001-04-9; 4-Meth ylmercapto-3-methylphenyl dimethyl thiophosphate; O,O-dimethyl O-(3-methyl-4-methylthiophenyl) thiophosphate; Dimethyl O-((4-me thylmercapto)-3-methylphenyl)thionophosphate; Dimethyl O-((4-methylmercapto)-3-methylphenyl)thionophosphate; O,O-dimethyl O-3-methyl-4-(methylthio)phenyl phosphorothioate; O,O-Dimethyl-O-(3-methyl-4-methylthio-phenyl)-thionophosphate; O,O-Dimethyl-O-(3-methyl-4-methylthiophenyl)-monothiophosphate; Cresol, 4-(methylthio)-, O-ester with O,O-dimethyl phosphorothioate; dimethoxy-(3-methyl-4-methylsulfanylphenoxy)-sulfanylidenephosphorane; O,O-dimethyl O-[3-methyl-4-(methylsulfanyl)phenyl] phosphorothioate; o,o-Dimethyl o-[3-methyl-4-(methylsulfanyl)phenyl] thiophosphate; O,O-Dimethyl O-[3-methyl-4-(methylsulfanyl)phenyl] thiophosphate #; O,O-dimethyl O-4-(methylmercapto)-3-methylphenyl phosphorothio ate; phosphorothioic acid O,O-dimethyl O-(4-methylthio)-m-tolyl ester; Cresol, 4-(methylthio)-, O-ester with O,O-d imethyl phosphorothioate; methyl 3-methyl-4-(methylsulfanyl)phenyl methoxy(sulfanylidene)phosphonite; O,O-Dimethyl O-[(3-methyl-4-methylthio)phenyl] phosphorothioate, 9CI; Phosphorothioic acid O,O-dimethyl O-[3-methyl-4-(methylthio)phenyl]ester; InChI=1/C10H15O3PS2/c1-8-7-9(5-6-10(8)16-4)13-14(15,11-2)12-3/h5-7H,1-4H3",
            "trade_name": "",
            "abbrev_name": "",
            "description": "positively charged organic molecule; neurotoxin; inhibiting Complex I",
            "molecular_formula": "C10H15O3PS2",
            "molecular_weight": "278.3",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "3346",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Drug",
            "drug_type": "",
            "target": [
                "T001"
            ],
            "function": [
                "F020403"
            ],
            "references": [
                "RC04942"
            ]
        },
        {
            "compound_ID": "D0204",
            "name": "MQ18",
            "synonyms": "N-Methyl-2-n-dodecyl-3-methylquinolinium",
            "trade_name": "",
            "abbrev_name": "",
            "description": "",
            "molecular_formula": "X",
            "molecular_weight": "X",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "X",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Others",
            "drug_type": "",
            "target": [
                "T001"
            ],
            "function": [
                "F020103"
            ],
            "references": [
                "RC01391"
            ]
        },
        {
            "compound_ID": "D0205",
            "name": "MPTP",
            "synonyms": "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPTP; 28289-54-5; 1,2,3,6-Tetrahydro-1-methyl-4-phenylpyridine; CCRIS 2186; HSDB 6942; PYRIDINE, 1,2,3,6-TETRAHYDRO-1-METHYL-4-PHENYL-; 1-METHYL-4-PHENYL-PIPERIDINE-3-EN; UNII-9P21XSP91P; N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NSC 139654; 1-Methyl-4-phenyl-1,2,3,6-tetrahydroxpyridine; 1-methyl-4-phenyl-3,6-dihydro-2H-pyridine; EINECS 248-939-7; BRN 0133712; CHEMBL24172; 9P21XSP91P; CHEBI:17963; 1-Methyl-4-phenyl-1,2,5,6-tetrahydropyridine; PLRACCBDVIHHLZ-UHFFFAOYSA-N; Pyridine,1,2,3,6-tetrahydro-1-methyl-4-phenyl-; 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine; SCHEMBL50923; DTXSID8040933; CTK4G1161; ZINC968184; BDBM50003599; NSC139654; STK191942; AKOS003657026; FCH1113171; MCULE-2830400928; NSC-139654; QC-3853; ACM28289545; AK116498; AS-38061; AB0076709; DB-047370; LS-132033; 4CH-024688; FT-0638772; ST24038114; ST45026142; C04599; N-Methyl-4-phenyl-1,2,5,6-tetrahydropyridine; X-2265; 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine; A819403; C-30529; Q239816; J-017031; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 97%; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, free base",
            "trade_name": "",
            "abbrev_name": "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",
            "description": "prodrug to the neurotoxin MPP+",
            "molecular_formula": "C12H15N",
            "molecular_weight": "173.25",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "1388",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [
                "T001"
            ],
            "function": [],
            "references": [
                "RC03441"
            ]
        },
        {
            "compound_ID": "D0206",
            "name": "MPP+",
            "synonyms": "Cyperquat; MPP+; 1-METHYL-4-PHENYLPYRIDINIUM; N-Methyl-4-phenylpyridine; N-Methyl-4-phenylpyridinium ion; 48134-75-4; Pyridinium, 1-methyl-4-phenyl-; N-Methyl-4-phenylpyridinium; Cyperquat [ANSI]; 1-methyl-4-phenylpyridin-1-ium; UNII-R865A5OY8J; CHEBI:641; CCRIS 2187; R865A5OY8J; BRN 1618932; 1 Methyl 4 Phenylpyridinium; Cyperquat [ANSI:ISO]; SCHEMBL37321; CHEMBL311617; GTPL4568; DTXSID4058106; BDBM81945; ZINC967769; CAS_39484; NSC_39484; Pyridinium, 1-methyl-4-phenyl- (9CI); LS-132763; C11310; 5-20-07-00550 (Beilstein Handbook Reference); Q161645",
            "trade_name": "Cyperquat; 1-Methyl-4-phenylpyridinium; N-Methyl-4-phenylpyridine",
            "abbrev_name": "MPP+",
            "description": "positively charged organic molecule; neurotoxin ; Complex I inhibitor",
            "molecular_formula": "C12H12N+",
            "molecular_weight": "170.23",
            "state": "",
            "clearance": "",
            "volume_of_distribution": "",
            "route_of_elimination": "",
            "protein_binding": "",
            "half_life": "",
            "absorption": "",
            "cid": "39484",
            "classification": "Others",
            "indications": "",
            "side_effects": "",
            "atc_codes": "",
            "group": "Compound",
            "drug_type": "",
            "target": [
                "T001"
            ],
            "function": [
                "F020103"
            ],
            "references": [
                "RC01388",
                "RC01389"
            ]
        }
    ]
}